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Abstract  
 
The heterocyclic carbazoles are privileged scaffolds present in many 
biologically active naturally occurring and synthetic compounds. Herein, we 
disclose our investigations into new approaches towards the 
diastereoselective synthesis of highly functionalised tetrahydropyrrolo[3,4-a] 
carbazole derivatives, and the subsequent evaluation of their biological 
activities.  Our synthetic methodology is based on an initial intermolecular 
Diels-Alder (D-A) reaction between a substituted 3-vinyl-1H-indole 1, containing 
an electron withdrawing N-protecting group, and a range of dienophiles. This 
key step allows access to a variety of the D-A cycloadducts 2 in good yields 
(64-85%) and as single diastereomers, arising from an endo selective D-A 
cycloaddition (Scheme 1).  
 
 
Scheme 1. D-A reaction of N-protected, substituted 3-vinyl-1H-indole 1 
 
The new alkene bond generated in the D-A reaction is highly reactive towards 
electrophiles and has a propensity towards migration, to rearomatise the 
indole ring. Thus we decided to exploit this reactivity to generate our target 
pyrrolo[3,4-a]carbazoles using a number of different approaches (Scheme 2).  
Route 1: D-A cycloadducts 2 was further functionalised using an 
intermolecular ene reaction to afford the tetrahydropyrrolo[3,4-a]carbazoles 3. 
Route 2: Alternatively intramolecular carbonyl-ene reactions of D-A 
cycloadducts 2 were investigated as a route to polycyclic 
tetrahydropyrrolo[3,4-a]carbazoles 4.  
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Route 3: Finally bromination of the reactive alkene followed by in situ trapping 
with a nucleophilic amines gave access to amine functionalised 
tetrahydropyrrolo[3,4-a]carbazoles 5. These could in turn be deprotected via 
a PtO2 catalysed hydrogenation to give a focussed library of biologically active 
molecules 6. 
 
Scheme 2. Synthetic approaches towards functionalised pyrrolo[3,4-a]carbazole
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 Chapter 1.  
Introduction 
The aim of this project is to discover and investigate efficient synthetic 
methodologies towards a diverse range of functionalised carbazole alkaloids. 
Therefore we will review the carbazole structure, related bioactive compounds 
and previously reported synthetic approaches towards carbazole alkaloids.  
 
1.1. Introduction to the carbazole alkaloids 
1.1.1. The discovery of the carbazole alkaloids 
A carbazole is an aromatic heterocyclic organic compound with a tricyclic 
strcuture,  consisting of two six-membered benzene rings fused on either side 
with a five membered nitrogen-containing pyrrole ring.1 Graebe and Glazer 
were the first to describe 9H-carbazole 1 (Figure 1.1), which was extracted 
from coal tar in 1872.2 
 
Figure 1.1. Structure of 9H-carbazole  
 
The first carbazole alkaloid isolated from a plant source was murrayanine 2 
(Figure 1.2).3 In 1965, Chakraborty and co-workers reported the isolation and 
antibiotic properties of murrayanine, from the stem bark of Murraya Koenigii 
Spreng (Family-Rutaceae).3,4 Since then, a large number of biologically active 
carbazole alkaloids have been isolated from natural sources over the last four 
decades.5 
 
Figure 1.2. Structure of murrayanine 
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1.1.2. Classification of the carbazole alkaloids  
Carbazole alkaloids are typically divided into two major classes depending 
upon their natural sources. The first class, which constitute a major class of 
carbazole alkaloids, originates from taxonomically related higher plants of the 
genus Murraya, Clausena and Glycosmis, all belonging to the family of 
Rutaceae. The second class of carbazole alkaloids are those that are isolated 
from microbial species, including bacteria (e.g. Streptomyces), blue-green 
algae (e.g. Hyella caespitosa), fungi (e.g. Aspergillus) and marine organisms 
(e.g. Iotrochota and Didemnum granulatum).6,7  
 
Due to the diverse and interesting biological properties of the carbazole 
alkaloids, synthetic chemists have developed many synthetic strategies 
towards these structures. A number of bioactive carbazole derivatives have 
been synthesised, based on N-substituted carbazoles, thiazolo[5,4-
b]carbazoles, tetrahydro-1H-carbazoles, thieno[3,2-b]carbazoles, 
indolopyrrolo[3,4-c]carbazoles and imidazo[4,5-c]carbazoles (Figure 1.3).1,8 
 
  
 
N-substituted carbazoles thiazolo[5,4-b]carbazoles tetrahydro-1H-carbazoles 
 
 
 
 
 
thieno[3,2-b]carbazoles indolopyrrolo[3,4-c]carbazoles imidazo[4,5-c]carbazoles 
Figure 1.3. Selected Structures of various carbazole classes 
 
1.1.3. The medicinal importance of the carbazole alkaloids 
The tricyclic carbazole skeleton is an essential structural scaffold found in 
many natural alkaloids and biologically active synthetic compounds. Among 
the carbazole derivatives, heterocycle-fused carbazoles are of considerable 
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interest due to their anticancer properties. For example, indole-fused 
carbazole rebeccamycin is a topoisomerase I inhibitor,9 whilst staurosporine, 
isolated from Streptomyces, was identified as a protein kinase C (PKC) 
inhibitor.10 Granulatimide and isogranulatimide, compounds isolated from the 
ascidian Didemnum granulatum that possess the pyrrolocarbazole framework, 
11,12 as well as synthetic indolocarbazole compounds such as SB-218078, 
were also found to be efficient checkpoint 1 kinase (ChK1) inhibitors.7, The 
structures of selected bioactive carbazole alkaloids with potential anticancer 
properties are given in Figure 1.4. 
 
 
Figure 1.4. Selected structures of anticancer carbazole alkaloids 
 
1.2. Selected synthetic approaches to the carbazole alkaloids         
1.2.1. Classical routes to the carbazoles  
Various strategies for the synthesis of the carbazoles have been developed. 
The earliest synthesis of a carbazole was reported in 1883 by Fischer and 
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Borsche,13 who described the synthesis of a carbazole 1 through a Fischer-
indole synthesis. This method involves the condensation of cyclohexanone 3 
and phenylhydrazine 4 under acidic conditions, followed by cyclisation of the 
formed phenylhydrazone 5 to generate tetrahydrocarbazole 6. Finally, 
dehydrogenation of tetrahydrocarbazole 6 using chloranil or palladium on 
activated carbon generates the fully aromatised carbazole 1 (Scheme 1.1).14,15 
 
 
Scheme 1.1. Fischer-Borsche carbazole synthesis 
 
Subsequently in 1896, Graebe and Ullmann reported the formation of 
carbazole 1 by the reaction of aminodiphenylamine 7 with nitrous acid, 
followed by thermolysis of the resulting benzotriazole 8 (Scheme 1.2).13 
 
 
Scheme 1.2. Graebe-Ullmann carbazole synthesis 
  
An alternative route to the carbazole framework 10 was developed by 
Cadogan, which involves deoxygenative cyclisation of o-nitrobiphenyls 9 in the 
presence of triethyl phosphite (Scheme 1.3).16  
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Scheme 1.3. Cadogan carbazole synthesis 
 
 
1.2.2. Transition metal–mediated routes to the carbazoles 
Beyond the traditional methods discussed previously, the use of transition 
metals including Cu,17 Pt,18 Au,19 Rh,20 Fe21 and Pd22 in the synthesis of 
carbazoles has been well documented. The most versatile approaches for the 
construction of highly functionalised carbazole frameworks, are based on the 
use of iron and palladium catalysed C-C bond forming events.  
 
1.2.2.1. Iron-mediated routes to carbazole alkaloids 
In 1989, Knölker and Bauer described an iron-catalysed oxidative cyclisation 
of arylamines or quinone amines for the construction of the carbazole skeleton. 
The key steps of this iron-mediated route are the sequential formation of both 
a C–C and a C–N bond.23 This method was subseqeuntly applied to the total 
synthesis of the naturally occuring alkaloids hyellazole 15 and 6-
chlorohyellazole 16 by Knölker (Scheme 1.4). 
 
Hyellazole 15 and 6-chlorohyellazole 16 represent the first carbazoles isolated 
from the blue-green algae Hyella caespitosa by Moore and co-workers in 
1979.24 The total synthesis of hyellazole 15 begins with electrophilic aromatic 
substitution of arylamine 12 by the complex salt 11, followed by rearrangement 
to give the desired complex 13. Oxidative cyclisation of 13 by ferrocenium 
hexafluorophosphate in the presence of sodium carbonate affords hyellazole 
15 in 84% yield. Hyellazole 15 can then be easily converted into 6-
chlorohyellazole 16 via an NBS bromination and  halogen exchange using 
copper (I) chloride. 24,25    
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Scheme 1.4. Synthesis of hyellazole 15 and 6-chlorohyellazole 16 
 
1.2.2.2. Palladium-catalysed synthetic routes to carbazole alkaloids 
Palladium-catalysed sequential C-N/C-C coupling was used for the synthesis 
of the naturally occurring compound, clausine L. The synthesis of clausine L 
20, which was isolated from the Chinese medicinal plant Clausena excavata,26 
is based on a Buchwald–Hartwig coupling reaction of iodobenzene 17 with 
arylamines 18 in the presence of Pd(0) to generate diarylamine 19.27,28 The 
following oxidative cyclisation of diarylamine 19, by the  double C-H bond 
activation in the presence of  of Pd (II) and manganese (III) acetate, provides 
clausine L 20 in 62% yield (Scheme 1.5).28 -  
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Scheme 1.5. Synthesis of clausine L 20 
 
A similar palladium-catalysed approach was used in the total synthesis of 
glycosinine 25, involving a Suzuki-Miyaura coupling of 2-chloroarylamine 21 
with phenyl boronic acid 22, followed by an oxidative cyclisation of the formed 
N-acetylated 2-aminobiphenyl 23. The final conversion of the ester moitey of 
24 to an aldehyde by a reduction/oxidation approach gave glycosinine 25 in 
74% yield (Scheme 1.6).29  
 
 
Scheme 1.6. Synthesis of glycosinine 25 
 
Recently, Ackermann et al. described the domino N–H/C–H bond activation 
reaction of anilines with 1,2-dihaloarenes.30,31 An analogous approach was 
applied to the total synthesis of murrayazoline 29, which was isolated from the 
genus Murraya.32, The key steps in the synthesis of murrayazoline involved 
Chapter 1 Introduction  
 
Page 8 
 
the preparation of N-substituted carbazole component 28, using the palladium 
catalysed Buchwald-Hartwig coupling reaction of the primary amine 27 with 
dibromobiphenyl 26 (Scheme 1.7).33  
 
 
Scheme 1.7. Synthesis of murrayazoline 29 
 
1.3. The Diels-Alder reaction 
In addition to the synthetic approaches described above, the use of  Diels-
Alder (D-A) reactions in the synthesis of carbazole derivatives have been well 
documented.34,35,36 The D-A reaction  has been extensively studied since its 
discovery in 1928 by Otto Diels and Kurt Alder.37 The cycloaddition reaction 
leads to the formation of two new C-C or C-X bonds and four new 
stereocentres simultaneously, with high levels of regio- and stereo selectivity, 
in a single step through a concerted mechanism (Scheme 1.8).  
 
 
Scheme 1.8. General Diels-Alder (D-A) reaction 
 
1.3.1. Diels-Alder reactions in the synthesis of bioactive 
carbazoles 
Due to the selectivity of the D-A reaction, it has been widely used by organic 
chemists for the synthesis of complex biologically active molecules, including 
those based on a carbazole scaffold, from simple starting materials. In this 
context, Pindur et al., have studied the D-A cycloaddition reaction of 
Chapter 1 Introduction  
 
Page 9 
 
substituted 3-vinyl-1H-indole 30, as a key step in the preparation of the 
antibiotic 4-deoxycarbazomycin B 33 (Scheme 1.9).  
 
Pindur and co-workers’ strategy involves a D-A reaction between substituted 
3-vinyl-1H-indole 30 and dimethyl acetylenedicarboxylate DMAD 31, followed 
by dehydrogenation with chloranil to give the trisubstituted carbazole 32. 
Reduction of the ester groups to methyl groups and removal of the protecting 
group provides 4-deoxycarbazomycin B 33 in 15% overall yield (Scheme 
1.9).38 
 
 
Scheme 1.9. Synthesis of 4-deoxycarbazomycin B 33 by D-A reaction 
 
The intermolecular D-A reaction of 2- and 3-vinyl-1H-indoles is also a powerful 
synthetic strategy towards the construction of heterocycle-fused carbazole 
frameworks. In 1959, Noland and co-workers examined the D-A reactions of 
substituted 3-vinylindoles, as a route to the carbazole scaffold.39 Subsequent 
work by the same author in 1963 also described the synthesis of carbazole 36 
by an intermolecular D-A reaction of 3-vinyl-1H-indole 34 with 1,4-
naphthoquinone, to give tetrahydrocarbazole intermediate 35. The 
subsequent  dehydrogenation of  tetrahydrocarbazoles 35 provided the more 
stable, fully aromatised carbazole 36 in 91% yield (Scheme 1.10).40  
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Scheme 1.10. D-A reaction to the synthesis of carbazole 36  
 
Lambert and Porter subsequently developed a method to synthesise a range 
of  stable tetrahydrocarbazoles (38 - 41) in good yields, from the D-A reaction 
of 1-benzyl-3-vinyl-1H-indole 37 with a range of dienophiles including 1,4 
naphthoquinone, maleic anhydride, N-phenylmaleimide (NPM), and 1,4 
benzoquinone (Scheme 1.11).41  
 
 
Scheme 1.11. D-A reaction towards tetrahydrocarbazoles (38 - 41) 
 
In 1992, Pindur and Otto also developed a new synthetic strategy towards 
tetrahydrocarbazole 43, which was shown to have antitumor activity, 42 using 
a D-A reaction between 2-vinyl-1H-indole 42 and NPM (Scheme 1.12).43 
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Scheme 1.12. D-A reaction towards bioactive tetrahydrocarbazole 43 
 
Carbazoles 47 which are structurally related to granulatimide and 
isogranulatimide have  recently been synthesised by Prudhomme et al., 
through the D-A reaction of 3-indolylmaleimide 44 with maleimide.44 The 
formed tetrahydrocarbazole intermediates 45 and 46 can be aromatised to 
afford  granulatimide and isogranulatimide analogues 47, by oxidation using 
DDQ (Scheme 1.13).12,45,46  These compounds proved to be potent ChK1 
inhibitors.47  
 
Scheme 1.13. D-A reaction to granulatimide and isogranulatimide analogues 47 
 
In contrast, Tao et al., have shown a new approach for the synthesis of 
compounds with a pyrrolocarbazole framework, from the D-A reaction of 2-
substituted-vinylindole 48 with maleimide, followed by DDQ oxidation 
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(Scheme 1.14). The resulting  pyrrolocarbazole 50 was identified as a potential 
poly (ADP-ribose) polymerase-1 (PARP-1) inhibitor with IC50 value of 36 µM.48  
 
 
Scheme 1.14. D-A reaction in the synthesis of (PARP-1) inhibitor 50 
 
1.4. Asymmetric Diels-Alder reactions to enantiopure carbazoles 
Recently, a number of organo-catalysed D-A reactions of 3-vinylindoles has 
been explored as an approach to the synthesis of enantioenriched 
tetrahydrocarbazoles. The organo-catalysed D–A reaction is dominated by 
activation of the LUMO of electron-poor dienophiles with chiral organic 
molecules. For example, Enders et al., used a proline 52 derived 
organocatalyst in a triple cascade reaction, to target tetracyclic 
pyridocarbazole derivatives 55 in a high enantiomeric excess.49  
 
The first step of this triple cascade reaction involves the preparation of 
tetrahydrocarbazole intermediate 53, through a D-A cycloaddition between 3-
vinyl-1H-indole 34 with cinnamaldehyde 51 under iminium activation. In the 
next step, the indolic nitrogen of 53 reacts with another molecule of 
cinnamaldehyde 51 in an aza-Michael addition to give the intermediate 54. 
The intramolecular aldol condensation of 54, under enamine activation, gives 
the fused tetracyclic pyridocarbazole 55 (Scheme 1.15). 
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Scheme 1.15. Proline-catalysed asymmetric D-A reaction  
 
Ricci et al., have also reported an interesting organo-catalysed approach to 
the synthesis of optically active tetrahydrocarbazole derivative 57, through the 
asymmetric Diels–Alder reaction of 3-vinyl-1H-indole 34 with a suitable 
dienophile, such as N-Methylmaleimide (NMM) using a hydrogen-bonding 
thiourea catalyst 60.50 Subsequently, Hall and co-workers have exploited this 
approach to access enantiomerically pure, highly functionalised 
tetrahydrocarbazole derivatives 59, through a D-A/ene reaction sequence of 
3-vinyl-1H-indole 34 (Scheme 1.16).51  
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Scheme 1.16. Thiourea-catalysed asymmetric D-A reaction of 3-vinyl-1H-indole 34 
 
1.5. Ene reaction  
The ene reaction, which was discovered in 1943 by Alder, is a pericyclic 
process involving the reaction between an olefin containing an allylic hydrogen 
(ene component) and an electron deficient multiple bond (enophile), to form a 
new acyclic product with transposition of the π-bond and simultaneous 1,5 
hydrogen shift (Scheme 1.17).52 Several variations of the electron-deficient 
enophile components have been used in ene reactions, including singlet 
oxygen (1O2),53 nitroso compounds,54 aza compounds 55 and carbonyl 
enophiles.56  
 
 
Scheme 1.17. General scheme of the ene-reaction 
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1.5.1. Regioselectivity of the ene reaction   
The regioselectivity of ene reactions of di-, tri- and tetra-substituted alkenes 
with enophiles is of special interest due to the availability of several allylic 
hydrogen atoms that could be abstracted.  
 
According to Krebs and co-workers,54 the regioselectivity of the ene reactions 
could be rationalised in terms of conformational accessibility to the allylic 
hydrogen atoms and the minimisation of the steric repulsion during the 
reaction. For example, singlet oxygen (1O2) has a preference to abstract the 
allylic hydrogen from the lone and twix positions of the more substituted side 
of the double bond, due to the coordination with the allylic hydrogen atoms (cis 
effect). Triazolinedione (TAD) prefer to abstract the twin or twix allylic 
hydrogen from the more crowded end of the double bond, due to formation of 
the more stable intermediate (gem effect). On the other hand, nitroso 
compounds (ArNO) abstract the allylic hydrogen form only the twix position of 
the alkene (skew effect), (Scheme 1.18).54, 57 
 
 
Scheme 1.18. Regioselectivity in the ene reaction of 1O2, TAD and ArNO 
 
The high twix regioselectivity in the ene reaction of the aryl-nitroso enophile 
(ArNO) can be rationalised in terms of the steric interactions between the 
substituents of the ene component with the aryl group of the nitroso enophile, 
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as well as to the conformational accessibility of the allylic hydrogen in the two 
possible transition states: TStwix and TStwin. 
 
In TStwix, the aryl group of the enophile points to the less substituted side of 
the alkene, with no conformational constraint on the hydrogen abstraction.  
Whereas when the ArNO approaches from the opposite direction in the TStwin, 
the aryl group of the enophile is located at more sterically hindered side of the 
alkene, between the lone and twix substituents of the ene component. 
Therefore, hydrogen abstraction from the twix position of the alkene has a 
tendency to predominate (Scheme 1.19).54, 58 
 
 
Scheme 1.19. The twix regioselectivity in the ene reaction of the nitroso enophile  
 
1.6. One-pot multicomponent reactions in the synthesis of carbazoles  
A multicomponent reaction is a process in which three or more starting 
materials react in one reaction vessel to generate the target molecule.  The 
synthesis time, costs of solvent use and waste production are minimalised,  as 
intermediates are not isolated.59,60 Although the one-pot multicomponent 
reactions are fashionable these days, they have been investigated for over 
150 years including the Strecker amino acid synthesis,61 the Hantzsch 
dihydropyridine synthesis,62 the Mannich reaction 63 and the Ugi four-
component synthesis.64  
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1.6.1. One-pot Diels-Alder/ene reactions in the synthesis of 
carbazoles 
The utilisation of a one-pot D-A/ene reaction in the synthesis of functionalised 
carbazoles was first reported by Gonzalez and co-workers.65 In 1996, 
Gonzalez et al., observed the formation of both D-A cycloadduct 62, along with 
functionalised carbazole 63 in their study of D-A reaction between substituted-
3-vinyl-1H-indole 61 and benzyne (Scheme 1.20). They suggested that 
functionalised carbazole 63 was formed in situ through an ene reaction of D-
A cycloadduct 62 with a second molecule of benzyne.  
 
 
Scheme 1.20. One pot D-A/ene reaction of substituted-3-vinyl-1H-indole 61 
 
An analogous result has also been reported in the case of D-A/ene reaction 
sequence of 2-vinyl-indole 64 with NPM when the reaction was performed in 
methanol at 50 oC (Scheme 1.21). 66 
 
Scheme 1.21. Sequential D-A/ene reaction of 2-vinylindole 64 
 
1.6.2. Multicomponent reactions in the synthesise of carbazoles 
The multicomponent reactions of indoles have been extensively studied to 
generate large libraries of biologically active carbazoles.67 Sapi and co-
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workers reported a four component reaction to synthesise a 1,3-diaryl 
substituted tetrahydrocarbazole 72, by the condensation  of 2-substituted 
indole 67, two equivalents of an aromatic aldehyde 68 and Meldrum’s acid 69 
(Scheme 1.22).68 The product is proposed to arise from the condensation of 
aldehyde 68 with indole 67 to generate a 2-vinyl indole intermediate 71, whilst 
condensation of Meldrum’s acid 69 and a further equivalent of 68 gave 
intermediate 70. Finally, D-A cycloaddition between 2-vinylindole intermediate 
71 and adduct 70 afforded the desired tetrahydrocarbazole 72.69  
 
 
Scheme 1.22. Multicomponent reactions towards carbazole 72 
  
Royer et al., utilised D-A cycloaddition of substituted 2-indole 73, aromatic 
aldehyde 74 and maleimide compounds 75 in the presence of Lewis acid 
catalyst (CuSO4), to target molecules such as 76 which are  structurally related 
to podophyllotoxin 77, a naturally occurring tubulin polymerization inhibitor 
(Scheme 1.23).70   
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Scheme 1.23. Synthesis of podophyllotoxin analogues 76 
 
Similarly, Ty et al., have reported a three component reaction of indole 78, 
3,4,5-trimethoxyacetophenone 79 and maleimides 75 to yield 
tetrahydrocarbazoles 80, which could be oxidised by DDQ to give the 
corresponding carbazoles 81 (Scheme 1.24).71 The biological activity of both 
tetrahydrocarbazoles 80 and carbazoles 81 have been investigated against 
murine B16 melanoma cells, and the inhibition of tubulin polymerization.67,71 
 
 
Scheme 1.24. Multicomponent reactions to bioactive carbazoles 80 and 81 
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1.7. Conclusion  
Although a number of well-developed synthetic strategies are available for the 
synthesis of bioactive functionalised carbazoles, the majority result in the 
synthesis of unsaturated systems. We thus wished to examine new synthetic 
approaches to partially saturated and polycyclic carbazole scaffolds, as new 
routes to biologically active molecules. 
 
 
1.8. Project plan 
In this project we aim to explore diastereoselective approaches to synthesise 
novel carbazole analogues and the application of this methodology towards 
the synthesis of potentially biologically active compounds.  
 
Following previous work within our research group, we decided to focus our 
attention on the D-A chemistry of substituted-3-vinyl-1H-indoles 82, containing 
an electron withdrawing N-protecting group, to target the synthesis of D-A 
cycloadducts 83 (Scheme 1.25), which contain an electron rich cyclohexenyl 
ring suitable for further functionalisation.  
 
 
Scheme 1.25. D-A reaction plan of N-protected, substituted-3-vinyl-1H-indoles 82 
 
We then aim to study the behaviour of the cyclohexenyl double bond of these 
cycloadducts 83 towards inter- and intramolecular ene reactions as well as 
towards the reaction with added electrophiles. This will allow access to novel, 
highly functionalised, partially saturated and polycyclic carbazole derivatives 
84, 85, and 86 (Scheme 1.26). 
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Scheme 1.26.  General plan to examine the chemistry of D-A cycloadducts 83  
 
Due to the structural relations between our target carbazole derivatives (84 – 
86) and the known biologically active compounds discussed in the introductory 
part of this thesis, we plan to remove the electron withdrawing N-protecting 
group to evaluate the biological activity of the synthesised carbazole 
derivatives 87 (Scheme 1.27).  
 
 
Scheme 1.27. General plan to pyrrolo[3,4-a]carbazole-1,3 dione derivatives 87 for 
biological assay
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 Chapter 2. 
Diels-Alder/Ene Chemistry of Substituted 3-Vinyl-1H-Indole 
In this chapter, we will discuss our work towards the synthesis of functionalised 
molecules containing a tetrahydropyrrolopyrrolo[3,4-a]carbazole-1,3-dione 
framework, through the use of stepwise D-A/ene chemistry of ethyl(Z)-5-(1-
tosyl-1H-indol-3-yl) pent-4-enoate 90.  
 
The initial aim of this research was therefore to find a suitable method for the 
synthesis of the key intermediate ethyl (Z)-5-(1-tosyl-1H-indol-3-yl) pent-4-
enoate 90 in order to use it in our planned D-A/ene chemistry. We envisioned 
that indole 90 could be synthesised by a sequential tosyl protection, Wittig 
reaction starting from the commercially available indole-3-carbaldehyde 88. 
Once indole 90 is obtained, the next stage of our synthetic plan is to investigate 
the intermolecular D-A reaction  of indole (Z)-90 as a diene with a range of 
dienophiles under different reaction conditions. We then aim to functionalise 
the resultant D-A cycloadducts 91 through an intermolecular ene reaction with 
various reactive enophiles X=Y, to generate our desired pyrrolo[3,4-
a]carbazole-1,3-diones 92 (Scheme 2.1).  
 
 
Scheme 2.1. Planned synthetic approach  towards functionalised carbazoles 92 
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2.1. Diels-Alder reaction of ethyl (Z)-5-(1-tosyl-1H-indol-3-yl)pent-4-
enoate (90) 
2.1.1.  Synthesis of indole (Z)-90  
Before our proposed D-A/ene reactions could be investigated, ethyl (Z)-5-(1-
tosyl-1H-indol-3-yl) pent-4-enoate 90 had to be synthesised. Our synthetic 
efforts towards compound 90 commenced with the protection of indole-3- 
carbaldehyde 88 with an electron withdrawing protecting group. Earlier 
research showed that when 3-vinyl-1H-indoles, incorporating free indolic 
nitrogen or an electron donating group, were subjected to D-A reactions, the 
resulting D-A cycloadducts underwent rapid rearomatisation under the 
reaction conditions.39,41,40  We therefore anticipated that the addition of a 
moderately electron withdrawing protecting group would be required, to 
stabilise the desired D-A cycloadducts sufficiently to allow further chemistry to 
be carried out.   
 
 Following a literature procedure, the indolic nitrogen of indole-3-carbaldehyde 
88 was protected with p-toluenesulfonyl chloride (TsCl) in the presence of 
triethylamine (Et3N) in DCM.72 The expected 1-tosyl-1H-indole-3-
carbaldehyde 89 was obtained in a very good yield of 79% after 
recrystallisation from ethyl acetate (Scheme 2.2). 
 
 
Scheme 2.2. Tosyl protection of indole-3-carbaldehyde 88 
 
The next step involved a Wittig reaction to synthesise indole 90. Wittig salt 94 
was synthesised according to a literature procedure by an SN2 reaction of 
triphenylphosphine with ethyl 4-bromobutanoate 93 (Scheme 2.3).73 The 
formed phosphonium salt 94 was isolated in 79% yield by direct filtration from 
the reaction. 1H NMR showed that the product was clean enough to be used 
with no further purification being necessary. 
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Scheme 2.3. Synthesis of Wittig salt 94 
 
Ylide 95 was then generated in situ by deprotonation of Wittig salt 94 with 
sodium bis(trimethylsilyl)amide (NaHMDS). The Wittig reaction was performed 
between the reactive phosphonium ylide 95 and the previously synthesised 1-
tosyl-1H-indole-3- carbaldehyde 89 at r.t. for 48 hours (Scheme 2.4), adapted 
from the reported procedure by Daniels and co-workers.74 The 1H NMR 
spectrum of the crude material showed two sets of signal corresponding to a 
mixture of Z- and E- alkenes of indole 90. Purification of the crude reaction 
mixture by column chromatography afforded the desired indole 90 as a mixture 
of Z- and E- isomers in a 10:1 ratio respectively as determined by 1H NMR 
spectrum, in 71% yield.  
 
 
Scheme 2.4: Wittig reaction of indole 89  
 
With indole (Z:E, 10:1)-90 in hand, the next stage was to investigate the D-A 
cycloaddition of indole (Z:E, 10:1)-90 as a diene with NMM as a dienophile 
under thermal conditions. The results are summarised in Table 2.1.  
 
Our initial investigations were carried out by dissolving indole (Z:E, 10:1)-90 
and NMM in DCM. After 24 hours at 40 oC, 1H NMR of the crude reaction 
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mixture indicated the presence of a single diastereomer, corresponding to D-
A cycloadduct 96, along with unreacted starting material. Purification by 
column chromatography gave the corresponding D-A cycloadduct 96 in 5% 
yield (entry 1). Increasing the reaction time from 24 hours to 48 hours slightly 
improved the yield of D-A cycloadduct 96 to 7% (entry 2). In order to optimise 
the yield of D-A cycloadduct 96 further, we decided to repeat the D-A reaction 
between indole (Z:E, 10:1)-90 and NMM at higher temperature. Therefore, 
indole (Z:E, 10:1)-90 and NMM were dissolved in toluene and the solution was 
refluxed for 48 hours. Under these reaction conditions, D-A cycloadduct 96 
was obtained in 9% isolated yield. However, the reaction was accompanied by 
the unwanted rearomatisation product 97 in 3% yield (entry 3).  
 
 
 
Entry Reaction condition 
Isolated yield % 
96 97 
1 DCM, 24 h, 40 oC 5 - 
2 DCM, 48 h, 40 oC 7 - 
3 Toluene, 48 h, 110 oC 9 3 
Table 2.1. Results of thermal D-A cycloaddition of indole (Z:E, 10:1)-90 with NMM 
 
2.1.2. Relative stereochemistry assignment of Diels-Alder 
cycloadduct (96) 
In a D-A reaction, two diastereomers can be formed from a diene/dienophile 
pair depending on the arrangement of the dienophile and the diene in the 
transition state.75 Thus, the reaction of the (Z)-90 with NMM can proceed via 
an endo or exo transition state to give either the endo D-A cycloadduct 98 or 
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the exo D-A cycloadduct 99 respectively, whilst the D-A reaction of the (E)-90 
and NMM can also give an endo or exo cycloadduct 96 and 100 (Figure 2.1). 
 
Figure 2.1. The four possible diastereomers of the D-A product  
 
However in our D-A reaction of compound (Z:E, 10:1)-90 with NMM, only one 
diastereomer was observed by the 1H NMR of the crude reaction mixture.  To 
verify the relative stereochemistry of D-A cycloadduct 96, crystals were grown 
by slow evaporation of a solution of D-A cycloadduct 96 in ethyl acetate/petrol. 
X-Ray analysis indicated that the product 96 was formed from the (E)-90 
through an endo-selective D-A reaction with NMM (Figure 2.2). The endo 
approach of the dienophile in the transition state is usually favoured by kinetic 
control due to secondary orbital interactions.75 The formation of endo D-A 
cycloadduct 96 was further supported by coupling constant analysis. The 3J 
value of between H23 and H22 is 7.6 Hz, which indicates to their cis relationship 
with a dihedral angle of about 60o as detected by the X-ray crystal structure. 
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Figure 2.2. X-ray crystal structure of D-A cycloadduct 96 
 
Based on this result we can conclude that the (Z)-90 isomer was unreactive 
under the tested thermal D-A reaction conditions and the only observable 
product arising from the (E)-90 isomer. We therefore postulated that the rate 
of the D-A reaction of the (E)-90 with NMM is faster than the reaction rate of 
the corresponding (Z)-90. To support our hypothesis, we decided to re-
examine the D-A reaction of the pure Z-isomer of indole 90. For this reason, 
the Wittig reaction of 1-tosyl-1H-indole-3- carbaldehyde 89 with phosphonium 
ylide 95 was repeated and the desired Z-isomer of indole 90 was successfully 
separated from the reaction mixture by careful column chromatography in 60% 
isolated yield (Scheme 2.5) 
 
 
Scheme 2.5. Wittig reaction to synthesise a pure (Z)-90 
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With the (Z)-90 in hand, the D-A reaction of the (Z)-90 with NMM could be 
investigated. However, first we decided to check the stability of Z-isomer to 
ensure that any subsequent D-A products had not been formed by a thermal 
isomerisation of the (Z)-90 isomer to give the more stable (E)-90 isomer under 
the reaction conditions. Thus, a mixture of (Z:E, 10:1)-90 in DCM was refluxed 
for 48 hours.  No change in the isomeric ratios of this mixture was observed 
by 1H NMR, which suggested that the Z-isomer of indole 90 was stable under 
the tested reaction conditions.  
 
The next step was to use the pure (Z)-90 as a diene in a D-A cycloaddition 
with NMM. This reaction was examined by heating a mixture of the (Z)-90 and 
NMM in DCM, iso-propanol or toluene for 5 days, with monitoring by TLC. 
However, in each case the starting material remained unchanged. This result 
clearly showed that the (Z)-90 was unreactive under the thermal D-A reaction 
conditions. Thus, we could conclude that the previously obtained D-A 
cycloadduct 96 arose from the E-isomer of indole 90.  
 
2.2. Improved conditions for the Diels-Alder reaction of the (Z)-90 with 
NMM  
Our earlier study of the D-A reaction of the (Z)-90 with NMM showed that the 
(Z)-90 was unreactive under the tested thermal reaction conditions. Thus, 
there was a need to develop a new method to accelerate the rate of our desired 
D-A reaction of the (Z)-90 with NMM, in order to examine our planned D-A/ene 
reaction sequence. One approach for accelerating our desired D-A reactions 
would be to examine the use of thiourea-based catalysts. Thiourea catalysts 
accelerate the rate of D-A reactions through hydrogen bonding to the carbonyl 
oxygen of the dienophile, lowering their LUMO.76,77  
 
2.2.1. Diels-Alder reaction of the (Z)-90 with thiourea catalyst (101) 
Tan et al., have shown the efficiency of a thiourea catalyst in promoting the D-
A  reaction of 1-benzyl-2-vinyl-1H-indole with 3-nitrocoumarin.78 We therefore 
decided to investigate the effect of thiourea catalysis on our planned D-A, by 
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dissolving the (Z)-90 and NMM in DCM in the presence of 20 mol% of 
bis(trifluoromethyl)phenyl)thiourea 101 (Scheme 2.6). 
 
 
Scheme 2.6. D-A reaction of the (Z)-90 catalysed by thiourea 101  
 
The investigation of D-A reaction between the Z-isomer of indole 90 and NMM 
in the presence of thiourea catalyst 101 was initially tested at r.t. for 24 hours. 
However, analysis of the1H NMR of the crude reaction mixture revealed 
unreacted starting material. Re-examination of the reaction at longer reaction 
times and higher temperatures failed to give the corresponding D-A 
cycloadduct 98. From these results, we concluded that the introduction of 
thiourea catalyst 101 showed no improvement in the rate of our proposed D-
A reaction of the (Z)-90 with NMM.  Therefore, we turned our attention to 
examine the influence of Lewis acids on the desired D-A reaction of the pure 
(Z)-90 with NMM. 
 
2.2.2. Diels-Alder reaction of the (Z)-90 with NMM catalysed by Lewis 
acids  
Lewis acid catalysts are well known in the literature for their ability to promote 
the D-A cycloaddition reactions by lowering the LUMO energy of the 
dienophiles, through the coordination to the carbonyl oxygen thus reducing the 
electron density of the double bond.79,80 We therefore decided to investigate 
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the D-A reaction of the (Z)-90 and NMM with various Lewis acids. The results 
are summarised in Table 2.2. 
We first examined D-A reaction of the (Z)-90 with NMM in the presence of 1.0 
equivalent of aluminium chloride (AlCl3) for 6 hours at both -78 oC and r.t. (entry 
1-2). In both cases only starting material was observed by1H NMR of the crude 
reaction mixture. Increasing the reaction time to 48 hours at r.t. slightly 
improved the D-A reaction outcome (entry 3), and D-A cycloadduct 98 being 
isolated in 10% yield along with recovered starting material.  
 
When the Lewis acid catalyst was changed to titanium tetrachloride (TiCl4, 1.0 
eq.), the D-A reaction of the (Z)-90 with NMM was carried out at -78 oC for 10 
min. Under these conditions, an efficient D-A reaction was achieved with no 
starting material observed; however the desired D-A product 98 was 
accompanied by the unwanted rearomatisation product 102 (entry 4). All 
attempts to isolate the desired D-A cycloadduct 98 by column chromatography 
failed due to the close similarity in the Rf values to that of the by-product 102.  
 
The use of dimethylaluminum chloride (Me2AlCl) in promoting the D-A reaction 
between the (Z)-90 with NMM was also examined. The addition of 1.0 
equivalent of Me2AlCl in DCM for 6 hours at both  -78 oC and 0 oC provided 
only starting material (entry 5-6). Re-examining the reaction at higher 
temperatures, both r.t. and reflux with 1.0 or 2.0 equivalents of Me2AlCl, gave 
low yields of the desired D-A cycloadduct 98 along with unreacted starting 
material (entry 7-9). Further optimisation resulted in the addition of 2.0 
equivalents of Me2AlCl at -78 oC to a solution of NMM in DCM, followed by the 
addition of a solution of the (Z)-90 in DCM. Warming the reaction mixture to 
reflux for 48 hours led to a smooth diastereoselective D-A reaction, affording 
the corresponding D-A cycloadduct 98 in an excellent yield of 85% after 
purification by column chromatography (entry 10). 
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Entry Reaction conditions Ratio of products [a] Yield [b] 
% 90 98 102 
1 1 eq. AlCl3, -78 oC, 6 h 100 0 0 - 
2 1 eq. AlCl3, r.t., 6 h 100 0 0 - 
3 1 eq. AlCl3, r.t., 48 h 81 19 0 10 
4 1 eq.TiCl4, -78 oC, 10 min 0 39 61 Product inseparable 
5 1 eq. Me2AlCl, -78 oC, 6 h 100 0 0 - 
6 1 eq. Me2AlCl, 0 oC, 6 h 100 0 0 - 
7 1 eq. Me2AlCl, r.t., 48 h 76 24 0 15 
8 1 eq. Me2AlCl, 40 oC, 24 h 60 40 0 38 
9 2 eq. Me2AlCl, 40 oC, 24 h 39 61 0 52 
10 2 eq. Me2AlCl, 40 oC, 48 h 0 100 0 85 
[a] ratio of the products was determined by 1H NMR of the crude reaction mixture. [b] Isolated 
yield of D-A cycloadduct 98 
 
Table 2.2. Results of the D-A reaction of the (Z)-90 catalysed by Lewis acids 
 
With the D-A reaction conditions optimised, we then decided to examine the 
D-A reaction of the pure (Z)-90 with other dienophiles such as N- 
phenylmaleimide (NPM) and maleimide. 
 
D-A reaction of the (Z)-90 with NPM catalysed by Me2AlCl led to the isolation 
of the D-A cycloadduct 103 as a single diastereomer in 71% yield. Maleimide 
was found to be less soluble in DCM, giving a cloudy reaction mixture, but still 
afforded a single diastereomer of the corresponding D-A cycloadduct 104 in 
an acceptable yield of 64% (Scheme 2.7).  
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Scheme 2.7. Results of the D-A reactions of the (Z)-90 with NPM and maleimide 
 
2.3. Relative stereochemistry of Diels-Alder cycloadducts (98), (103) and 
(104) 
The relative stereochemistry of the D-A cycloadduct 98, was assigned based 
on the X-ray crystal structure (Figure 2.3). Crystals were grown by slow 
evaporation of a solution of D-A cycloadduct 98 in ethyl acetate/petrol. X-ray 
analysis of D-A cycloadduct 98 indicates that H10, H13 and H14 are all cis to 
each other, which confirms the formation of endo D-A cycloadduct 98 arising 
from the (Z)-90.  
 
 
 
 
Figure 2.3. X-ray crystal structure of D-A cycloadduct 98 
 
The formation of endo D-A cycloadducts 103 and 104 was also confirmed by 
X-ray analysis (Figure 2.4 and 2.5). 
  
Chapter 2 Diels-Alder/Ene Chemistry of Substituted 3-Vinyl-1H-Indole 
 
Page 33 
 
Figure 2.4. X-ray crystal structure of D-A cycloadduct 103 
 
 
 
 
Figure 2.5. X-ray crystal structure of D-A cycloadduct 104 
 
2.4. Intermolecular ene reactions of Diels-Alder cycloadducts (98), 
(103) and (104) 
With successful demonstration of the diastereoselective intermolecular D-A 
reactions of the (Z)-90 with various electron-deficient dienophiles, the next 
step towards the desired functionalised carbazoles, was to subject the D-A 
cycloadducts 89, 103, and 104 to intermolecular ene reactions with a range of 
reactive enophiles X=Y to generate pyrrolo[3,4-a]carbazole-1,3-dione 
derivatives 92 (Scheme 2.8).  
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Scheme 2.8. Proposed intermolecular ene reactions of D-A cycloadduct 98,103,  
and 104 
 
2.4.1. Nitroso ene reactions of Diels-Alder cycloadducts (98) and 
(103)  
Following previous work by Hall and co-workers on the D-A/ene reactions of 
vinyl-imidazoles,81 we started our investigation of the proposed intermolecular 
ene reactions by examining the ene chemistry of endo D-A cycloadducts 98 
and 103 with nitroso compounds. The presence of electronegative 
heteroatoms in the nitroso compounds lowering their LUMO energy and thus 
making them powerful enophiles in the ene chemistry.54 The nitroso 
compounds chosen in our investigation were 2-nitrosotoluene and 
nitrosobenzene (Table 2.3).  
 
We initially examined the nitroso-ene reaction between D-A cycloadduct 98 
and 2-nitrosotoluene. After 24 hours at r.t.,1H NMR of the crude reaction 
mixture indicated the presence of a new compound and unreacted starting 
material in a 7:3 ratio respectively. Increasing the reaction time to 48 hours did 
not improve the reaction outcome. Purification by column chromatography led 
to the isolation of desired D-A/ene adduct 105 in 59% yield, as a single 
diastereomer (Table 2.3, entry 1). Analogous result was observed in the 
reaction of D-A cycloadduct 103 with 2-nitrosotoluene. The corresponding D-
A/ene adduct 106 was isolated in 58% yield (Table 2.3, entry 2). Also the ene 
reaction of D-A cycloadduct 98 with nitrosobenzene at r.t. for 24 hours led to 
the isolation of the corresponding D-A/ene adduct 107 in 52% yield (Table 2.3, 
entry 3). 
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It is noteworthy that the 1H NMR spectra of D-A/ene adduct 107 when CDCl3 
or CD2Cl2 was used showed broad peaks. However, the broad peaks were 
resolved into sharp, well-defined peaks when the 1H NMR was performed in 
DMSO-d6. This is possibly due to aggregation of the product in chlorinated 
solvents. 
 
Entry SM Enophile 
Reaction 
conditions 
D-A/ene 
adducts 
Yield [a] 
% 
1 
 
 
r.t., 24 h, 
DCM 
 
59 
2 
 
 
r.t., 24 h, 
DCM 
 
58 
3 
 
 
r.t., 24 h, 
DCM 
 
52 
[a] Isolated yield of the desired D-A/ene adduct 
Table 2.3. Nitroso-ene reactions of D-A cycloadducts 98 and 103 
 
2.4.2. Aza ene reactions of Diels-Alder cycloadducts (98) and (104)  
With a working method for the nitroso-ene reactions (Table 2.3, entry 1-3) in 
hand, we then moved on to look at the aza-ene reactions of D-A cycloadducts 
98 and 104 with 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD). Previous 
research has shown that PTAD is a highly reactive enophile,82, 83  thus, the ene 
reaction between the D-A cycloadduct 98 and PTAD was performed at 0 oC 
for 6 hours.  The desired D-A/ene adduct 108 was isolated in 56% yield after 
purification through column chromatography. Under similar reaction 
conditions, the ene reaction of D-A cycloadduct 104 and PTAD gave the 
corresponding D-A/ene adduct as observed by TLC and 1H NMR of the crude 
reaction mixture. However, when we attempted to purify the desired D-A/ene 
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adduct 109 through column chromatography, the crude product was poorly 
soluble in DCM. We therefore attempted to purify the D-A/ene adduct 109 by 
trituration from DCM, which led to the isolation of 109 in a 57% yield (Scheme 
2.9).  
 
Scheme 2.9. Aza-ene reactions of D-A cycloadducts 98 and 104 
 
2.5. Assignment of the relative stereochemistry of Diels-Alder/ene 
adduct (109) 
The relative stereochemistry of D-A/ene adduct 109 was initially determined 
based on the crystal structure of D-A cycloadduct 104 obtained previously, 
which was consistent with an endo D-A reaction between the Z-isomer of 
indole 90 and NMM. We envisioned that the ene reaction between D-A 
cycloadduct 104 as the ene component and 2-nitrosotoluene as the enophile, 
had one possible stereochemical outcome as a consequence of the directing 
effect of the allylic hydrogen (H) in the twix position of the ene component 
(Figure 2.6).54 Thus, 2-nitrosotoluene abstracts Htwix, and the carbon-nitrogen 
bond is fully formed during hydrogen transfer, leading to the formation of D-
A/ene adduct 109 with anti stereochemistry between the PTAD and the 
succinimide group. This process is consistent with a concerted ene 
mechanism (Figure 2.6).   
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Figure 2.6. Concerted intermolecular ene mechanism 
 
We then sought to gain X-ray crystallographic information about the D-A/ene 
adduct 109 to confirm our proposed relative stereochemistry. Therefore, 
crystals of D-A/ene adduct 109 were grown by slow evaporation from DCM. 
The X-ray crystallographic analysis of D-A/ene adduct 109 proved the anti 
arrangement between the PTAD and the succinimide groups (Figure 2.7.).  
 
 
 
Figure 2.7. X-ray crystal structure of D-A/ene adduct 109 
 
The structure assignment of D-A/ene adduct 109 was further supported by a 
ROESY experiment. Analysis of the 2D ROESY spectrum of D-A/ene adduct 
109 showed a correlation between protons H12 and H11, which suggests that 
H12 and H11 are close to each other in the space. Also, correlations between 
H12 and H15 were clearly visible. The lack of a correlation between H12, H9A and 
H10, suggests a trans- disposition of H12 with respect to protons H9 and H10 
(Figure 2.7). Therefore the relative stereochemistry of D-A/ene adduct 109 is 
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consistent with our proposed structure, resulting from a concerted ene 
mechanism. The relative stereochemistry of D-A/ene adducts 105 - 108 was 
confirmed though comparisons of the 1H NMR spectral data with that of  D-
A/ene adduct 109. 
 
2.6. Conclusion 
Building on previous work within our research group, we have developed a 
diastereoselective method for the synthesis of complex tetrahydropyrrolo[3,4-
a]carbazole derivatives, with up to four new stereogenic centres with complete 
control of relative stereochemistry for each of the 4 stereocentres, through a 
stepwise D-A/ene reaction sequence of ethyl (Z)-5-(1-tosyl-1H-indol-3-yl) 
pent-4-enoate 90.  
 
The D-A reactivity of both the (E)- and (Z) isomers of indole 90 showed 
significant differences under thermal conditions. The use of Me2AlCl required 
to ensure high yields of D-A products arising from the (Z)-90 with various 
dienophiles. 
 
In addition the synthesised D-A cycloadducts 98, 103 and 104 have been 
shown to undergo high stereospecific ene reactions. The stereochemistry 
arising from a proposed concerted ene reaction directed by the twix proton of 
the ene component. 
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 Chapter 3. 
Diels-Alder/Ene Chemistry of Substituted-3-Vinyl-1H-Indole 
 
As an extension of our ongoing research, which directed toward the 
development of new diastereoselective synthetic methodologies for the 
synthesis of tetrahydropyrrolo[3,4-a]carbazole-1,3-dione derivatives, we aim 
in this chapter to report our efforts in the synthesis of pyrrolo[3,4-a]carbazoles 
incorporating a fused five- or six- membered ring, 113 and 122 respectively 
(Figure 3.1).   
 
 
Figure 3.1. Chemical structures of our target compounds 113 and 122 
 
3.1. Proposed synthetic approach for the synthesis of polycyclic 
pyrrolo[3,4-a]carbazole (113) 
We postulated that our desired polycyclic pyrrolo[3,4-a]carbazole 113 could 
be synthesised in a single step, through a one-pot intermolecular D-
A/intramolecular carbonyl-ene reaction sequence from indole 111. The 
preparation of indole 111 could be achieved through a reduction of the 
previously synthesised compound (Z)-90.  In this route, we hoped that once 
the intermediate 112 is formed from D-A reaction of indole 111 with NMM, the 
reactive terminal aldehyde of 112 can be serve as an enophile in an 
intramolecular carbonyl-ene reaction to give the desired carbazole 113 
(Scheme 3.1).  
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Scheme 3.1. Proposed one-pot D-A/ene reaction to synthesise carbazole 113 
 
3.2. One-pot D-A/ene reaction to synthesise polycyclic carbazole (113) 
3.2.1. Synthesis of (Z)-5-(1-tosyl-1H-indol-3-yl)pent-4-en-1-ol (110)  
We started our synthesis by a selective reduction of the previously synthesised 
indole (Z)-90 using DIBAL-H as a reducing agent. The reaction was performed 
at -78 oC in toluene for 3 hours, adapted from the written procedure.84 The 1H 
NMR of the crude reaction mixture indicated the disappearance of the ethyl 
group of the starting material. Purification of the crude reaction mixture by 
column chromatography afforded the corresponding (Z)-5-(1-tosyl-1H-indol-3-
yl)pent-4-en-1-ol 110 in a good yield of 87% (Scheme 3.2).   
 
 
Scheme 3.2. Synthesis of indole 110  
 
3.2.2. Oxidation of indole (Z)-110  
In the next step, primary alcohol of indole 110 was oxidised to the 
corresponding aldehyde 111 under Swern conditions.85 The oxidation reaction 
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was carried out in DCM for 3 hours. Following purification by column 
chromatography, the desire indole 111, with terminal aldehyde, was isolated 
in 70% yield (Scheme 3.3). 
 
 
Scheme 3.3. Swern oxidation of 110 to form indole 111 
 
With indole 111 in hand, we were ready to examine our proposed 
intermolecular D-A/intramolecular carbonyl-ene reaction of indole 111 in one- 
pot to synthesise polycyclic carbazole 113.  
 
The intermolecular D-A reaction was performed between indole 111 as a diene 
and NMM as a dienophile in the presence of 2.0 equivalents of Me2AlCl in 
DCM (Scheme 3.4).  After 24 hours at 40 oC, a single new spot was evident 
by TLC. However, none of the desired carbazole 113 or the expected 
intermediate 112 was observed by 1H NMR of the crude reaction mixture.  
 
 
Scheme 3.4. The outcome of the one-pot D-A/carbonyl-ene reaction of indole 111 
 
Further analysis of the resulting crude reaction mixture by 1H NMR 
spectroscopy indicated the formation of a new product. We then attempted to 
isolate the new product in a pure form through column chromatography to 
allow further analysis to elucidate its structure. A new carbazole was isolated 
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in 52% yield. Examination of 1H NMR of the purified carbazole indicated the 
presence of a new 3H doublet at 1.22 ppm, corresponding to a methyl group. 
High-resolution mass spectroscopy (HRMS) of the purified carbazole showed 
a parent ion of m/z 481.1787, consistent with a chemical formula of 
C26H29N2O5S. Therefore, based on our analysis, the structure of the isolated 
carbazole was assigned as shown in Figure 3.2. 
 
 
Figure 3.2. Chemical structure of the resulting carbazole 116 from the one-pot D-A/ene 
reaction of indole 111 
 
3.2.3. Proposed mechanism to give by-product (116) 
Snider et al., found that treatment of a terminal aldehyde with 2.0 equivalents 
of Me2AlCl results in the formation of the corresponding secondary alcohol.86  
We therefore proposed that the formation of unexpected carbazole 116, is due 
to the Me2AlCl acting as a source of nucleophilic methyl in the reaction.  
 
Our first proposed route to carbazole 116 involves the addition of a methyl 
group of Me2AlCl to the aldehyde of indole 111 followed by D-A reaction of the 
intermediate 114 with NMM. In the second alternative route,  the D-A reaction 
of indole 111 with NMM occurs first and then Me2AlCl reacts with the aldehyde 
of D-A cycloadduct 112 to give the by-product 116 (Scheme 3.5). 
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Scheme 3.5. Proposed synthetic routes to the unwanted carbazole 116 
 
Since the one-pot intermolecular D-A/intramolecular carbonyl-ene reaction of 
indole 111 led to the formation of the unwanted carbazole 116. We therefore 
suggested an alternative route for the synthesis of our desired polycyclic 
pyrrolo[3,4-a]carbazole 113. 
 
3.3. New approach to polycyclic pyrrolo[3,4-a]carbazole (113)  
In the following route, we intend to use the previously synthesised indolic 
alcohol 110 as a diene in D-A reaction with NMM. Once the D-A cycloadduct 
117 is obtained, ene cyclisation precursor 112 can be generated directly using 
a Swern oxidation. Following this, the intramolecular carbonyl-ene reaction of 
adduct 112 will be examined towards the desired polycyclic carbazole 113 
(Scheme 3.6).  
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Scheme 3.6. New stepwise route to polycyclic carbazole 113 
 
3.3.1. Synthesis of Diels-Alder cycloadduct (117) 
Following our synthetic plan, the previously prepared indole 110 was utilised 
in a D-A reaction with NMM in the presence of 2.0 equivalents of Me2AlCl. 
Following purification by column chromatography, the expected D-A 
cycloadduct 117 was isolated in a good yield of 75% (Scheme 3.7). 
 
 
Scheme 3.7. Synthesis of D-A cycloadduct 117 
 
The relative stereochemistry of D-A cycloadduct 117 was confirmed by X-ray 
diffraction analysis. Crystals of D-A cycloadduct 117 were grown from slow 
diffusion of petrol/ethyl acetate. The crystal structure showed that the relative 
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stereochemistry of D-A cycloadduct 117, was consistent with an endo 
selective D-A reaction between indole 110 and NMM (Figure 3.3). 
 
 
 
Figure 3.3. X-ray crystal structure of D-A cycloadduct 117 
 
3.3.2. Synthesis of ene precursor (112) 
Subsequently, D-A cycloadduct 117 was subjected to a Swern oxidation to 
provide the desired ene cyclisation precursor 112 in 69% yield (Scheme 3.8).  
 
 
Scheme 3.8. Synthesis of ene precursor 112 
 
3.4. Planned extensions of intramolecular ene chemistry, increase ring 
size 
With an efficient method for the synthesis and purification of ene precursor 
112, the next step was to examine the intramolecular carbonyl-ene reaction of 
112 to synthesise the desired polycyclic carbazole 113. However, before we 
investigated the intramolecular carbonyl-ene reaction of compound 112, we 
planned to apply our synthetic approach to the formation of other C-5 
substituted indoles, such as 121, in order to test the formation of larger rings 
using our planned intramolecular carbonyl-ene chemistry. Thus we decided to 
synthesise ene precursor 121 (Scheme 3.9), which could then be transformed 
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into a pyrrolo[3,4-a]carbazole incorporating a fused six- membered ring 122. 
This approach would allow a direct comparison to be made between the rates 
and the yields of intramolecular carbonyl-ene reactions of the two different ene 
precursors 112 and 121. 
Scheme 3.9. Synthetic plan to pyrrolo[3,4-a]carbazole 122 
 
3.5. Synthesis of ene precursor (121) 
3.5.1. Synthesis of diene (119) 
In order to synthesise ene precursor 121, diene 119 with Z-stereochemistry 
around the double bond had to be synthesised first. We envisioned that diene 
119 could be generated by a selective reduction of the ester moiety of indole 
118, which in turn could be synthesised by a Wittig reaction.  Thus, the Wittig 
salt 124 was synthesised by a reaction of triphenylphosphine with ethyl 5-
bromopentanoate 123. The resultant white precipitate was purified by column 
chromatography to give the desired pure salt in 77% isolated yield as a white 
foam (Scheme 3.10). 
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Scheme 3.10. Synthesis of Wittig salt 124 
 
Wittig salt 124 was then converted in situ to the corresponding reactive ylide 
125 using NaHMDS, and reacted with 1-tosyl-1H-indole-3-carbaldehyde 89 in 
THF for 20 hours (Scheme 3.11). However, no indication of the formation of 
the desired product 118 was detected. Analysis of the crude reaction mixture 
by 1H NMR indicated extensive degradation of starting materials under the 
reaction conditions. Since the Wittig salt 124 was only partially soluble in THF, 
modification of the Wittig reaction outcome was attempted in a different 
solvent. Therefore, the Wittig reaction of indole 89 with salt 124 was re-
examined in DMF (Scheme 3.11). However, only the starting material was 
observed by the 1H NMR of the crude reaction mixture. Examination of the 
literature showed a few examples of the use of salt 124, thus we decided to 
change the ylide to one more commonly used. 
 
 
Scheme 3.11. Results from the Wittig reaction of 89 to indole 118 
 
Thus alternative Wittig salt 127 was generated by a reaction of 
triphenylphosphine with 5-bromopentanoic acid 126 following a literature 
procedure.87 The resultant phosphonium salt 127 was then isolated cleanly by 
direct filtration from the reaction in 95% yield (Scheme 3.12).   
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Scheme 3.12. Synthesis of Wittig salt 127 
 
Wittig salt 127 was then deprotonated in situ by 2.0 equivalents of NaHMDS 
to generate ylide 128, which was in turn reacted with 1-tosyl-1H-indole-3-
carbaldehyde 89.  After 4 hours at r.t., the reaction was acidified with 1.0 M 
HCl to quench the added base and to protonate the carboxylic acid (Scheme 
3.13).88 Analysis of the resulting crude reaction mixture by 1H NMR spectrum 
indicated a mixture corresponding to both the Z- and E- isomers of the desired 
compound 129. However, the Z- and E- isomers could not be separated by 
flash column chromatography and the desired compound was obtained in 64% 
yield as a mixture of Z:E in a 4:1 ratio. 
 
 
Scheme 3.13 Wittig reaction of 89 to form indole 129 
 
In the next step, the inseparable mixture of (Z:E, 4,1)-129 was reduced with 
lithium aluminium hydride (LiAlH4), following a literature procedure.89 After 8 
hours at r.t.,1H NMR of the crude material indicated a mixture of Z- and E- 
isomers of the desired diene 119 in a 2:1 isomeric ratio along with the 
unreacted starting material. When purification was attempted using flash 
column chromatography, the desired Z-isomer of indole 119 was isolated in 
30% yield (Scheme 3.14).  
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Scheme 3.14. Reduction of indole 129 by LiAlH4 
 
3.5.1.1. Esterification reaction of a (Z:E, 4:1)-129  
Although the diene 119 was isolated as the required Z-stereochemistry around 
the double bond, the isolated yield was very low (30%). Thus, to improve the 
yield of compound 119, we decided to examine the esterification reaction of 
129 followed by the DIBAL-H reduction as an alternative route to generate 
diene 119.  
 
Two different routes to generate the ester from the carboxylic acid of 
compound 129 have been examined. The results are summarised in Table 
3.1.  
 
We first attempted the esterification reaction of 129 using a slight excess of 
methyl iodide (MeI, 1.1 eq.), under mildly basic conditions of K2CO3 in DMF at 
room temperature.90 The reaction was stopped after 2 hours when the starting 
material was no longer visible by TLC.  Purification of the crude reaction 
mixture by column chromatography was attempted. The Z- and E- isomers 
were inseparable due to close similarity in their Rf value, therefore the product 
130 was obtained in 93% yield as a mixture of Z- and E- isomers in a 4:1 ratio 
(Table 3.1, entry 1).  
 
In the second method, the carboxylic acid of compound 129 was treated with 
a large excess of EtOH in the presence of a catalytic amount of concentrated 
H2SO4.91 TLC showed the esterification reaction of 129 was completed after 
1.5 hours. Analysis of the 1H NMR spectrum of the crude reaction mixture 
indicated the formation of the ethyl ester through the appearance of new 
quartet CH2 and triplet CH3 signals at 4.10 and 1.21 ppm respectively. An 
attempt to separate the Z-isomer through column chromatography was 
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successfully and compound 118 was obtained in a pure Z-isomer in 56% 
isolated yield (Table 3.1, entry 2). 
 
 
 
Entry Reaction 
conditions 
Product Z:E ratio [a] Yield 
% 
1 
MeI, K2CO3, 
DMF, r.t., 
2 h  
4:1 93 [b] 
2 
H2SO4(cat), 
EtOH, 78 oC, 
1.5 h 
 
4:1 56 [c] 
          [a] Z:E ratio of the crude reaction mixture by 1H NMR. [b] The isolated yield of a mixture  
       of isomers (Z:E, 4:1) of 130. [C] The isolated yield of the pure Z- isomer of indole 118 
 
Table 3.1. Results of the esterification reactions of indole (Z/E 4:1)-129 
 
Then the ester moiety of compound 118 was reduced with DIBAL-H at -78 oC 
for 3 hours.  The desired diene with terminal alcohol 119 was obtained in 94% 
yield, with no further purification being necessary as shown by 1H NMR 
(Scheme 3.15). 
 
 
Scheme 3.15. DIBAL-H reduction of 118 to form 119 
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3.5.2. Diels-Alder reaction of diene (119) with NMM   
In the subsequent step, diene 119 was subjected to a D-A reaction with NMM 
catalysed by Me2AlCl. The corresponding D-A cycloadduct 120 was isolated 
in 78% yield as a single diastereomer, after purification by column 
chromatography (Scheme 3.16).  
 
Scheme 3.16. Synthesis of D-A cycloadduct 120 
 
The formation of endo D-A cycloadduct 120 was confirmed through 
comparison of the 1H NMR spectral data of D-A cycloadduct 120 with those of 
D-A cycloadduct 117 (Figure 3.4) 
 
Figure 3.4.1H NMR of D-A cycloadducts 117 and 120 
 
120, n = 2 
    
120, n = 2 
117, n = 1 
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In the next step, D-A cycloadduct 120 was transformed into the ene precursor 
121, using Swern oxidation, in 79% isolated yield (Scheme 3.17). 
 
 
Scheme 3.17. Synthesis of ene precursor 121 
 
3.6. Investigation of the intramolecular ene reaction of (112) and (121) 
With ene precursors 112 and 121 in hand, we then decided to examine the 
ring closure of 112 and 121 to give our target pyrrolocarbazole fused 
compounds 113 and  122, through an intramLocular carbonyl-ene reaction 
(Scheme 3.18).  
 
 
Scheme 3.18. Planned synthetic route to synthesise 113 and 122 
 
A survey of the literature revealed that high temperatures or Lewis acid 
activation are often required in the case of carbonyl ene reactions.92,93,94 
Coordination of Lewis acids to the oxygen of the carbonyl activates the carbon 
centre towards the nucleophilic addition. However, a problem in the use of 
Lewis acid to catalyse our intramolecular carbonyl-ene reaction is the 
possibility of generating catalytic quantities of protic acid, thus initiating 
unwanted side reactions such as the rearomatisation of the D-A 
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cycloadducts.95 We therefore decided to use Me2AlCl as the Lewis acid 
catalyst, due to its ability to act also as a proton scavenger.  
 
Our investigation of the intramolecular carbonyl-ene reaction was carried out 
by dissolving ene precursor 112 in DCM, followed by the addition of 1.0 
equivalent of Me2AlCl at -78 oC. After 30 min, TLC indicated the reaction was 
completed when compound 112 had disappeared.  Purification of the crude 
reaction mixture by column chromatography afforded the target polycyclic 
carbazole 113 in an excellent yield of 89% as a single diastereomer (Scheme 
3.19). 
 
 
Scheme 3.19. Intramolecular carbonyl-ene reaction of precursor 112 
 
The investigation of the intramolecular carbonyl-ene reaction of ene precursor 
121 (Scheme 3.20), was also undertaken and the results are reported in Table 
3.2.  
 
 
Scheme 3.20. Intramolecular carbonyl-ene reaction of 121 
 
We initially examined the intramolecular carbonyl-ene reaction of ene 
precursor 121 under the previously discussed conditions for 8 hours. However, 
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1H NMR of the crude reaction mixture showed no reaction had occurred and 
only the starting material was observed (Table 3.2, entry 1). Re-examined the 
reaction at a higher temperature (0 oC), also failed to give the desired product 
122 (Table 3.2, entry 2). Optimisation of the reaction conditions involved 
refluxing the reaction mixture containing ene precursor 121 and 1.0 equivalent 
of Me2AlCl in DCM for 3 hours. Under these reaction conditions, the 
corresponding polycyclic pyrrolo[3,4-a]carbazole 122 was obtained in 57% 
yield after purification by column chromatography (Table 3.2, entry 3).  
 
Entry Temperature/ 
oC 
Reaction time/ 
h 
SM: product 
ratio [a] 
Yield [b] 
% 
1 -78 8 100:0 - 
2 0 10 100:0 - 
3 25 3 40:60 57 
[a] Ratio was determined by 1H NMR of the crude reaction mixture. [b] Isolated yield of the 
desired product 122 
 
Table 3.2. Results of varying the temperature on the intramolecular carbonyl ene 
reaction of ene precursor 121  
 
In our investigations of the intramolecular carbonyl-ene reaction of 112, we 
noticed that the reaction went to completion in a very short time of 30 min at -
78 oC to give the corresponding carbazole 113. However, in the synthesis of 
carbazole 122, the reaction required higher temperatures and longer reaction 
times. We thus proposed that varying on the length of the tether led to a major 
effect on the rate of the intramolecular carbonyl-ene reaction, due to the steric 
influence of tether length on the formation of the ene transition state. 
 
3.7. Relative stereochemistry assignment of polycyclic carbazoles (113) 
and (122) 
The X-ray crystallographic analysis of the synthesised polycyclic carbazoles 
113 and 122 was performed to elucidate their relative stereochemistry. 
Crystals of carbazoles 113 and 122 were grown by slow evaporation from the 
DCM at room temperature. Both crystal structures showed that the aldehyde 
Chapter 3 Diels-Alder/Ene Chemistry of Substituted-3-Vinyl-1H-Indole 
 
Page 55 
 
of both ene precursors 112 and 121 is abstracted the allylic hydrogen from the 
twix position, to give the corresponding products 113 and 122 with anti-
arrangement between the newly formed ring and succinimide groups (Figure 
3.5). In addition, the formation of a cis fused ring of the resultant carbazole 
122 was confirmed further by coupling constant analysis. The 3J value 
between the ring junction protons (H14 and H19) was 5.2 Hz, which is indicative 
of a cis fused ring. 
 
 
 
 
 
Figure 3.5. X-ray crystal structure of 113 and 122 
 
To rationalise the relative stereochemistry of the previously synthesised 
carbazoles 113 and 122, we proposed the following  concerted ene 
mechanism with a cyclic transition state (Figure 3.6) occurs to form both the 
five and six membered rings. 
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Figure 3.6. Proposed concerted intramolecular carbonyl-ene mechanism 
 
Although the intramolecular carbonyl-ene reaction often procceds by a 
concerted mechanism, it can also take a place through a stepwise pathway 
involving the foramation of the carbocation intermediate 132 (Figure 3.7).93 
 
 
Figure 3.7. Proposed stepwise intramolecular carbonyl-ene mechanism 
 
3.8. Investigation of the intramolecular carbonyl-ene mechanism 
To confirm whether the ene mechanism occurs through a stepwise or 
concerted mechanism, we sought to study the intramolecular carbonyl-ene 
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reaction of ene precursor 136 under previously discussed conditions. From a 
mechanistic standpoint, if the ene reaction proceeds via a stepwise 
mechanism, then in the case of ene precursor 136, the reaction would be able 
to proceed with the cyclopentanol ring being formed cis to the succinimide 
group, giving product 137 (Scheme 3.21). However, if a concerted mechanism 
prevailed, no cyclisation process would be expected as the aldehyde would be 
unable to reach the twix hydrogen (Figure 3.6, page 56). 
 
 
Scheme 3.21. Planned synthetic approach to investigate the intramolecular carbonyl-
ene mechanism  
 
We envisaged that the desired ene precursor 136 could be synthesised by a 
Swern oxidation of D-A cycloadduct 135. In turn, the D-A cycloadduct 135 with 
the required alternate stereochemistry could be accessed from a D-A 
cycloaddition between the indole (E)-134 and NMM (Scheme 3.22).  
 
Scheme 3.22.  Retrosynthetic analysis to synthesise ene precursor 136 
 
3.9. Synthesis of (E)-5-(1-tosyl-1H-indol-3-yl)pent-4-en-1-ol (134) 
3.9.1. Synthesis of tetrazole 139 
We began our synthesis with olefination reaction of 1-tosyl-1H-indole-3-
carbaldehyde 89 utilising E-selective Julia-Kocienski reaction with tetrazole 
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139. In order to synthesise the tetrazole 139, compound 138 was synthesised 
according to the literature procedure by an SN2 reaction of 1-phenyl-1H-
tetrazol-5-thiol and ethyl-4-bromobutyrate 93 in the presence of K2CO3 
(Scheme 3.23).96 The reaction went to completion after 18 hours at room 
temperature as observed by the TLC. The crude reaction mixture was purified 
by column chromatography and the expected ethyl 4-((2-phenyl-2H-tetrazol-
5-yl)thio)butanoate 138 was obtained in 98% isolated yield. 
 
 
Scheme 3.23. Synthesis of compound 138 
 
Selective oxidation of sulfide 138 to sulfone 139 was investigated using two 
different possible routes. The results are summarised in Table 3.3 
 
In the first route, oxidation of sulfide 138 to sulfone 139 was attempted using 
m-chloroperoxybenzoic (m-CPBA) in DCM for 24 hours (Table 3.3, entry 1), 
following a literature procedure.97  Analysis of the 1H NMR of the crude 
reaction mixture indicated a 1:1 mixture of a new product along with unreacted 
starting material. Increasing the equivalents of the oxidising agent did not 
change the observed ratio. Purification of the crude reaction mixture by column 
chromatography afforded the sulfone 139 in a moderate yield of 46%.  
 
Alternatively, oxidation of sulfide 138 was tested using 35% hydrogen peroxide 
(H2O2) solution and a molybdenum catalyst (NH4)6 Mo7O24 . 4H2O following a 
literature procedure.96, 98 Purification of the crude reaction mixture by column 
chromatography afforded the desired tetrazole 139  in 78% yield (Table, 3.3, 
entry 2).  
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Entry Reaction conditions Isolated yield % 
1 m-CPBA, DCM , 24 h, 0 oC to r.t. 46 
2 (NH4)6Mo7O24 . 4H2O, 35% H2O2, MeOH, r.t., 18 h 78 
Table 3.3. Synthesis of the desired tetrazole 139 
 
3.9.1.1. Julia-Kocienski reaction of indole (89) 
With tetrazole 139 in hand, the next step was to use it in the E-selective Julia-
Kocienski reaction in order to synthesise indole 141. Therefore, tetrazole 139 
was deprotonated in situ with NaHMDS to generate ylide 140,98 which was 
then reacted with 1-tosyl-1H-indole-3-carbaldehyde 89 (Scheme 3.24). The 
crude reaction mixture was purified through column chromatography to give 
the desired E-isomer of indole 141 in 39% isolated yield. The stereochemistry 
of 141 was confirmed using coupling constant analysis.  The large coupling 
constant between the olefinic protons was 16.3 Hz, which indicated that 
compound 141 has an E-configuration around the double bond. 
 
 
Scheme 3.24. Synthesis of indole (E)-141 using Julia-Kocienski olefination 
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3.9.1.2. DIBAL-H reduction of indole (E)-141 
The ester group of indole (E)-141 was subsequently reduced with DIBAL-H in 
toluene at -78 oC to give the desired diene (E)-134 in 96% isolated yield after 
purification by column chromatography (Scheme 3.25).  
 
 
Scheme 3.25. Synthesise of diene (E)-134 
 
3.10. Synthesis of ene precursor (136)  
The resulting (E)-134 was then used as a diene in a D-A reaction with NMM in 
the presence of Me2AlCl. The corresponding D-A cycloadduct 135 was 
obtained in 89% isolated yield (Scheme 2.26).  
 
 
Scheme 2.26. Synthesis of D-A cycloadduct 135 
 
The relative stereochemistry of the D-A cycloadduct 135 was assigned based 
on the X-ray crystal structure (Figure 3.8). Crystals of D-A cycloadduct 135 
were grown by slow evaporation of a solution of 135 in ethyl acetate/petrol. 
The crystal structure confirmed that compound 135 was formed through an 
endo selective cycloaddition between the (E)-134 and NMM. Our desired syn 
arrangement between the alkyl side chain and the succinimide group of D-A 
cycloadduct 135 was also confirmed by X-ray analysis.  
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Figure 3.8. X-ray crystal structure of D-A cycloadduct 135 
 
In the next step, the D-A cycloadduct 135 was subjected to a Swern oxidation 
to give the desired ene cyclisation precursor 136 in 75% isolated yield, after 
purification by column chromatography (Scheme 2.27). 
 
 
Scheme 2.27. Synthesis of ene precursor 136 
 
3.11. Intramolecular carbonyl-ene reaction of precursor (136) 
At this point, we were ready to investigate the intramolecular carbonyl-ene 
mechanism as the terminal aldehyde of the ene precursor 136 could serve as 
a reactive enophile to close the ring. All of the attempts to close the ring by 
intramolecular carbonyl-ene reaction of 136 in the presence of 1.0 equivalent 
of Me2AlCl, failed to give the cyclised five membered ring-containing product 
137 and only the starting material was recovered despite the testing of different 
reaction conditions (Table 3.3).  
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Entry Temperature/ 
oC 
Reaction time/ 
h 
1H NMR of the crude 
reaction mixture 
1 -78 8  
 
Only SM was observed 
2 0 8 
3 25 24 
4 40 72 
Table 3.3. Investigation of the intramolecular carbonyl-ene reaction of aldehyde 136 
under various reaction conditions 
 
This result provides clear evidence that the intramolecular carbonyl-ene 
reaction of precursors 112 and 121 occurs via a concerted mechanism, as the 
reaction only proceeds when the reacting aldehyde is on the same face as the 
twix proton. 
 
3.12. Conclusion  
In this chapter, we discovered a new synthetic route to cis-fused polycyclic 
tetrahydropyrrolo[3,4-a]carbazole frameworks through the use of a three-step 
sequence; an intermolecular D-A, Swern oxidation and intramolecular 
carbonyl-ene reaction of Z-precursor indoles 110 and 119. We also found that 
the synthesised polycyclic carbazoles 113 and 122 were most likely formed by 
a concerted ene mechanism governed by the stereochemistry of the allylic 
hydrogen. Therefore, only cyclisation precursor 112 and 121, which derived 
from the Z-isomers, underwent an intramolecular carbonyl-ene reaction to give 
the corresponding polycyclic carbazoles 113 and 122. 
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 Chapter 4.  
Bromination/Substitution Chemistry of 3-Vinyl-1H-Indole  
 
The forgoing chapters have described two successful approaches for the 
synthesis of functionalised tetrahydropyrrolo[3,4-a]carbazole-1,3-dione 
derivatives, through the use of an intermolecular D-A reaction in conjunction 
with an inter- or an intramolecular ene reaction. Our work in this chapter will 
focus on an alternative approach to the synthesis of tetrahydropyrrolo[3,4-
a]carbazoles 144, through the use of a D-A cycloaddition of the protected 3-
vinyl-1H-indole 142 with a range of dienophiles, followed by a one-pot 
bromination/substitution reaction of the formed D-A cycloadducts 143 
(Scheme 4.1).  
 
 
 
Scheme 4.1. D-A/one-pot bromination/substitution reaction approach to the 
pyrrolo[3,4-a]carbazole ring system 144 
  
4.1. Synthetic plan to substituted carbazole (151) 
Although there were no reported reactions for the functionalisation of D-A 
cycloadducts such as 143 through a bromination/substitution reaction 
sequence, our proposed synthetic plan was guided by work published by 
Lovely’s research group.99 Lovely et al., have shown that enamine 146, the 
product of a D-A reaction of vinyl imidazole 145 and NPM, can be converted 
to an alcohol 147 in the presence of N-bromosuccinimide (NBS) and water via 
a proposed halogenation of the alkene followed by substitution by water 
sequence (Scheme 4.2).  
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Scheme 4.2. Lovely’s enamine to alcohol conversion 
 
We have therefore decided to start our investigation using tosyl protected 3-
vinyl-1H-indole 148 in the D-A reaction with NMM, to give D-A cycloadduct 
149. Then we will test the reactivity of the formed D-A cycloadduct 149 towards 
electrophilic brominating reagents in the presence of alcohols or amines to 
investigate the potential for one-pot bromination/substitution reactions. Once 
the target compounds 151 are obtained, removal of the N-protecting group will 
be examined and subsequently the biological activities of the produced 
compounds 152 will evaluated (Scheme 4.3). 
 
 
Scheme 4.3. Synthetic plan to substituted carbazoles 151 and N-deprotection to 152 
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4.2. Diels-Alder chemistry of 1-tosyl-3-vinyl-1H-indole (148) 
4.2.1. Synthesis of 1-tosyl-3-vinyl-1H-indole (148) 
The first step in the investigation of our proposed bromination/substitution 
reactions of D-A cycloadduct 149, was to synthesise1-tosyl-3-vinyl-1H-indole 
148. We envisioned that indole 148 could be synthesised by a Wittig reaction 
between the previously synthesised 1-tosyl-1H-indole-3-carbaldehyde 89 and 
methyltriphenylphosphonium iodide 153. Compound 153 was synthesised by 
a nucleophilic substitution reaction of methyl iodide with triphenylphosphine 
following a literature procedure (Scheme 4.4).100 The resulting crude 
phosphonium salt 153 was isolated in an almost quantitative yield of 96% by 
filtration, and used in the subsequent Wittig reaction without the need for 
further purification.  
 
Scheme 4.4. Synthesis of Wittig salt 153 
 
The next step was to utilise salt 153 in a Wittig reaction with 1-tosyl-1H-indole-
3-carbaldehyde 89. Therefore, Wittig Salt 153 was converted in situ to the 
reactive ylide 154 using n-butyllithium following a literature procedure 
(Scheme 4.5).101 The Wittig reaction between ylide 154 and 1-tosyl-1H-indole-
3-carbaldehyde 89 afforded the expected 1-tosyl-3-vinyl-1H-indole 148 in a 
good yield of 72% after purification by column chromatography. 
 
 
Scheme 4.5. Wittig reaction of 89 to form 148 
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The desired D-A cycloadduct 149 was then synthesised through a thermal 
cycloaddition reaction between 1-tosyl-3-vinyl-1H-indole 148 as a diene and 
NMM as a dienophile. The reaction was carried out in refluxing DCM for 48 h 
monitored by TLC. 1H NMR spectrum of the crude reaction mixture indicated 
the loss of the signals corresponding to the vinylic CH2 protons at 6.75, 5.79 
and 5.33 ppm, and showed significant conversion to a single major product. 
Purification of the crude reaction mixture by column chromatography gave the 
D-A cycloadduct 149 in 68% yield as a single diastereomer (Scheme 4.6).  
 
 
Scheme 4.6. Synthesis of D-A cycloadduct 149  
 
4.3. Relative stereochemistry of D-A cycloadduct (149) 
To determine the relative stereochemistry of the resultant D-A cycloadduct 
149, crystals were grown from a solution of D-A cycloadduct 149 in ethyl 
acetate/petrol by slow evaporation. X-ray analysis indicated that the D-A 
cycloadduct 149 had been formed through the expected endo-selective D-A 
reaction (Figure 4.1). 
 
 
Figure 4.1. X-ray crystal structure of 149 *  
 
* X-ray crystal structure of D-A cycloadduct 149 was done by Joseph Cowell. 
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4.4. Investigation of the one-pot bromination/substitution reactions of  
D-A cycloadduct (149) 
4.4.1. Bromination/substitution reactions using a range of alcohols 
We started our investigation into a potential one-pot bromination/substitution 
reaction using NBS as an electrophilic source of halogen to brominate the 
cyclohexenyl double bond of D-A cycloadduct 149. Water or an alcohol was 
used as both a co-solvent and as a nucleophile to react with the brominated 
intermediate in situ through a nucleophilic substitution reaction. The results 
are summarised in Table 4.1. 
 
In the first attempt, NBS was added to a solution of D-A cycloadduct 149 in a 
1:1 mixture of THF/water at 0 °C.  After 2 hours at r.t., two diastereomers in a 
4:1 ratio were observed in the 1H NMR spectrum of the crude reaction mixture. 
Purification by column chromatography afforded the major diastereomer of 
carbazole 156 in 52% yield (Table 4.1, entry 1).  Following this successful 
reaction to give carbazole 156, we then decided to examine the one-pot 
bromination/substitution reactions of D-A cycloadduct 149 under the 
previously discussed conditions using a range of alcohol solvents.  
 
Treatment of D-A cycloadduct 149 with NBS in a 1:1 mixture of THF and 
MeOH, EtOH or 2-propanol at 0 oC for 1 hour led to the formation of the 
corresponding substituted carbazole as a mixture of two diastereomers as 
shown by the 1H NMR spectrum of the crude reaction mixture. Purification of 
the diastereomers was attempted by flash column chromatography and the 
major diastereomers 157, 158 and 159 were successfully isolated in yields 
ranging from 64-75% (Table 4.1, entry 2-4).  
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           [a] Diastereomeric ratio was determined by 1H NMR of the crude reaction mixture  
           [b] Isolated yield of the major diastereomer   
  
Table 4.1. Results of bromination/substitution reactions of D–A cycloadduct 149 
 
The most notable feature of the previously reported bromination/substitution 
reactions is that the diastereomeric ratio of the product is strongly dependent 
on the nature of the external nucleophile. The use of a small nucleophile such 
Entry Solvent 
1:1 
Diastereomeric 
ratio [a] 
Product Yield [b] 
% 
1 THF/H2O 4:1 
 
52 
2 THF/MeOH 14:1 
 
75 
3 THF/EtOH 14:1 
 
67 
4 
THF/ 
Isopropanol 
19:1 
 
64 
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as water gave two diastereomers of the desired substituted product 156 in a 
4:1 ratio whereas the use of isopropyl alcohol, which is a sterically more bulky 
nucleophile, led to the formation of the corresponding substituted carbazole 
159 in a 19:1 diastereomeric ratio. 
 
4.4.2. Proposed mechanism for the bromination/substitution 
reactions 
We postulated that the one-pot bromination/substitution reaction occurs via 
two successive elementary steps. The initial step may involve formation of two 
diastereomers of the brominated intermediates 160 and 161. We can suppose 
that the bromination might occur under steric control, directed by the 
succinimide group. Thus, we propose that the major diastereomer 160 of the 
brominated intermediate would result from addition of bromine to the si-face 
of the alkene, opposite the succinimide group, whereas the minor 
diastereomer 161 might arise from addition to the re-face of the alkene, the 
same face as the succinimide group (Scheme 4.7). 
 
Scheme 4.7. Proposed brominated intermediates 160 and 161 
 
The second step in the bromination/substitution reaction would be a 
nucleophilic substitution reaction, which could take place by either an SN1 or 
an SN2 mechanism. In the SN1 mechanism, after loss of bromide the 
nucleophile can attack form either face of the planar secondary carbocation 
162, to afford the major diastereomer 163 of the corresponding carbazole with 
anti-stereochemistry and the minor diastereomer 164 with syn-
stereochemistry, again under steric control from the succinimide group 
(Scheme 4.8). 
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Scheme 4.8. Proposed SN1 pathway 
 
Whilst in the proposed SN2 mechanism, the substitution reaction of bromine 
by the nucleophile would proceed with inversion of the configuration at position 
(14), to give the corresponding major diastereomer 164 and minor 
diastereomer 163 of the desired carbazole with syn- and anti-arrangement 
between the incoming nucleophile and the succinimide groups respectively 
(Scheme 4.9).  
 
 
Scheme 4.9. Proposed SN2 pathway for the substitution of Br with O-nucleophiles 
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4.4.3. Assignment of the relative stereochemistry of carbazole (158) 
In order to determine whether the substitution step had occurred via an SN1 or 
SN2 mechanism, we needed to confirm the relative stereochemistry of the 
synthesised carbazoles (156–159). Therefore, crystals of the major 
diastereomer of carbazole 158 were grown from a DCM solution by slow 
evaporation, and examined by X-ray crystallography. The X-ray analysis 
revealed that the ethoxy and succinimide groups were syn to each other 
(Figure 4.2), which is consistent with an SN2 mechanism according to our 
mechanistic proposal (Scheme 4.9). 
 
 
 
Figure 4.2. X-ray crystal structure of compound 158 
 
The relative stereochemistry of carbazoles 156, 157 and 159 was then 
determined through comparison of the 1H NMR spectrum of the major 
diastereomers. The coupling constants between H12 and the two 
diastereotopic protons (H11A and H11B) were measured to be 3.2 and 2.3 Hz 
respectively. Similar coupling constants could be observed for carbazoles 156, 
157 and 159, suggesting that the major diastereomers formed by bromination 
and nucleophilic substitution were in a syn-orientation. 
 
4.5. Bromination/amination reaction of D-A cycloadduct (149) 
With an efficient method for the synthesis of ether substituted carbazoles in 
hand, we decided to examine the use of secondary amine reagents as an 
alternative nucleophile for the development of a novel one-pot 
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bromination/substitution reaction sequence, to form amino-substituted 
carbazole derivatives 165 (Scheme 4.10). 
 
 
Scheme 4.10. Planned synthesis of amino-substituted carbazoles 165 
 
Initially we thought that amino-substituted carbazole derivatives 165 could be 
synthesised using the previously discussed bromination/substitution method 
by simple replacement of the alcohol with a nucleophilic amine. Therefore, 2.0 
equivalents of NBS were added to a solution of D-A cycloadduct 149 in a 1:1 
mixture of THF/Et2NH. However after 4 hours at 0 °C, only the starting material 
was observed by 1H NMR of the crude reaction mixture (Table 4.2, entry 1). 
When we re-examined the bromination/amination reaction of D-A cycloadduct 
149 at a higher temperature (r.t.), still with 2.0 equivalents of NBS in a 1:1 
mixture of THF/Et2NH, the 1H NMR spectrum of the crude reaction mixture still 
showed no change in the starting material (Table 4.2 entry 2).  
 
 
Entry Solvent 
1:1 
Reaction 
conditions 
Temperature/ 
°C 
Result [a] 
1 THF/Et2NH NBS, 4 h 0 Only SM observed 
2 THF/Et2NH NBS, 4 h r.t. Only SM observed 
[a] Result determined by 1H NMR of the crude reaction mixture  
Table 4.2. Initial examination of the one-pot bromination/amination reaction 
conditions of D-A cycloadduct 149 
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Since NBS can act as a source of Br2 and thus a source of “Br+”, but only when 
catalysed by hydrogen bromide (HBr), we postulated that the presence of a 
base, such as diethylamine, may inhibit the desired bromination step and thus 
prevent the bromination/substitution reaction from occurring. 
 
Therefore we repeated the reaction by adding 2.0 equivalents of NBS to D-A 
cycloadduct 149 in THF at 0 °C, without the presence of the amine. After 1 
hour, diethylamine was added and the reaction mixture was stirred for a further 
3 hours at 0 °C. 1H NMR of the crude reaction mixture indicated a mixture of 
a new product and unreacted starting material in a 1:3 ratio respectively. 
Purification of the crude material by column chromatography afforded the 
corresponding substituted carbazole 166, as a single diastereomer in 21% 
yield (Table 4.3, entry 1).  
 
The formation of the desired carbazole 166 in a low yield, alongside the 
recovery of a significant quantity of starting material, suggested that the 
desired brominated intermediate was formed but the bromination had not gone 
to completion prior to the addition of diethylamine.  
 
We therefore repeated the reaction, increasing the time for the bromination 
step from 1 hour to 3 hours. Unfortunately when the reaction was examined 
by 1H NMR, it showed that D-A cycloadduct 149 had undergone a [1,3]-H shift 
under these reaction conditions to form the rearomatised product 168. 
Purification by column chromatography led to the isolation of this unwanted 
rearomatised carbazole 168 in 72% yield (Table 4.3, entry 2).  
 
We speculated that unwanted rearomatised product 168 could be generated 
in the reaction through an acid catalysed alkene rearrangement catalysed by 
the HBr formed in the bromination step (Scheme 4.11). 
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Scheme 4.11. Possible mechanism for the rearomatisation of D-A cycloadduct 149 to 
give 168 in the presence of HBr 
  
Based on the above results, we decided to increase the number of equivalents 
of NBS whilst maintaining the reaction time for 1 hour in the bromination step, 
in an attempt to speed up the desired bromination in comparison to unwanted 
rearomatisation. A 32% yield of the desired product 166 was isolated after 
purification by column chromatography, giving only a marginal improvement. 
 
 
 
Table 4.3. Results of initial condition screening for the bromination/amino-
substitution reactions of D-A cycloadduct 149 
 
4.5.1. Optimisation of the bromination/amination reaction conditions 
The limited conversion of D-A cycloadduct 149 to the desired amino-
substituted carbazole 166 under the previously described conditions (Table 
4.3), can be attributed to the low concentration of bromine in the reaction 
Entry Reaction conditions NBS 
eq. 
Isolated yield % 
166 168 
1  i. NBS,  1 h, 0 °C 
ii.Et2NH, 3 h, 0 °C 
2 21 0 
2  i. NBS,  3 h, 0 °C 
ii.Et2NH, 3 h, 0 °C 
2 0 72 
3  i. NBS,  1 h, 0 °C 
ii.Et2NH, 3 h, 0 °C 
3.5 32 0 
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(generated from NBS) and / or solubility of the starting material, as it was 
noticed that D-A cycloadduct 149 was only partially soluble in THF. Therefore 
we decided to look at the use of different solvents and brominating reagents 
in order to develop a convenient, practical and high yielding method for the 
bromination/amination reaction of D-A cycloadduct 149, whilst avoiding the 
formation of unwanted rearomatised product 168.  
 
Optimisation of the bromination/substitution reaction of 149 to give 
diethylamine-substituted carbazole 166 was therefore examined using 
bromine (Br2) as an electrophilic brominating agent instead of NBS, and DCM 
as the solvent in place of THF. The results are summarised in Table 4.4.  
 
In our first attempt, the reaction mixture containing D-A cycloadduct 149 in 
DCM was stirred for 30 min, after the addition of 1.2 equivalents of Br2. 
Diethylamine was then added at 0 °C and the mixture was stirred for a further 
3 hours (Table 4.4, entry 1). Under these reaction conditions, three major 
products were isolated from the crude reaction mixture following column 
chromatography: the desired amino-substituted product 166 which was 
obtained in 15% yield, the rearomatised compound 168 in 20% yield and 
carbazole 170 in 12% yield. We postulated that carbazole 170 may have been 
generated from an elimination reaction (E1) of the brominated intermediate 
150 (Scheme 4.12). 
 
Scheme 4.12. Proposed reaction mechanism to form compound 170 
 
We reasoned that reducing the reaction time for the bromination step might 
reduce the formation of these unwanted side-products. Therefore the next 
bromination of D-A cycloadduct 149 by 1.2 equivalents of Br2 was performed 
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over 5 minutes. Diethylamine was then added and the mixture was stirred for 
a further 3 hours (Table 4.4, entry 2). Purification of the crude material by 
column chromatography gave the desired amino-substituted product 166 in 
35% yield, the rearomatised compound 168 in 25% yield, and the starting 
material was recovered in 20% yield. 
 
Since the rearomatised carbazole 168 is likely formed due to HBr being 
present during the reaction, we decided to add diethylamine at the beginning 
of the reaction to trap the HBr from the mixture as it is formed. Hence, 
diethylamine was added to the reaction first, followed by the addition of 1.2 
equivalents of Br2. After 5 min at 0 °C, the reaction was stirred for a further 3 
hours. Under these reaction conditions, no rearomatised product was 
observed by 1H NMR of the crude reaction mixture however the spectrum  
indicated a 1:1 mixture of unreacted D-A cycloadduct 149 and the desired 
amino-substituted carbazole 166,  which was subsequently isolated in 42% 
yield (Table 4.4, entry 3).  
 
Further optimisation of the reaction conditions to form our desired 
diethylamine-substituted carbazole 166, involved the use of a non-nucleophilic 
base to remove the HBr generated in the bromination step. When the reaction 
was carried out in the presence of 2.0 equivalents of potassium carbonate 
(K2CO3), in DCM and with 1.2 equivalents of bromine, followed after 2 minutes 
by the addition of diethylamine, an efficient bromination/amination reaction 
was achieved. No starting material was observed, however only 52% of 
desired amino-substituted product 166 was obtained along with an 11% yield 
of compound 170 and 8% yield of compound 171 (Table 4.4, entry 4). In 
contrast, an 80% yield of the desired amino-substituted carbazole 166 was 
obtained when the reaction was performed under the same conditions but in 
the presence of a more organic soluble non-nucleophilic base, cesium 
carbonate (Cs2CO3) (Table 4.4, entry 5). 
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Entry Reaction conditions Isolated yield % 
149 166 168 170 171 
1 i. Br2, 30 min, 0°C 
ii. Et2NH, 3 h,  0°C 
- 15 20 12 - 
2 i. Br2, 5 min,  0°C 
ii. Et2NH, 3 h, 0°C 
20 35 25 - - 
3 i. Et2NH, 5 min, 0°C 
ii. Br2, 3h, 0°C 
35 42 - - - 
4 i. K2CO3, Br2, 2 min, 0°C 
ii. Et2NH, 2 h, 0°C 
- 52 - 11 8 
5 i. Cs2CO3, Br2, 2 min, 0°C 
ii. Et2NH, 2h, 0°C 
- 80 - - - 
Table 4.4. Optimisation of the bromination/amination reactions of the D-A cycloadduct 
149 
 
To test the scope and limitations of our optimised reaction conditions, a variety 
of secondary amine derivatives including pyrrolidine, piperidine and 
morpholine were then examined as nucleophiles. Pleasingly, using our 
optimised bromination/amino-substitution conditions we were able to access 
a number of amino-substituted carbazoles 172, 173 and 174 in good yields 
ranging from 77-92% (Table 4.5, entry 1-3). 
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Entry (R)2NH Product Yield [a] 
% 
1 
 
 
92 
2 
 
 
77 
3 
 
 
83 
                                   [a] Isolated yield of the product  
Table 4.5. Synthesis of amino-substituted carbazole derivatives (172-174) 
 
4.5.2. Relative stereochemistry of carbazoles (166) and (172) 
To deduce the relative stereochemistry of amino-substituted carbazoles 166 
and 172, crystals of both were grown from DCM, by slow evaporation at room 
temperature and examined using single crystal X-ray crystallography. The X-
ray analysis revealed that the secondary amines had added to the opposite 
face of the molecule relative to the succinimide ring (Figure 4.3).  
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Figure 4.3. X- ray crystal structures of compounds 166 and 172 
 
 
4.5.3. Proposed mechanism of bromination/amination reactions of 
D-A cycloadduct (149) 
Considering the previously discussed mechanism for the 
bromination/substitution reactions involving alcohol nucleophiles (Scheme 
4.8, page 70), we inferred that substitution of bromine by nitrogen might 
proceed through an SN1 reaction mechanism. Although an SN1 reaction might 
be expected to give a mixture of diastereomers as the nitrogen could attack 
from either face of the planar secondary carbocation intermediate 162, in this 
case the addition of the secondary amine can occur selectively on the least 
hindered face of the carbocation, due to the steric influence of the succinimide 
group, leading to the observed single diastereomer of the corresponding 
substituted compounds 165 (Scheme 4.13). 
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Scheme 4.13. Postulated SN1 mechanism in the synthesis of amino-substituted 
carbazole 165 
 
With the successful development of a new diastereoselective approach for the 
construction of amino-substituted carbazoles, we then focused our attention 
on removal of the N-protecting group. Deprotection of this group is important 
if we wish to apply our bromination/substitution approach to the synthesis of 
bioactive carbazoles, such as 80 and 175 (Figure 4.4), as these systems 
typically have a free indolic nitrogen to engage in H-bonding to their targets. 
 
 
Figure 4.4. A comparison of the structure of the bioactive pyrrolocarbazole (80,175), 
and our synthesised compounds 165 
 
4.6. Removal of the N-protecting group  
Earlier work within our group had demonstrated the difficulties in removing the 
tosyl protecting group from an indolic nitrogen under basic conditions, 
including using sodium hydroxide, potassium hydroxide or potassium 
ethoxide. Single electron transfer reagents including sodium or magnesium 
mercury amalgam have also been investigated to no avail (Scheme 4.14).   
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Scheme 4.14. Removal of the tosyl protecting group (Reaction Conditions, see page 
(80)  
 
Therefore, we decided to use an alternative electron withdrawing N-protecting 
group that would be tolerated in both the D-A reactions and one-pot 
bromination/substitution reaction conditions and yet would readily undergo 
deprotection at the end of the synthesis.  
 
4.7. Alternative electron withdrawing protecting group  
4.7.1. Synthesis of benzyl 3-vinyl-1H-indole-1-carboxylate (179) 
The previous chapters highlighted the importance of an electron withdrawing 
protecting group to control the rate of the D-A reaction. We therefore needed 
to use an electron withdrawing protecting group which would allow the 
formation of the precursor D-A cycloadduct under mild conditions and yet be 
easily cleaved in the final step of the synthesis. The carboxybenzyl group 
(Cbz) was chosen as an alternative protecting group to tosyl, as recent studies 
in our group have found that Adam's catalyst (PtO2) can be used as a 
hydrogenation catalyst, to deprotect Cbz protected indolic nitrogen.102 
 
 Our study began with the protection of indole-3- carbaldehyde 88 with benzyl 
chloroformate (CbzCl) in the presence of Et3N following a literature procedure 
(Scheme 4.15).103 The protection reaction was carried out at r.t. for 24 hours, 
to provide the expected benzyl 3-formyl-1H-indole-1-carboxylate 177 in a good 
yield of 81%. 
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Scheme 4.15. Cbz protection of 1H-indole-3-carbaldehyde 88 
 
The subsequent step involved a Wittig reaction between the previously 
synthesised phosphonium salt 153, deprotonated with n-butyllithium, and 
benzyl 3-formyl-1H-indole-1-carboxylate 177, to give benzyl 3-vinyl-1H-indole-
1-carboxylate 179 in 46% yield along with 32% yield of 3-vinyl-1H-indole 178 
after purification by column chromatography (Scheme 4.16). 
 
 
Scheme 4.16. Wittig reaction of benzyl 3-formyl-1H-indole-1-carboxylate 177 
 
From these results, we speculated that compound 177 is decomposed under 
the Wittig reaction conditions to give deprotected 3-vinyl-1H-indole 178. Due 
to the low yield in this step, we then turned our attention to examine an 
alternative route to the desired benzyl 3-vinyl-1H-indole-1-carboxylate 179. 
We envisioned that by reversing the step order, benzyl 3-vinyl-1H-indole-1-
carboxylate 179 could be synthesised from the Wittig reaction of indole-3- 
carbaldehyde 88 followed by a Cbz protection.  
 
4.7.1.1. Alternative route to benzyl 3-vinyl-1H-indole-1-carboxylate 
(179) 
The research group of Ricci have previously investigated the Wittig reaction of 
indole-3- carbaldehyde 88  with phosphorus ylide 154 to form 3-vinyl-1H-indole 
178.50 In this procedure, a strong non-nucleophilic base such as lithium 
bis(trimethylsilyl)amide (LiHMDS) was used to deprotonate the NH of indole-
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3-carbaldehyde 88 before it was added to the reaction mixture, to prevent the 
deprotonation of the indolic NH by phosphorus ylide 154 from competing with 
the desired Wittig reaction. Therefore, indole-3-carbaldehyde 88 was 
deprotonated by NaHMDS, before addition to phosphorus ylide 154.  The 
corresponding 3-vinyl-1H-indole 178 was isolated in an excellent yield of 90% 
after purification by column chromatography (Scheme 4.17).  
 
 
Scheme 4.17. Deprotonation/Wittig reaction of 3-formyl-1H-indole 88 
 
The next step was to protect the indolic nitrogen of 3-vinyl-1H-indole 178 with 
a Cbz group. Deprotonation of the NH with NaHMDS in THF followed by 
addition of CbzCl gave the desired benzyl 3-vinyl-1H-indole-1-carboxylate 179 
in 70% yield (Scheme 4.18). 
 
 
Scheme 4.18. Protection of 3-vinyl-1H-indole 178 with CbzCl 
 
It is worth mentioning that a strong base, such as NaHMDS was needed to 
deprotonate the NH of 3-vinyl-1H-indole 178, whilst only a weak base such as 
Et3N was needed to deprotonate the NH in indole-3-carbaldehyde 88. This is 
due to the conjugated nature of indole-3-carbaldehyde 88, with electron 
withdrawing aldehyde group stabilising the formation of the anion and thus 
making the NH more acidic. In the absence of aldehyde, such as in compound 
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178, the resulting anion is not stabilised, therefore the NH is comparatively 
less acidic which results in the need for a strong base. 
 
4.8. Synthesis of Cbz protected Diels-Alder cycloadduct (180) 
With a reliable pathway for the synthesis and purification of benzyl 3-vinyl-1H-
indole-1-carboxylate 179 in hand, the next step was to test the planned D-A 
reaction between benzyl 3-vinyl-1H-indole-1-carboxylate 179 as the diene, 
and NMM, as the dienophile. The D-A reaction of indole 179 with NMM was 
performed in refluxing DCM for 24 h. Gratifyingly, the corresponding D-A 
cycloadduct 180 was isolated in 77% yield as a single diastereomer (Scheme 
4.19).  
 
 
Scheme 4.19. Synthesis of Cbz protected D-A cycloadduct 180 
 
The Cbz group showed moderate rate-enhancement of the D-A cycloaddition 
in comparison to the tosyl group. Whilst the D-A reaction of 1-tosyl-3-vinyl-1H-
indole 148 with NMM took 48 h to form the corresponding D-A cycloadduct 
149, reaction of the more electron rich diene benzyl 3-vinyl-1H-indole-1-
carboxylate 179 with NMM took only 20 h. Both reactions were performed in 
refluxing DCM. 
 
The 1H and 13C NMR analysis of D-A cycloadduct 180, recorded at ambient 
temperature, showed two sets of peaks, which revealed the presence of two 
rotamers, resulting from a high rotational energy barrier around the amide 
bond (Figure 4.5). To confirm this hypothesis, D-A cycloadduct 180 was 
examined by variable temperature 1H NMR using DMSO-d6 as a solvent. At 
100 °C, the two sets of signals coalesced to a single set of signals (Figure 4.6). 
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82 °C 
100 °C 
60 °C 
40 °C 
25 °C 
 
 
Figure 4.5. The two possible rotamers of the D-A cycloadduct 180 
 
Figure 4.6. (VT) 1H NMR experiment of D-A cycloadduct 180 
 
4.9. Bromination/amino-substitution reaction of D-A cycloadduct (180) 
In the next step, D-A cycloadduct 180 was subjected to our previously modified 
bromination/amination reaction conditions with a variety of secondary amines. 
This allowed us to assess the influence of the Cbz protected D-A cycloadduct 
180 on our bromination/substitution reactions for the synthesis of amino-
substituted-carbazoles. The bromination/substitution reactions of D-A 
cycloadduct 180 with pyrrolidine, morpholine, diethylamine and 1-
methylpiperazine, proceeded smoothly at 0 °C in DCM following our previously 
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optimised conditions (Br2, Cs2CO3 then amine), to give the corresponding 
amino-substituted carbazoles (182-185) in yields ranging from 68-75% (Table 
4.6, entry 1-4).  
 
 
Entry (R)2NH Time/ 
h 
Product Yield [a] 
% 
 
1 
 
 
 
1 
 
 
71 
 
2  
 
2 
 
 
69 
 
3  
2 
 
 
68 
4 
 
2.5 
 
75 
                     [a] Isolated yield of the product 
Table 4.6. Results of the bromination/amination reactions of D-A cycloadduct 180 
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The relative stereochemistry of carbazole 183 was confirmed by X-ray 
diffraction analysis. Crystals of 183 were grown from a DCM by slow 
evaporation. The crystal structure showed that the morpholine had added to 
the carbazole ring on the opposite face to that of the succinimide group (Figure 
4.7). The relative stereochemistry of 182, 184 and 185 was confirmed though 
comparison of the 1H NMR spectral data for each compound with those 
observed for carbazole 183. 
 
 
 
Figure 4.7. X-ray crystal structure of carbazole 183 
 
4.10. The functional groups important for bioactivity   
The good results obtained from the preparation of Cbz protected amino-
substituted carbazoles (Table 4.6, entry 1-4) encouraged us to extend this 
methodology to generate a library of potentially bioactive compounds, since 
our target compounds shared a number of common structural features with 
several known biologically active molecules such as 80 and 175 (Figure 4.4).  
 
Ty and co-workers have been reported the structure activity relationship (SAR) 
of the tetrahydrocarbazole series 80, 71 based on their cytotoxicity against B16 
melanoma cells and the inhibition of tubulin polymerization (ITP), (Figure 4.8).  
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Figure 4.8. SAR of tetrahydrocarbazole series 80 against B16 melanoma cells 
 
The biological activity of tetrahydrocarbazole derivatives 175 has recently 
been studied within our research group (Figure 4.9). The influence of a variety 
of functional groups at the R1, R2 and R3 positions of the library of test 
compounds were determined against Staphylococcus aureus (S. aureus) and 
Escherichia coli (E. coli), Figure 4.9. 
 
 
Figure 4.9. SAR of tetrahydrocarbazole series 175 
 
4.11. Synthetic plan to pyrrolo[3,4-a]carbazoles for biological assay 
Based on the biological activity of known tetrahydrocarbazoles 80 and 175, we 
decided to synthesise a series of substituted carbazoles bearing electron 
withdrawing (EWG) or donating (EDG) groups at the R1 position of the indole 
ring. We would then be able to generate a library of substituted carbazoles 
and evaluate their biological activities, after Cbz deprotection.  
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Following our successful bromination/substitution method, we planned to 
synthesise amino-substituted carbazoles 192 by a formylation reaction of the 
commercially available 5-substituted-1H-indoles 186, followed by a 
Wittig/protection reaction sequence to provide dienes 188. The D-A 
cycloaddition of 188 with a range of dienophiles would give cycloadducts 190, 
which could then be functionalised further with different secondary amines. 
The Final step towards 192 involves removing the Cbz protecting group of 
compounds 191 (Scheme 4.20).   
 
Scheme 4.20. Synthesis of amino-substituted carbazoles192 for biological assay 
 
4.11.1. Formylation reaction of 5-substituted-1H-indoles (193) and 
(194) 
We started our investigation with a formylation reaction of commercially 
available 5-fluoro-1H-indole 193 and 5-(benzyloxy)-1H-indole 194, using 
Vilsmeier-Haack formylation conditions following a literature procedure.104,105 
In the presence of dimethylformamide (DMF) and phosphorus oxychloride 
(POCl3), compounds 193 and 194 were regioselectively formylated at the 3-
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position to give the corresponding indoles 195 and 196 in excellent yields of 
97% and 83% respectively (Table 4.7, entry 1-2). Due to the high purity of the 
products, assessed by 1H NMR of the crude reaction mixtures, both 
compounds were used in the next step without any further purification being 
necessary.  
 
 
 
Entry SM Product Yield 
% 
1 
 
 
97 
2 
  
83 
Table 4.7. Results of Vilsmeier-Haack reaction to form 195 and 196 
 
Once we had synthesised gram quantities of indoles 195 and 196, the 
subsequent step was to synthesise the corresponding 3-vinyl-1H-indole 
compounds 197 and 198 through a Wittig reaction.  
 
Following our previously optimised conditions, the NH of indoles 195 and 196 
were first deprotonated with NaHMDS followed by reaction with the 
phosphonium ylide, formed from Wittig salt 153 and n-butyllithium. The 
expected 5-fluoro-3-vinyl-1H-indole 197 and 5-phenethoxy-3-vinyl-1H-indole 
198 were obtained in very good isolated yields of 87% and 78%, respectively 
(Table 4.8, entry 1-2). 
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Entry SM product Yield [a] 
% 
1 
  
 
87 
 
2 
  
78 
                        [a] Isolated yield of the product  
Table 4.8. Wittig reaction of indoles 197 and 198 
 
4.11.2. Synthesis of dienes (199) and (200) 
The indolic nitrogens of 197 and 198 were then protected with a Cbz group 
using CbzCl at 0 °C, in the presence of NaHMDS. After 4 hours, the 
corresponding Cbz protected compounds 199 and 200 were obtained in good 
isolated yields after purification by column chromatography (Scheme 4.20). 
 
 
Scheme 4.20. Cbz protection reaction of 197 and 198 
 
4.11.3. Diels-Alder reaction of dienes (199) and (200) 
With dienes 199 and 200 in hand, the D-A reaction was then attempted with a 
range of maleimide compounds. The D-A reaction of 5-fluoro-3-vinyl-1H-indole 
199 with NMM, NPM or maleimide, was performed in DCM at 40 °C for 24 
hours.  The corresponding D-A cycloadducts (201-203) were isolated as single 
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diastereomers in good yields (Table 4.7, entry 1-3). The more electron rich 
diene 5-phenethoxy-3-vinyl-1H-indole 200, reacted more rapidly with NMM in 
the D-A reaction, requiring only 18 hours in refluxing DCM to give a single 
diastereomer of the corresponding D-A cycloadduct 204, in 76% isolated yield 
(Table 4.7, entry 4). 
 
 
 
Entry SM Reaction 
conditions 
D-A cycloadduct [a] Yield[b] 
%  
1 
 
 
NMM, 40 °C, 
24 h, DCM 
  
69 
2 
 
NHM, 40 °C, 
24 h, DCM 
 
70 
3 
 
NPM, 40 °C, 
24 h, DCM 
 
72 
4 
 
NMM, 40 °C, 
18 h, DCM 
 
 
76 
[a] Two rotamers of D-A cycloadduct were obtained. [b] Isolated yield of D-A cycloadduct 
Table 4.7. Results of the D-A reaction of 199 and 200 with NMM, NPM or NHM 
 
The relative stereochemistry of the D-A cycloadduct 201 was confirmed by X-
ray diffraction analysis. Crystals of D-A cycloadduct 201 were grown from 
petrol/ethyl acetate by slow evaporation. The crystal structure showed that the 
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relative stereochemistry of D-A cycloadduct 201 was consistent with an endo 
selective D-A reaction between diene 199 and NMM (Figure 4.9). 
 
 
 
Figure 4.9. X-ray crystal structure of D-A cycloadduct 201 
 
 
4.11.4. Bromination/ substitution reactions of D-A cycloadducts 
(201 - 204) 
In the next step our previously synthesised substituted D-A cycloadducts (201-
204), were functionalised with a range of secondary amines in DCM. The 
outcome of these reactions are summarised in Table 4.8.  
 
The one-pot bromination/substitution reactions of D-A cycloadducts 201 and 
202 with pyrrolidine, morpholine, piperidine and 1-methylpiperazine were 
examined. The corresponding amino-substituted carbazoles (205 - 210) were 
isolated in good yields ranging from 67-81% (Table 4.8, entry 1-6).  
 
A reaction between D-A cycloadduct 203 and morpholine was also 
investigated. This reaction was performed at 0 °C for 5 hours in DCM. Analysis 
of the resulting 1H NMR of the crude reaction mixture indicated a 3:1 mixture 
of the desired substituted product 211 and unreacted starting materials (Table 
4.8, entry 7). All of the attempts to purify the desired compound by column 
chromatography failed due to the close similarity in the Rf values to that of the 
starting material.  
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In addition, the one pot bromination/amination reaction of D-A cycloadduct 204 
with pyrrolidine led to the isolation of the corresponding substituted-carbazole 
212 in a 70% isolated yield (Table 4.8, entry 8). 
 
 
 
Entry SM (R3)2NH Time 
h 
Product Yield 
 %[a] 
1 
 
 
 
1 
 
76 
2 
 
 
 
2 
 
81 
3 
 
 
2 
 
67 
4 
 
 
 
1 
 
75 
Chapter 4 Bromination/Substitution Chemistry of 3-Vinyl-1H-Indole 
 
Page 95 
 
5 
 
 
 
2 
 
76 
6 
 
 
2 
 
81 
7 
 
 
5 
 
N/A[
b] 
8 
 
 
 
1 .5 
 
70 
[a] Isolated yield of the product. [b] A 3:1 mixture of the desired compound and the SM was 
observed but separation was not possible by chromatography 
 
Table 4.8. Synthesis of amino-substituted carbazole derivatives (205-212) 
 
4.11.5. Removal of the Cbz protecting group  
With a range the Cbz substituted carbazoles in hand, the next step in our 
synthetic plan was to remove the Cbz protecting group in order to explore the 
biological activity of the generated molecules.  
 
Deprotection of the Cbz group was examined using Adam’s catalyst (platinum 
dioxide, PtO2) in THF at r.t. under an atmosphere of hydrogen. The reaction 
mixture was filtered through the celite to remove the catalyst and purified by 
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column chromatography to give the desired compounds (213– 220) as single 
diastereomers in high yields ranging from 67-90% (Table 4.9, entry 1-8).  The 
Cbz deprotection reaction of 184 was also examined. 1H NMR of the crude 
reaction mixture showed a peak at 8.80 ppm corresponds to the NH of the 
desired product 221. However, all attempts to isolate the desired product 221 
by column chromatography were unsuccessful might due to decomposition of 
184 on the acidic silica gel during chromatography. Similarly, when the Cbz 
removal from carbazole 185 was attempted, the 1H NMR spectrum of the 
crude reaction mixture revealed the formation of the desired compound 222 
along with unreacted starting material in a (3:1) ratio. However, all attempts to 
isolate the desired carbazole 222 by column chromatography failed, due to the 
close similarity in the Rf values to that of the starting material. Finally, the 
double deprotection of the Cbz and benzyl groups of carbazole 212 was 
investigated. 1H NMR spectrum of the crude reaction mixture indicated a 
mixture of unidentified compounds. We expected that the desired compound 
223 might be formed in the reaction, but the electron donating properties of 
the hydroxyl group resulted in an unstable carbazole which decomposed 
during purification attempts. 
 
 
 
Entry SM Time/ 
h 
Product Yield 
[a] 
% 
 
1 
 
 
6 
 
 
75 
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2 
 
 
7 
 
 
80 
 
3 
 
 
6 
 
 
90 
 
4 
 
 
8 
 
 
81 
 
5 
 
 
5 
 
 
67 
 
6 
 
 
7 
 
 
78 
 
7 
 
 
6 
 
 
75 
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8 
 
 
5 
 
 
80 
 
9 
 
 
6 
 
N/A[b] 
 
10 
 
 
5 
 
 
N/A[b] 
 
11 
 
 
7 
 
 
N/A[b] 
         [a] Isolated yield of the product. [b] The product was unobtainable  
Table 4.9. Removal of the Cbz protecting group 
 
The anti- arrangement between the amine and succinimide groups of the 
synthesised deprotected substituted carbazoles (Table 4.9, entry 1-8) was 
determined using coupling constant analysis in a comparison with those of 
Cbz-protected amino-substituted carbazole 183, which have in turn been 
corroborated previously by single crystal X-ray crystallography (Figure 4.7).  
 
4.12. Epimerisation of diastereomer (213) to (225)  
Although the catalytic hydrogenation reaction of our synthesised substituted 
carbazoles over PtO2 produced single diastereomers of the corresponding 
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deprotected compounds (Table 4.9, entry 1-8), the 1H NMR spectrum of the 
purified product 213 showed two similar sets of signals after 24 hours in 
solution. Further analysis by 13C, COSY, and HMQC spectroscopy indicated 
that this mixture appeared to be two diastereomers of carbazole 213 in a 5:1 
ratio. We thus proposed that the initial isolated diastereomer 213 is not stable 
in solution and can epimerise to give the more thermodynamically stable 
diastereomer 225 (Scheme 4.21).  
 
 
Scheme 4.21. Epimerisation reaction of 213 to give 225 
 
4.12.1. Investigation of the epimerisation reaction of (213) to (225) 
In order to understand the mechanism of the previously proposed 
epimerisation process, a solution of 5.0 milligrams of the isolated diastereomer 
213 in 3.0 mL of deuterated DCM was transferred into an the NMR tube. The 
change in the ratio between epimers 213 and 225 was recorded over time 
using 1H NMR spectroscopy while the solvent, sample concentration and 
temperature (r.t.) kept constant in each experiment. The signal intensities of 
selected peaks, including the broad NH, and Ha of each individual 
diastereomers were employed to determine the epimeric ratio of 213 to 225 in 
the solution (Figure 4.10). After 672 hours, the ratio of 213 to 225 was 1:3 and 
this ratio did not change, suggesting that equilibrium had been reached. 
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Figure 4.10. Epimerisation of isolated diastereomer 213 to 225 in DCM 
 
This result showed that epimerisation of 213 was slow under the used 
conditions; therefore we decided to examine the influence of the acid on the 
rate of the epimerisation process. The proposed interconversion of 213 to 225 
by change of the pyrrolidine configuration could proceed by either an SN1 or 
SN2 mechanism. We hypothesised that addition of catalytic amount of acid 
would speed up the rate of epimerisation, by protonation of the pyrrolidine and 
thus accelerating the rate of the formation of the carbocation intermediate in 
the case of an SN1 pathway. To examine this hypothesis, 0.05 mol% of 
trifluoroacetic acid (TFA) was added to a solution of 213 in 3.0 mL of 
deuterated DCM. However, 1H NMR spectrum did not show the expected 
epimerisation process, indicating TFA may not be the optimal catalyst in this 
reaction and may favour the production of other products.  
  
24 h 
48 h 
72 h 
96 h 
120 h 
168 h 
672 h 
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Next, we decided to monitor the epimeric ratio of 213 to 225 at higher 
temperature as an attempt to promote the rate of the epimerisation. Therefore 
the ratio of 213 to 225 was recorded over time by 1H NMR over 3 days in 
deuterated DMSO at 60 °C. Selected spectra are given in Figure 4.11. 
 
 
 
Figure 4.11. Epimerisation of isolated diastereomer 213 to 225 in DMSO 
 
The recorded ratios of the epimers 213 and 225 were then plotted against the 
time (Figure 4.12), data from this study showed that diastereomer 213 
undergoes epimerisation rapidly to give 225 in a solution of DMSO at 60 °C, 
and the system reached equilibrium after approximately 990 min, based on the 
integration of the 1H NMR spectrum.  
  
30 min 
90 min 
  210 min 
Hc 
  330 min 
  510 min 
  990 min 
Hb 
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Figure 4.12. Ratio of 213 to 225 in DMSO over time 
 
4.12.2. Proposed mechanism for the epimerisation of diastereomer 
(213) to (225) 
We therefore propose that the observed epimerisation of 213 to 225 starts with 
elimination of the pyrrolidine followed by re-addition of the eliminated 
pyrrolidine to the sp2 hybridised cation of 224 to give diastereomer 225 with a 
syn-arrangement between the pyrrolidine and the succinimide groups 
(Scheme 4.22).  
 
 
Scheme 4.22. Postulated epimerisation mechanism of 213 to 225 
 
The HRMS data of the isolated diastereomer 213 also provides supporting 
data for the postulated mechanism for this epimerisation. The mass 
spectrometric data showed an m/z of [M-(N-CH2)4]+ as the major peak 
suggesting that the pyrrolidine group is labile under these conditions, 
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supporting the hypothesis that intermediate 224 could be generated in solution 
after elimination of the pyrrolidine group from compound 213.  
 
 
Figure 4.13. HRMS of carbazole 213 
 
4.13. Biological evaluation  
Due to the structural relationship between our synthesised amino-substituted 
pyrrolo[3,4-a]carbazole-1,3-dione derivatives with a range of biologically 
active compounds, discussed previously, the next stage was to evaluate the 
biological activity of the produced compounds (213 - 220) and to assess how 
distinct bioactivity may be correlated with structural variation. Therefore we 
decided to screen the biological activity of compounds (213 - 220) against the 
key ESKAPE pathogens Escherichia coli (E. coli), Klebsiella pneumoniae (K. 
pneumoniae), Acinetobacter baumannii (A. baumannii), Pseudomonas 
aeruginosa (P. aeruginosa), and Staphylococcus aureus (S. aureus), as well 
as the fungi Cryptococcus neoformans (C. neoformans) and Candida albicans 
(C. albicans).  
The antimicrobial assays of Cbz deprotected compounds (213 - 220) were 
carried by J. Zuegg at the Community for Open Antimicrobial Discovery at the 
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University of Queensland. The Sample preparation and procedures for the 
bioassay are given in appendix 2.   
 
The obtained results from this study showed that only amino-substituted 
carbazole 220 showed a moderate activity against C. albicans at a 
concentration of γβ ȝg/mL. Further investigations need to be carried out in 
order to propose the mode of action of the bioactive compound 220.  
 
4.14. Conclusion  
In this chapter, we have developed a one-pot bromination/substitution 
approach for the synthesis of pyrrolo[3,4-a]carbazole-1,3-dione frameworks. 
We demonstrated that a bromination/substitution reaction sequence of the 
tosyl protected D-A cycloadduct 149 with a range of alcohols or secondary 
amines could procced by either an SN1 or an SN2 mechanism, to give the 
corresponding substituted carbazole (156 - 159 ) and (172 - 174) in syn- or 
anti- stereochemistry respectively, as observed by the X-ray analysis.  
 
Due to the difficulty in removing the tosyl protecting grouop, Cbz was used to 
protect the indolic nitrogen of the 5-substituted-3-vinyl-1H-indoles 197 and 
198.  The Cbz protecting group of the amino-substituted carbazole derivatives 
(182 - 185), and (205 - 212) was then easily removed using a hydrogenation 
reaction. The deprotected compounds (213 - 220) have been tested for 
antimicrobial activity against key ESKAPE pathogens, E. coli, K. pneumoniae, 
A. baumannii, P. aeruginosa and S. aureus (MRSA), as well as the fungi C. 
neoformans and C. albicans. Only compound 220 showed some activity 
against C. albicans. 
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 Chapter 5. 
Conclusion and future work 
 
5.1. Conclusion  
The overall aim of this research project was to explore new synthetic routes to 
the tetrahydropyrrolo[3,4-a]carbazole ring system, which is found in many 
synthetic and naturally occurring biologically active compounds. We have 
investigated two new synthetic approaches for the construction of molecules 
in this class, first via a D-A/ene approach and secondly via a D-A/ 
bromination/substitution approach. 
 
5.1.1. Diels-Alder/ene approaches to the pyrrolo[3,4-a]carbazoles  
Firstly, we have developed a new diastereoselective approach for the 
synthesis of a functionalised pyrrolo[3,4-a]carbazole ring system through the 
use of an intermolecular D-A reaction in conjunction with an inter- or an 
intramolecular ene reaction. 
 
A range of D-A cycloadducts 227 have been synthesised through a D-A 
reaction of N- protected-substituted 3-vinyl-1H-indoles 226 with maleimides in 
the presence of a Lewis acid catalyst (Scheme 5.1). We demonstrated that the 
Me2AlCl catalyst was highly efficient in accelerating the rate of D-A 
cycloaddition of N- protected-substituted-3-vinyl-1H-indoles 226, which was 
unreactive diene under either thermal or thiourea catalysed conditions. 
 
 
Scheme 5.1. Route to the D-A cycloadducts 227 
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The intermolecular ene reactions of D-A cycloadducts 91 with nitroso and aza 
enophiles afforded a single diastereomer of the corresponding 
tetrahydropyrrolo[3,4-a]carbazole 92 (Scheme 5.2).  
 
 
Scheme 5.2. Intermolecular ene reaction of D-A cycloadducts 91 
 
The relative stereochemistry of the isolated D-A/ene adducts 92 was deduced 
using X-ray crystallography, which revealed that the enophiles was added to 
the opposite face of the succinimide group.  
 
Polycyclic pyrrolo[3,4-a]carbazoles 113 and 122 was also synthesised in a 
good yield using a three-step sequence involving an intermolecular D-A, 
Swern oxidation and intramolecular carbonyl-ene reaction of indole (Z)-110 
and (Z)-119  (Scheme 5.3). The X-ray crystal structures revealed that the 
reactive aldehyde of 112 and 121 abstracted the hydrogen from the same face, 
and therefore the formed ring was on the opposite face of the molecule relative 
to the succinimide group.   
 
Examination of the intramolecular carbonyl-ene mechanism indicates that the 
intramolecular ene reaction of both precursors 112 and 121 were most likely 
formed by a concerted ene mechanism 
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Scheme 5.3. Synthetic approach to polycyclic pyrrolo[3,4-a]carbazoles 113 and 122 
 
5.1.2. Diels-Alder/one-pot bromination/substitution reaction 
approaches to the pyrrolo[3,4-a]carbazole ring system 
Secondly we have successfully demonstrated a sequential D-A/one-pot 
bromination/substitution reaction to give substituted tetrahydropyrrolo[3,4-a] 
carbazole derivatives with relative stereocontrol of up to three stereocentres 
(Scheme  5.4 and  5.5). 
 
 
Scheme 5.4.  Synthesis of a range of substituted carbazoles 159 
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Scheme 5.5.  Synthesis of amino-substituted carbazoles 232 
 
Interestingly oxygen nucleophiles showed a propensity to add to the same face 
as the succinimide ring, whilst amine based nucleophiles added to the 
opposite face (Figure 5.1).This suggests that a different mechanism maybe 
operating in the case of the two different nucleophiles, either due to a change 
in the experimental conditions (reaction solvent, addition order etc.) or due to 
the nature of the nucleophile. Further experiments are planned to probe the 
mechanism and the stereoselectivity of this process. 
 
 
 
 
 
Figure 5.1.  X-ray structure of substituted carbazoles 158 and 166 
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5.1.3. Preparation of pyrrolo[3,4-a]carbazole-1,3-diones for 
biological assay 
Since our synthesised substituted compounds possess a pyrrolo[3,4-a] 
carbazole-1,3-dione framework found in many biologically active 
compounds,48 we needed to remove the N-protecting groups (tosyl or Cbz) to 
free up the NH of indole as it is an important H-bonding site required for 
biological activity. After showing that removal of the tosyl group was difficult, 
we focused on the use of a Cbz protecting group that could be easily removed 
by hydrogenation (Scheme 5.6). The deprotected compounds 232 are 
currently awaiting biological evaluation for their antibiotic properties against a 
range of ESKAPE pathogens. 
 
 
Scheme 5.6.  Deprotection of synthesised carbazoles 231 for biological assay 
 
5.2. Future Work 
Further work on the construction of fused pyrrolo[3,4-a]carbazole molecules 
would primarily focus on the investigation of the intramolecular imine-ene 
reactions of ene precursors  233 and 234. The imine-ene reaction has been 
extensively reported,106,107 thus an in situ condensation of different primary 
amines to the aldehyde of the previously synthesised compounds 112, and 
121, would allow the rapid formation of a library of imines. We predict that the 
formed imines would undergo an imine-ene reaction to generate a range of a 
fused pyrrolo[3,4-a]carbazole compounds, which could be of potential interest 
as building blocks for drug design. 
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Scheme 5.7. Synthetic plan to investigate the intramolecular imine-ene reaction 
 
In addition we wish to further investigate the mechanism behind the 
bromination/substitution chemistry developed in this thesis, to better 
understand the reaction and the stereocontrol observed. This would also 
include a study of the epimerisation reaction of 213 to give 225 (Scheme 5.8), 
by examining the influence of different concentrations of the substrate, the 
influence of different solvents and how the reaction varies with temperature.  
 
 
Scheme 5.8. The epimerisation of 215 to 227 
 
Finally, studying the results of bioactivity assays (currently underway) of the 
compound series (213–220) will allow us to determine whether these 
compounds show any promise as antibiotics or as biological probes. 
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Chapter 6.  
Experimental 
 
6.1. General experimental procedures 
All reactions were performed in dried glassware under a nitrogen atmosphere. 
The reagents and chemicals were purchased from commercial suppliers 
(Sigma Aldrich, Alfa Aesar and TCI.The solvents were distilled prior to use; 
toluene, DMF and DCM were distilled from calcium hydride; THF and diethyl 
ether were distilled from sodium wire in the presence of benzophenone. Thin 
layer chromatography (TLC) was visualized with UV light (Ȝ = βγ5 nm). 
Purification was carried out by column chromatography (flash, Kieselgel 60 
silica gel). Infrared spectra (IR) analysis was performed using Varian 800 FT-
IR Scimitar Series spectrometer scanning from 4000-600 cm-1. Melting points 
were carried out on a Stuart SMP3 melting point apparatus and are 
uncorrected. 1H and 13C NMR spectra were recorded using a Jeol Lambda 
500 spectrometer, Jeol ECS-400 spectrometer or a Brüker AMX300 
spectrometer. HRMS data were provided by National Mass Spectrometry 
Service (University of Swansea). X-ray diffraction data was obtained on an 
Oxford Diffraction Gemini.  
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6.2. Synthetic procedures  
 
1-Tosyl-1H-indole-3- carbaldehyde (89)  
 
A solution of indole-3-carbaldehyde 88 (5.00 g, 43.45 
mmol) in DCM (120 mL) was cooled down to 0 oC.  
Triethylamine (12 mL, 86.15 mmol) was added dropwise 
over 10 min to the solution. The reaction mixture was stirred 
for 10 min and 4-toluenesulfonyl chloride (7.225 g, 37.90 
mmol) was added. The mixture was stirred for 2 h at 0 oC 
before it warmed to room temperature. After 48 h, the 
reaction mixture was quenched with water (50 mL).  The organic layer was 
extracted with DCM (2 x 150 mL), washed with brine, dried with anhydrous 
MgSO4 and filtered. The solvent was removed under reduced pressure. The 
crude red product was purified by recrystallisation from ethyl acetate to give 
1-tosyl-1H-indole-3-carbaldehyde in (8.11 g, 27.09 mmol, 79%) as bright 
yellow crystals. 
 
Mp. 145 – 147 oC (lit. 148 – 150 oC).72 Rf : 0.42 (petrol / ethyl acetate 7:3). 1H 
NMR (400 MHz, CDCl3): δH 10.08 (s, 1H, H10), 8.24 (d, J = 7.0 Hz, 1H, H(1 or 
4)), 8.22 (s, 1H, H9), 7.94 (d, J = 7.4 Hz, 1H, H(1 or 4)),  7.84 (d, J = 8.5 Hz, 2H, 
H(5-6) or (7-8)), 7.40 (t, J = 7.4 Hz, 1H, H(2 or 3)), 7.35 (t, J = 7.0 Hz, 1H, H(2 or 3)), 
7.29 (d, J = 8.0 Hz, 2H, H(5-6) or (7-8)),  2.35 (s, 3H, H11). 13C NMR (100 MHz, 
CDCl3): δC 185.5 (C10), 146.2, 136.4, 135.2, 134.4, 130.4, 127.3, 126.4, 126.3, 
125.0, 122.6, 122.4, 113.2, 22.1 (C11). IR (neat): νmax/cm-1: 1663 (CHO), 1539 
(C=C). 
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Ethyl (Z)-5-(1-tosyl-1H-indol-3-yl)pent-4-enoate (90) 
 
In a Schlenk flask, (4-ethoxy-4-oxobutyl) 
triphenylphosphonium bromide (3.32 g, 7.26 
mmol) was dissolved in THF (20 mL).  The 
solution was cooled to -78 oC. Sodium bis 
(trimethylsilyl) amide (1.0 M in THF, 8.58 mL, 
8.58 mmol) was added dropwise over 10 min. 
The mixture was warmed to 0 oC and left to stir 
for 2 h.   In a separate round bottomed flask, 1-(toluene-4-sulfonyl)–1H-indol-
3-carbaldehyde 89 (2.00 g, 6.60 mmol) was dissolved in THF (10 mL) and 
transferred via cannula into the reaction solution. The reaction mixture was 
stirred at room temperature and for 48 h, quenched with saturated NH4Cl(aq) 
(30 mL), the organic layer was extracted with EtOAc (2 x 200 mL), washed 
with brine, dried over MgSO4 and filtered.  The solvent was removed under 
reduced pressure to give an orange crude product as a mixture of E and Z 
isomers of ethyl-5-(1-tosyl-1H-indol-3-yl)pent-4-enoate. The product was 
purified by column chromatography (petrol / ethyl acetate 10:1) to give the 
desired ethyl (Z)-5-(1-tosyl-1H-indol-3-yl)pent-4-enoate (1.568 g, 3.94 mmol, 
60%) as a colourless oil.  
 
Rf : 0.7 (petrol / ethyl acetate 7:3).1H NMR (400 MHz, CDCl3): δH 7.97 (d, J = 
7.9 Hz, 1H, H(1 or 4)), 7.77 (d, J = 7.8 Hz, 2H, H(5, 6) or (7,8)), 7.57 (s, 1H, H10), 7.49 
(d, J = 7.9 Hz, 1H, H(1 or 4)), 7.32 (t, J = 7.9 Hz, 1H, H(2 or 3)), 7.25 (t, J = 7.9 Hz, 
1H,  H(2 or 3)), 7.20 (d, J = 7.8 Hz, 2H, H(5,6)  or  (7,8)), 6.44 (d, J = 11.2 Hz, 1H, 
H11), 5.78 (dt, J = 11.2, 7.5 Hz, 1H, H12), 4.14 (q, J = 6.5 Hz, 2H, H15), 2.67 - 
2.62 (m, 2H, H13), 2.48 (t, J = 6.9 Hz, 2H, H14), 2.30 (s, 3H, H9), 1.24 (t, J = 6.5 
Hz, 3H, H16). 13C NMR (100 MHz, CDCl3): δC 172.8 (CO2Et), 145.1, 135.1, 
134.6, 132.1, 130.8, 129.9, 126.8, 124.9, 123.6, 123.4, 119.5, 118.96, 113.6, 
60.5 (C15), 34.1 (C13 or 14), 25.2 (C13 or 14), 21.6 (C9), 14.3 (C16). IR (neat): ν 
max/cm-1: 1727 (CO), 1597 (C=C). MS (pNSI): 415.2 (100%, [M+NH4]+), 398.1 
(20%, [M+H]+), 420.1 (10%, [M+Na]+); HRMS (pNSI): calcd C22H24NO4S 
[M+H]+: 398.1412; observed: 398.1412.  
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 (4-Ethoxy-4-oxobutyl)triphenylphosphonium bromide  (94) 
 
A solution of triphenylphosphine (4.600 g, 17.6 
mmol) and ethyl-4-bromobutyrate 93 (1.8 mL, 
12.60 mmol) in toluene (20 mL) was refluxed for 
24 h. The resultant white precipitate was filtered off with suction and washed 
with toluene to give (4-ethoxy-4-oxobutyl) triphenylphosphonium bromide in 
(4.531 g, 9.90 mmol, 79%) as a white solid.  
 
Mp. 175  – 177 oC (lit. 173 - 174 oC).73 1H NMR (400 MHz, CDCl3): δH 7.90 - 
7.83 (m, 6H), 7.79 - 7.74 (m, 3H), 7.70 - 7.65 (m, 6H), 4.07 (q, J = 7.1 Hz, 2H, 
H4), 4.07 - 3.99 (m, 2H, H1), 2.87 (td, J = 6.6, 1.5 Hz, 1H), 1.95 - 1.85 (m, 2H, 
H2), 1.21 (t, J = 7.1 Hz, 3H, H5).13C NMR (100 MHz, CDCl3): δC 173.1 (CO2Et), 
135.1 (Jcp = 2.8 Hz), 133.7 (Jcp = 10.2 Hz), 130.5 (Jcp = 12.2 Hz), 118.1 (Jcp = 
87.0 Hz), 60.5(C4), 33.2 (Jcp = 23.2 Hz), 21.7 (Jcp = 52.4 Hz), 18.0, 14.2(C5). 
IR (neat): νmax/cm-1: 2890 (CH), 1720 (CO2Et), 1598 (C=C, Ar). HRMS 
(pNSI): calcd C24H26O2P [M-Br]+: 377.1665; observed: 377.1660. 
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Ethyl 3-((3aS,4S,10aS,10bS)-2-methyl-1,3-dioxo-10-tosyl-
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate 
(96)   
 
A mixture of N-methylmaleimide (0.421 g, 0.38 
mmol) and ethyl-5-(1-tosyl-1H-indol-3-yl) pent-4-
enoate (Z:E, 10:1)-90 (0.154 g, 0.38 mmol) in 
toluene (15 mL) was refluxed for 72 h. The solvent 
was removed under reduced pressure to give the 
crude product which was purified by column 
chromatography (petrol / ethyl acetate 2:1) to yield 
ethyl 3-((3aS,4S,10aS,10bS)-2- methyl-1,3-dioxo-
10-tosyl-1,2,3,3a,4,10,10a, 10b- 
octahydropyrrolo[3,4-a] carbazol-4-yl) propanoate in (0.017 g, 0.03 mmol, 9%) 
as a white solid.  
 
Mp.  175 – 177 oC. Rf : 0.3 (petrol / ethyl acetate 2:1). 1H NMR (400 MHz, 
CDCl3): δH 7.77 (d, J = 7.5 Hz, 2H, H(5,6)  or  (7,8)), 7.67 (d, J = 7.0 Hz, 1H,  H(1 or 
4)), 7.26 - 7.22 (m, 4H, H(5,6) or (7,8), H(2 or 3), H(1 or 4)),  6.98 (t, J = 7.0 Hz, 1H, H(2 
or 3)), 5.84 (t, J = 3.7 Hz, 1H, H10), 4.54 - 4.51 (m, 1H, H11), 4.15 (q, J = 7.5 Hz, 
2H, H17), 4.01 (t, J = 7.8 Hz, 1H, H12), 3.19 - 3.15 (m, 1H, H13),  2.77 (s, 3H, 
H19), 2.58 (t, J = 7.4 Hz, 2H, H16), 2.38 - 2.22 (m, 3H, H(14, 15)), 2.34 (s, 3H, H9), 
1.26 (t, J =7.5 Hz, 3H, H18). 13C NMR (100 MHz, CDCl3): δC 176.2 (CO), 173.7 
(CO), 173.0 (CO), 144.6, 139.8, 137.6, 134.1, 130.6, 129.9, 127.4, 126.0, 
123.7, 121.1, 117.4, 115.2, 61.8 (C17), 60.6 (C11), 43.9 (C12), 40.1 (C13), 37.1 
(C14), 32.4 (C16), 26.5 (C15), 24.3 (C19), 21.7 (C9), 14.3 (C18). IR 
(neat):νmax/cm-1: 1733 (CO2Et), 1698 (N-CO), 2973 (CH). HRMS (pNSI): 
calcd C27H29N2O6S [M+H]+: 509.1741; observed: 509.1730. 
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Ethyl 3-((3aS,4R,10aS,10bS)-2-methyl-1,3-dioxo-10-tosyl 
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate 
(98)     
 
Dimethylaluminum chloride (1.0 M in hexane, 
9.38 mL, 9.38 mmol) was added dropwise to a 
solution of N-methylmaleimide (0.521 g, 4.69 
mmol) in DCM (15 mL) at -78 oC. The mixture left 
to stir for 30 min.  Then, a solution of ethyl (Z)-5-
(1-tosyl-1H-indol-3-yl)pent-4-enoate 90 (4.69 
mmol, 1.863 g) in DCM (15 mL) was added 
dropwise at -78 oC. The reaction mixture was 
refluxed for 48 h, quenched with saturated 
NaHCO3 (aq). The organic layer was extracted with DCM (2 x 100 mL), washed 
with brine, dried over MgSO4 and filtered. The solvent was removed under 
reduced pressure to give the crude yellow solid. The product was purified by 
column chromatography (petrol / ethyl acetate 2:1) to yield ethyl 3-
((3aS,4R,10aS,10bS)-2-methyl-1,3-dioxo-10-tosyl 1,2,3,3a,4,10,10a,10b-
octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate in (2.038 g, 4.01 mmol, 85%) 
a bright yellow solid. 
 
Mp.  187 – 188 oC. Rf : 0.3 (petrol / ethyl acetate 2:1)1H NMR (400 MHz, 
CDCl3):  δH 7.79 (d, J = 7.3 Hz, 2H, H(5,6) or (7,8)), 7.62 (d, J = 7.0 Hz, 1H, H(1 or 
4)), 7.25 - 7.21 (m, 4H, H(5,6)  or  (7,8),  H(2 or 3),  H(1 or 4)),  6.95 (t, J = 7.0 Hz, 1H, H(2 
or 3)), 6.09 (dd, J = 3.7, 6.7 Hz, 1H, H10), 4.85 (dd, J = 3.7, 6.9 Hz, 1H, H11), 
4.15 (t, J = 6.9 Hz, 1H, H12), 4.07 (m, 2H, H17), 3.15 - 3.12 (m, 1H, H14), 3.05 - 
3.02 (m, 1H, H13), 2.83 (s, 3H, H19), 2.43 - 2.36 (m, 2H, H16), 2.35 (s, 3H, H9), 
1.91 - 1.75 (m, 2H, H15), 1.19 (t, J = 7.3 Hz, 3H, H18). 13C NMR (100 MHz, 
CDCl3): δC 178.6 (CO), 174.0 (CO), 172.79 (CO), 144.6, 144.0, 136.6, 134.0, 
130.5, 130.0, 127.5, 126.6, 123.9, 121.0, 116.3, 115.4, 60.6 (C17), 59.9 (C11), 
44.22(C12), 42.98 (C13), 37.2 (C14), 33.1 (C16), 28.3 (C15), 25.3 (C19), 21.70 
(C9), 14.3(C18). IR (neat): νmax/cm-1: 1776 (CO2Et), 1698 (N-CO). HRMS 
(pNSI): calcd C27H29N2O6S [M+H]+: 509.1741; observed: 509.1731. 
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Ethyl 3-((3aS,4R,10aS,10bS)-1,3-dioxo-2-phenyl-10-tosyl-
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate 
(103) 
 
Dimethylaluminum chloride (1.0 M in THF, 2.39 
mL, 2.39 mmol) was added dropwise to a solution 
of N-phenylmaleimide (0.207 g, 1.19 mmol) in 
DCM (5 mL) at -78 oC. The mixture left to stir for 
30 min. Then, a solution of ethyl (Z)-5-(1-tosyl-1H-
indol-3-yl) pent-4-enoate 90 (0.475 g, 1.19 mmol) 
in DCM (10 mL) was added. The reaction mixture 
was heated to reflux for 48 h, quenched with 
saturated NaHCO3 (aq) (10 mL). The organic layer was extracted with DCM (1 
x 100 mL), washed with brine, dried over MgSO4 and filtered. The solvent was 
removed under reduced pressure to give the crude yellow solid product which 
was purified by column chromatography (petrol / ethyl acetate 2:1) to yield 
ethyl3-((3aS,4R,10aS,10bS)-1,3-dioxo-2-phenyl-10-tosyl-
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate in 
(0.5095 g, 0.84 mmol, 71%) as a white solid. 
 
Mp.  201 – 203 oC. Rf : 0.2 (petrol / ethyl acetate 2:1). 1H NMR (400 MHz, 
CDCl3): δH 7. 81 (d, J = 7.3 Hz, 2H, H(5, 6) or (7,8)), 7. 60 (d, J = 7.3 Hz, 1H, H(1 
or 4)), 7.34 – 7.21 (m, 7H, Ar), 7.06 (d, J = 7.3 Hz, 2H, H(5, 6)  or  (7,8)), 6.97 (t,  J 
= 7.3 Hz, 1H, H(2 or 3)), 6.20 (dd, J = 3.4, 7,1 Hz, 1H, H10), 4.59 (dd, J = 3.4, 7.1 
Hz, 1H, H11), 4.18 (t, J = 7.3 Hz, 1H, H12), 4.13 – 4.05 (m, 2H, H17), 3.26 - 3.20 
(m, 2H, H(13, 14)), 2.45 – 2.40 (m, 2H, H16), 2.35 (s, 3H, H9), 1.89 - 1.85 (m, 2H, 
H15), 1.20 (t, J = 6.9 Hz, 3H, H18). 13C NMR (100 MHz, CDCL3): δC 177.5 (CO), 
172.9 (CO), 172.7 (CO).144.6, 144.3, 137.0, 134.1, 131.7, 130.7, 130.0, 
129.0, 128.5, 127.6, 126.7, 126.3, 124.0, 120.9, 116.2, 115.5, 60.8 (C17), 60.0 
(C11), 44.3 (C12), 43.1 (C13), 37.7 (C14), 33.2 (C16), 28.3 (C15), 21.6 (C9), 14.2 
(C18). IR (neat): νmax/cm-1: 1776 (CO2Et), 1703 (N-CO). MS (pNSI): 588.21 
(100%, [M+NH4]+), 1158.39 (33%, [2M+NH4]+);  HRMS (pNSI): calcd 
C32H31N2O6S [M+H]+: 571.18; observed: 571.1891. 
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Ethyl3-((3aS,4R,10aS,10bS)-1,3-dioxo-10-tosyl-1,2,3,3a,4,10,10a,10b-
octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate   (104) 
 
Dimethylaluminum chloride (1.0 M in in hexane, 
2.86 mL, 2.86 mmol) was added dropwise to a 
solution of maleimide (0.14 g, 1.43 mmol) in DCM 
(5 mL) at -78 oC. The mixture left to stir for 30 min. 
Then, a solution of ethyl (Z)-5-(1-tosyl-1H-indol-3-
yl) pent-4-enoate 90 (0.57 g, 1.43 mmol) in DCM 
(10 mL) was added. The reaction mixture was 
slowly heated to reflux for 48 h, quenched with 
saturated NaHCO3 (aq) (5 mL). The organic layer 
was extracted with DCM (1 x 100 mL), washed with brine, dried over MgSO4 
and filtered. The solvent was removed under reduced pressure to give the 
crude yellow solid product which was purified by column chromatography 
(petrol / ethyl acetate 2:1 gradient to 1:1 petrol / ethyl acetate) to yield ethyl 3-
((3aS,4R,10aS,10bS)-1,3-dioxo-10-tosyl-1,2,3,3a,4,10,10a,10b-
octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate in (0.452 g, 0.91 mmol, 64%) 
as a white solid. 
 
Mp.  218 – 220 oC. Rf : 0.14 (petrol / ethyl acetate 1:1). 1H NMR (400 MHz, 
CDCl3):  δH 7.78 (d, J = 6.9 Hz, 2H, H(5, 6) or (7, 8)), 7. 64 (d, J = 6.8 Hz, 1H, H(1 
or 4)),  7.27 – 7.22 (m, 4H, H(5,6)  or  (7,8), H(1 or 4), H(2 or 3)), 6.98 (t, J = 7.8 Hz, 1H, 
H(2 or 3)), 6.16 (dd, J = 3.6, 7,1 Hz, 1H, H10), 4.84 (dd, J = 3.6, 7.3 Hz, 1H, H11), 
4.18 (t, J = 7.3 Hz, 1H, H12), 4,12 – 4.05 (m, 2H, H17), 3.16 - 1.12 (m, 1H, H14), 
3.10 (t, J = 7.3 Hz, 1H, H13), 2.40 (t, J = 7.3 Hz, 2H, H16), 2.35 (s, 3H, H9), 1.89 
- 1.76 (m, 2H, H15), 1.20 (t, J = 7.5 Hz, 3H, H18). 13C NMR (100 MHz, CDCL3): 
δC 178.3 (CO), 173.6 (CO), 172.7 (CO), 144.5, 144.1, 136.6, 133.8, 130.5, 
129.8, 127.5, 126.6, 123.8, 120.0, 116.4, 115.5, 60.8 (C17), 59.6 (C11), 45.2 
(C12), 44.0 (C13), 36.9 (C14), 33.0 (C16), 27.8 (C15), 21.5 (C9), 14.1(C18).IR 
(neat): νmax/cm-1: 3657 (br, NH), 2981 (CH), 1776 (CO2Et), 1703 (N-CO). MS 
(pNSI):  512.18 (100 %, [M+NH4]+), 495.15 (55 %, [M+H]+), 340.14 (31%, [M-
Ts]+); HRMS (pNSI): calcd C26H27N2O6S [M+H]+: 495.1584; observed: 
495.1585. 
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Ethyl 3-((3aS,4S,5S,10bS)-5-(hydroxy(o-tolyl)amino)-2-methyl-1,3-dioxo-
10-tosyl-1,2,3,3a,4,5,10,10b-octahydropyrrolo[3,4-a]carbazol-4-yl) 
propanoate (105) 
 
A solution of 2-nitrosotoluene (0.035 g, 0.29 
mmol) and ethyl 3-((3aS,4R,10aS,10bS)-2-
methyl-1,3-dioxo-10-tosyl1,2,3,3a,4,10,10a,10b-
octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate 
98 (0.150 g, 0.29 mmol) in DCM (10 mL) was 
stirred at room temperature for 24 h. The solvent 
was removed under reduced pressure to give the 
crude green solid product which was purified by 
column chromatography (petrol / ethyl acetate 2:1) to give ethyl 3-
((3aS,4S,5S,10bS)-5-(hydroxy(o-tolyl)amino)-2-methyl-1,3-dioxo-10-
tosyl1,2,3,3a,4,5,10,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanoatein 
(0.109 g, 0.17 mmol,  59%) as a bright yellow solid. 
 
Mp.  190 – 192 oC. Rf : 0.26 (petrol / ethyl acetate 2:1). 1H NMR (400 MHz, 
CDCl3):  δH 7.95 (d, J = 7.2 Hz, 1H, H(1 or 4)), 7.61 (d,  J = 7.2 Hz, 2H, H(5,6) or 
(7,8)), 7.18 (d,  J = 7.2 Hz, 2H, H(5,6)  or (7,8)), 7.10 (d, J = 7.2 Hz, 1H, H(1 or 4)), 7.05 
(t, J = 7.2 Hz, 1H, H(2 or 3)), 6.81 (t, J = 7.2 Hz, 1H, H(2 or 3)), 6.65 (t,  J = 7.5 Hz, 
1H, H(21 or 22)), 6.19 (t, J = 7.5 Hz, 1H, H(21 or 22)), 5.88 (d, J = 7.2 Hz, 1H, H(20 or 
23)), 5.46 (d, J = 7.2 Hz, 1H, H(20 or 23)), 4.99 (br, OH), 4.95 (d, J = 7.2 Hz, 1H, 
H10), 4.30 (d, J = 4.6 Hz, 1H, H11), 4.11 (q, J = 7.0 Hz, 2H, H17), 3.80 - 3.75 (m, 
1H, H12), 3.01 (s, 3H, H14), 2.70 - 2.54 (m, 4H, H(15, 16)), 2.41 (s, 3H, H19), 2.33 
(s, 3H, H9), 1.92 - 1.85 (m, 1H, H13), 1.24 (t, J = 7.0 Hz, 3H, H18). 13C NMR 
(100 MHz, CDCl3): δC 178.2 (CO), 173.3 (CO), 149.9, 144.6, 139.9, 137.1, 
134.1, 131.9, 130.6, 130.3, 129.4, 128.7, 127.0, 125.7, 124.8, 124.4, 123.6, 
122.1, 118.9, 118.0, 115.7, 60.6 (C17), 57.8, 45.1, 42.4, 40.0, 32.5, 25.2, 23.3 
(C19), 21.6 (C9), 18.5 (C14), 14.3(C18). IR (neat): νmax/cm-1: 3655 (OH), 2980 
(CH), 1702 (CO).MS (pNSI):  507.15 (100 %, [M-(Tol-N-OH)]+), 652.20 (55 %, 
[M+Na]+); HRMS (pNSI): calcd C34H35N3O7S [M+Na]+: 652.2088; observed: 
652.2082.   
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Ethyl 3-((3aS,4S,5S,10bS)-5-(hydroxy(o-tolyl)amino)-1,3-dioxo-2-phenyl-
10-tosyl-1,2,3,3a,4,5,10,10b-octahydropyrrolo[3,4-a]carbazol-4-yl) 
propanoate  (106)   
 
A solution of 2-nitrosotoluene (0.016 g, 0.13 
mmol) and ethyl 3-((3aS,4R,10aS,10bS)-1,3-
dioxo-2-phenyl-10-tosyl-1,2,3,3a,4,10,10a,10b-
octahydropyrrolo [3,4-a] carbazol-4-yl) 
propanoate 103 (0.08 g, 0.13 mmol) in dry DCM 
(10 mL) was stirred at room temperature for 24 
h. The solvent was removed under reduced 
pressure to give the crude yellow product which 
was purified by column chromatography (petrol / ethyl acetate 2:1) to give ethyl 
3-((3aS,4S,5S,10bS)-5-(hydroxy(o-tolyl)amino)-1,3-dioxo-2-phenyl-10-tosyl-
1,2,3,3a,4,5,10,10b-octahydropyrrolo[3,4-a]carbazol-yl)propanoate in (0.415 
g, 0.059 mmol, 58%) as a bright yellow solid.  
 
Mp.  182 – 184 oC. Rf : 0.34 (petrol / ethyl acetate 2:1). 1H NMR (400 MHz, 
CDCl3):  δH 7.94 (d, J = 6.7 Hz, 1H, Ar), 7.64 (d, J = 6.7 Hz, 2H, Ar), 7.45 – 
7.37 (m, 5H, Ar), 7.20 - 7.00 (m, 4H Ar), 6.84 (t, J = 6.9 Hz, 1H, Ar), 6.66 (t, J 
= 6.9 Hz, 1H, Ar), 6.24 (t, J = 6.2 Hz, 1H, Ar), 5.95 (d, J = 6.9 Hz, 1H, Ar), 5.66 
(d, J = 6.4 Hz, 1H, Ar), 5.20 (d, J = 7.4 Hz, 1H, H10), 4.99 (br, OH), 4.39 (d, J 
= 4.0 Hz, 1H, H13), 4.08 (q, J = 7.2 Hz, 2H, H17), 4.03 – 3.98 (m, 1H, H12), 2.72 
– 2.61 (m, 4H, H(15 ,16)), 2.42 (s, 3H, H19), 2.33 (s, 3H, H9), 2.14 – 2.08 (m, 1H, 
H13). 1.20 (t, J = 7.2 Hz, 3H, H18). 13C NMR (100 MHz, CDCL3): δC 177.0 (CO), 
173.3 (CO), 172.2 (CO), 150.1, 144.6, 137.1, 134.2, 131.0, 131.8, 130.5, 
130.3, 129.4, 129.0, 128.6, 128.5, 127.0, 126.5, 125.8, 124.8, 124.5,123.5, 
122.2, 119.1, 118.1, 115.6, 60.0 (C17), 57.7, 45.3, 42.6, 40.0, 32.4, 23.1 (C19), 
21.6 (C9), 18.5, 14.5 (C18). R (neat): νmax/cm-1: 3858 (NH), 3826 (OH), 1709 
(CO2Et), 1595 (N-CO).MS (pNSI): 569.17 (100%, [M-tol-NOH]+), 692.24 (30%, 
[M+H]+); HRMS (pNSI): calcd C39H36N3O7S [M-H]+: 690.2268; observed: 
690.2266. 
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Ethyl 3-((3aS,4S,5S,10bS)-5-(hydroxy(phenyl)amino)-2-methyl-1,3-dioxo-
10-tosyl-1,2,3,3a,4,5,10,10b-octahydropyrrolo[3,4-a]carbazol-4-yl) 
propanoate (107) 
 
A solution of nitrosobenzene (0.026 g, 0.23 
mmol) and ethyl 3-((3aS,4R,10aS,10bS)-2-
methyl-1,3-dioxo-10-tosyl1,2,3,3a,4,10,10a,10b-
octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate 
98 (0.12 g, 0.23 mmol) in DCM (5 mL) was stirred 
at room temperature for 24 h. The solvent was 
removed under reduced pressure to give the 
crude green solid product which was purified by 
column chromatography (petrol / ethyl acetate 2:1) to give ethyl 3-
((3aS,4S,5S,10bS)-5-(hydroxy(phenyl)amino)-2-methyl-1,3-dioxo-10-tosyl-
1,2,3,3a,4,5,10,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate in (0.75 
g, 0.12 mmol, 52%) as a bright yellow solid. 
 
Mp.  175 – 177 oC. Rf : 0.26 (petrol / ethyl acetate 2:1).1H NMR (700 MHz, 
DMSO-d6): δH 8.45 (s, 1H, OH), 7.72 (d, J = 8.3 Hz, 1H, H(1 or 4)), 7.58 (d, J = 
8.0 Hz, 2H, H(5,6) or (7,8)), 7.28 (d, J = 8.0 Hz, 2H, H(5,6) or (7,8)), 7.09 (t, J = 7.7 Hz, 
2H, Ar), 7.04 (t, J = 7.8 Hz, 1H, Ar), 6.87 (d, J = 7.9 Hz, 2H, Ar), 6.81 (t, J = 
7.3 Hz, 1H, Ar), 6.72 (t, J = 7.6 Hz, 1H, Ar), 6.28 (d, J = 7.9 Hz, 1H, Ar), 5.18 
(d, J = 7.5 Hz, 1H, H10), 4.92 (d, J = 4.7 Hz, 1H, H11), 4.08 (q, J = 7.1 Hz, 2H, 
H17), 3.68 (dd, J = 12.4, 7.6 Hz, 1H, H12), 2.89 (s, 3H, H19), 2.73 – 2.68 (m, 1H, 
H13), 2.48 – 2.41 (m, 2H, H16), 2.32 (s, 3H, H9), 2.31 – 2.24 (m, 1H, H15), 1.96 
– 1.92 (m, 1H, H15), 1.19 (t, J = 7.1 Hz, 3H, H18). 13C NMR (176 MHz, DMSO-
d6): δC 178.4 (CO), 174.3 (CO), 173.5 (CO), 154.0, 145.08, 136.8, 134.9, 
133.1, 130.0, 129.6, 128.8, 126.7, 124.4, 123.5, 121.4, 120.5, 118.2, 117.0, 
114.8, 60.2 (C10), 58.7, 45.3, 42.1, 39.1, 31.8, 25.1, 24.0, 21.4 (C19), 14.6 (C9). 
IR (neat): νmax/cm-1: 3659 (br, OH), 2981 (CH), 1770 (CO2Et), 1703 (N-CO).  
MS (pNSI): 1253.39 (100%, [2M+Na]+), 507.15 (22%, [[M-(Ph-N-OH)+]); 
HRMS (pNSI): calcd C3 H33N3O7SNa [M+Na]+: 638.1931; observed: 
638.1924. 
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Ethyl3-((3aS,4S,5S,10bS)-5-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-1-yl)-2-
methyl-1,3-dioxo-10-tosyl-1,2,3,3a,4,5,10,10b-octahydropyrrolo[3,4-
a]carbazol-4-yl)propanoate (108) 
                                                                                                                                                    
A solution of 4-phenyl-1,2,4-triazoline-3,5-dione 
(0.052 g, 0.29 mmol) and ethyl 3 
((3aS,4R,10aS,10bS)- 2-methyl-1,3-dioxo-10-
tosyl1,2,3,3a,4,10,10a,10boctahydropyrrolo[3,4-
a]carbazol-4-yl) propanoate 98 (0.150 g, 0.29 
mmol) in DCM (10 mL) was stirred at 0 oC for 6 
h. The solvent was removed under reduced 
pressure to give the crude product which was 
purified by column chromatography (petrol / ethyl acetate 1:1) to give ethyl 3-
((3aS,4S,5S,10bS)-5-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-1-yl)-2-methyl-1,3-
dioxo-10-tosyl-1,2,3,3a,4,5,10,10b-octahydropyrrolo[3,4-a]carbazol-4-
yl)propanoate in (0.110 g, 0.161 mmol, 56%) as a white solid. 
 
Mp.  264 – 265 oC. Rf : 0.3 (petrol / ethyl acetate 1:1).1H NMR (400 MHz, 
CDCl3):  δH 8.86 (br, s, NH), 7.78 (d, J = 7.0 Hz, 2H, H(5,6) or (7,8)), 7.71 (d, J = 
7.9 Hz, 1H, H(1 or 4)), 7.47 (d, J = 7.9 Hz, 1H, H(1 or 4)), 7.44 - 7.40 (m, 1H, Ar), 
7.36 – 7.30 (m, 3H, Ar), 7.23 - 7.17 (m, 2H, Ar), 7.02 (d, J = 7.0 Hz, 2H, H(5,6)  
or (7,8)), 5.66 (d, J = 6.2 Hz, 1H, H10), 5.04 (d, J = 6.5 Hz, 1H, H11), 4.08 (q, J = 
6.2 Hz, 2H, H17), 3.44 (dd, J = 6.5, 11.9 Hz, 1H, H12), 3.02 (s, 3H, H14), 2.68 -
2.51 (m, 3H, H(15 , 16)), 2.15 (s, 3H, H9), 2.14 - 2.09 (m, 1H, H13), 1.90 - 1.82 
(m, 1H, H15), 1.20 (t, J = 6.2 Hz, 3H, H18). 13C NMR (100 MHz, CDCL3): δC 
176.6 (CO), 173.4 (CO), 173.2 (CO), 153.6 (CO), 152.6 (CO), 145.2, 136.8, 
135.5, 132.1, 130.7, 129.7, 129.3, 128.6, 127.2, 126.8, 125.6, 124.2, 119.0, 
114.8, 114.4, 60.8 (C17), 44.3 (C10), 42.0 (C11), 39.3 (C12), 30.9 (C13), 25.4 
(C15,16), 23.0 (C14), 21.5 (C9), 14.2 (C18). IR (neat): νmax/cm-1: 3659 (NH), 1775 
(CO2Et), 1691 (N-CO). MS (pNSI): 701.23 (100%, [M+NH4]+), 1384.44 (17%, 
[2M+NH4]+); HRMS (pNSI): calcd C35H34N5O8S [M+H]+: 684.2123 ; observed: 
684.2115. 
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Ethyl 3-((3aS,4S,5S,10bS)-5-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-1-yl)-
1,3-dioxo-10-tosyl-1,2,3,3a,4,5,10,10b-octahydropyrrolo[3,4-a]carbazol-
4-yl)propanoate   (109) 
 
A solution of 4-phenyl-1,2,4-triazoline-3,5-dione 
(0.037 g, 0.21 mmol) and ethyl 3-((3aS,4R,10aS, 
10bS)-1,3-dioxo-10-tosyl-1,2,3,3a,4,10,10a,10b- 
octahydropyrrolo[3,4-a] carbazol-4-yl)propanoate   
104 (0.105 g, 0.21 mmol) in DCM (10 mL) was 
stirred at 0 oC for 6 h. The solvent was removed to 
give the crude white solid product which was 
purified by trituration from DCM to yield ethyl 3-
((3aS,4S,5S,10bS)-5-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-1-yl)-1,3-dioxo-10-
tosyl-1,2,3,3a,4,5,10,10b octahydropyrrolo [3,4-a]carbazol-4-yl) propanoate in 
(0.08 g, 0.119 mmol, 57%) as a white solid. 
 
Mp.  269 – 271 oC. 1H NMR (300 MHz, DMSO-d6):  δH 11.44 (br, s, NH), 10.68 
(br, s, NH), 7.87 – 7.76 (m, 3H, Ar), 7.51 – 7.39 (m, 4H, Ar), 7.29 – 7.25 (m, 
6H, Ar), 5.69 (d, J = 6.1 Hz, 1H, H1), 5.28 (d, J = 6.8 Hz, 1H, H2), 4.05 (q, J = 
6.8 Hz, 2H, H7), 3.45 (dd, J = 6.8 , 11.3 Hz, 1H, H3), 3.58 – 3.52 (m, 1H, H4), 
2.67 – 2.65 (m, 1H, H5), 2.25 (s, 3H, H9),2.49 – 2.44 (m, 2H, H6), 1.80 – 1.70 
(m, 1H, H5), 1.18 (t, J = 6.8 Hz, 3H, H8).13C NMR (75 MHz, DMSO-d6): δC 
178.6 (CO), 175.0 (CO), 172.9 9 (CO), 154.4 (CO), 153.1 (CO), 145.5, 136.6, 
134.9, 133.1, 131.7, 130.4, 129.4, 128.6, 127.6, 127.1, 126.3, 125.6, 124.5, 
119.3, 115.9, 114.9, 60.3 (C7), 45.2, 43.0, 38.0, 30.7, 23.6, 21.4 (C9), 14.5 
(C8).IR (neat): ν max/cm-1: 3659 (NH), 1775 (CO2Et), 1692 (N-CO). MS (pNSI): 
687.22 (100%, [M+NH4]+), 1356.41 (27%, [2M+NH4]+), 692.17 (12%, 
[M+Na]+); HRMS (pNSI): calcd C34H35N6O8S [M+H]+: 687.2232; observed: 
687.2229. 
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 (Z)-5-(1-tosyl-1H-indol-3-yl)pent-4-en-1-ol  (110) 
 
DIBAL-H (1.0 M in toluene, 11.45 mL, 11.45 mmol) 
was added to a solution of ethyl (Z)-5-(1-tosyl-1H-
indol-3-yl) pent-4-enoate 90 (1.300 g, 3.27 mmol) 
in toluene (20 mL) at -78 oC under nitrogen. The 
reaction mixture was stirred at room temperature 
for 3 h, slowly hydrolysed with 1.0 M of hydrochloric 
acid (20 mL).  The organic layer was extracted with 
EtOAc (2 x 100 mL), washed with brine, dried over MgSO4 and filtered. The 
solvent was removed under reduced pressure to give the crude colourless oil 
product which was purified by column chromatography (petrol / ethyl acetate 
2:1) to yield (Z)-5-(1-tosyl-1H-indol-3-yl)pent-4-en-1-ol in (1.009 g, 2.83 mmol,  
87%) as a colourless oil.  
                                                                                                                                                    
Rf : 0.26 (petrol / ethyl acetate 2:1).1H NMR (400 MHz, CDCl3): δH 7.98 (d, J = 
8.3 Hz, 1H, H(1 or 4)), 7.77 (d, J = 8.5 Hz, 2H, H(5,6) or (7,8)), 7.61 (s, 1H, H10), 7.50 
(d, J = 6.4 Hz, 1H, H(1 or 4)), 7.32 (t, J = 7.3 Hz , 1H, H(2 or 3)),  7.23 (t, J = 7.3 
Hz, 1H, H(2 or 3)), 7.18 (d, J = 8.5 Hz, 2H, H(5,6) or (7,8)), 6.42 (d, J = 11.7 Hz, 1H, 
H11), 5.85 (dt, J = 11.7, 7.3 Hz, 1H, H12), 3.69 (t, J = 6.4 Hz, 2H, H15), 2.42 (m, 
2H, H14), 2.29 (s, 3H, H9), 1.76 (dt, J =13.2, 10.6 Hz, 1H, H13).13C NMR (100 
MHz, CDCl3): δC 145.1, 135.1, 134.5, 133.7, 130.7, 129.8, 126.8, 124.9, 
123.7, 123.3, 119.5, 119.1, 118.1, 113.6, 62.4 (C15), 32.4 (C13 or 14), 26.13 (C13 
or 14), 21.6 (C9). IR (neat): νmax/cm-1: 3335 (OH), 2972 (CH).MS (p NSI): 373.15 
(100 %, [M+NH4]+), 356.13 (63%,  [M+H]+), 201.11 (21%,  [M-Ts]+); HRMS (p 
NSI): calcd C20H22NO3S [M+H]+: 356.1315; observed: 356.1317. 
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 (Z)-5-(1-tosyl-1H-indol-3-yl)pent-4-enal (111) 
 
DMSO (6.68 mmol, 0.47 mL) was added dropwise at 
-78 oC to a stirred solution oxalyl chloride (3.20 mL, 
0.27 mmol) in DCM (5 mL). After 30 min, a solution of 
(Z)-5-(1-tosyl-1H-indol-3-yl)pent-4-en-1-ol 110 
(0.950 g, 2.67 mmol) in DCM (10 mL) was added. The 
reaction mixture left to stir for 30 min at -78 oC 
followed by the addition of triethylamine (1.48 mL, 
10.68 mmol). The reaction mixture was warmed to r.t. and stirred for 2 h, 
quenched with saturated NaHCO3 (aq) (10 mL). The organic layer was extracted 
with DCM (3 x 50 mL), washed with brine, dried over MgSO4 and filtered. The 
solvent was removed under reduced pressure to give the crude yellow  product 
which was purified by column chromatography (petrol/ ethyl acetate 2:1) to 
yield (Z)-5-(1-tosyl-1H-indol-3-yl)pent-4-enal in (0.659 g, 1.86 mmol,  70%) as 
a colourless oil.  
                                                                                                                                                    
Rf : 0.8 (petrol / ethyl acetate 2:1).1H NMR (400 MHz, CDCl3): δH  9.78 (s, 1H, 
H15), 7.99 (d, 1H, J = 7.4 Hz, H(1or 4)), 7.77 (d, 2H, J = 7.4 Hz, H(5,6) or (7,8)), 7.55 
(s, 1H, H10), 7.48 (d, 1H, J = 7.4 Hz, H(1or 4)), 7.32 (t, 1H, 7.4Hz ,H(2 or 3)), 7.24 
(t, 1H, 7.4Hz, H(2 or 3)), 7.19 (d, 2H, J=7.4Hz, H(5,6) or (7,8)), 6.45 (d, 1H, J = 11.7 
Hz, H11),  5.85 (dt, 1H, J = 11.7, 7.3 Hz, H12), 2.65 - 2.95 (m, 4H, H(13 and 14)),  
2.29 (s, 3H, H9).13C NMR (100 MHz, CDCl3): δH 201.8 (CHO), 145.1, 135.0, 
134.6, 131.9, 130.7, 129.9, 126.8, 125.1, 123.6, 123.4, 119.6, 119.1, 118.7, 
113.7, 43.5, 22.3, 21.6 (C9), IR (neat): νmax/cm-1: 2890 (CHO), 1719 (CO). 
HRMS (pNSI): calcd C20H20NO3S [M+H]+: 354.1158; observed: 354.1162. 
 
 
 
 
 
Chapter 6 Experimental  
 
Page 126 
 
3-((3aS,4R,10aS,10bS)-2-methyl-1,3-dioxo-10-tosyl-
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanal           
(112) 
DMSO (0.04 mL, 0.69 mmol) was added dropwise at -
78 oC to a stirred solution of oxalyl chloride (0.02 mL, 
0.33 mmol) in DCM (2 mL). After 30 min, a solution of 
(3aS,4R,10aS,10bS)-4-(3-hydroxypropyl)- 2-methyl-
10-tosyl-4,10,10a,10b-tetrahydropyrrolo [3,4-a] 
carbazole-1,3 (2H,3aH)-dione  117 (0.130 g, 0.27 
mmol) in DCM (8 mL) was added. The reaction mixture 
left to stir for 30 min at -78 oC followed by the addition 
of triethylamine (0.15 mL, 1.11 mmol). The reaction mixture was warmed to 
r.t. and stirred for 2 h, quenched with saturated NaHCO3 (aq) (10 mL). The 
organic layer was extracted with DCM (1 x 50 mL), washed with brine, dried 
over MgSO4 and filtered. The solvent was removed under reduced pressure to 
give the crude yellow solid product which was purified by column 
chromatography (petrol / ethyl acetate 1:1) to yield 3-((3aS,4R,10aS,10bS)-2-
methyl-1,3-dioxo-10-tosyl-1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-
a]carbazol-4-yl)propanal in (0.086 g, 0.185 mmol,  69%) as a white solid.  
 
Mp.  135 – 137 oC. Rf : 0.30 (petrol / ethyl acetate 1:1). 1H NMR (400 MHz, 
CDCl3):  δH 9.74 (s, 1H, H17), 7.79 (d, J = 7.1 Hz, 2H, H(5,6) or (7,8)), 7.62 (d, J = 
7.1 Hz, 1H, H(1 or 4)), 7.25 - 7.21 (m, 4H, Ar), 6.95 (t, J = 7.1 Hz, 1H,  H(2 or 3)), 
6.08 (dd, J = 3.3, 6.8 Hz, 1H, H10), 4.85 (dd, J = 3.3, 7.2 Hz, 1H, H11), 4.16 (t, 
J = 7.9 Hz, 1H, H12), 3.12 - 3.03 (m, 2H, H(14, 13)), 2.81 (s, 3H, H19), 2.63 - 2.49 
(m, 2H, H16), 2.33 (s, 3H, H9),  1.90 – 1.74 (m, 2H, H15). 13C NMR (100 MHz, 
CDCl3):  δC 200.9 (C17), 178.7 (CO), 173.8 (CO), 144.7, 144.2, 136.8, 133.9, 
130.7, 130.0, 127.6, 126.6, 123.9, 121.0, 116.2, 115.4, 59.9 (C16), 44.1 (C11), 
43.0 (C12), 42.7 (C13), 37.1 (C14), 25.3 (C15,), 25.2 (C19), 21.6 (C9). IR (neat): 
νmax/cm-1: 1697 (CHO), 2925 (C=C). MS (pNSI): 482.14 (12%, [M+NH4]+), 
487.17(9%, [M+Na]+) ; HRMS (pNSI): calcd C25H25N2O5S [M+H]+: 465.1479 ; 
observed: 465.1486.       
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(3aR,3bS,6R,6aS,11bR)-6-hydroxy-2-methyl-11-tosyl 
3a,3b,4,5,6,6a,11,11b-octahydro-1H-cyclopenta[c]pyrrolo[3,4 a] 
carbazole-1,3(2H)-dione (113) 
 
Dimethylaluminum chloride (1.0 M in hexane, 0.09 mL, 
0.09 mmol) was added dropwise at -78 oC to a solution 
of 3-((3aS,4R,10aS,10bS)-2-methyl-1,3-dioxo-10-
tosyl-1,2,3, 3a ,4,10, 10a,10b-octahydropyrrolo[3,4-a] 
carbazol-4-yl)propanal 112 (0.045 g, 0.09 mmol) in 
DCM (5 mL). The reaction mixture left to stir for 30 min, 
quenched with saturated NaHCO3 (aq) (5mL). The 
organic layer was extracted with DCM (1 x 20 mL), 
washed with brine, dried over MgSO4 and filtered. The solvent was removed 
under reduced pressure to give the crude white solid product which was 
purified by column chromatography (petrol / ethyl acetate 1:1) to yield 
(3aR,3bS,6R,6aS,11bR)-6-hydroxy-2-methyl-11-tosyl-3a,3b,4,5,6,6a,11,11b-
octahydro-1H-cyclopenta[c]pyrrolo[3,4-a]carbazole-1,3(2H)-dione in (0.038 g, 
0.08 mmol, 89%) as a white solid. 
 
Mp.  240 – 242 oC. Rf : 0.6 (petrol / ethyl acetate 1:1).1H NMR (400 MHz, 
CDCl3):  δH 7.91 (d, J =7.3 Hz, 1H, H(1 or 4)), 7.85 (d, J = 7.3 Hz, 2H, H(5,6) or 
(7,8)), 7.42 (d,  J = 7.3 Hz, 1H, H(1 or 4)),  7.29 (t, J =7.3 Hz, 1H, H(2 or 3)), 7.24 - 
7.20 (m, 3H, H (5,6) or (7,8), H(2 or 3)),  4.93 (d, J = 7.3 Hz, 1H, H10), 4.50 (t, J = 6.1 
Hz, 1H, H16), 3.30 (dd, J = 7,3, 6.8 Hz, 1H, H11),  3.19 - 3.16 (m, 1H, H15), 3.02 
(s, 3H, H17), 2.38 - 2.33 (m, 4H, H(14, 9)), 2.25 - 2.02 ( m, 4H, H(12,13,14)). 13C 
NMR (100 MHz, CDCl3): δC 178.4 (CO), 174.1 (CO), 145.1, 137.3, 135.5, 
130.6, 129.3, 128.3, 127.1, 125.8, 123.8, 118.8, 117.3, 115.5, 73.5 (C16), 46.4 
(C11), 44.2 (C15), 41.8 (C10), 38.9 (C12), 33.2 (C13), 27.6 (C14), 25.0 (C17), 21.9 
(C9). IR (neat): νmax/cm-1: 3655 (br, OH), 2980 (CH).MS (pNSI): 465.14 (100 
%, [M+H]+), 482.17 (75 %, [M+NH4]+) ; HRMS (pNSI): calcd C25H25N2O5S 
[M+H]+: 465.1479 ; observed: 465.1484. 
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(3aS,4R,10aS,10bS)-4-(3-hydroxypropyl)-2-methyl-10-tosyl-4,10,10a,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (117)  
 
 Dimethylaluminum chloride (1.0 M in hexane, 1.8 mL, 
1.8 mmol) was added dropwise at -78 oC to a solution 
of N-methylmaleimide (0.100 g, 0.90 mmol) in DCM 
(10 mL). The mixture left to stir for 10 min followed by 
the addition of (Z)-5-(1-tosyl-1H-indol-3-yl) pent-4-en-
1-ol 110 (0.32 g, 0.90 mmol) in DCM (10 mL). The 
reaction mixture was refluxed for 48 h, quenched with 
saturated NaHCO3 (aq) (25 mL). The organic layer was 
extracted with DCM (1 x 50 mL), washed with brine, dried over MgSO4 and 
filtered. The solvent was removed under reduced pressure to give the crude 
white solid product which purified by column chromatography (petrol / ethyl 
acetate 1:1 gradient to 100 ethyl acetate) to yield (3aS,4R,10aS,10bS)-4-(3-
hydroxypropyl)-2-methyl-10-tosyl-4,10,10a,10b-tetrahydropyrrolo[3,4-
a]carbazole-1,3(2H,3aH)-dione  in (0.313 g, 0.67 mmol, 75%) as a white solid.  
 
Mp.  112 – 114 oC. Rf : 0.3 (petrol / ethyl acetate 2:1).1H NMR (400 MHz, 
CDCl3):  δH 7.79 (d, J = 7.4 Hz, 2H, H(5,6) or (7,8)), 7.59 (d, J = 7.2 Hz, 1H, H(1 or 
4)), 7.24 - 7.20 (m, 4H, Ar), 6.96  (t, J = 7.2 Hz, 1H, H(2 or 3)), 6.14 (dd, J = 3.6, 
7.3 Hz, 1H, H10), 4.58 (dd, J = 3.6, 7.1 Hz, 1H, H11), 4.14 (t, J = 7.9 Hz, 1H, 
H12), 3.65 (t, J = 6.5 Hz, 2H, H17), 3.15 - 3.05 (m, 2H, H(13, 14)), 2.82 (s, 3H, 
H19), 2.35 (s, 3H, H9), 1.70 - 1.54 (m, 4H, H(15, 16)).13C NMR (100 MHz, CDCl3): 
δC 178.8 (CO), 174.1 (CO), 144.7, 144.2, 135.8, 134.2, 130.3, 129.9, 127.6, 
126.9, 123.9, 120.9, 117.5, 115.4, 62.4 (C17), 59.9 (C11), 44.2 (C12), 43.2 (C13), 
37.6 (C14), 31.5 (C15 or 16), 29.7 (C15 or 16), 25.1 (C19), 21.6 (C9).  IR (neat): 
νmax/cm1:  3657 (br, OH), 1639 (N-CO).MS (pNSI): 467.16 (100%, [M+H]+), 
484.18 (50%, [M+Na]+), 312.14 (42%, [M-Ts]+); HRMS (pNSI): calcd 
C25H27N2O5S [M+H]+: 467.1635 ; observed: 467.1628. 
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Ethyl (Z)-6-(1-tosyl-1H-indol-3-yl)hex-5-enoate (118) 
 
6-(1-Tosyl-1H-indol-3-yl)hex-5-enoic acid 129 
(0.516 g, 1.34 mmol) was dissolved in anhydrous 
EtOH (35 mL) and treated with concentrated 
sulfuric acid (0.2 mL). After the solution was 
refluxed for 1.5 h, the reaction mixture was added 
to saturated NaHCO3 (aq) (15 mL) and extracted 
with EtOAc (2 x 75 mL). The combined organic 
layers were washed with brine, dried over MgSO4 and filtered. The solvent 
was removed under reduced pressure to give the crude as an orange solid 
which was purified by column chromatography in (petrol: ethyl acetate 10:1) 
to yield a (Z)-6-(1-tosyl-1H-indol-3-yl)hex-5-enoate in (0.308 g, 0.75 mmol, 
56%) as a colourless oil.  
 
Rf : 0.7 (petrol / ethyl acetate 7:3).1H NMR (300 MHz, CDCl3): δH 7.97 (d, J = 
7.9 Hz, 1H, H(1 or 4)), 7.76 (d, J = 8.2 Hz, 2H, H(5, 6) or (7,8)), 7.51 (s, 1H, H10), 7.49 
(d, J = 7.9 Hz, 1H, H(1 or 4)), 7.32 (t, J = 7.9 Hz, 1H, H(2 or 3)), 7.25 (t, J = 7.9 Hz, 
1H,  H(2 or 3)), 7.20 (d, J = 8.2 Hz, 2H, H(5,6) or (7,8)), 6.42 (d, J = 11.5 Hz, 1H, H11), 
5.77 (dt, J = 11.5, 7.5 Hz, 1H, H12), 4.10 (q, J = 6.8 Hz, 2H, H16), 2.39 - 2.31 
(m, 4H, H(14,15)), 2.30 (s, 3H, H9), 1.85 – 1.77 (m, 2H, H13), 1.21 (t, J = 6.8 Hz, 
3H, H17). 13C NMR (75 MHz, CDCl3): δC 173.5 (CO2Et), 145.0, 135.1, 133.4, 
131.3, 130.8, 129.9, 126.9, 124.9 123.5, 123.3, 119.6, 119.0, 118.5, 113.6, 
60.3 (C16), 33.7, 29.1, 24.7, 21.5 (C9), 14.3 (C17). IR (neat): νmax/cm-1: 1727 
(CO), 1597 (C=C). MS (pNSI): 429.18 (100%, [M+NH4]+), 412.15 (63%, 
[M+H]+), 840.33 (15%, [2M+NH4]+); HRMS (pNSI): calcd C23H26NO4S [M+H]+: 
412.1577; 412.1575. 
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(Z)-6-(1-Tosyl-1H-indol-3-yl)hex-5-en-1-ol (119) 
Method A 
Lithium aluminum hydride (1.0 M in THF, 1.01 mL, 
1.01 mmol) was added to a solution of 6-(1-tosyl-
1H-indol-3-yl)hex-5-enoic acid 129 (0.156 g, 0.4 
mmol) in THF (10 mL) at -78 oC under nitrogen. 
The reaction mixture was stirred at room 
temperature for 24 h.  The organic layer was 
extracted with EtOAc (2 x 100 mL), washed with brine, dried over MgSO4 and 
filtered. The solvent was removed under reduced pressure to give the crude 
product as a colourless oil. Purification of the crude reaction mixture gave the 
desired (Z)-6-(1-tosyl-1H-indol-3-yl)hex-5-en-1-ol in (0.043 g, 0.12 mmol, 
30%) as a colourless oil.  
 
Method A  
DIBAL-H (1.0 M in toluene, 1.55 mL, 3.40 mmol) was added to a solution of 
ethyl 6-(1-tosyl-1H-indol-3-yl)hex-5-enoate 118 (0.183 g, 0.44 mmol) in 
toluene (10 mL) at -78 oC under nitrogen. The reaction mixture was stirred at 
room temperature for 3 h, slowly hydrolysed with 1.0 M of hydrochloric acid (5 
mL).  The organic layer was extracted with EtOAc (2 x 100 mL), washed with 
brine, dried over MgSO4 and filtered. The solvent was removed under reduced 
pressure to yield (Z)-6-(1-tosyl-1H-indol-3-yl)hex-5-en-1-ol in (0.153 g, 0.41 
mmol, 94%) as a colourless oil.  
 
1H NMR (300 MHz, CDCl3): δH 7.90 (d, J = 7.5 Hz, 1H, H(1 or 4)), 7.67 (d, J = 
7.5 Hz, 2H, H(5,6) or (7,8)), 7.45 (s, 1H, H10), 7.41 (d, J = 7.5 Hz, 1H, H(1 or 4)), 7.23 
(t, J = 7.5 Hz , 1H, H(2 or 3)),  7.14 (t, J = 7.5 Hz, 1H, H(2 or 3)), 7.10 (d, J = 7.5 
Hz, 2H, H(5,6) or (7,8)), 6.32 (d, J = 10.1 Hz, 1H, H11), 5.73 (dt, J = 10.1, 7.5 Hz, 
1H, H12), 3.57 (t, J = 7.5 Hz, 2H, H16), 2.26 (dt, J = 7.5, 6.4 Hz, 2H, H13), 2.21 
(s, 3H, H9), 1.61 – 1.44 (m, 4H, H(14,15)).13C NMR (75 MHz, CDCl3): δC 144.9, 
135.1, 134.6, 134.3, 130.8, 129.8, 126.8, 124.9, 123.3, 119.5119.1, 117.8, 
113.6, 62.5, 32.2, 29.3, 25.6, 21.5. IR (neat) νmax/cm-1: 3435 (OH), 2972 (CH). 
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MS (pNSI): 387.1738 (100%, [M+NH4]+), 756.3138 (45%, [2M+NH4]+); HRMS 
(pNSI): calcd C21H27N2O3S [M+NH4]+: 387.1737; observed: 387.1738. 
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(3aS,4R,10aS,10bS)-4-(4-hydroxybutyl)-2-methyl-10-tosyl-4,10,10a,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione  (120) 
 
Dimethylaluminum chloride (1.0 M in hexane, 0.58 
mL, 0. 58 mmol) was added dropwise at -78 oC to a 
solution of N-methylmaleimide (0.0325 g, 0.29 
mmol) in DCM (5 mL). The mixture left to stir for 10 
min followed by the addition of (Z)-6-(1-tosyl-1H-
indol-3-yl)hex-5-en-1-ol 119 (0.108 g, 0.29 mmol,) in 
DCM (5 mL). The reaction mixture allowed to worm 
slowly to reflux for 48 h, quenched with saturated 
NaHCO3 (aq) (10 mL). The organic layer was extracted with DCM (2 x 25 mL), 
washed with brine, dried over MgSO4 and filtered. The solvent was removed 
under reduced pressure to give the white crude solid product which was 
purified by column chromatography (petrol / ethyl acetate  1:1 gradient to 100 
EtOAc) to yield (3aS,4R,10aS,10bS)-4-(4-hydroxybutyl)-2-methyl-10-tosyl-
4,10,10a,10b tetrahydropyrrolo [3,4-a]carbazole-1,3(2H,3aH)-dione in (0.1093 
g, 0.23 mmol, 78%) as a white solid.  
 
Mp. 189 – 201 oC. Rf : 0.26 (petrol / ethyl acetate 1:1). (1H NMR 300 MHz, 
CDCl3): δH 7.73 (d, J = 7.7 Hz, 2H, H(5,6) or (7,8)), 7.53 (d, J = 7.9 Hz, 1H, H(1 or 
4)), 7.20 - 7.15 (m, 4H, Ar), 6.96  (t, J = 7.9 Hz, 1H, H(2 or 3)), 6.08 (dd, J = 3.0, 
6.9 Hz, 1H, H10), 4.77 (dd, J = 3.0, 7.5 Hz, 1H, H11), 4.06 (t, J = 7.5 Hz, 1H, 
H12), 3.57 (t, J = 6.3 Hz, 2H, H18), 3.15 - 3.05 (m, 2H, H(13, 14)), 2.76 (s, 3H, 
H19), 2.30 (s, 3H, H9), 1.56 - 1.39 (m, 6H, H(15,16,17)). 13C NMR (75 MHz, CDCl3): 
δC 178.8 (CO), 173.9 (CO), 144.6, 144.0, 135.6, 134.0, 130.3, 129.8, 127.4, 
126.9, 123.8, 120.9, 117.6, 115.4, 62.4 (C18), 59.9 (C11), 44.2 (C12), 43.2 (C13), 
37.6 (C14), 33.3 (C15 or 16 or 17), 31.5 (C15 or 16 or 17), 25.1 (C19), 24.8 (C15 or 16 or 17), 
21.6 (C9). IR (neat): νmax/cm-1: 3636 (OH), 2981 (Ar, CH), 1727 (CO). MS 
(pNSI): 983.3311 (100%, [2M+Na]+), 503.1598 (28%, [M+Na]+), 498.2047 
(15%, [M+NH4]+); HRMS (pNSI): calcd C26H29N2O5S [M+H]+: 481.1792; 
observed: 481.1786. 
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4-((3aS,4R,10aS,10bS)-2-methyl-1,3-dioxo-10-tosyl-
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)butanal (121) 
       
DMSO (0.07 mL, 1.04 mmol) was added dropwise at 
-78 oC to a stirred solution of oxalyl chloride (0.1 mL 
0.49 mmol) in DCM (2 mL). After 30 min a solution of 
(3aS,4R,10aS,10bS) -4-(4-hydroxybutyl)-2-methyl-
10-tosyl-4,10,10a,10b-tetrahydropyrrolo [3,4-a] 
carbazole-1,3(2H,3aH)-dione 121 (0.200 g, 0.42 
mmol) in DCM (8 mL) was added . The reaction 
mixture left to stir for 30 min at -78 oC followed by the 
addition of triethylamine (0.23 mL, 1.68 mmol). The 
reaction mixture was warmed to r.t. and stirred for 2 h, quenched with 
saturated NaHCO3 (aq) (10 mL). The organic layer was extracted with DCM (2 
x 25 mL), washed with brine, dried over MgSO4 and filtered. The solvent was 
removed under reduced pressure to give the crude yellow solid product which 
was purified by column chromatography (petrol / ethyl acetate 1:1) to yield 4-
((3aS,4R,10aS,10bS)-2-methyl-1,3-dioxo-10-tosyl-1,2,3,3a,4,10,10a,10b-
octahydropyrrolo[3,4-a]carbazol-4-yl)butanal in (0.1588 g, 0.33 mmol, 79%) as 
a white solid.  
 
Mp.  171 – 173 oC. Rf : 0.3 (petrol / ethyl acetate 1:1). 1H NMR (300 MHz, 
CDCl3):  δH 9.74 (t, J = 1.5 Hz, 1H, H18), 7.73 (d, J = 8.0 Hz, 2H, H(5,6) or (7,8)), 
7.54 (d, J = 8.0 Hz, 1H, H(1 or 4)), 7.21 - 7.16 (m, 4H, Ar), 6.90 (t, J = 8.0 Hz, 
1H,  H(2 or 3)), 6.07 (dd, J = 3.4, 7.2 Hz, 1H, H10), 4.77 (dd, J = 3.4, 7.7 Hz, 1H, 
H11), 4.06 (t, J = 7.7 Hz, 1H, H12), 3.10 - 2.96 (m, 2H, H(14, 13)), 2.77 (s, 3H, 
H19), 2.63 - 2.49 (m, 2H, H16), 2.30 (s, 3H, H9),  1.70 – 1.43 (m, 4H, H(15,16)). 
13C NMR (75 MHz, CDCl3):  δC 201.4 (C18), 178.6 (CO), 173.8 (CO), 144.5, 
144.2, 136.9, 134.0, 130.4, 129.9, 127.5, 126.7, 123.7, 120.9, 116.8, 115.4, 
59.9 (C17), 44.1 (C11), 43.0 (C12), 42.9 (C13), 37.1 (C14), 32.7 (C15), 25.1 (C16,), 
21.5 (C19), 20.9 (C9). IR (neat): νmax/cm-1: 1699 (CHO), 1773 (CO), 2944 (CH, 
Ar). HRMS (pNSI): calcd C26H27N2O5S [M+H]+: 479.1826; observed: 
479.1628. 
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(3aS,3bR,7S,7aS,12bS)-7-hydroxy-2-methyl-12-tosyl-
3b,4,5,6,7,7a,12,12b-octahydrobenzo[c]pyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione (122)        
 
Dimethylaluminum chloride (1.0 M in hexane, 0.06 mL, 
0.06 mmol) was added dropwise at -78 oC to a solution 
of -((3aS,4R,10aS,10bS)-2-methyl-1,3-dioxo-10-tosyl-
1,2,3,3a,4,10,10a,10b-octahydropyrrolo [3,4-
a]carbazol-4-yl)butanal 120 (0.03 g, 0.06 mmol) in 
DCM (5 mL). The reaction mixture left to stir for three 
hours at 25 oC, quenched with saturated NaHCO3 (aq) 
(5mL). The organic layer was extracted with DCM (1 x 
20 mL), washed with brine, dried over MgSO4 and filtered. The solvent was 
removed under reduced pressure to give the crude white solid product which 
was purified by column chromatography (petrol / ethyl acetate 1:1) to yield 
(3aS,3bR,7S,7aS,12bS)-7-hydroxy-2-methyl-12-tosyl-3b,4,5,6,7,7a,12,12b- 
octahydrobenzo[c]pyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione in (0.0165 g, 
0.034 mmol, 57%) as a white solid. 
 
Mp.  265 – 267 oC. Rf : 0.6 (petrol / ethyl acetate 1:1).1H NMR (300 MHz, 
CDCl3): δH 7.96 – 7.87 (m, 1H, H(1 or 4)), 7.65 (dd, J = 8.2, 1.3 Hz, 2H, H(5,6) or 
(7,8)), 7.31 – 7.09 (m, 6H, Ar), 4.89 (d, J = 7.2 Hz, 1H, H10), 3.99 (s, 1H, OH), 
3.73 (dd, J = 12.4, 7.2 Hz, 1H, H11), 3.00 (dd, J = 5.2, 2.7 Hz, 1H, H18), 2.94 
(s, 3H, H17), 2.40 - 2.25 (m, 4H, H(16, 9)), 2.00 – 1.42 (m, 7H, H(12, 13,14,15)). 13C 
NMR (126 MHz, CDCl3):  δC 177.7 (CO), 174.1 (CO), 145.0, 137.8, 135.2, 
130.1, 129.6, 128.1, 126.6, 125.3, 123.9, 121.4, 118.7, 115.8, 67.6, 43.3, 42.1, 
38.6, 34.2, 32.0, 26.8, 24.9, 21.5 (C17), 14.5 (C9). IR (neat): νmax/cm-1: 3655 
(OH), 2980 (CH).  MS (pNSI): 479.16 (100%, [M+H]+), 501.14 (85%, [M+Na]+). 
496.18 [M+NH4]+); HRMS (pNSI): calcd C26H27N2O5S [M+H]+: 479.1635; 
observed: 479.1629. 
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 (5-Ethoxy-5-oxopentyl) triphenylphosphonium bromide (124) 
 
Triphenylphosphine (2.000 g, 7.60 mmol) was 
dissolved in acetonitrile (10 mL). Ethyl 5-
bromovalerate 123 (1.20 mL, 7.6 mmol) was 
added. The mixture was refluxed for 48 h. The resultant white precipitate was 
purified by column chromatography (petrol / ethanol 3:2) to give the desired 
compound in (5.83 mmol, 2.750 g, 77%) as white foam.   
 
Mp.  162 – 164 oC. 1H NMR (400 MHz, CDCl3): δH 7.84 – 7.74 (m, 9H, Ar), 
7.69 - 7.64 (m, 6H, Ar), 3.99 (q, J = 6.9 Hz, 2H, H5), 3.88 - 3.81 (m, 2H, H1), 
2.35 (t, J = 6.3 Hz, 2H, H4), 2.01 – 1.94 (m, 2H, H(2 or 3)), 1.74 - 1.63 (m, 2H, 
H(2 or 3)), 1.14 (t, J = 6.9 Hz, 2H, H6). 13C NMR (100 MHz, CDCl3): δC 173.2 
(CO2Et), 135.1 (Jcp = 2.8 Hz), 133.8 (Jcp = 10.3 Hz), 130.5 (Jcp = 12.9 Hz), 118.1 
(Jcp = 85.7 Hz), 60.4 (C4), 33.4, 25.5 (Jcp = 19.2 Hz), 22.6 (Jcp = 52.5 Hz), 21.9 
(Jcp = 4.9 Hz), 14.2 (C5). IR (neat): νmax/cm-1: 2890 (CH), 1778 (CO2Et), 1598 
(C=C, Ar).  
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  (4-Carboxybutyl) triphenylphosphonium bromide (127) 
 
A solution of triphenylphosphine (3.18 g, 12.10 
mmol) and 5-bromovaleric acid 126 (2.00 g, 11.04 
mmol) in acetonitrile (20 mL) was refluxed for 48 h. 
The resultant white precipitate was filtered off with suction and washed with 
ether (2 X 50 mL) to give the desired compound in (4.6321 g, 10.44 mmol, 
95%) as white crystals.  
 
Mp. 204 – 206 oC (lit. 209 – 210 oC).87 1H NMR (400 MHz, CDCl3): δH 7.79 -
7.63 (m, 15H, Ar), 5.75 (br, OH), 3.63 - 3.56 (m, 2H, H1), 2.65 (t, J = 6.5 Hz, 
2H, H4), 1.95 – 1.92 (m, 2H, H(2 or 3)), 1.76 – 1.67 (m, 2H, H(2 or 3)).  13C NMR 
(100 MHz, CDCl3):  δC 175.0 (CO2H), 135.2 (Jcp = 4.0 Hz), 133.7 (Jcp = 10.2 
Hz), 130.7 (Jcp = 12.1 Hz), 118.1 (Jcp = 85.7 Hz), 33.7, 25.5 (Jcp = 19.4 Hz), 
22.6 (Jcp = 45.9 Hz), 21.5 (Jcp = 4.8 Hz). IR (neat): νmax/cm-1: 3659 (OH), 2980 
(CH), 1767 (CO). HRMS (pNSI): calcd C23H24O2P [M-Br]+: 363.1508; 
observed: 363.1506. 
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6-(1-Tosyl-1H-indol-3-yl)hex-5-enoic acid (129) 
In a Schlenk flask, (4-carboxybutyl) 
triphenylphosphonium bromide 127 (3.60 g, 8.12 
mmol) was dissolved in THF (20 mL) and cooled 
to -78 oC. Sodium bis (trimethylsilyl) amide (1.0 M 
in THF, 16.24 mL, 16.24 mmol) was added 
dropwise over 10 min. The mixture was warmed 
to 0 oC and left to stir for 1 h.   In a separate round 
bottomed flask, 1-(toluene-4-sulfonyl)–1H-Indol-3-carbaldehyde 89 (1.69 g, 
7.38 mmol) was dissolved in THF (10 mL) and transferred via cannula to the 
solution. The reaction mixture was stirred at room temperature for 4 h, 
quenched with water (20 mL). The aqueous layer was acidified with 2.0 M of 
HCl (20 mL) to pH = 1. The organic layer was extracted with EtOAc (3 x 100 
mL), washed with brine, dried over MgSO4 and filtered. The solvent was 
removed under reduced pressure. The crude oil product was purified by 
column chromatography (petrol / ethyl acetate 7:3) to give a 4:1 mixture of (Z) 
and (E)-6-(1-tosyl-1H-indol-3-yl)hex-5-enoic acid in (1.8122 g, 4.72 mmol, 
64%) as a colourless oil.  
 
Rf : 0.25 (petrol / ethyl acetate 1:1).1H NMR (300 MHz, CDCl3): δH 7.91 (d, J = 
7.4 Hz, 1H, H(1 or 4)), 7.69 (d, J = 7.6 Hz, 2H, H(5, 6) or (7,8)), 7.45 (s, 1H, H10), 7.45 
– 7.42 (d, J = 7.4 Hz, 1H, H(1 or 4)), 7.25 (t, J = 7.4 Hz, 1H, H(2 or 3)), 7.20 – 7.12 
(m, 3H, H (5, 6) or (7, 8) and H(2 or 3)),  6.37 (d, J = 10.9 Hz, 1H, H11), 5.71 (dt, J = 
10.9, 6.5 Hz, 1H, H12), 2. 36 - 2.31 (m, 4H, H(14, 15)), 2.26 (s, 3H, H9), 1.77 (dt, 
J = 6.5, 7.9 Hz, 1H, H13).13C NMR (75 MHz, CDCl3): δC 179.6 (CO), 179.2 
(CO), 145.0, 135.5, 135.2, 134.7, 133.0, 131.0, 130.8, 129.9, 129.2, 126.9, 
124.9, 123.4, 123.1, 121.4, 120.7, 120.4, 119.5, 119.0, 118.7, 113.7, 33.4, 
32.8, 28.9, 24.3, 21.6 (C9). IR (neat): νmax/cm-1: 3659 (OH), 2979 (CH), 1707 
(CO). MS (pNSI): 401.15 (100%, [M+NH4]+), 784.27 (52%, [2M+NH4]+), (15%, 
[M+Na]+); HRMS (pNSI): calcd C21H25N2O4S [M+NH4]+: 401.1530; observed: 
401.1528. 
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Methyl 6-(1-tosyl-1H-indol-3-yl)hex-5-enoate (130) 
 
6-(1-Tosyl-1H-indol-3-yl)hex-5-enoic acid 129 
(0.10 g, 0.26 mmol) and MeI (17mL, 0.28 mmol) 
were added successively to a suspension of 
K2CO3 (0.055 g, 0.40 mmol) in DMF (5 mL). The 
reaction mixture left to stir for 2 h at room 
temperature. The mixture was poured into water 
and extracted with EtOAc (2 x 25 mL) washed 
with brine, dried over MgSO4 and filtered. The solvent was removed under 
reduced pressure. The crude reaction mixture was purified by column 
chromatography (petrol / ethyl acetate 7:3) to give methyl 6-(1-tosyl-1H-indol-
3-yl)hex-5-enoate as a mixture of (E:Z, 1:4) in (0.965 g, 0.24 mmol, 93%) as a 
colourless oil. 
 
Rf : 0. 8 (petrol / ethyl acetate 7:3). 1H NMR (300 MHz, CDCl3): δH 7.91 (d, J 
= 7.5 Hz, 1H, H(1 or 4)), 7.70 (d, J = 7.7 Hz, 2H, H(5, 6) or (7,8)), 7.44 (s, 1H, H10), 
7.45 – 7.42 (m, 1H, H(1 or 4)), 7.19 – 7.11 (m, 3H, H(2 or 3),  H(5, 6) or (7, 8)),  6.36 (d, 
J = 11.2 Hz, 1H, H11), 5.70 (dt, J = 11.2, 7.5 Hz, 1H, H12), 3.58 (s, 3H, H16), 
2.33 – 2.24 (m, 7H, H(9, 14, 15)), 1.75 (dt, J = 6.7, 6.3 Hz, 3H, H16).13C NMR (75 
MHz, CDCl3): δC 173.9 (CO), 144.9, 135.1, 134.6, 133.3, 130.8, 129.8, 126.8, 
125.0,124.8, 123.4, 119.6, 119.0, 118.5, 113.6, 51.6 (C16), 33.5, 29.0, 24.7, 
21.6 (C9). IR (neat): νmax/cm-1: 1727 (CO), 1597 (C=C). 
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(E)-5-(1-tosyl-1H-indol-3-yl)pent-4-en-1-ol (134) 
 
DIBAL-H (1.0 M in toluene, 1.5 mL, 1.5 mmol) was 
added to a solution of ethyl (E)-5-(1-tosyl-1H-indol-3-
yl) pent-4-enoate 141 (0.170 g, 0.43 mmol) in dry 
toluene (10 mL) at -78 oC under nitrogen. The reaction 
mixture was stirred at room temperature for 3 h, slowly 
hydrolysed with 1.0 M of hydrochloric acid (20 mL).  
The organic layer was extracted with EtOAc (2 x 100 
mL), washed with brine, dried over MgSO4 and filtered. 
The solvent was removed under reduced pressure to give the crude cooler 
less oil product which was purified by column chromatography (petrol / ethyl 
acetate 1:1) to yield (E)-5-(1-tosyl-1H-indol-3-yl)pent-4-en-1-ol in (0.1461 g, 
0.41 mmol, 96%) as a colourless oil.  
                                                                                                                                                    
Rf : 0.3 (petrol / ethyl acetate 1:1).1H NMR (400 MHz, CDCl3): δH 7.91 (d, J = 
7.3 Hz, 1H, H(1 or 4)), 7.67 (d, J = 7.4 Hz, 2H, H(5,6) or (7,8)), 7.61 (d, J = 7.3 Hz, 
1H, H(1 or 4)), 7.44 (s, 1H, H10), 7.26 – 7.14 (m, 2H, H(2,3)) 7.11 (d, J = 7.4 Hz, 
2H, H(5,6) or (7,8)),  6.39 (d, J = 16.5 Hz, 1H, H11), 6.20 (dt, J = 16.5, 6.5 Hz, 1H, 
H12), 3.64 (t, J = 6.3 Hz, 2H, H15), 2.29 – 2.22 (m, 5H, H(14, 9)), 1.69 (dt, J = 6.5, 
13.9 Hz, 1H, H13).13C NMR (100 MHz, CDCl3): δC 144.8, 135.4, 135.2, 131.7, 
129.8, 129.2, 126.7, 124.8, 123.4, 122.8, 120.8, 120.7, 120.3, 113.7, 62.3 
(C15), 32.2 (C13), 29.8 (C14), 21.6 (C9) IR (neat): νmax/cm-1: 3335 (OH), 2972 
(CH).  
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(3aS,4S,10aS,10bS)-4-(3-hydroxypropyl)-2-methyl-10-tosyl-4,10,10a,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (135) 
 
Dimethylaluminum chloride (1.0 M in hexane, 0.82 
mL, 0.82 mmol) was added dropwise to a solution of 
N-methylmaleimide (0.046 g, 0.41 mmol) in DCM (5 
mL) at -78 oC. The mixture left to stir for 30 min 
followed by the addition of (E)-5-(1-tosyl-1H-indol-3-
yl)pent-4-en-1-ol 134 (0.146 g, 0.41 mmol) in DCM (7 
mL). The reaction mixture was refluxed for 5 h, 
quenched with saturated NaHCO3 (aq) (25 mL). The 
organic layer was extracted with DCM (2 x 50 mL), washed with brine, dried 
over MgSO4 and filtered. The solvent was removed under reduced pressure 
to give the crude product which was purified by column chromatography (petrol 
/ ethyl acetate 1:1 gradient to 100 ethyl acetate) to yield (3aS,4S,10aS,10bS)-
4-(3-hydroxypropyl)-2-methyl-10-tosyl-4,10,10a,10b-tetrahydropyrrolo[3,4-
a]carbazole-1,3(2H,3aH)-dione in (0.1699 g, 0.36 mmol, 89%) as a white solid. 
 
Mp.  207 – 209 oC. Rf : 0.33 (petrol / ethyl acetate 1:1). 1H NMR (400 MHz, 
CDCl3): δH 7.74 – 7.69 (m, 2H, H(5,6 or 7,8)), 7.65 – 7.59 (m, 1H, H(1 or 4)), 7.21 – 
7.16 (m, 4H, Ar), 6.92 (td, J = 7.5, 1.0 Hz, 1H, H(2 or 3)), 5.81 (t, J = 3.7 Hz, 1H, 
H10), 4.49 (ddd, J = 7.2, 3.3, 1.8 Hz, 1H, H13), 3.96 (dd, J = 8.6, 7.2 Hz, 1H, 
H11), 3.69 (t, J = 6.2 Hz, 2H, H17), 3.13 (dd, J = 8.6, 6.3 Hz, 1H, H12), 2.71 (s, 
3H, H19), 2.30 (s, 3H, H9), 2.22 – 2.16 (m, 1H, H14), 2.08 –1.83 (m, 2H, H(15 or 
16)), 1.79 – 1.69 (m, 2H, H(15 or 16)). 13C NMR (100 MHz, CDCl3): δC 176.3 (CO), 
173.7 (CO), 144.5, 136.8, 134.2, 133.8, 130.4, 129.8, 127.2, 125.9, 123.8, 
120.9, 118.0, 115.2, 62.4 (C17), 61.8 (C11), 43.9 (C12), 40.3 (C13), 38.0 (C14), 
31.2 (C15 or 16), 27.4 (C15 or 16), 24.8 (C19), 21.4 (C9).  IR (neat): ν max/cm-1:  3553 
(br, OH), 1659 (N-CO).MS (pNSI): 484.18 (100%, [M+NH4]+), 467.16 (90%, 
[M+H]+); HRMS (pNSI): calcd C25H26N2O5SNa [M+Na]+: 489.1455; observed: 
489.1446. 
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3-((3aS,4S,10aS,10bS)-2-methyl-1,3-dioxo-10-tosyl-
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanal 
(136) 
 
DMSO (0.02 mL, 0.33 mmol) was added dropwise at -
78 oC to a stirred solution of oxalyl chloride (0.01 mL, 
0.15 mmol) in DCM (2 mL). After 30 min, a solution of 
(3aS,4S,10aS,10bS)-4-(3hydroxypropyl)-2-methyl-
10-tosyl-4,10,10a,10b tetrahydropyrrolo[3,4-
a]carbazole-1,3(2H,3aH)-dione 135 (0.062 g, 0.13 
mmol) in DCM (5 mL) was added. The reaction mixture 
left to stir for 30 min at -78 oC followed by the addition 
of triethylamine (0.10 mL, 0.53 mmol). The reaction mixture was warmed to 
room temperature and stirred for 2 h, quenched with saturated NaHCO3 (aq) (10 
mL). The organic layer was extracted with DCM (1 x 50 mL), washed with 
brine, dried over MgSO4 and filtered. The solvent was removed under reduced 
pressure to give the crude yellow solid product which was purified by column 
chromatography (petrol / ethyl acetate 1:1) to yield 3-((3aS,4S,10aS,10bS)-2-
methyl-1,3-dioxo-10-tosyl-1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-
a]carbazol-4-yl)propanal in (0.045 g, 0.097 mmol, 75%) as a white solid.  
 
Mp.  139 – 141 oC. Rf : 0.2 (petrol / ethyl acetate 1:1). 1H NMR (400 MHz, 
CDCl3): δH  9.79 (t, J = 1.4 Hz, 1H, H17), 7.73 – 7.68 (m, 2H, H(5,6) or (7,8)), 7.67 
– 7.60 (m, 1H, H(1 or 4)), 7.24 – 7.15 (m, 4H, Ar), 6.93 (t, J = 7.5 Hz, 1H, H(2 or 
3)), 5.77 (t, J = 3.4 Hz, 1H, H10), 4.45 (dd, J = 7.3, 3.3, Hz, 1H, H11), 3.96 (dd, 
J = 8.6, 7.3 Hz, 1H, H13), 3.10 (dd, J = 8.7, 5.4 Hz, 1H, H12), 2.75 – 2.63 (m, 
5H, H(19,16)), 2.34 – 2.16 (m, 6H, H(9,14,15)). 13C NMR (100 MHz, CDCl3): δC 
201.7 (C17), 178.7 (CO), 173.8 (CO), 144.7, 144.2, 136.8, 133.9, 130.7, 130.0, 
127.6, 126.6, 123.9, 121.0, 116.2, 115.4, 59.9 (C16), 44.1 (C11), 43.0 (C12), 
42.7 (C13), 37.1 (C14), 25.3 (C15,), 25.2 (C19), 21.6 (C9). IR (neat): νmax/cm-1: 
1697 (CHO), 2925 (C=C). HRMS (pNSI): calcd C25H25N2O5S [M+H]+: 
465.1479; observed: 465.1485.  
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Ethyl 4-((2-phenyl-2H-tetrazol-5-yl)thio)butanoate (138) 
 
Potassium carbonate (3.80 g, 27.7 mmol) was 
added to a stirred solution of 1-phenyl-1H-tetrazol-
5-thiol (2.48 g, 13.9 mmol) and ethyl-4-
bromobutyrate 93 (1.8 mL, 12.6 mmol) in acetone (30 mL) at room 
temperature and stirred vigorously for 18 h. The precipitate was filtered off and 
washed with acetone (2 x 15 mL), and the filtrate was evaporated under 
reduced pressure. The resultant residue was diluted with DCM (2 x 40 mL) 
and water (50 mL). The organic layer was washed with brine, dried over 
MgSO4 and filtered. The solvent was removed under reduced pressure.  The 
crude materials was purified by column chromatography (petrol / ethyl acetate 
4:1) to give the desired compound in (3.6196 g, 12.3 mmol, 98%) as a 
colourless thick oil.  
 
Rf : 0.4 (petrol / ethyl acetate 4:1).1H NMR (400 MHz, CDCl3): δH 7.45 – 7.36 
(m, 5H, Ar), 3.96 (q, J = 7.5 Hz, 2H, H4), 3.30 (t, J = 7.5 Hz, 2H, H3), 2.42 – 
2.38 (m, 2H, H1), 2.09 (dt, J = 6.9, 13.4 Hz, 2H, H2), 1.16 (t, J = 7.5 Hz, 3H, 
H5). 13C NMR (100 MHz, CDCl3): δC 172.0 (CO2Et), 153.6, 133.3, 130.1, 
129.7, 123.7, 60.4 (C4), 37.7, 32.3, 24.4, 14.2 (C5). IR (neat): νmax/cm-1: 2982 
(Ph, CH), 1727 (CO2Et). MS (pNSI): 293.10 (100%, [M+H]+), 247.06 (22%, [M-
OCH2CH3]+); HRMS (pNSI): calcd C13H17N4O2S [M+H4]+: 293.1067; observed: 
293.1068. 
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Ethyl 4-((2-phenyl-2H-tetrazol-5-yl)sulfonyl)butanoate (139) 
 
Method A 
Ammonium molybdate tetrahydrate (0.0741 g, 0.06 
mmol) was dissolved in 35% hydrogen peroxide 
(0.27 g, 8.16 mmol) to give a bright yellow solution. 
A solution of ethyl 4-((2-phenyl-2H-tetrazol-5-yl)thio)butanoate 138 (0.200 g, 
0.68 mmol) in MeOH (5 mL) was added. The reaction mixture left to stir at 
room temperature for 18 h, diluted with water (10 mL). The organic layer was 
extracted with EtOAc (2 x 50 mL), washed with brine, dried over MgSO4 and 
filtered. The solvent was removed under reduced pressure to give the desired 
compound as a pale yellow oil  The crude materials was purified by column 
chromatography (petrol / ethyl acetate 1:1) to give the desired compound in 
(0.174 g, 0.53 mmol, 78%) as a white solid.  
 
Method B         
A solution of m-chloroperoxybenzoic acid (0.587g, 3.4mmol) in DCM (10 mL) 
was added to a solution of ethyl 4-((2-phenyl-2H-tetrazol-5-yl)thio)butanoate 
138 (0.2 g, 0.68 mmol) in DCM (5 mL) at 0 oC. The mixture was stirred at room 
temperature for 24 h, filtered through celite. The organic layer was extracted 
with DCM (2 50 mL), washed with brine, dried over MgSO4 and filtered. The 
solvent was removed under reduced pressure to give the desired compound 
as pale yellow oil.  The crude materials was purified by column 
chromatography (petrol / ethyl acetate 1:1) to give the desired compound in 
(0.1 g, 0.30 mmol, 46%) as a white solid.  
 
Mp.  87 – 89 oC. Rf : 0.8 (petrol / ethyl acetate 1:1).1H NMR (300 MHz, CDCl3): 
δH 7.65 (dd, J = Hz, 2H, Ar), 7.61 - 7.56 (m, 3H, Ar), 4.11 (q, J = 7.3 Hz, 2H, 
H4), 3.82 (t, J = 6.7 Hz, 2H, H3), 2.52 (t, J = 7.5 Hz, 2H, H1), 2.24 (dt, J = 6.7, 
13.0 Hz, 2H, H2), 1.23 (t, J = 7.3 Hz, 2H, H5). 13C NMR (75 MHz, CDCl3): δC 
171.5 (CO), 153.3, 132.9, 131.4, 129.6, 125.1, 60.9 (C4), 55.0, 31.8, 17.8, 14.2 
(C5). IR (neat): νmax/cm-1: 1712 (CO2Et). HRMS (pNSI): calcd C13H17N4O4S 
[M+H]+:325.0965; observed: 325.0960. 
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Ethyl (E)-5-(1-tosyl-1H-inol-3-yl) pent-4-enoate (141)     
 
NaHMDS (1.0 M in THF, 1.48 mL, 1.48 mmol) was 
added to a solution of ethyl 4-((2-phenyl-2H-
tetrazol-5-yl) sulfonyl)butanoate 139 (0.49 g, 0.34 
mmol) in THF (10 mL) at -78 oC. The mixture was 
stirred at -78 oC for 30 min. In a separate round 
bottomed flask, 1-(toluene-4-sulfonyl)–1H-indol-3- 
carbaldehyde 89 (0.3 g, 1.30 mmol) was dissolved 
in THF (5 mL) and transferred via cannula into the 
reaction solution.  The mixture was warmed slowly 
to room temperature over 4 h and left to stir for 14 h. The solution poured into 
a saturated NH4Cl (5 mL), the organic layer was extracted with EtOAc (2 x 80 
mL), washed with brine, dried over MgSO4 and filtered. The solvent was 
removed under reduced pressure. The resulting crude product was purified by 
flash chromatography (petrol / ethyl acetate  10:1) to give ethyl (E)-5-(1-tosyl-
1H-indol-3-yl) pent-4-enoate in (0.198 g, 0.50 mmol, 39%) as a colourless oil. 
 
Rf : 0.65 (petrol / ethyl acetate 7:3).1H NMR (400 MHz, CDCl3): δH 7.90 (d, J = 
8.8 Hz, 1H, H(1 or 4)), 7.67 (d, J = 8.0 Hz, 2H, H(5, 6) or (7,8)), 7.60 (d, J = 8.0 Hz, 
1H, H(1 or 4)), 7.44 (s, 1H, H10), 7.23 (t, J = 8.0 Hz, 1H, H(2 or 3)), 7.18 (t, J = 8.0 
Hz, 1H,  H(2 or 3)),  7.12 (d, J = 8.0 Hz, 2H, H(5,6)  or  (7,8)), 6.40 (d, J = 16.3 Hz, 
1H, H11), 6.19 (dt, J = 16.3, 6.4 Hz, 1H, H12), 4.07 (q, J = 6.9 Hz, 2H, H16), 2.50 
- 2.39 (m, 6H, H(13,14,15)), 1.17 (t, J = 6.9 Hz, 3H, H16). 13C NMR (100 MHz, 
CDCl3): δC 173.0 (CO2Et), 145.1, 135.5, 135.2, 130.2, 129.9, 129.2, 126.9, 
124.9, 123.4, 123.1, 121.5, 120.6, 120.3, 113.8, 60.5 (C15), 34.1, 28.8, 21.6 
(C9), 14.3 (C16). IR (neat): νmax/cm-1: 1727 (CO), 1597 (C=C). MS (pNSI): 
415.2 (100%, [M+NH4]+), 812.30 (100%, [2M+NH4]+); HRMS (pNSI): calcd 
C22H24NO4S [M+H]+: 398.1421; observed: 398.1417. 
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1-Tosyl-3-vinyl-1H-indole (148) 
 
Methyltriphenylphosphonium iodide 153 (1.29 g, 3.2 mmol) 
was dissolved in THF under a nitrogen atmosphere.  The 
reaction mixture was cooled down to -78 oC. n-Butyllithium 
(2.5 M in hexane, 1.18 mL, 2.97 mmol) was added dropwise 
over 10 min. The mixture was warmed to 0 oC and left to stir 
for 2 h. In a separate round,  a solution of 1-(toluene-4-
sulfonyl)–1H-Indol-3-carbaldehyde 89 (0.800  g, 2.7 mmol) 
was dissolved in THF (10 mL) and transferred via cannula to the flask which 
containing the solution of methyltriphenylphosphonium iodide. The reaction 
mixture was warmed up to room temperature and stirred for 24h. The reaction 
mixture was quenched with water (30 mL). The organic layer was extracted 
with ethyl acetate (3 x 100 mL), washed with brine, dried with anhydrous 
MgSO4 and filtered. The solvent was removed under reduced pressure. The 
crude yellow oil product was purified by column chromatography (petrol / ethyl 
acetate 10:1) to give 1-tosyl-3-vinyl-1H-indole in (0.580 g, 1.93 mmol, 72%) as 
a yellow solid. 
 
Mp. 93 – 95 oC (lit. 93 - 94 oC).101 Rf : 0.31 (petrol / ethyl acetate 10:1). 1H 
NMR (400 MHz, CDCl3): δH  7.98 (d, J = 8.1 Hz, 1H, H(1 or 4)), 7.76 (d, J = 7.7 
Hz, 2H, H(5-6) or (7-8)), 7.73 (d, J = 8.1 Hz, 1H, H(1 or 4)), 7.59 (s, 1H, H10),  7.32 (t, 
J = 7.7 Hz, 1H, H(2 or 3)), 7.26 (t, J = 7.7 Hz, 1H, H(2 or 3)),  7.21 (d, J = 7.7 Hz, 
2H, H(5-6) or (7-8), 6.75 (dd, J = 16.8, 11.3 Hz, 1H, H11),  5.79 (d, J = 16.8 Hz, 1H, 
H12), 5.33 (d, J = 11.3 Hz,1H, H13), 2.33 (s, 3H, H9). 13C NMR (100 MHz, 
CDCl3): δC 145.0, 135.5, 135.1, 130.0, 129.0, 127.6, 126.8, 125.0, 124.1, 
123.5, 120.9, 120.4, 115.3, 113.8, 21.6 (C9). IR (neat): νmax/cm-1: 3119 (CH).  
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(3aS,10aS,10bS)-2-methyl-10-tosyl-4,10,10a,10b-tetrahydropyrrolo 
[3,4-a]carbazole-1,3(2H,3aH)-dione (149) 
 
N-methylmaleimide (1, 0.373 g, 3.36 mmol) and 1-
tosyl-3-vinyl-1H-indole 148 (1.00 g, 3.36 mmol) were 
dissolved in DCM (15 mL). The mixture was refluxed 
for 48 h and the solvent was removed under reduced 
pressure. The crude white product was purified by 
column chromatography (petrol / ethyl acetate 2:1) to 
give (3aS,10aS,10bS)-2-methyl-10-tosyl-
4,10,10a,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione in (0.931 
g,  2.28 mmol, 68%) as a white solid. 
 
Mp.  223 – 225 oC. Rf  : 0.25 (petrol / ethyl acetate 2:1).1H NMR (400 MHz, 
CDCl3): δH 7.78 (d, J = 7.5 Hz, 2H, H(5-6) or (7-8)), 7.66 (d, J = 7.5 Hz, 1H, H(1 or 
4)), 7.23 (d, J = 8.0 Hz, 2H, H(5-6) or (7-8)), 7.26 - 7.22 (m, 4H, Ar), 6.98 (t, J = 7.3 
Hz, 1H, H(2 or 3)), 6.04 (dt, J = 4.0, 7.0 Hz, 1H, H10), 4.54 - 4.51 (m, 1H, H11), 
4.05 (t, J = 7.6 Hz, 1H, H15), 3.19 (t, J = 7.6 Hz, 1H, H(12 or 13)), 3.04 - 2.98 (m, 
1H, H14), 2.82 (s, 3H, H16),  2.35 (s, 3H, H9), 2.20 - 2.13 (m, 1H, H(12 or 13)). 13C 
NMR (100 MHz, CDCl3): δC 178.9 (CO), 174.1 (CO), 144.6, 137.4, 134.3, 
130.4, 129.9, 127.4, 127.1, 126.3, 123.9, 121.0, 115.4, 112.9, 61.5 43.2, 37.2, 
25.3, 25.1 (C16), 21.6 (C9).  IR (neat): νmax/cm-1: 2972 (CH), 1693 (CO).  
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Methyltriphenylphosphonium iodide (153) 
 
Methyl iodide (2.47 g, 17.4 mmol) was added to a solution of 
triphenylphosphine (5.00 g, 19.1 mmol) in toluene (40 mL).  The 
solution was stirred at room temperature for 24 h. The resultant 
precipitate was filtered off with suction and washed with toluene to give 
methyltriphenylphosphonium iodide in (6.750 g, 16.69 mmol, 96%) as white 
crystals. 
 
Mp. 186 – 188 oC (lit. 183 - 184 oC).100 1H NMR (400 MHz, CDCl3):  δH 7.81 - 
7.65 (m, 15H, Ar), 3.18 (d, 3H, J = 13.5 Hz, Me). 13C NMR (100 MHz, CDCl3): 
δC 135.3 (Jcp = 3.2 Hz), 133.4 (Jcp = 10.6 Hz), 130.6 (Jcp = 12.9 Hz), 11.50 (Jcp 
= 55.4 Hz, Me). IR (neat): νmax/cm-1: 2984 (CH),1441 (P-Ph).  
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(3aS,5S,10bS)-5-hydroxy-2-methyl-10-tosyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (156)   
  
NBS (0.045 g, 0.24 mmol) was dissolved in (THF / H2O,  
2:2 mL) and the solution was cooled down to 0 oC. 
Then, (3aS,10aS,10bS) -2-methyl-10-tosyl-
4,10,10a,10b-tetrahydropyrrolo [3,4-a]carbazole-1,3 
(2H,3aH)-dione 149 (0.05 g, 0.12 mmol) was added to 
the solution in one portion. The solution was stirred at 
room temperature for 2 h, quenched with 5 mL of 
NaHCO3 (aq). The organic layer was extracted with DCM (2 x 15 mL), washed 
with brine, dried with anhydrous MgSO4 and filtered. The solvent was removed 
under reduced pressure to afford the crude orange solid as a mixture of two 
diastereomers in a 4:1 ratio. Purification of the crude material in (petrol / ethyl 
acetate 1:1) gave the major diastereomer of (3aS,5S,10bS)-5-hydroxy-2-
methyl-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-
dione  in (0.0263 g, 0.062 mmol, 52%) as a white solid.  
 
M.p.  211 – 213 oC. Rf: 0.3 (petrol / ethyl acetate 1:1). 1H NMR (300 MHz, 
CDCl3): δH 8.01 – 7.90 (m, 2H, H(5,6) or (7,8)), 7.81 – 7.67 (m, 1H, H(1 or 4)), 7.51 
– 7.41 (m, 1H, H(1 or 4)), 7.30 – 7.12 (m, 4H, Ar), 5.29 (d, J = 9.2 Hz,1H, H12), 
5.23 (t, J = 2.7 Hz,1H, H15), 3.42 – 3.29 (m, 1H, H13), 2.94 (s, 3H, H19), 2.75 
(ddd, J = 14.2, 3.5, 2.0 Hz, 1H, H14), 2.31 (s, 3H, H9), 1.90 (ddd, J = 14.2, 7.9, 
2.7 Hz, 1H, H14). 13C NMR (176 MHz, CDCl3): δC 179.6 (CO), 174.7(CO), 
144.8, 136.4, 135.8, 131.2, 129.7, 127.6, 127.0, 124.9, 123.6, 121.4, 118.2, 
114.7, 61.3 (C15), 38.9, 37.6, 32.3, 25.6 (C19), 21.7 (C9). IR (neat): νmax/cm-1: 
1692 (CO), 3659 (OH). MS (pNSI): 447.0 (68%, [M+H]+), 871.2 (17%, 
[2M+Na]+), 442.1 (47%, [M+NH4]+); HRMS (pNSI): calcd C22H21N2O5S [M+H]+: 
425.1166; observed: 425.1166. 
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(3aS,5S,10bS)-5-methoxy-2-methyl-10-tosyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (157)        
 
NBS (0.045 g, 0.24 mmol) was dissolved in (THF / 
MeOH, 2:2 mL) and the solution was cooled down to 0 
oC. Then, (3aS,10aS,10bS)-2-methyl-10-tosyl-
4,10,10a,10b-tetrahydropyrrolo [3,4-a]carbazole-1,3 
(2H,3aH)-dione 149 (0.05 g, 0.12 mmol) was added to 
the solution in one portion. The solution was stirred at 
0 oC for 1 h, quenched with (5 mL) of NaHCO3(aq). The 
organic layer was extracted with DCM (2 x 15 mL), 
washed with brine, dried with anhydrous MgSO4 and filtered. The solvent was 
removed under reduced pressure to afford the crude orange solid as a mixture 
of two diastereomers in a 14:1 ratio. Purification of the crude material in (petrol 
/ ethyl acetate 2:1) gave the major diastereomer of (3aS,5S,10bS)-5-methoxy-
2-methyl-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-
dione in (0.0391 g, 0.09 mmol, 75%) as a yellow solid.  
 
Mp. 192 – 194 oC. Rf : 0.30 (petrol / ethyl acetate 2:1). 1H NMR (300 MHz, 
CDCl3): δH 8.06 – 7.95 (m, 2H, H(5,6) or (7,8)), 7.82 – 7.65 (m, 1H, H(1 or 4)), 7.51 
– 7.36 (m, 1H, H(1 or 4)), 7.29 – 7.08 (m, 4H, Ar), 5.32 (d, J = 9.3 Hz, 1H, H12), 
4.66 (dd, J = 3.2, 2.3 Hz, 1H, H15), 3.38 – 3.25 (m, 1H, H13), 3.09 (s, 3H, H16), 
2.92 (s, 3H, H19), 2.88 (ddd, J = 14.2, 3.2, 1.4 Hz, 1H, H14), 2.30 (s, 3H, H9), 
1.74 (ddd, J = 14.3, 8.3, 2.4 Hz, 1H, H14).13C NMR (75 MHz, CDCl3): δC 179.4 
(CO), 175.3 (CO), 145.0, 136.2, 135.7, 131.8, 129.8, 128.0, 127.6, 124.7, 
123.7, 120.0, 118.1, 114.5, 69.4, 56.6, 38.8, 37.6, 29.7, 25.5 (C19), 21.5 (C9). 
IR (neat): νmax/cm-1: 1707 (CO), 2970 (CH). MS (pNSI): 439.1321 (100%, 
[M+H]+), 894.2 (47%, [2M+NH4]+), 456.1 (42%, [M+NH4]+); HRMS (pNSI): 
calcd C23H23N2O5S [M+H]+: 439.1322; observed: 439.1321. 
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(3aS,5S,10bS)-5-ethoxy-2-methyl-10-tosyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (158) 
 
NBS (0.045 g, 0.24 mmol) was dissolved in (THF / 
EtOH, 2:2 mL) and the solution was cooled down to 0 
oC. Then, (3aS,10aS,10bS)-2-methyl-10- tosyl-
4,10,10a, 10b-tetrahydropyrrolo [3,4-a]carbazole-1,3 
(2H,3aH)-dione 149 (0.05 g, 0.12 mmol) was added to 
the solution in one portion. The solution was stirred at 
0 oC for 1 h, quenched with 5 mL of NaHCO3 (aq). The 
organic layer was extracted with DCM (2 x 15 mL), 
washed with brine, dried with anhydrous MgSO4 and filtered. The solvent was 
removed under reduced pressure to afford the crude orange solid as a mixture 
of two diastereomers in a 14:1 ratio. Purification of the crude material in (petrol 
/ ethyl acetate 2:1) gave the major diastereomer of (3aS,5S,10bS)-5-ethoxy-
2-methyl-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-
dione in (0.0362 g, 0.08 mmol, 67%) as a brown solid.  
 
Mp.  195 – 197 oC. Rf : 0.38 (petrol / ethyl acetate 2:1). 1H NMR (300 MHz, 
CDCl3): δH 7.98 (d, J = 8.1 Hz, 2H, H(5,6) or (7,8)), 7.78 – 7.70 (m, 1H, H(1 or 4)), 
7.46 – 7.38 (m, 1H, H(1 or 4)), 7.26 – 7.13 (m, 4H, Ar), 5.33 (d, J = 9.3 Hz, 1H, 
H11), 4.75 (dd, J = 3.2, 2.3 Hz, 1H, H15), 3.43 – 3.27 (m, 2H, H(13,16)), 3.14 (dq, 
J = 8.6, 7.0 Hz, 1H, H16), 2.93 (s, 3H, H19), 2.87 (ddd, J = 14.1, 3.2, 1.4 Hz, 
1H, H14), 2.31 (s, 3H, H9), 1.73 (ddd, J = 14.1, 8.4, 2.3 Hz, 1H, H14), 0.90 (t, J 
= 7.0 Hz, 3H, H17).13C NMR (75 MHz, CDCl3): δC 179.5 (CO), 175.5 (CO), 
145.1, 136.1, 135.7, 131.8, 129.8, 128.0,127.8, 124.7, 123.5, 120.5, 118.1, 
114.6, 67.6, 64.1, 38.9, 37.7, 30.2, 25.3, 21.7 (C9),15.2. IR (neat): νmax/cm-1: 
1707 (CO), 2970 (CH). MS (pNSI): 470.1 (42%, [M+NH4]+), 475.1293 (25%, 
[2M+Na]+); HRMS (pNSI): calcd C24H25N2O5S [M+H]+: 453.1479; observed: 
453.1477. 
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(3aS,5R,10bS)-5-isopropoxy-2-methyl-10-tosyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (159)         
 
NBS (0.045 g, 0.24 mmol) was dissolved in THF / 2-
propanol, 2:2 mL) and the solution was cooled down to 
0 oC. Then, (3aS,10aS,10bS)-2-methyl-10-tosyl-
4,10,10a,10b-tetrahydropyrrolo[3,4-a] carbazole-1,3 
(2H,3aH)-dione (0.05 g, 0.12 mmol) was added to the 
solution in one portion. The solution was stirred at 0 oC 
for 1 h, quenched with 5 mL of NaHCO3 (aq). The 
organic layer was extracted with DCM (2 x 15 mL), 
washed with brine, dried with anhydrous MgSO4 and filtered. The solvent was 
removed under reduced pressure to afford the crude white solid as a mixture 
of two diastereomers in a 19:1 ratio. Purification of the crude material in (petrol 
/ ethyl acetate 2:1) gave the major diastereomer of (3aS,5R,10bS)-5-
isopropoxy-2-methyl-10-tosyl-4,5,10,10b-tetrahydro pyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione in (0.0341 g, 0.076 mmol, 64%) as a yellow solid.  
 
Mp.  196 – 198 oC. Rf : 0.6 (petrol / ethyl acetate 2:1). 1H NMR (300 MHz, 
CDCl3): δH 8.14 – 7.94 (m, 2H, Ar), 7.83 – 7.62 (m, 1H, Ar), 7.47 – 7.33 (m, 
1H, Ar), 7.27 – 7.15 (m, 4H, Ar), 5.33 (d, J = 9.4 Hz, 1H, H12), 4.88 (dd, J = 
3.2, 2.4 Hz, 1H, H15), 3.48 – 3.38 (m, 1H, H17), 3.35 – 3.22 (t, J = 8.5 Hz, 1H, 
H13), 2.93 (s, 3H, H19), 2.80 (ddd, J = 14.1, 3.2, 1.4 Hz, 1H, H14), 2.31 (s, 3H, 
H9), 1.72 (ddd, J = 14.1, 8.5, 2.4 Hz, 1H, H14), 1.04 (d, J = 6.0 Hz, 3H, H(16 or 
18)), 0.86 (d, J = 6.0 Hz, 3H, H(16 or 18)).13C NMR (75 MHz, CDCl3): δC 179.6 
(CO), 175.4 (CO), 145.1, 136.1, 135.8, 131.8, 129.8, 127.9, 127.8, 124.7, 
123.5, 120.7, 118.1, 114.6, 68.5, 64.2, 38.8, 37.7, 30.6, 25.3, 22.4, 21.6,  
21.4 (C9). IR (neat): νmax/cm-1: 170.5 (CO), 2923 (CH). MS (pNSI): 467.16 
(100%, [M+H]+), 489.14 (32%, [M+Na]+), 955.30 (90%, [M+Na]+); HRMS 
(pNSI): calcd C25H27N2O5S [M+H]+: 467.1626; observed: 467.1635. 
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(3aS,5S,10bS)-5-(diethylamino)-2-methyl-10-tosyl-4,5,10,10b 
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (166)   
 
(3aS,10aS,10bS)- 2-methyl-10- tosyl-4,10,10a,10b-
tetrahydropyrrolo [3,4-a]carbazole-1,3(2H,3aH)-dione 
149 (0.05 g, 0.12 mmol) and Cs2CO3 (0.80 g, 0.24 
mmol) was dissolved in DCM (5 mL). The solution was 
cooled down to 0 oC and bromine (7.5 µL, 0.14 mmol) 
was added dropwise to the mixture. After 2 min 
diethylamine (0.12 mL, 1.22 mmol) was added. The 
reaction mixture was stirred at 0 oC for 2 h, quenched 
with water (5 mL). The organic layer was extracted with DCM (2 x 15 mL), 
washed with brine, dried with anhydrous MgSO4 and filtered. The solvent was 
removed under reduced pressure to afford the crude yellow compound. 
Purification using column chromatography (petrol / ether / DCM 2:1:1) gave 
(3aS,5S,10bS)-5-(diethylamino)-2-methyl-10-tosyl-4,5,10,10b-tetrahydro 
pyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione  in (0.0469 g, 0.096 mmol, 80%) as 
a yellow solid. 
 
Mp.  202 – 204 oC. Rf : 0.25 (petrol / ether / DCM 2:1:1). 1H NMR (300 MHz, 
CDCl3): δH 8.02 (d, J = 8.1 Hz, 2H, Ar), 7.95 (d, J = 8.1 Hz, 2H, Ar), 7.28 – 
7.12 (m, 4H, Ar), 5.03 (dd, J = 8.3, 1.8 Hz, 1H, H12), 4.00 (ddd, J = 9.4, 4.6, 
1.8 Hz, 1H, H15), 3.67 – 3.36 (m, 1H, H13), 2.97 (s, 3H, H9), 2.49 – 2.33 (m, 
5H,H(16,19,14)), 1.87 (ddd, J = 13.3, 9.4, 5.7 Hz, 1H, H14), 0.97 (t, J = 7.1 Hz, 6H, 
H(17,18)).13C NMR (75 MHz, CDCl3): δC 178.3 (CO), 173.7 (CO), 144.6, 138.4, 
134.5, 130.0, 129.8, 129.3, 126.9, 126.8, 125.2, 123.8, 122.2, 116.0, 51.4 (C16, 
19), 43.4, 40.3, 39.3, 25.3, 21.5 (C20), 21.1 (C9), 14.0 (C18, 17). IR (neat): 
νmax/cm-1: 1702 (CO), 2981 (CH). MS (pAPCI): 407.1 (100%, [M-NEt2+]), 
959.4 (21%, [2M+H+]); HRMS (pAPCI): calcd C26H30N3O4S [M+H]+: 480.1592; 
observed: 480.1946.* 
 
* HRMS was collected by Joseph Cowell. 
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(3aS,5S,10bS)-2-methyl-5-(pyrrolidin-1-yl)-10-tosyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione  (172) 
 
(3aS,10aS,10bS)-2- methyl-10-tosyl-4,10,10a,10b 
tetrahydropyrrolo [3,4-a]carbazole-1,3(2H,3aH)-dione 
(0.05 g, 0.12 mmol) and Cs2CO3 (0.80 g, 0.24 mmol) 
was dissolved in DCM (5 mL). The solution was cooled 
down to 0 oC and bromine (7.5 µL, 0.14mmol) was 
added dropwise to the mixture. After 2 min pyrrolidine 
(0.1 mL, 1.22 mmol) was added to the mixture.   The 
solution was stirred at 0 oC for 2 h, quenched with 
water (5 mL). The organic layer was extracted with DCM (2 x 15 mL), washed 
with brine, dried with anhydrous MgSO4 and filtered. The solvent was removed 
under reduced pressure. The crude yellow solid product was purified using 
column chromatography (petrol / ethyl acetate 1:1 gradient to 100% ethyl 
acetate) to give (3aS,5S,10bS)-2-methyl-5-(pyrrolidinee-1-yl)-10-tosyl-
4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione  in (0.0528 
g, 0.11 mmol, 92%) as a yellow solid. 
 
Mp. 197 – 199 oC. Rf : 0.1 (petrol / ethyl acetate 1:1).1H NMR (300 MHz, 
CDCl3): δH 7.88 – 7.78 (m, 1H, Ar), 7.57 – 7.49 (m, 2H, Ar), 7.49 – 7.42 (m, 
1H), 7.19 – 7.08 (m, 2H, Ar), 7.09 – 7.03 (m, 2H, Ar), 4.86 (d, J = 7.7 Hz, 1H, 
H12), 3.72 – 3.62 (m, 1H, H13), 3.58 (t, J = 3.8 Hz, 1H, H15), 2.95 (s, 3H, H19), 
2.64 – 2.51 (m, 2H, H(16,19)), 2.40 (dt, J = 13.5, 4.7 Hz, 1H, H14), 2.23 (s, 3H, 
H9), 2.14 (m, 2H, H(16 or 19)), 1.70 – 1.54 (m, 5H, H (17,18,14)).13C NMR (75 MHz, 
CDCl3): δC 179.0 (CO), 173.3 (CO), 144.6, 137.5, 134.8, 130.0, 129.6, 129.4, 
126.7, 124.8, 124.7, 123.8, 119.6, 115.8, 53.5, 51.5, 41.6, 38.8, 28.8, 25.2 
(C19), 23.6, 21.5 (C9). IR (neat): νmax/cm-1: 1710 (CO), 1593 (C=C). MS 
(pNSI): 478.17 (100%, [M+H]+), 500.16 (15%, [M+Na]+); HRMS (pNSI): calcd 
C26H28N3O4S [M+H]+: 478.1795; observed: 478.1787. 
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(3aS,5S,10bS)-2-methyl-5-(piperidin-1-yl)-10-tosyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione  (173) 
 
(3aS,10aS,10bS)-2- methyl-10-tosyl-4,10,10a,10b-
tetrahydropyrrolo [3,4-a]carbazole-1,3(2H,3aH)-dione 
149 (0.05 g, 0.12 mmol) and Cs2CO3 (0.80 g, 0.24 
mmol) was dissolved in DCM (5 mL). The solution was 
cooled down to 0 oC and bromine (7.5 µL, 0.14 mmol) 
was added dropwise to the mixture. After 2 min 
piperidine (0.12 mL, 1.22 mmol) was added to the 
mixture.   The solution was stirred at 0 oC for 1 h, 
quenched with water (5 mL). The organic layer was extracted with DCM (2 x 
15 mL), washed with brine, dried with anhydrous MgSO4 and filtered. The 
solvent was removed under reduced pressure. The crude yellow product was 
purified using column chromatography (petrol / ethyl acetate 1:1) to give 
(3aS,5S,10bS)-2-methyl-5- (piperidin-1-yl)-10-tosyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione in (0.0451 g, 0.092 
mmol, 77%) as a white solid. 
 
Mp.  163 – 165 oC.  Rf : 0.26 (petrol / ethyl acetate 2:1).1H NMR (300 MHz, 
CDCl3)μ δH 7.91 (t, J = 8.3 Hz, 2H, H(2, 3)), 7.56 (d, J = 8.3 Hz, 2H, H(5,6) or (7,8)), 
7.21 – 7.02 (m, 4H, Ar), 4.95 (dd, J = 8.3, 1.4 Hz, 1H, H12), 3.65 (ddd, J = 8.4, 
4.2, 1.4 Hz, 1H, H15), 3.49 (dt, J = 8.4, 5.8 Hz, 1H, H13), 2.90 (s, 3H, H21), 2.29 
– 2.22 (m, 4H, H(16,20)), 2.22 (s, 3H, H9),  2.21 – 2.17 (m, 1H, H14) 2.05 – 1.94 
(m, 1H, H14), 1.39 (m, 6H, H(17,18,19)). 13C NMR (75 MHz, CDCl3): δC 178.5 
(CO), 173.6 (CO), 144.6, 137.9, 134.6, 129.8, 129.6, 129.4, 126.7, 125.1, 
125.0, 123.9, 121.5, 115.6, 56.3, 50.1, 40.3, 39.1, 26.3, 25.2 9, 24.6, 22.5 
(C21), 21.5 (C9). IR (neat): νmax/cm-1: 1703 (CO), 2981 (Ar, CH). HRMS 
(pNSI): calcd C27H30N3O4S [M+H]+: 492.1952; observed: 492.1939. 
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(3aS,5S,10bS)-2-methyl-5-morpholino-10-tosyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione  (174) 
 
(3aS,10aS,10bS)- 2-methyl-10-tosyl-4,10,10a,10b-
tetrahydropyrrolo [3,4-a]carbazole-1,3(2H,3aH)-dione 
(0.05 g, 0.12 mmol) and Cs2CO3 (0.80 g, 0.24 mmol) 
was dissolved in DCM (5 mL). The solution was cooled 
down to 0 oC and bromine (7.5 µL, 0.14 mmol) was 
added dropwise to the mixture. After 2 min morpholine 
(0.1 mL, 1.22 mmol) was added to the mixture.  The 
solution was stirred at 0 oC for 1 h, quenched with water 
(5 mL). The organic layer was extracted with DCM (2 x 15 mL), washed with 
brine, dried with anhydrous MgSO4 and filtered. The solvent was removed 
under reduced pressure. The crude yellow solid product was purified using 
column chromatography (petrol / ethyl acetate 1:1) gave (3aS,5S,10bS)-2-
methyl-5-morpholino-10-tosyl-4,5,10,10b-tetrahydropyrrolo [3,4-a]carbazole-
1,3(2H,3aH)-dione in (0.0489 g, 0.09 mmol, 83%). 
 
Mp.  170 – 172 oC. Rf : 0.24 (petrol / ethyl acetate 1:1)1H NMR (300 MHz, 
CDCl3): δH 7.89 (d, J = 7.9 Hz, 1H, H(1 or 4)), 7.80 (d, J = 7.6 Hz, 1H, H(1 or 4)), 
7.60 (d, J = 8.6 Hz, 2H, H(5,6 or 7,8)),  7.23 – 7.12 (m, 2H, H(2, 3)), 7.08 (d, J = 7.6 
Hz, 2H, H(5,6) or (7,8)), 4.95 (dd, J = 8.3, 1.2 Hz, 1H, H12), 3.66 (t, J = 5.8 Hz, 1H, 
H13), 3.55 (t, J = 4.6 Hz, 5H, H(15, 17,18)), 2.92 (s, 3H, H20), 2.44 – 2.37 (m, 2H, 
H(16 or 19)), 2.33 – 2.26 (m, 2H, H14), 2.25 (s, 3H, H9), 2.15 – 2.05 (m, 2H, H(16 or 
19)). 13C NMR (75 MHz, CDCl3): δC 178.3 (CO), 173.4 (CO), 144.6, 137.7, 
134.7, 130.1, 129.5, 129.4, 126.7 , 125.1 , 124.3, 124.0, 120.8, 115.8, 67.2, 
55.6, 49.5, 40.5, 38.8, 25.2, 23.3 (C19), 21.5 (C9). IR (neat): νmax/cm-1: 1706 
(CO), 2981 (CH). HRMS (pNSI): calcd C26H28N3O5S [M+H]+: 494.1744; 
observed: 494.1737. 
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Benzyl 3-formyl-1H-indole-1-carboxylate (177) 
 
A solution of 3-indole carbaldehyde 88 (5.00 g, 34.4 
mmol) in DCM (100 mL) was cooled down to 0 oC. 
Triethylamine (12 mL, 86.15 mmol) was added to the 
solution. After 10 min, benzyl chloroformate (5.39 mL, 
37.80 mmol) was added. The reaction mixture was stirred at room temperature 
for 24 h. The reaction mixture quenched with water (100 mL), the organic layer 
was extracted with DCM (2 x 150 mL), washed brine, dried with anhydrous 
MgSO4 and filtered. The solvent was removed under reduced pressure. The 
orange crude solid was purified by column chromatography in (petrol / ethyl 
acetate 7:3) to give benzyl 3-formyl-1H-indole-1-carboxylate in (7.8 g, 27.9 
mmol, 81%) as white crystals. 
 
Mp.   89 – 91 oC. Rf : 0.68 (petrol / ethyl acetate 1:1).1H NMR (400 MHz, 
CDCl3): δH 10.07 (s. 1H, H5), 8.27 (d, J = 7.9 Hz, 1H, H(1 or 4)), 8.25 (s, 1H, H7), 
8.17 (d, J = 7.9 Hz, 1H, H(1 or 4)), 7.51 (m, 7H, Ar), 5.50 (s, 2H, H6). 13C NMR 
(100 MHz, CDCl3): δC 185.8 (CHO), 156.7 (CO), 150.1, 136.8, 134.2, 130.6, 
129.1, 128.9, 128.5, 128.0, 127.6, 126.9, 122.0, 116.1, 70.1 (C6). IR (neat): 
νmax/cm-1: 1743 (CHO), 1671 (N-CO).  
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3-Vinyl-1H-indole (178) 
 
n-Butyllithium (2.5 M in hexane, 3.9 mL, 9.66 mmol) was 
added dropwise to a solution of methyltriphenylphosphonium 
iodide 153 (4.5 g, 11.12 mmol) in THF (25 mL)  at -78 oC. The 
reaction mixture was warmed up to 0 oC and left to stir for 1 
h. In a separate round, NaHMDS (1.0 M in THF, 9.66 mL, 9.66 mmol) was 
added to a solution of 1H-indole-3-carbaldehyde 88 (1.402 g, 9.66 mmol) in 
THF (5 mL). This solution was transferred via cannula into the reaction mixture 
at -78 oC. The reaction mixture was stirred at room temperature for 2 h.  The 
organic layer was extracted with ethyl acetate (2 x 100 mL), washed with brine, 
dried over MgSO4 and filtered.  The solvent was removed under reduced 
pressure. The crude yellow oil product was purified by column chromatography 
(petrol / ethyl acetate 4:1) to give 3-vinyl-1H-indole (1.23 g, 8.6 mmol, 90%) 
as a yellow solid. 
 
Mp. 90 – 92 oC (lit. 80 - 81 °C).50 Rf : 0.65 (petrol / ethyl acetate 5:1).1H NMR 
(400 MHz, CDCl3):  δH 7.88 – 7.70 (m, 2H, H(1, Ar)), 7.21 – 7.01 (m, 4H, H2, 
HAr), 6.77 (ddd, J = 17.8, 11.3, 0.6 Hz, 1H, H3), 5.59 (dd, J = 17.8, 1.5 Hz, 
1H, H5), 5.07 (dd, J = 11.3, 1.5 Hz, 1H, H4). 13C NMR (100 MHz, CDCl3): δC 
136.7, 129.4, 125.6, 123.6, 122.5, 120.3, 120.1, 115.7, 111.3, 110.7.  IR 
(neat): νmax/cm-1: 3390 (NH), 2980 (CH).  
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Benzyl 3-vinyl-1H-indole-1-carboxylate (179) 
 
                                       Method A 
Methyltriphenylphosphonium iodide 153 (4.32 g, 10.7 
mmol) was dissolved in THF (10mL) and the solution 
was cooled to -78 oC. n-Butyllithium (2.5 M in hexane, 
3.80 mL, 9.30 mmol) was added to the solution 
dropwise over 10 min. The reaction mixture was 
warmed to 0 oC and left to stir for 2 h.   In a separate 
round, a solution of benzyl 3-formyl-1H-indole-1-carboxylate 177 (2.600  g, 
9.30 mmol) was dissolved in THF (10 mL) and transferred via cannula to the 
flask which containing the solution of methyltriphenylphosphonium iodide. The 
reaction mixture was warmed up to room temperature and stirred for 24 h. The 
reaction mixture was quenched with water (50 mL). The organic layer was 
extracted with ethyl acetate (3 x 100 mL), washed with brine, dried with 
anhydrous MgSO4 and filtered.  The solvent was removed under reduced 
pressure. The crude orange solid product was purified by column 
chromatography (petrol / ethyl acetate 5:1) to give benzyl 3-vinyl-1H-indole-1-
carboxylate in (1.176 g, 4.24 mmol, 46%) as a white solid.  
 
Method B       
A solution of 3-vinyl-1H-indole 178 (0.2 g, 1.39 mmol) in THF (5 mL) was 
cooled down to 0 oC. NaHMDS (1.0 M in THF, 2.09 mL, 2.09 mmol) was added 
to the solution. After 30 min, benzyl chloroformate (0.21 mL, 1.52 mmol) was 
added. The reaction mixture was stirred at room temperature for 4 h. The 
solution was diluted with DCM (3 x 30 mL), washed with water (2 x 20 mL), 
brine, dried with anhydrous MgSO4 and filtered. The solvent was removed 
under reduced pressure. The orange crude solid was purified by column 
chromatography in (petrol / ethyl acetate 5:1) to give benzyl 3-vinyl-1H-indole-
1-carboxylate in as a white solid in (0.262 g, 0.96 mmol, 70%).  
 
Mp. 56 – 58 oC. Rf : 0.65 (petrol: ethyl acetate 5:1).1H NMR (400 MHz, CDCl3):  
δH 8.46 – 8.20 (m, 1H, Ar), 7.89 (d, J = 7.6 Hz, 1H, Ar), 7.74 (s, 1H, H6), 7.59 
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– 7.38 (m, 7H, Ar), 6.88 (dd, J = 17.9, 11.5 Hz, 1H, H7), 5.92 (dd, J = 17.9, 1.8 
Hz, 1H, H8), 5.52 (s, 2H, H5), 5.44 (dd, J = 11.4, 1.8 Hz, 1H, H9). 13C NMR (100 
MHz, CDCl3): δC 155.1 (CO), 150.7, 136.1, 135.1, 128.8, 128.6, 128.4, 128.0, 
128.59, 128.43, 128.06, 125.0, 123.6, 123.4, 120.19, 120.1, 115.4, 114.9, 
69.7. IR (neat): νmax/cm-1: 1743 (N-CO), 2979 (CH). HRMS (pNSI): calcd 
C18H16NO2 [M+H]+: 278.1176; observed: 278.1173. 
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Benzyl (3aS,10aS,10bS)-2-methyl-1,3-dioxo-2,3,3a,4,10a,10b-
hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate  (180) 
 
Benzyl 3-vinyl-1H-indole-1-carboxylate 179 
(0.50 g, 1.80 mmol) and N-methylmaleimide 
(0.200 g 1.80 mmol) were dissolved in DCM (10 
mL). The mixture was refluxed for 20 h.  The 
solvent was removed under reduced pressure. 
The crude yellow solid was purified by column 
chromatography (petrol / ethyl acetate 2:1) to yield benzyl (3aS,10aS,10bS)-
2-methyl-1,3-dioxo-2,3,3a,4,10a,10b-hexahydropyrrolo[3,4-a]carbazole-
10(1H)-carboxylate in (0.5388 g, 1.38 mmol, 77%) as a white solid.  
 
Mp. 175 – 177 oC.  Rf : 0.4 (petrol / ethyl acetate 2:1). 1H NMR (300 MHz, 
CDCl3): δH 8.04 (d, J = 8.2 Hz, 1H, Ar, a), 7.55 (d, J = 7.6 Hz, 1H, Ar, b), 7.46 
– 7.10 (m, 15H, Ar, a,b), 6.91 (dt, J = 11.4, 7.4 Hz, 2H, Ar, a,b), 6.08 (dt, J = 
7.4, 3.7 Hz, 2H, H10, a,b), 5.51 – 5.17 (m, 4H, H5, a,b), 4.81 – 4.53 (m, 2H,H11, 
a,b), 4.26  (t, J = 8.1 Hz, 1H, H8, b), 3.89 (t, J = 8.3 Hz, 1H, H8, a), 3.12 (t, J = 
8.1 Hz, 1H, H6, b), 3.04 - 2.94 (m, 3H, H(6a), H(9b)), 2.70 (s, 6H, H7, a , b), 2.25 
– 2.00 (m, 2H, H9, a). 13C NMR (75 MHz, CDCl3): δC 179.2 (CO), 178.9(CO), 
175.0 (CO), 174.6 (CO), 153.1, 152.1, 145.0, 143.8, 137.4 , 137.2 , 135.95 , 
130.2, 130.18 , 128.72 , 128.41 , 128.16 , 126.0, 125.6, 123.0 , 122.8, 120.6, 
120.2, 115.8, 112.5, 112.4, 68.2 (C5), 67.7 (C5), 59.7 (C11), 59.2 (C11), 41.2 
(C6 or 8), 40.3 (C6 or 8), 37.79 (C6 or 8), 37.6 (C6 or 8), 30.9 (C9), 25.0 (C9), 24.9 
(C7), 24.7 (C7). IR (neat): νmax /cm-1: 1773 (CO), 1699 (CO), 2981 (Ar, CH). 
MS (pNSI): 406.17 (60%, [M+NH4]+), 411.13 (26%, [M+Na]+); HRMS (pNSI): 
calcd C23H21N2O4 [M+H]+: 389.1496; observed: 389.1499. 
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Benzyl (3aS,5S,10bS)-2-methyl-1,3-dioxo-5-(pyrrolidin-1-yl)-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate 
(182)  
 
Benzyl (3aS,10aS,10bS)-2-methyl-1,3-dioxo-
2,3,3a,4,10a,10b-hexahydropyrrolo[3,4-a]carbazole-
10(1H)-carboxylate 180 (0.20 g, 0.51 mmol) and 
Cs2CO3 (0.332 g, 1.02 mmol) was dissolved in DCM 
(10 mL). The solution was cooled down to 0 oC. 
Bromine (31.6 µL, 0.61 mmol) was added dropwise to 
the mixture followed by the addition of pyrrolidine 
(0.42 mL, 5.10 mmol). The reaction mixture was 
stirred at 0 oC for 1 h and quenched with water (10 mL). The organic layer was 
extracted with DCM (2 x 50 mL), washed with brine, dried with anhydrous 
MgSO4 and filtered. The solvent was removed under reduced pressure. The 
crude yellow product was purified using column chromatography (petrol / ethyl 
acetate 1:1 gradient to 100% ethyl acetate) to give  benzyl (3aS,5S,10bS)-2-
methyl-1,3-dioxo-5-(pyrrolidinee-1-yl)-2,3,3a,4,5,10bhexahydropyrrolo[3,4-a] 
carbazole-10(1H)-carboxylate in (0.148 g, 0.36 mmol, 71%) as yellow solid.  
 
Mp.  156 – 158 oC. Rf : 0.1 (petrol / ethyl acetate 1:1).1H NMR (300 MHz, 
CD2Cl2)μ δH 8.16 (d, J = 8.1 Hz, 1H, Ar), 7.84 – 7.58 (m, 1H, Ar), 7.53 – 7.12 
(m, 7H, Ar), 5.56 (d, J = 11.8 Hz, 1H, H5), 5.40 (d, J = 11.8 Hz, 1H, H5), 4.76 
(d, J = 7.8 Hz, 1H, H6), 3.71 (t, J = 3.7 Hz, 1H, H10), 3.64 (ddd, J = 12.1, 7.9, 
5.0 Hz, 1H, H8), 2.96 (s, 3H, H7), 2.83 – 2.73 (m, 2H, H(11,14)), 2.55 – 2.38 (m, 
3H, H(11,14, 9)), 1.83 – 1.66 (m, 5H, H(12,13, 9)). 13C NMR (75 MHz, CD2Cl2)μ δC 
178.8 (CO), 174.4 (CO), 173.9, 156.2, 151.5, 136.9, 136.6, 128.8, 128.7, 
128.6, 124.4, 123.0, 122.7, 119.2, 114.7, 69.2, 65.6, 51.9, 41.1, 38.3, 29.0, 
24.7, 23.5. IR (neat): νmax / cm-1: 1703 (CO), 2981 (CH, Ar). MS (pNSI): 
915.40 (100%, [2M+H]+), 937.38 (35%, [2M+Na]+); HRMS (pNSI): calcd 
C27H28N3O4 [M+H]+: 458.2074; observed: 458.2073. 
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Benzyl (3aS,5S,10bS)-2-methyl-5-morpholino-1,3-dioxo-2,3,3a,4,5,10b-
hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (183) 
 
Benzyl (3aS,10aS,10bS)-2-methyl-1,3-dioxo-
2,3,3a,4,10a,10b-hexahydropyrrolo[3,4-a]carbazole-
10(1H)-carboxylate 180 (0.20 g, 0.51 mmol) and 
Cs2CO3 (0.332 g, 1.02 mmol) was dissolved in DCM 
(10 mL). The solution was cooled down to 0 oC. 
Bromine (31.6 µL, 0.61 mmol) was added dropwise to 
the mixture followed by the addition of morpholine 
(0.44 mL, 5.10 mmol). The reaction mixture was 
stirred at 0 oC for 2 h and quenched with water (10 mL). The organic layer was 
extracted with DCM (2 x 50 mL), washed with brine, dried with anhydrous 
MgSO4 and filtered. The solvent was removed under reduced pressure. The 
crude green product was purified using column chromatography (petrol / ethyl 
acetate 1:1 gradient to 100% ethyl acetate) to give benzyl(3aS,5S,10bS)-2-
methyl-5-morpholino-1,3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo [3,4-a] 
carbazole-10(1H)-carboxylate in (0.1651 g, 0.35 mmol, 69%) as a white solid. 
 
Mp.  175 – 177 oC. Rf : 0.4 (petrol / ethyl acetate 1:1).1H NMR (300 MHz, 
CD2Cl2): δH 8.01 (dt, J = 8.4, 0.9 Hz, 1H, Ar), 7.96 – 7.84 (m, 1H, Ar), 7.44 – 
7.10 (m, 7H, Ar), 5.48 (d, J = 11.9 Hz, 1H, H5), 5.33 (d, J = 11.9 Hz, 1H, H5), 
4.76 (d, J = 8.1 Hz, 1H, H6), 3.70 (t, J = 5.4, Hz, 1H, H10), 3.57 (t, J = 4.6 Hz, 
4H, H(12,13)), 3.48 – 3.39 (m, 1H, H8), 2.61 – 2.51 (m, 2H, H(11,14)), 2.48 – 2.37 
(m, 2H, H(11,14)), 2.10 – 2.02 (m, 2H, H9).13C NMR (75 MHz, CD2Cl2): δC 178.6 
(CO), 174.5 (CO), 151.2, 136.8, 134.9, 128.9, 128.8, 128.7,128.6, 128.2, 
124.7, 122.8, 120.6, 119.8, 114.7, 69.2 (C5), 67.2, 55.6, 49.7, 40.2, 38.5, 24.8, 
22.8. IR (neat): νmax/cm-1: 1708 (CO), 2981 (CH, Ar). MS (pNSI): 947.39 
(100%, [2M+H]+), 969.3795 (58%, [2M+Na]+); HRMS (pNSI): calcd 
C27H28N3O5 [M+H]+: 474.2023; observed: 474.2018. 
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Benzyl (3aS,5S,10bS)-5-(diethylamino)-2-methyl-1,3-dioxo-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate   
(184) 
Benzyl (3aS,10aS,10bS)-2-methyl-1,3-dioxo-
2,3,3a,4,10a,10b-hexahydropyrrolo[3,4-a]carbazole-
10(1H)-carboxylate 180 (0.112 g, 0.28 mmol) and 
Cs2CO3 (0.183 g, 0.57 mmol) was dissolved in DCM 
(5 mL). The solution was cooled down to 0 oC. 
Bromine (17.0 µL, 0.33 mmol) was added dropwise to 
the mixture followed by the addition of diethylamine 
(0.43mL, 2.8 mmol). The reaction mixture was stirred 
at 0 oC for 2 h and quenched with water (5 mL). The organic layer was 
extracted with DCM (2 x 30 mL), washed with brine, dried with anhydrous 
MgSO4 and filtered. The solvent was removed under reduced pressure. The 
crude yellow product was purified using column chromatography (petrol / ether 
/ DCM 2:1:1) to give benzyl (3aS,5S,10bS)-5-(diethylamino)-2-methyl-1,3-
dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10 (1H) -carboxylate 
in  (0.0861 g, 0.19 mmol, 68%) as a yellow solid. 
 
Mp. 185 – 187 oC. Rf : 0.3 (petrol / ether /  DCM 2:1:1). 1H NMR (300 MHz, 
CD2Cl2): δH 8.09 – 7.98 (m, 2H, Ar), 7.54 – 7.27 (m, 5H, Ar), 7.22 – 7.02 (m, 
2H, Ar),  5.49 (d, J = 11.9 Hz, 1H, H5), 5.35 (d, J = 11.9 Hz, 1H, H5), 4.81 (d, J 
= 8.3 Hz, 1H, H6), 3.95 (ddd, J = 9.7, 4.5, 1.8 Hz, 1H, H10), 3.34 (dt, J = 8.5, 
5.0 Hz, 1H, H8), 2.78 (s, 3H, H7), 2.63 – 2.29 (m, 5H, H(9,11,14)), 1.82 (ddd, J = 
13.3, 9.7, 5.6 Hz, 1H, H9), 0.98 (t, J = 7.1 Hz, 6H, H(12,13)).13C NMR (75 MHz, 
CD2Cl2): δC 178.2 (CO), 174.5 (CO), 151.5, 137.0, 134.9, 128.8, 128.7, 128.6, 
128.5, 128.4, 128.2, 124.6, 122.4, 122.3, 121.9, 69.2 (C5), 51.4 (C11,14), 43.3 
(C12, 13), 39.8, 39.0, 24.8, 20.2, 13.7 (C7). IR (neat): νmax/cm-1: 1703 (CO), 
2981 (CH). MS (pNSI): 919.43 (100%, [2M+H]+), 460.22 (70%, [M+H]+), 
941.4206 (20%, [2M+Na]+); HRMS (pNSI): calcd C27H30N3O4 [M+H]+: 
460.2231; observed: 460.2220.  
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Benzyl(3aS,5S,10bS)-2-methyl-5-(4-methylpiperazin-1-yl)-1,3-dioxo-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate 
(185)  
Benzyl (3aS,10aS,10bS)-2-methyl-1,3-dioxo-
2,3,3a,4,10a,10b-hexahydropyrrolo[3,4-a]carbazole-
10(1H)-carboxylate 180 (0.038 g, 0.09 mmol) and 
Cs2CO3 (0.064 g, 0.19 mmol) was dissolved in DCM 
(3 mL). The solution was cooled down to 0 oC. 
Bromine (6.0 µL, 0.11 mmol) was added dropwise to 
the mixture followed by the addition of 1-
methylpiperazine (0.10 mL, 0.97 mmol). The reaction 
mixture was stirred at 0 oC for 2.5 h and quenched with water (5 mL). The 
organic layer was extracted with DCM (2 x 30 mL), washed with brine, dried 
with anhydrous MgSO4 and filtered. The solvent was removed under reduced 
pressure. The crude yellow product was purified using column 
chromatography (petrol / ethyl acetate 2:1 gradient to 100% MeOH) to give 
benzyl(3aS,5S,10bS)-2-methyl-5-(4-methylpiperazin-1-yl)-1,3-dioxo-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate in 
(0.0326 g, 0.067 mmol, 75%) as a white solid. 
 
Mp. 195 – 197 oC. Rf : 0.2 (petrol / methanol 1:1).  1H NMR (300 MHz, CD2Cl2): 
δH 8.12 (d, J = 8.1 Hz, 1H, Ar), 8.07 - 8.03 (m, 1H, Ar), 7.56 - 7.52 (m, 2H, Ar), 
7.49 – 7.40 (m, 3H, Ar), 7.35 - 7.23 (m, 2H, Ar), 5.60 (d, J = 11.9 Hz, 1H, H5), 
5.46 (d, J = 11.9 Hz, 1H, H5), 4.88 (d, J = 8.2 Hz, 1H, H6), 3.84 (t, J = 5.8Hz, 
1H, H10), 3.54 (dt, J = 8.3, 6.0 Hz, 1H, H8), 2.92 (s, 3H, H7), 2.75 – 2.67 (m, 
2H, H(11,14)), 2.61 - 2.53 (m, 2H, H(11,14)), 2.26 - 2.38 (m, 4H, H(12,13)), 2.26 – 
2.14 (m, 3H, H15), 2.23 – 2.14 (m, 2H, H9).13C NMR (75 MHz, CD2Cl2): δC 
178.4 (CO), 174.6 (CO), 151.5, 150.0, 136.8, 135.1, 128.8, 128.7, 128.5, 
128.3, 124.6, 122.7, 120.9, 120.5, 114.6, 69.2 (C5), 55.5,  55.4, 45.8, 40.1, 
38.8, 24.7, 24.9, 22.5 (C15). IR (neat): νmax/cm-1: 1703 (CO), 2980 (CH). MS 
(pNSI): 973.46 (100%, [2M+H]+), 995.44 (30%, [2M+Na]+), 509.21 (25%, 
[M+Na]+); HRMS (pNSI): calcd C28H31N4O4 [M+H]+: 487.2340; observed: 
487.2327.  
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5-Fluoro-1H-indole-3-carbaldehyde  (195) 
 
Phosphorus oxychloride (0.82 mL, 8.87 mmol) was added 
dropwise to the stiring mixture of 5-fluoro-1H-indole 193 
(1.00 g, 7.39 mmol) in DMF (2.86 mL, 36.99 mmol) at 0 oC. 
The reaction mixture was stirred at 40 oC for 2h and then was 
cooled to room temperature. Cold water (10 mL) was added followed by 
addition of 2.0 M solution of NaOH in water (20 mL), until pH about 10. The 
organic layer was extracetd with EtOAc, washed with brine, dried over MgSO4 
and filtered. The solvent was removed under reduced pressure to give 5-
fluoro-1H-indole-3-carbaldehyde in (1.17 g, 7.18 mmol, 97%) as an orange 
solid.  
 
 
Mp. 177 – 179 oC (lit. 182 – 187 oC).104 1H NMR (400 MHz, DMSO-d6): δH 
12.25 (br, s, NH), 9.88 (s, 1H, H3), 8.36 (s, 1H, H2), 7.76 (dd, J = 2.8, 8.5 Hz, 
1H, Ar), 7.53 (dd, J = 4.4, 8.4, Hz, 1H, Ar), 7.12 (t, J = 8.2 Hz, 1H, Ar).13C NMR 
(100 MHz,DMSO-d6): δC 185.5 (CO), 158.8 (d, JC-F = 234.0 Hz, C6), 140.3, 
134.0, 125.2 (d, JC-F = 11.2 Hz), 118.7, 114.3 (d, JC-F = 9.4 Hz), 112.1 (d, JC-F 
= 25.9 Hz), 106.3 (d, JC-F = 24.4 Hz). IR (neat): νmax/cm-1: 3210 (NH), 2840 
(CO), 1060 (C-F). MS (pNSI): 186.0 [100% (M+Na)+], 164.0 (M+H)+], 349.0 
[95% (2M+Na)+]; HRMS (pNSI): calcd C9H7FNO [M+H]+: 164.0506; 
observed:164.0504.  
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5-(Benzyloxy)-1H-indole-3-carbaldehyde (196) 
 
Phosphorus oxychloride (1.00 mL, 10.74 mmol) was 
added dropwise to a solution of 5-(benzyloxy) -1H-
indole 194 (2.00 g, 8.95 mmol) in DMF (3.27 mL, 44.48 
mmol) at 0 oC. to the reaction mixture. The reaction 
mixture was stirred at 40 oC for 2h and then cooled to room temperature . Cold 
water (10 mL) was added followed by addition of 2.0 M solution of NaOH in 
water (20 mL), until pH about 10. The organic layer was extracetd with EtOAc 
(4 x 50 mL), washed with brine, dried over MgSO4 and filtered. The solvent 
was removed by reduced pressure to give 5-(benzyloxy)-1H-indole-3-
carbaldehyde in (1.86 g, 7.41 mmol, 83%) as bright brown solid.  
 
Mp. 231 – 233 oC (lit. 237 – 238 oC).108 1H NMR (400 MHz, DMSO-d6): δH 
11.99 (br, s, NH), 9.86 (s,1H, H3),  8.19 (s,1H, H2), 7.66 (d, J = 1.9 Hz, 1H, Ar), 
7.45 (d, J = 7.4 Hz, 1H, Ar), 7.39 – 7.33 (m, 3H, Ar), 7.30- 7.26 (m, 1H, Ar), 
5.16 (s, 2H, H9).13C NMR (100 MHz, DMSO-d6): δC 185.3 (CHO), 155.2, 139.2, 
138.1, 132.3, 128.8, 128.2,128.0, 125.2, 118.3, 114.4,113.6, 104.5, 70.1 (C5). 
IR (neat): νmax/cm-1:3660 (NH), 1734 (CO), 2981 (C-H). MS (pNSI): 274.08 
(100%, [M+Na]+), 525.17 (30%, [2M+Na]+); HRMS (pNSI): calcd 
C16H13NO2Na [M+Na]+: 274.0838; observed: 274.0841. 
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5-Fluoro-3-vinyl-1H-indole (197) 
 
n-Butyllithium (2.5 M in hexane, 2.4 mL, 6.12 mmol) was  
added dropwise to a solution of 
methyltriphenylphosphonium iodide 153 (2.84 g, 7.38 
mmol) in THF (10 mL)  at -78 oC. The reaction mixture 
was warmed up to 0 oC and left to stir for 1 h. In a separate round, a solution 
of 5-fluoro-1H-indole-3-carbaldehyde 195 (1.00 g, 6.12 mmol) in THF (10 mL) 
was transferred via cannula into the solution at -78 oC. The reaction mixture 
was stirred at room temperature for 1 h.  The organic layer was extracted with 
ethyl acetate (2 x 100 mL), washed with brine, dried over MgSO4 and filtered.  
The solvent was removed under reduced pressure. The crude yellow oil 
product was purified by column chromatography (petrol / ethyl acetate 4:1) to 
give 5-fluoro-3-vinyl-1H-indole in (0.8525 g, 5.29 mmol, 87%) as a yellow solid. 
 
Mp.  79 – 81 oC. Rf : 0.3 (petrol / ethyl acetate 4:1).1H NMR (400 MHz, DMSO-
d6): δH 11.3 (br, s, NH), 7.55 (d, J = 2.9 Hz, 1H, H2), 7.51 (dd, J = 2.6, 9.9 Hz, 
1H, Ar), 7.35 (dd, J = 4.7, 8.4 Hz, 1H, Ar), 6.93 (t, J = 6.7 Hz, 1H, Ar), 6.79 (dd, 
J = 11.3, 17.3 Hz, 1H, H3), 5.55 (dd, J = 15.8, 1.8 Hz, 1H, H4), 5.01 (dd, J = 
11.3, 1.8 Hz, 1H, H5).13C NMR (400 MHz, DMSO-d6): δC 159.3, 156.7, 134.0, 
130.2 (d, JC-F = 241.0 Hz, C6), 125.7 (d, JC-F = 10.9 Hz), 114.5 (d, JC-F = 4.7 
Hz), 113.2 (d, JC-F = 9.6 Hz), 110.0 (d, JC-F = 5.8 Hz), 109.8, 104.8 (d, JC-F = 
23.3 Hz). IR (neat): νmax/cm-1: 3408 (NH), 1060 (C-F).  
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5-Phenethoxy-3-vinyl-1H-indole (198) 
 
n-Butyllithium (2.5 M in hexane, 3.01 mL, 7.89 mmol) 
was added dropwise to a solution of 
methyltriphenylphosphonium iodide 153 (3.50 g, 9.07 
mmol) in THF (10 mL)  at -78 oC. The reaction mixture 
was warmed up to 0 oC and left to stir for 1 h. In a separate round, a solution 
of 5-(benzyloxy)-1H-indole-3-carbaldehyde 196 (2.00 g, 7.89 mmol) in THF 
(10 mL) was transferred via cannula into the solution at -78 oC. The reaction 
mixture stirred at room temperature for 1 h.  The organic layer was extracted 
with ethyl acetate (4 x 150 mL), washed with brine, dried over MgSO4 and 
filtered.  The solvent was removed under reduced pressure. The crude orange 
solid product was purified by column chromatography (petrol / ethyl acetate 
4:1) to give 5-phenethoxy-3-vinyl-1H-indole in (1.530 g, 6.14 mmol, 78%) as a 
yellow solid.  
 
Mp. 148 – 150 oC. Rf : 0.3 (petrol / ethyl acetate 4:1). 1H NMR (300 MHz, 
CDCl3): δH  8.14 (br, s, NH), 7.59 - 7.38 (m, 6H, Ar), 7.23 (d, J = 7.3 Hz,1H, 
Ar), 7.17 (s,1H, H2), 7.04 (d, J = 7.3 Hz ,1H, Ar), 6.94 (dd, J = 11.3, 17.2 Hz, 
1H, H3), 5.71 (d, J = 17.2 Hz, 1H, H5),  5.25 (d, J =11.3 Hz, 1H, H4), 5.20 (s, 
2H, H9).13C NMR (75 MHz, CDCl3): δC 153.9, 137.6, 132.0, 129.5, 128.6, 
127.9, 127.7, 126.0, 124.3, 115.6, 113.2, 112.0, 110.3, 103.9, 71.1. IR (neat): 
νmax/cm1: 3429 (NH), 1183 (C-N).  
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Benzyl 5-fluoro-3-vinyl-1H-indole-1-carboxylate (199) 
A solution of 5-fluoro-3-vinyl-1H-indole 197 (0.833 
g, 5.16 mmol) in THF (10 mL) was cooled down to 
0 oC. NaHMDS (1.0 M in THF, 10.32 mL, 10.32 
mmol) was added to the solution. After 30 min, 
benzyl chloroformate (0.81 mL, 5.67 mmol,) was 
added. The reaction mixture was stirred at 0 oC for 4 h. The solution was 
diluted with DCM (3 X 50 mL), washed with water (2 x 100 mL), brine, dried 
with anhydrous MgSO4 and filtered. The solvent was removed under reduced 
pressure. The orange crude solid was purified by column chromatography in 
(petrol / ethyl acetate 4:1) to give benzyl 5-fluoro-3-vinyl-1H-indole-1-
carboxylate (1.39 g, 4.70 mmol, 91%) as a white solid. 
 
Mp.  189 – 200 oC. Rf : 0.30 (petrol / ethyl acetate 4:1).1H NMR (400 MHz, 
DMSO-d6): δH  8.1 (s, 1H, Ar), 7.70 (s, 1H, H2), 7.52 – 7.36 (m, 6H, Ar), 7.09 
(t, J = 7.0 Hz, 1H, Ar), 6.75 (dd, J = 11.7, 16.9 Hz, 1H, H3), 5.77 (d, J = 16.9 
Hz, 1H, H5), 5.64 (s, 2H, H1), 5.36  (d, J = 11.7 Hz, 1H, H4). 13C NMR (100 
MHz, DMSO-d6): δC160.9 (d, JC-F = 241.0 Hz, C8), 155.2, 150.5, 135.3, 135.0, 
132.3, 128.9, 128.7, 128.4, 127.6, 124.9, 119.8 (d, JC-F = 4.3 Hz), 116.4 (d, JC-
F = 9.5 Hz), 112.6 (d, JC-F = 26.5 Hz), 106.0 (d, JC-F = 24.7 Hz), 69.6 (C1). IR 
(neat): νmax/cm-1: 1737 (N-CO), 1066 (C-F). HRMS (pNSI): calcd C18H15F 
NO2 [M+H]+: 296.1081; observed: 296.1084. 
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Benzyl 5-(benzyloxy)-3-vinyl-1H-indole-1-carboxylate (200) 
        
A solution of 5-phenethoxy-3-vinyl-1H-indole 
198 (0.455g, 1.72 mmol) in THF (10 mL) was 
cooled dawn to 0 oC. NaHMDS (1.0 M in 
THF, 2.07 mL, 2.07 mmol) was added 
dropwise over 5 min. The mixture left to stir 
for 30 min, and then benzyl chloroformate (0.26 mL, 1.89 mmol) was added. 
The reaction mixture was stirred at 0 oC for 4 h and quenched with water (15 
mL). The organic layer was extracted with ethyl acetate (3 x 50 mL), washed 
with brine, dried with anhydrous MgSO4 and filtered.  The solvent was 
removed under reduced pressure. The crude orange solid product was purified 
by column chromatography (petrol / ethyl acetate 6:1) to give benzyl 5-
(benzyloxy)-3-vinyl-1H-indole-1-carboxylate in (0.520 g 1.36 mmol, 80%) as a 
white solid.  
 
Mp.  182 – 184oC. Rf : 0.30 (petrol / ethyl acetate 4:1). 1H NMR (400 MHz, 
CDCl3): δH  8.11 (m, 1H, Ar), 7.64 (s, 1H, H2), 7.50 - 7.32 (m, 11H, Ar), 7.04 
(d, J = 8.6 Hz, 1H, Ar), 6.75 (dd, J = 11.6, 16.6 Hz, 1H, H5), 5.75 (d, J = 16.6 
Hz, 1H, H3), 5.43 (s, 2H, H1),  5.33 (d, J = 11.6 Hz, 1H, H4), 5.12 (s, 2H, H9).13C 
NMR (75 MHz, CDCl3): δC 155.6, 150.7, 137.2, 135.1, 130.9, 129.6, 128.8, 
128.7, 128.6, 128.4, 128.0, 127.9, 127.6, 124.3, 119.8, 116.3, 114.7, 113.8, 
104.7, 70.7, 68.7. IR (neat): νmax/cm-1: 1729 (CO), 1183 (C-N). MS (pNSI): 
384.15 (100%, [M+H]+), 784.33 (57%, [2M+NH4]+), 406.14 (10%, [M+Na]+); 
HRMS (pNSI): calcd C25H22NO3 [M+H]+: 384.1594; observed: 384.1596. 
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Benzyl(3aS,10aS,10bS)-7-fluoro-2-methyl-1,3-dioxo-2,3,3a,4,10a,10b-
hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (201) 
 
Benzyl 5-fluoro-3-vinyl-1H-indole-1-carboxylate 
199 (0.323 g, 1.09 mmol) and N-
methylmaleimide (0.122 g 1.09 mmol) were 
dissolved in DCM (10 mL). The mixture was 
refluxed for 24 h.  The solvent was removed 
under reduced pressure. The crude white solid 
was purified by column chromatography (petrol / ethyl acetate 2:1) to yield 
benzyl(3aS,10aS,10bS)-7-fluoro-2-methyl-1,3-dioxo-2,3,3a,4,10a,10b-
hexahydropyrrolo[3,4-a]carbazole-10(1H)- carboxylate in (0.3055 g, 0.75 
mmol, 69%) as a white solid. 
 
Mp. 130 – 132 oC. Rf : 0.48 (petrol / ethyl acetate 2:1). 1H NMR (400 MHz, 
CDCl3): δH  8.90 (dd, J = 6.4, 8.5 Hz, 1H, Ar, a), 7.53 (dd, J = 6.4, 8.5 Hz, 1H, 
Ar, b), 7.50 - 6.84 (m, 14H, Ar, a, b), 6.14 (dt, J = 3.7,7.4 Hz, 2H, H4, a,b), 5.46 
(d, J = 12.2 Hz, 1H, H1, b), 5.41 (d, J = 12.2 Hz, 1H, H1, b), 5.38 (d, J = 12.2 
Hz, 1H, H1, a), 5.33 (d, J = 12.2, 1H, H1, a), 4.81 - 4.78 (m, 1H, H5, b), 4.74 – 
4.70 (m, 1H, H5, a), 4.32 (t, J = 8.8 Hz, 1H, H3, b), 3.93 (t, J = 8.8 Hz, 1H, H3, 
a), 3.18 (t, J = 8.4 Hz, 1H, H2, a), 3.11 - 3,03 (m, 3H, H(6a), H(2b)), 2.79 (s, 6H, 
H9, a,b), 2.24 - 2.11 (m, 2H, H6, b).13C NMR (100 MHz, CDCl3): δC  179.0 (CO), 
178.7 (CO), 174.9 (CO), 174.5 (CO), 160.7 (d, JC-F = 235.8 Hz), 160.5 (d, JC-F 
= 232.0 Hz), 152.9, 152.0, 151.3, 141.2, 139.9, 136.7 (d, JC-F = 11.9 Hz), 135.8 
(d, JC-F = 10.1 Hz), 134.5, 128.9, 128.3, 128.1, 127.5, 127.4, 127.0 (d, JC-F = 
11.9 Hz), 126.8, 117.0, 116.9, 116.8, 116.6, 114.1 (d, JC-F = 5.9 Hz), 113.9, 
109.9, 107.7 (d, JC-F = 5.9 Hz), 106.8, 68.4, 67.7, 60.2, 59.6, 41.2, 40.3, 37.6, 
37.4, 25.2, 25.0, 24.9, 24.7. IR (neat): νmax/cm-1: 1775 (CO), 1690 (N-CO), 
1600 (C=C). MS (pNSI): 424.1 [100% (M+NH4)+], 407.1 [45% (M+H)+], 271.0 
[10% (M-Cbz)+]; HRMS (pNSI): calcd C23H20FN2O4 [M+H]+: 407.1402; 
observed: 407.1404.  
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Benzyl (3aS,10aS,10bS)-7-fluoro-1,3-dioxo-2-phenyl-2,3,3a,4,10a,10b-
hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (202) 
 
Benzyl 5-fluoro-3-vinyl-1H-indole-1-
carboxylate 199 (1.633 g, 5.50 mmol) and N-
phenylmaleimide (0.952 g, 5.50 mmol) were 
dissolved in DCM (20 mL). The reaction mixture 
was refluxed for 24 h.  The solvent was 
removed under reduced pressure. The crude 
green solid was purified by column chromatography (petrol / ethyl acetate 2:1) 
to yield benzyl (3aS,10bS)-7-fluoro-1,3-dioxo-2-phenyl-2,3,3a,4,10a,10b-
hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate in (1.8 g, 3.84 mmol, 
70%) as a white solid.  
 
Mp.  165 – 167 oC. Rf = 0.28 (petrol / ethyl acetate 2:1). 1H NMR (300 MHz, 
CDCl3): δH 8.11 – 8.06 (m, 1H, Ar, 1H, a), 7.57 – 7.51 (m, 1H, Ar, b), 7.51 – 
7.30 (m, 16H, Ar, a, b), 7.14 – 6.86 (m, 8H, Ar, a, b), 6.28 (dt, J = 7.3, 3.8 Hz, 
2H, H10, a, b), 5.52 – 5.31 (m, 4H, H5, a,b), 4.93 – 4.78 (m, 2H, H6, a, b), 4.52 
(t, J = 7.1 Hz, 1H, H7, a), 4.15 - 4.09 (t, J = 7.3 Hz, 1H, H7, b), 3.44 – 3.11 (m, 
4H, H9, a,b), 2.39 – 2.24 (m, 2H, H8, a,b). 13C NMR (176 MHz, CDCl3): δC 
177.9 (CO), 177.7 (CO), 173.8 (CO), 173.5 (CO), 160.7, 160.5, 158.4, 158.2, 
152.9, 151.9, 141.2, 140.0, 136.9, 135.8, 135.6, 131.5 (d, JC-F  = 7.8 Hz), 129.2, 
129.1, 128.8, 128.7, 128.5, 128.4, 128.2, 127.4 (d, JC-F  = 8.9 Hz), 127.3 (d, JC-
F  = 8.9 Hz), 126.9, 126.8, 126.2, 126.1, 117.1, 117.0, 116.8, 114.1 (d, JC-F  = 
16.5 Hz), 113.9, 107.2, 107.0 (d, JC-F  = 9.2 Hz), 106.8, 106.7, 68.3 (C5, a or 
b), 67.8 (C5, a or b), 60.3, 59.7, 41.2, 40.3, 37.8, 37.6, 25.6, 25.2.. IR (neat): 
νmax/cm-1: 2981 (CH). 1698 (N-CO). MS (pNSI): 486.18 (100%, [M+NH4]+), 
954.33 (87%, [2M+NH4]+), 469.15 (25%, [M+H]+); HRMS (pNSI): calcd 
C28H22FN2O4 [M+H]+: 469.1558; observed: 469.1556. 
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Benzyl (3aS,10aS,10bS)-7-fluoro-1,3-dioxo-2,3,3a,4,10a,10b-
hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (203) 
 
Benzyl 5-fluoro-3-vinyl-1H-indole-1-carboxylate 
199 (1.027g, 3.47mmol) and maleimide (0.337g, 
3.47 mmol) were dissolved in DCM (10 mL). The 
mixture was refluxed for 24 h.  The solvent was 
removed under reduced pressure. The crude 
white solid was purified by column 
chromatography (petrol / ethyl acetate 2:1 gradient to 100% ethyl acetate) to 
yield benzyl (3aS,10aS,10bS)-7-fluoro-1,3-dioxo-2,3,3a,4,10a,10b-
hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylatein (0.969 g, 2.47 mmol, 
72%) as a white solid.  
 
Mp. 213 – 215 oC. Rf : 0.2 (petrol / ethyl acetate 2:1). 1H NMR (300 MHz, 
DMSO-d6): δH 11.09 (s, 1H, NH), 7.88 (dd, J = 9.0, 4.7 Hz, 1H, Ar), 7.57 – 7.30 
(m, 6H, Ar), 7.10 (t, J = 7.8 Hz, 1H, Ar), 6.45 (dt, J = 7.5, 3.7 Hz, 1H, H10), 5.47 
– 5.20 (m, 2H, H5), 4.93 – 4.89 (m, 1H, H7, a), 4.87 – 4.81 (m, 1H, H7, b), 4.10 
(t, J = 7.9 Hz, 1H, H6, b), 3.95 (t, J = 8.3 Hz, 1H, H6), 3.27 – 3.17 (m, 2H, H8, 
a,b), 2.75 (dd, J = 15.5, 7.3 Hz, 2H, H9, a,b), 2.21 (m, 2H, H9, a,b). 13C NMR 
(75 MHz, DMSO-d6): δC 180.9 (CO), 177.1 (CO), 160.3 (d, JC-F  = 254.1`Hz, 
C11), 152.3, 141.5, 136.7, 136.4, 128.9, 128.6, 128.4, 128.2, 128.0, 116.5, 
116.2, 108.1 (d, JC-F  = 24.8 Hz), 67.2 (C5), 59.6 (C7), 42.6 (C6 or 8), 38.9 (C6 or 
8), 24.8 (C9). IR (neat): νmax/cm-1: 3654 (NH), 1705 (CO), 2981 (CH). MS 
(pNSI): 410.15 (100%, [M+NH4] +), 802.26 (57%, [2M+NH4] +), 393.12 (15%, 
[M+H]+); HRMS (pNSI): calcd C22H18FN2O4 [M+H]+: 393.1245; observed: 
393.1249. 
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Benzyl(3aS,10aS,10bS)-7-(benzyloxy)-2-methyl-1,3-dioxo-
2,3,3a,4,10a,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate 
(204) 
 
Benzyl 5-(benzyloxy)-3-vinyl-1H-indole-
1-carboxylate 200 (0.160 g, 0.41 mmol) 
and N-methylmaleimide (0.055mg, 
0.41mmol) were dissolved in DCM (5 mL). 
The mixture was refluxed for 18 h. The 
solvent was removed under reduced 
pressure. The crude yellow solid product was purified by column 
chromatography (petrol / ethyl acetate 2:1) to yield benzyl (3aS,10aS,10bS)-
7-(benzyloxy)-2-methyl-1,3-dioxo-2,3,3a,4,10a,10b-hexahydropyrrolo[3,4-a] 
carbazole-10(1H)-carboxylate in (0.155 g, 0.31 mmol, 76%) as a white solid. 
 
Mp.  138 – 140 oC. Rf : 0.3 (petrol / ethyl acetate 2:1). 1H NMR (400 MHz, 
CDCl3): δH 8.00 (d, J = 9.3 Hz, 1H, Ar, a), 7.94, 7.46 - 6.81 (m, 25H, Ar, a,b). 
6.09 (dt, J = 3.8, 6.9 Hz, 2H, H3, a,b), 5.42 (dd, J = 11.5 Hz, 4H, H1, a, b), 5.00 
(s, 4H, H10, a,b), 4.76 (m, 1H, H5, b),  4. 69 (m, 1H, H5, a), 4.30 (t, J = 8.3 Hz, 
1H, H2, b), 3.93 (t, J = 8.3 Hz, 1H, H2, a), 3.16 (t, J = 7.3 Hz, 1H, H6, b), 3.09 -
2.94 (m, 4H, H6,),  2.96 (t, J = 7.3 Hz, 1H, H4, b), 3.17 (t, J = 7.3 Hz, 1H, H6, 
b), 3.00 (m, 3H, H(6,4), a), 2.78 (s, 6H, H7, a,b), 2.15 (m, 2H, H4, b).13C NMR 
(100 MHz, CDCl3): δC 179.3 (CO), 179.0 (CO), 175.1 (CO), 174.9 (CO), 155.5, 
154.9, 153.1, 152.1, 139.3, 138.1, 137.5, 137.3, 136.9, 136.1, 128.8, 128.7, 
128.5, 128.2, 128.1, 127.6, 127.1,126.7,  117.2, 116.6, 112.9, 106.6, 106.4, 
70.6, 67.7, 60.1, 59.4, 41.2, 40.4, 25.1, 24.8, 23.9, 14.7, 14.1. IR (neat): 
νmax/cm-1: 1770 (CO), 1694 (N-CO), 3657 (N-Me). MS (pNSI): 512.21 (100%, 
[M+NH4]+), 495.19 (15%, [2M+H]+); HRMS (pNSI): calcd C30H30N3O5 
[M+NH4]+: 512.2180; observed: 512.2175. 
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Benzyl(3aS,5S,10bS)-7-fluoro-2-methyl-1,3-dioxo-5-(pyrrolidin-1-yl)-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate  
(205) 
 
Benzyl (3aS,10aS,10bS)- 7-fluoro-2-methyl-1,3-dioxo-
2,3,3a,4,10a,10b hexahydropyrrolo[3,4-a]carbazole-
10(1H)- carboxylate 201 (0.100 g, 0.24 mmol) and 
Cs2CO3 (0.1596 g, 0.49 mmol) was dissolved in DCM 
(5 mL). The solution was cooled down to 0 oC. Bromine 
(14.7 µL, 0.28 mmol) was added dropwise to the 
mixture followed by the addition of pyrrolidine (0.20 
mL, 2.4 mmol). The reaction mixture was stirred at 0 oC for 1 h and quenched 
with water (5 mL). The organic layer was extracted with DCM (2 x 30 mL), 
washed with brine, dried with anhydrous MgSO4 and filtered. The solvent was 
removed under reduced pressure. The crude yellow product was purified using 
column chromatography (petrol / ethyl acetate 1:1 gradient to 100% ethyl 
acetate) to give benzyl 7-fluoro-2-methyl-1,3-dioxo-5-(pyrrolidin-1-yl)-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate 
(0.837g, 0.183 mmol, 76%) as a yellow solid. 
 
Mp. 176 – 178 oC. Rf : 0.3 (petrol / ethyl acetate 1:1). 1H NMR (400 MHz, 
CD2Cl2):  δH 8.12 (dd, J = 9.1, 4.7 Hz, 1H, Ar), 7.63 – 7.19 (m, 6H, Ar), 7.06 (t, 
J = 9.2, 2.7 Hz, 1H, Ar), 5.56 (d, J = 11.8 Hz, 1H, H5), 5.40 (d, J = 11.8 Hz, 1H, 
H5), 4.76 (d, J = 7.9 Hz, 1H, H6), 3.76 – 3.48 (m, 2H, H(10, 8)), 2.96 (s, 3H, H7), 
2.80 – 2.71 (m, 2H, H(11,14)), 2.59 – 2.32 (m, 3H, H(11, 14, 9)), 1.80 – 1.70 (m, 5H, 
H(12, 13, 9)). 13C NMR (75 MHz, CD2Cl2)μ δC 178.6 (CO), 174.2 (CO), 160.7 (d, 
JC-F  = 237.7 Hz, C15), 151.4,  134.7, 132.9, 130.1, 129.8, 129.3, 129.2, 128.9, 
120.7 (d, JC-F  = 4.4 Hz), 115.8 (d, JC-F  = 10.0 Hz), 112.0 (d, JC-F  = 24.1 Hz), 
105.0 (d, JC-F  = 24.1 Hz), 69.4 (C5), 51.4, 41.0, 38.3, 28.1, 24.8, 23.5, 22.3. IR 
(neat):νmax/cm-1: 1729 (CO), 1597 (C=C). MS (pNSI): 951.38 (100%, 
[2M+H]+), 973.37 (18%, [2M+Na]+); HRMS (pNSI): calcd C27H26FN3O4Na 
[M+Na]+: 498.1800; observed: 498.1790. 
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Benzyl (3aS,5S,10bS)-7-fluoro-2-methyl-5-morpholino-1,3-dioxo-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate 
(206)    
Benzyl(3aS,10aS,10bS)-7-fluoro-2-methyl-1,3-dioxo-
2,3,3a,4,10a,10b-hexahydropyrrolo [3,4-a]carbazole-
10(1H)- carboxylate 201 (0.150 g, 0.36 mmol) and 
Cs2CO3 (0.2378 g, 0.73 mmol) was dissolved in DCM 
(10 mL). The solution was cooled down to 0 oC. 
Bromine (22.0 µL, 0.43 mmol) was added dropwise to 
the mixture followed by the addition of the morpholine 
(0.31 mL, 3.6 mmol). The reaction mixture was stirred 
at 0 oC for 2 h and quenched with water (10 mL). The organic layer was 
extracted with DCM (3 x 30 mL), washed with brine, dried with anhydrous 
MgSO4 and filtered. The solvent was removed under reduced pressure. The 
crude yellow product was purified using column chromatography (petrol / ethyl 
acetate 1:1) to give benzyl(3aS,5S,10bS)-7-fluoro-2-methyl-5-morpholino-1,3-
dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate 
in (0.1421g, 0.29 mmol, 81%) as a white solid. 
 
Mp.  149 – 151 oC. Rf : 0.5 (petrol / ethyl acetate 1:1). 1H NMR (300 MHz, 
CD2Cl2): δH 7.97 (dd, J = 9.1, 4.6 Hz, 1H, Ar), 7.63 (dd, J = 9.4, 2.7 Hz, 1H, 
Ar), 7.43 – 7.26 (m, 5H, Ar), 6.94 (td, J = 9.1, 2.7 Hz, 1H, Ar), 5.48 (d, J = 11.8 
Hz, 1H, H5), 5.33 (d, J = 11.8 Hz, 1H, H5), 4.77 (d, J = 8.2 Hz, 1H, H6) 3.72 – 
3.64 (m, 1H, H8), 3.59 (t, J = 4.6 Hz, 4H, H(12,13)), 3.45 – 3.37 (m, 1H, H10), 
2.81 (s, 3H, H7), 2.58 – 2.51 (m, 2H, H(11,14)), 2.46 – 2.39 (m, 2H, H(11,14)), 2.18 
– 2.06 (m, 2H, H9). 13C NMR (75 MHz, CD2Cl2): δC 178.2 (CO), 174.3 (CO), 
160.8 (d, JC-F = 239.3 Hz, C15), 151.2 (CO), 148.0, 134.9, 133.4, 130.6, 128.9, 
128.8, 128.7, 119.8 (d, JC-F  = 5.0 Hz), 115.8 (d, JC-F  = 8.9 Hz), 112.0 (d, JC-F  
= 23.9 Hz), 106.5 (d, JC-F  = 24.8 Hz), 69.5 (C5), 67.1, 55.7, 49.6, 40.1, 38.6, 
24.9, 22.0. IR (neat): νmax/cm-1: 1727 (CO), 2980 (CH, Ar), 1072 (C-F). MS 
(pNSI): 983.37 (100%, [2M+H]+), 492.19 (85%, [M+H]+), 405.12 (75%, [M-
O(CH2)4N]+; HRMS (pNSI): calcd C27 H27FN3O5 [M+H]+: 492.1929; observed: 
492.1922. 
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Benzyl (3aS,5S,10bS)-7-fluoro-2-methyl-1,3-dioxo-5-(piperidin-1-yl)-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate 
(207)  
Benzyl (3aS,10aS,10bS)-7-fluoro-2-methyl-1,3-dioxo-
2,3,3a,4,10a,10b-hexahydropyrrolo [3,4-a] carbazole-
10 (1H)- carboxylate 201 (0.100 g, 0.24 mmol) and 
Cs2CO3 (0.156 g, 0.48 mmol) was dissolved in DCM 
(5 mL). The solution was cooled down to 0 oC. 
Bromine (15.1 µL, 0.29 mmol) was added dropwise to 
the mixture followed by the addition of piperidine (0.23 
mL, 2.4 mmol). The reaction mixture was stirred at 0 oC for 2 h, and quenched 
with water (5 mL). The organic layer was extracted with DCM (2 x 30 mL), 
washed with brine, dried with anhydrous MgSO4 and filtered. The solvent was 
removed under reduced pressure. The crude yellow product was purified using 
column chromatography (petrol / ethyl acetate 2:1) to give benzyl 
(3aS,5S,10bS)-7-fluoro-2-methyl-1,3-dioxo-5-(piperidin-1-yl)-2,3,3a,4,5,10b-
hexahydropyrrolo [3,4-a]carbazole-10(1H)-carboxylate in (0.078 g, 0.16 mmol, 
67%) as a white solid. 
 
Mp.  180 – 182 oC. Rf : 0.5 (petrol / ethyl acetate 1:1). 1H NMR (300 MHz, 
CD2Cl2): δH 7.95 (dd, J = 9.1, 4.6 Hz, 1H, Ar), 7.74 (ddd, J = 9.6, 2.7, 1.0 Hz, 
1H, Ar), 7.45 – 7.36 (m, 2H, Ar), 7.39 – 7.26 (m, 3H, Ar), 6.92 (t, J = 9.1,Hz, 
1H, Ar), 5.49 (d, J = 11.9 Hz, 1H, H5), 5.33 (d, J = 11.8 Hz, 1H, H5), 4.79 (d, J 
= 8.4 Hz, 1H, H6), 3.66 (ddd, J = 9.3, 4.5, 2.5 Hz, 1H, H10), 3.37 (dt, J = 8.4, 
5.3 Hz, 1H, H8), 2.80 (s, 3H, H7), 2.53 – 2.35 (m, 4H, H(11,15)), 2.29 – 2.21 (m, 
1H, H9), 1.99 – 1.90 (m, 1H, H9), 1.56 – 1.32 (m, 6H, H(12,13,14)).13C NMR (75 
MHz, CD2Cl2)μ δC 178.3 (CO), 174.6 (CO), 160.68 (d, JC-F = 236.3 Hz, C16), 
151.6 (CO), 134.6, 133.3, 130.3, 129.2, 128.2, 128.7, 128.8, 121.0 (d, JC-F = 
5.5 Hz), 115.6 (d, JC-F = 9.2 Hz), 112.1 (d, JC-F = 25.1 Hz), 106.8 (d, JC-F = 25.1 
Hz), 69.4 (C5), 56.4, 49.9, 39.9, 38.8, 26.3, 24.9, 24.7, 20.9. IR (neat): 
νmax/cm-1: 1780 (CO), 1706 (CO), 1087 (C-F), 2981 (Ar, CH).MS (pNSI): 
490.21 (100%, [M+H]+), 512.19 (35%, [M+Na]+), 979.42 (15%, [2M+H]+); 
HRMS (pNSI): calcd C28H29FN3O4 [M+H]+: 490.2137; observed: 490.2131. 
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Benzyl (3aS,5S,10bS)-7-fluoro-1,3-dioxo-2-phenyl-5-(pyrrolidin-1-yl)-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate 
(208) 
 Benzyl(3aS,10aS,10bS)-7-fluoro- 1,3-dioxo-2-
phenyl-2,3,3a,4,10a,10b-hexahydropyrrolo [3,4-a] 
carbazole-10(1H)-carboxylate 202 (0.100 g, 0.25 
mmol) and Cs2CO3 (0.167 g, 0.51 mmol) was 
dissolved in DCM (5 mL). The solution was cooled 
down to 0 oC. Bromine (15.1 µL, 0.30 mmol) was 
added dropwise to the mixture followed by the 
addition of pyrrolidine (0.20 mL, 2.5 mmol). The reaction mixture was stirred 
at 0 oC for 1 h and quenched with water (5 mL). The organic layer was 
extracted with DCM (2 x 30 mL), washed with brine, dried with anhydrous 
MgSO4 and filtered. The solvent was removed under reduced pressure. The 
crude yellow product was purified using column chromatography (petrol / ethyl 
acetate 2:1) to give benzyl (3aS,5S,10bS)-7-fluoro-1,3-dioxo-2-phenyl-5-
(pyrrolidin-1-yl)-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-
carboxylate in (0.101 g, 0.19 mmol, 76%) as a white solid. 
 
Mp.  165 – 167 oC. Rf : 0.42 (petrol / ethyl acetate 2:1) 1H NMR (300 MHz, 
CD2Cl2): δH 8.16 (dd, J = 9.1, 4.6 Hz, 1H, Ar), 7.59 – 7.35 (m, 9H, Ar), 7.28 – 
7.15 (m, 2H, Ar), 7.08 (t, J = 9.2 Hz, 1H, Ar), 5.51 (d, J = 11.7 Hz, 1H, H5), 
5.39 (d, J = 11.8 Hz, 1H, H5), 4.95 (d, J = 7.9 Hz, 1H, H6), 3.85 – 3.77 (m, 1H, 
H8), 3.73 (t, J = 4.9 Hz, 1H, H10), 2.84 2.78 (m, 2H, H(11,14)), 2.60 (dt, J = 13.5, 
4.5 Hz, 1H, H9), 2.52 – 2.44 (m, 2H, H(11,14)), 1.92 – 1.86 (m, 1H, H9), 1.83 – 
1.74 (m, 4H, H(12,13)). 13C NMR (75 MHz, CD2Cl2): δC 177.6 (CO), 173.1 (CO), 
160.7 (d, JC-F = 246.5 Hz, C15), 151.5 (CO), 134.8, 132.7, 131.7, 129.6, 129.4, 
129.3, 129.0, 128.8, 128.7, 126.6, 120.6 (d, JC-F = 8.3 Hz), 116.0 (d, JC-F = 10.3 
Hz), 112.1 (d, JC-F = 24.2 Hz), 104.8 (d, JC-F = 25.1 Hz), 69.5 (C5), 52.0, 53.6, 
41.5, 38.5, 29.3, 23.4. IR (neat): νmax/cm-1: 1775 (CO), 1077 (Ar, CH). MS 
(pNSI): 538.21 (100%, [M+H]+), 1075.42 (45%, [2M+H]+), 560.19 (17%, 
[M+Na]+); HRMS (pNSI): calcd C32H29FN3O4 [M+H]+: 538.2137; observed: 
538.2129. 
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Benzyl (3aS,5S,10bS)-7-fluoro-5-morpholino-1,3-dioxo-2-phenyl-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate 
(209)   
Benzyl (3aS,10aS,10bS)-7-fluoro-1,3-dioxo-2-
phenyl-2,3,3a,4,10a,10b-hexahydropyrrolo [3,4-a] 
carbazole-10(1H)-carboxylate 202 (0.150 g, 0.32 
mmol) and Cs2CO3 (0.2086g, 0.64 mmol) were 
dissolved in DCM (5 mL). The solution was cooled 
down to 0 oC. Bromine (19.6 µL, 0.38 mmol) was 
added dropwise to the mixture followed by the 
addition of morpholine (0.27 mL, 3.2 mmol). The reaction mixture was stirred 
at 0 oC for 2 h, and quenched with water (5 mL). The organic layer was 
extracted with DCM (2 x 40 mL), washed with brine, dried with anhydrous 
MgSO4 and filtered. The solvent was removed under reduced pressure. The 
crude yellow product was purified using column chromatography (petrol: ethyl 
acetate 2:1) to give Synthesis of benzyl (3aS,5S,10bS)-7-fluoro-5-morpholino-
1,3-dioxo-2-phenyl-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-
carboxylate  (0.1342 g, 0.24 mmol, 76%) as a white solid. 
 
Mp. 159 – 161 oC. Rf : 0.21 (petrol / ethyl acetate 2:1). 1H NMR (300 MHz, 
CD2Cl2): δH  8.12 (dd, J = 9.1, 4.6 Hz, 1H, Ar), 7.70 (dd, J = 9.3, 2.6 Hz, 1H, 
Ar), 7.54 – 7.41 (m, 8H, Ar), 7.26 – 7.17 (m, 2H, Ar), 7.08 (td, J = 9.1, 2.7 Hz, 
1H, Ar), 5.57 (d, J = 11.8 Hz, 1H, H5), 5.43 (d, J = 11.8 Hz, 1H, H5), 4.94 (d, J 
= 8.2 Hz, 1H, H6), 3.81 – 3.72 (m, 1H, H8), 3.60 (dt, J = 9.2, 5.0 Hz, 5H, 
H(10,12,13)), 2.59 (dt, J = 11.4, 4.6 Hz, 2H, H(11,14)), 2.44 (dt, J = 11.1, 4.6 Hz, 
2H, H(11,14)),  2.32 – 2.06 (m, 2H, H9).13 C NMR (75 MHz, CD2Cl2): δC 177.5 
(CO), 173.1 (CO), 160.5 (d, JC-F = 234.3 Hz, C15), 151.2, 134.6, 133.2, 131.8, 
130.1, 129.2, 129.0, 128.9, 128.8, 128.7, 128.6, 126.5, 119.6 (d, JC-F = 4.2 Hz), 
115.9 (d, JC-F = 8.6 Hz), 112.4 (d, JC-F = 24.9 Hz), 106.0 (d, JC-F = 24.9 Hz), 
69.7 (C5), 66.9, 55.8, 49.7, 40.4, 38.6, 32.2. IR (neat): νmax/cm-1: MS (pNSI): 
554.20 (100%, [M+H]+), 576.18 (16%, [M+Na]+), 1107.41 (20%, [2M+H]+); 
HRMS (pNSI): calcd C32H29FNO5 [M+H]+: 554.2086; observed: 554.2080. 
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Benzyl(3aS,5S,10bS)-7-fluoro-5-(4-methylpiperazin-1-yl)-1,3-dioxo-2-
phenyl-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-
carboxylate (210) 
Benzyl (3aS,10aS,10bS)-7-fluoro-1,3-dioxo-2-
phenyl-2,3,3a,4,10a,10b-hexahydropyrrolo [3,4-a] 
carbazole-10(1H)-carboxylate 202 (0.170 g, 0.36 
mmol) and Cs2CO3 (0.2364 g, 0.72 mmol) were 
dissolved in DCM (10 mL). The solution was cooled 
down to 0 oC. Bromine (22.0 µL, 0.43 mmol) was 
added dropwise to the mixture followed by the 
addition of 1-methylpiperazine (0.39 mL, 3.6 mmol). 
The reaction mixture was stirred at 0 oC for 1 h and quenched with water (5 
mL). The organic layer was extracted with DCM (2 x 50 mL), washed with 
brine, dried with anhydrous MgSO4 and filtered. The solvent was removed 
under reduced pressure. The crude yellow product was purified using column 
chromatography (petrol / ethyl acetate 2:1 gradient to 100% methanol) to give 
benzyl (3aS,5S,10bS)-7-fluoro-5-(4-methylpiperazin-1-yl)-1,3-dioxo-2-phenyl-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (0.164 
g, 0.29 mmol, 81%) as a white solid. 
 
Mp. 172 – 174 oC. Rf : 0.1 (petrol / methanol 1:1). 1H NMR (300 MHz, CD2Cl2): 
δH 8.11 (dd, J = 9.1, 4.6 Hz, 1H, Ar), 7.74 (dd, J = 9.4, 2.7 Hz, 1H, Ar), 7.56 – 
7.38 (m, 8H, Ar), 7.24 – 7.12 (m, 2H, Ar), 7.07 (t, J = 9.2 Hz, 1H, Ar), 5.57 (d, 
J = 11.8 Hz, 1H, H5), 5.44 (d, J = 11.8 Hz, 1H, H5), 5.06 (d, J = 8.4 Hz, 1H, 
H6), 3.92 (t, J = 5.8 Hz, 1H, H10), 3.72 (ddd, J = 8.4, 6.6, 5.7 Hz, 1H, H8), 2.77 
- 2.69 (m, 2H, H(11, 14)), 2.63 – 2.39 (m, 5H, H(9,12,13)), 2.31 (t, J = 6.4 Hz, 2H, H 
(11, 14)), 2.27 (s, 3H, H15), 1.74 – 1.69 (m, 1H, H9). 13 C NMR (75 MHz, CD2Cl2): 
δC 177.3 (CO), 173.2 (CO), 160.6 (d, JC-F = 241.5 Hz, C16), 151.2 (CO), 135.1, 
134.8, 133.2, 131.8, 129.9, 129.3, 129.1, 128.9, 128.7, 126.5, 120.3 (d, JC-F = 
6.3 Hz), 115.9 (d, JC-F = 7.7 Hz), 112.5 (d, JC-F = 24.2 Hz), 106.2 (d, JC-F = 24.2 
Hz), 69.5 (C5), 55.4, 55.2, 49.1, 45.7, 40.5, 38.8, 23.0. IR (neat): νmax/cm-1: 
1707 (CO), 2973 (CH). MS (pNSI): 1133.47 (100%, [2M+H]+), 1165.46 (35%, 
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[2M+Na]+), 979.42 (15%, [2M+H]+); HRMS (pNSI): calcd C33H32FN4O4 [M+H]+: 
567.2402; observed: 567.2396. 
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Benzyl (3aS,5S,10bS)-7-(benzyloxy)-2-methyl-1,3-dioxo-5-(pyrrolidin-1-
yl)-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate 
(212)  
 
Benzyl (3aS,10aS,10bS)-7-(benzyloxy)-2-methyl-
1,3-dioxo-2, 3, 3a,4,10a, 10b-hexahydropyrrolo 
[3,4-a] carbazole-10 (1H)-carboxylate 204 (0.07 g, 
0.14 mmol) and Cs2CO3 (0.912 g, 0.28 mmol) 
were dissolved in DCM (5 mL). The solution was 
cooled down to 0 oC. Bromine (8.7 µL, 0.16 mmol) 
was added dropwise to the mixture followed by the 
addition of pyrrolidine (0.11 mL, 1.4 mmol). The reaction mixture was stirred 
at 0 oC for 1 h and quenched with water (5 mL). The organic layer was 
extracted with DCM (2 x 30 mL), washed with brine, dried with anhydrous 
MgSO4 and filtered. The solvent was removed under reduced pressure. The 
crude yellow product was purified using column chromatography (petrol / ethyl 
acetate 2:1) to give benzyl (3aS,5S,10bS)-7- (benzyloxy)- 2-methyl-1,3-dioxo-
5-(pyrrolidin-1-yl)-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-
carboxylate (0.055 g, 0.098 mmol, 70%) as a bright yellow solid. 
 
Mp. 153 – 155 oC. Rf : 0.16 (petrol / ethyl acetate 2:1). 1H NMR (300 MHz, 
CD2Cl2): δH 8.03 (d, J = 9.0 Hz, 1H, Ar), 7.46 – 7.15 (m, 11H, Ar), 6.93 (d, J = 
9.1 Hz, 1H, Ar), 5.39 (d, J = 11.8 Hz, 1H, H1), 5.26 (d, J = 11.8 Hz, 1H,H1), 
5.07 (s, 2H, H2), 4.75 (t, J = 2.9 Hz, 1H, H3), 4.57 (d, J = 7.8 Hz, 1H, H6), 3.57 
(ddd, J = 12.9, 7.9, 5.1 Hz, 1H, H5), 2.97 - 2.82 (m, 2H, H(8,11)), 2.85 (s, 3H, 
H7), 2.47 (ddd, J = 12.9, 5.1, 3.2 Hz, 1H, H4), 2.35 -2.27 (m, 2H, H(8,11)),1.64 – 
1.54 (m, 4H, H(9,10)), 1.43 – 1.31 (m, 1H, H4). 13C NMR (75 MHz, CD2Cl2): δC 
179.3 (CO), 174.2 (CO), 151.5, 151.3, 136.8, 134.7, 132.6, 130.7, 129.0, 
128.8, 128.7, 128.4, 127.9, 127.5, 127.4, 120.6, 114.2, 111.5, 103.7, 72.0 (C2), 
69.6 (C5), 51.4, 50.9, 41.3, 37.6, 31.1, 24.8, 23.8 (C7). IR (neat): νmax/cm-1: 
1710 (CO), 2973 (CH).  
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(3aS,5S,10bS)-2-methyl-5-(pyrrolidin-1-yl)-4,5,10,10b-tetrahydropyrrolo 
[3,4-a]carbazole-1,3(2H,3aH)-dione (213)  
 
Benzyl (3aS,5S,10bS)-2-methyl-1,3- dioxo-5- (pyrrolidin-
1-yl)-2,3,3a,4,5,10b-hexahydropyrrolo [3,4-a]carbazole-
10(1H)-carboxylate 182 (0.889 g, 0.19 mmol) and 
platinum (IV) oxide (0.441g, 0.19 mmol) were dissolved 
in THF (5 mL). The reaction mixture was placed under 
hydrogen atmosphere for 6 h.  The resulting suspension was filtered through 
celite and the solvent was removed under reduced pressure. The crude brown 
solid was purified by column chromatography (petrol / ethyl acetate 1:1 to 
100% methanol) to give (3aS,5S,10bS)-2-methyl-5-(pyrrolidine-1-yl)-
4,5,10,10b-tetrahydropyrrolo [3,4-a]carbazole 1,3(2H,3aH)-dione in (0.461 g, 
0.14 mmol, 75%) as a yellow solid. 
 
Mp. 123 – 125 oC. Rf : 0.12 (petrol / methanol 1:1). 1H NMR (300 MHz, 
CD2Cl2): δH 8.82 (s, 1H, NH), 7.57 – 7.40 (m, 1H, Ar), 7.35 – 7.19 (m, 1H, Ar), 
7.17 –  6.91 (m, 2H, Ar), 4.10 (d, J = 8.6 Hz, 1H, H6), 3.81 – 3.42 (m, 2H, 
H(8,10)), 2.90 (s, 3H, H7), 2.74 (dt, J = 7.9, 6.3 Hz, 2H, H(11,14)), 2.58 (ddd, J = 
13.6, 5.9, 3.5 Hz, 1H, H9), 2.38 (m, 2H, H(11,14)), 1.83 – 1.48 (m, 5H, H(9,12,13)). 
13C NMR (75 MHz, CDCl3): δC 179.7 (CO), 176.4 (CO), 135.9, 128.3, 126.6, 
122.0, 119.7, 118.4, 113.9, 111.1, 55.1 (C10), 52.9 (C11, 14), 38.8 (C6 or 8), 37.2 
(C6 or 8), 30.7 (C9), 24.8 (C7), 23.4 (C12,13). IR (neat): νmax/cm-1: 3660 (NH), 
2980 (CH), 1689 (CO).  MS (pNSI): 253.09 (100%, [M-N(CH2)4H]+), 324.17 
(57%, [M+H]+); HRMS (pNSI): calcd C19H22N3O2 [M+H]+: 324.1707; observed: 
324.1714. 
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(3aS,5S,10bS)-5-morpholino-2-phenyl-4,5,10,10b-tetrahydropyrrolo 
[3,4-a] carbazole-1,3(2H,3aH)-dione (214)    
 
Benzyl (3aS,10bS)-2-methyl-5-morpholino-1,3-dioxo- 
2,3,3a,4,10a,10b- hexahydropyrrolo[3,4-a]carbazole-
10(1H)-carboxylate 183 (0.093 g, 0.19 mmol) and 
platinum (IV) oxide (0.0446 g, 0.19 mmol) were dissolved 
in THF (5 mL). The reaction mixture was placed under 
hydrogen atmosphere for 7 h.  The resulting suspension was filtered through 
celite and the solvent was removed under reduced pressure. The crude green 
solid was purified by column chromatography (petrol / ethyl acetate 1:1 to 
100% methanol) to give 2-methyl-5-(pyrrolidinee-1-yl)-4,5,10,10b- 
tetrahydropyrrolo [3,4-a]carbazole-1,3 (2H,3aH)- dione in (0.052 g, 0.15 mmol, 
80%) as an orange solid. 
 
Mp. 203 – 205 oC. Rf : 0.1 (petrol / ethyl acetate 1:1).1H NMR (300 MHz, 
CD2Cl2): δH 8.80 (s, 1H, NH), 7.66 (d, J = 7.6, 1.5, 0.8 Hz, 1H, Ar), 7.29 (ddd, 
J = 8.1, 1.3, 0.8 Hz, 1H, Ar), 7.14 – 6.91 (m, 2H, Ar), 4.07 (d, J = 8.3 Hz, 1H, 
H6), 3.72 – 3.64 (m, 1H, H10), 3.65 – 3.46 (m, 5H, H(12,14,8)), 2.85 (s, 3H, H7), 
2.62 (dt, J = 11.6, 4.6 Hz, 2H, H(11,15)), 2.39 (m, 3H, H(11,15,9)), 1.82 (ddd, J = 
13.3, 9.6, 3.5 Hz, 1H, H9).13C NMR (176 MHz, CD2Cl2): δC 179.2 (CO), 176.1 
(CO), 136.1, 128.3, 127.1, 122.0, 119.8, 119.3, 112.2, 111.0, 67.2, 55.7, 50.7, 
39.0, 37.8, 25.6, 24.7. IR (neat): νmax/cm-1: 3656 (NH), 2981 (CH, Ar), 1697 
(CO). MS (pNSI): 340.16 (100%, [M+H]+), 701.30 (10%, [2M+Na]+); HRMS 
(pNSI): calcd C19H22N3O3 [M+H]+: 340.1656; observed: 340.1656. 
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(3aS,5S,10bS)-7-fluoro-2-methyl-5-(pyrrolidin-1-yl)-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (215)  
 
Benzyl 7-fluoro-2-methyl-,3-dioxo-  5-(pyrrolidin-1-yl) -
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-
10(1H)-carboxylate  205 (0.75 g, 0.16 mmol) and 
platinum (IV) oxide (0.363 g, 0.16 mmol) were 
dissolved in THF (5 mL). The reaction mixture was 
placed under hydrogen atmosphere for 6 h.  The resulting suspension was 
filtered through celite and the solvent was removed under reduced pressure. 
The crude brown solid was purified by column chromatography (petrol / ethyl 
acetate 1:1 to 100% methanol) to give 7-fluoro-2-methyl-5-(pyrrolidin-1-yl)-
4,5,10,10b-tetrahydropyrrolo[3,4-a] carbazole-1,3 (2H,3aH)-dione  in (0.049 g, 
0.14 mmol, 90%) as a brown solid. 
 
Mp. 118 – 120 oC. Rf : 0.12 (petrol / methanol 1:1). 1H NMR (300 MHz, 
CD2Cl2): δH 8.97 (s, 1H, NH), 7.23 (dd, J = 8.8, 4.5 Hz, 1H, Ar), 7.17 (dd, J = 
9.8, 2.6 Hz, 1H, Ar), 6.82 (td, J = 9.1, 2.5 Hz, 1H, Ar), 4.09 (d, J = 8.6 Hz, 1H, 
H6), 3.62 (ddd, J = 12.3, 8.7, 5.8 Hz, 1H, H8), 3.54 (t, J = 3.5 Hz, 1H, H10), 2.89 
(s, 3H, H7), 2.80 – 2.67 (m, 2H, H(11,14)), 2.57 (ddd, J = 13.6, 5.9, 3.5 Hz, 1H, 
H9), 2.39 (dt, J = 8.6, 6.1 Hz, 2H, H(11,14)), 1.75 – 1.50 (m, 5H, H(12,13,9)).13C 
NMR (75 MHz, CD2Cl2): δC 179.4 (CO), 176.0 (CO), 159.5 (d, JC-F = 231.8 Hz, 
C15), 132.6, 130.1, 127.1, 114.0 (d, JC-F = 7.4 Hz), 111.9 (d, JC-F = 11.1 Hz), 
109.6 (d, JC-F = 24.5 Hz), 103.4 (d, JC-F = 24.5 Hz), 55.0 (C10), 52.7 (C11,14), 
38.8 (C6 or 8), 37.2 (C6 or 8), 30.5 (C12,13), 24.8 (C9), 23.5 (C7). IR (neat): νmax/cm-
1: 3660 (NH), 1695 (CO). HRMS (pNSI): calcd C19H21FN3O2 [M+H]+: 
342.1612; observed: 342.1617. 
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(3aS,5S,10bS)-7-fluoro-2-methyl-5-morpholino-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (216) 
 
Benzyl (3aS,5S,10bS)-7-fluoro-2-methyl-5-
morpholino-1,3- dioxo-2,3,3a,4,5,10b-hexahydro 
pyrrolo[3,4-a]carbazole-10(1H)-carboxylate 206 (0.05 
g, 0.10 mmol) and platinum (IV) oxide (0.023 g, 0.10 
mmol) were dissolved in THF (5 mL). The reaction 
mixture was placed under hydrogen atmosphere for 8 h.  The resulting 
suspension was filtered through celite and the solvent was removed under 
reduced pressure. The crude green solid was purified by column 
chromatography (petrol / ethyl acetate 1:1 to 100% methanol) to give 
((3aS,5S,10bS)-7-fluoro-2-methyl-5-morpholino- 4,5,10,10b-tetrahydropyrrolo 
[3,4-a]carbazole-1,3(2H,3aH)-dione in (0.029 g, 0.08 mmol, 81%) as a brown 
solid. 
 
Mp. 185 – 187 oC. Rf : 0.11 (petrol / methanol 1:1). 1H NMR (300 MHz, 
CD2Cl2):  δH  8.73 (s, 1H, NH), 7.35 (dd, J = 9.9, 2.6 Hz, 1H, Ar), 7.23 (dd, J = 
8.8, 4.4 Hz, 1H, Ar), 6.87 – 6.80 (m, 1H, Ar), 4.07 (d, J = 8.4 Hz, 1H, H6), 3.65 
(dd, J = 6.2, 3.6 Hz, 1H, H10), 3.57 (t, J = 4.6 Hz, 4H, H(12,13)), 3.55 -3.50 (d, 
1H, H8), 2.86 (s, 3H, H7), 2.60 (dt, J = 9.9, 4.6 Hz, 2H, H(11,14)), 2.37 (dd, J = 
13.4, 6.6 Hz, 3H, H(11,14, 9)), 1.87 (ddd, J = 13.7, 9.1, 3.6 Hz, 1H, H9). 13C NMR 
(176 MHz, CD2Cl2): δC 179.0 (CO), 175.7 (CO), 157.5 (d, JC-F = 230.8 Hz), 
132.7, 130.3, 127.6 (d, JC-F = 9.7 Hz), 112.7 (d, JC-F = 4.6 Hz), 111.9 (d, JC-F = 
9.3 Hz), 110.1 (d, JC-F = 24.6 Hz), 104.3 (d, JC-F = 24.6 Hz), 67.3, 55.7, 50.6, 
39.2, 37.9, 25.0, 24.8. IR (neat): νmax/cm-1: 3451 (NH). MS (pNSI): 358.15 
(100%, [M+H]+); HRMS (pNSI): calcd C19H21FN3O3 [M+H]+: 358.1561; 
observed: 358.1562. 
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(3aS,5S,10bS)-7-fluoro-2-methyl-5-(piperidin-1-yl)-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (217)  
 
Benzyl(3aS,5S,10bS)-7-fluoro-2-methyl-1,3-dioxo-5-
(piperidin-1-yl)-2,3,3a,4,5,10b-hexahydropyrrolo 
[3,4-a]carbazole-10(1H)-carboxylate 207 (0.077 g, 
0.15 mmol) and platinum (IV) oxide (0.0357 g, 0.15 
mmol) were dissolved in THF (7 mL). The reaction 
mixture   was placed under hydrogen atmosphere for 5 h.  The resulting 
suspension was filtered through celite and the solvent was removed under 
reduced pressure. The crude green solid was purified by column 
chromatography (petrol / ethyl acetate 1:1 to 100% methanol) to give 
(3aS,5S,10bS)-7-fluoro-2-methyl-5-(piperidin-1-yl)-4,5,10,10b-tetrahydro 
pyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione  in (0.0355 g, 0.1 mmol, 67%) as a 
green solid. 
 
Mp. 147 – 149 oC. Rf : 0.1 (petrol: methanol 1:1). 1H NMR (300 MHz, CD2Cl2): 
δH 8.61 (s, 1H, NH), 7.44 (dd, J = 10.1, 2.6 Hz, 1H, Ar), 7.21 (dd, J = 8.8, 4.4 
Hz, 1H, Ar), 6.82 (m, 1H, Ar), 4.06 (d, J = 8.3 Hz, 1H, H6), 3.67 (dd, J = 7.3, 
4.0 Hz, 1H, H10), 3.58 – 3.42 (m, 1H, H8), 2.84 (s, 3H, H7), 2.62 – 2.47 (m, 2H, 
H(11,15)), 2.40 – 12.32 (m, 2H, H(11,15)), 2.22 (m, 1H, H9), 2.01 (ddd, J = 13.4, 
7.5, 4.0 Hz, 1H, H9), 1.53 – 1.37 (m, 6H, H(12,13,14)). 13C NMR (176 MHz, 
CD2Cl2)μ δC 178.9 (CO), 176.0 (CO), 158.4 (d, JC-F = 221.1 Hz, C16), 132.9, 
130.0, 127.6, 125.3, 111.5 (d, JC-F = 9.1 Hz), 110.0 (d, JC-F = 24.2 Hz), 105.0 
(d, JC-F = 24.2 Hz), 56.2 (C10), 50.9, 39.3 (C(12,14) or (11,15)), 38.4, 26.6, 24.7 (C(12, 
14) or (11,15)), 23.6 (C17). IR (neat): νmax/cm-1: 3655 (NH), 1694 (CO).  MS (pNSI): 
356.17 (65%, [M+H]+), 378.15 (10%, [M+Na]+); HRMS (pNSI): calcd C20 
H23FN3O2 [M+H]+: 356.1769; observed: 356.1768. 
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(3aS,5S,10bS)-7-fluoro-2-phenyl-5-(pyrrolidin-1-yl)-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (218)    
 
Benzyl (3aS,5S,10bS)-7-fluoro-1,3-dioxo-2-phenyl-
5-(pyrrolidin-1-yl)-2,3,3a,4,5, 10b-hexahydropyrrolo 
[3,4-a]carbazole-10(1H)-carboxylate 208 (0.101 g, 
0.18 mmol) and platinum (IV) oxide (0.0427 g, 0.18 
mmol) were dissolved in THF (5 mL). The reaction 
mixture was placed under hydrogen atmosphere for 7 h.  The resulting 
suspension was filtered through celite and the solvent was removed under 
reduced pressure. The crude brown solid was purified by column 
chromatography (petrol / ethyl acetate 1:1 to 100% methanol) to 
give(3aS,5S,10bS)-7-fluoro-2-phenyl-5-(pyrrolidin-1-yl)-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione in (0.056 g, 0.14 mmol, 
78%) as a white solid. 
 
Mp. 143 – 145 oC. Rf : 0.12 (petrol / methanol 1:1). 1H NMR (300 MHz, 
CD2Cl2): δH 8.99 (s, 1H, NH), 7.44 – 7.14 (m, 7H,  Ar), 6.85 (t, J = 9.1, Hz, 1H, 
Ar), 4.40 (d, J = 8.9 Hz, 1H, H6), 3.96 – 3.84 (m, 1H, H10), 3.74 – 3.69 (m, 1H, 
H8), 2.90 - 2.81 (m, 2H, H(11, 14)), 2.70 (ddd, J = 13.8, 5.9, 3.3 Hz, 1H, H9), 2.58 
– 2. 50 (m, 2H, H(11, 14)), 1.87-1.66 (m, 5H, H(12, 13, 9)). 13C NMR (176 MHz, 
CD2Cl2): δC 178.1(CO), 174.9 (CO), 158.7 (d, JC-F = 230.1 Hz, C15), 132.6, 
131.8, 129.1, 128.8, 126.8, 126.6, 124.0, 119.6, 112.2 (d, JC-F = 9.1 Hz), 110.2 
(d, JC-F = 24.3 Hz), 103.4 (d, JC-F = 24.3 Hz), 55.4 (C10), 53.0 (C11, 14), 39.0 (C6 
or 8), 37.2 (C6 or 8), 30.4 (C 12, 13), 23.4 (C9). IR (neat): νmax/cm-1: 3660 (NH), 
1694 (CO). HRMS (pNSI): calcd C24H23FN3O2 [M+H]+: 404.1769; observed: 
404.1765.                                                                                                                           
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(3aS,5S,10bS)-7-fluoro-5-morpholino-2-phenyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (219)    
 
Benzyl (3aS,5S,10bS)-7- fluoro-5-morpholino-1,3-
dioxo-2- phenyl - 2,3,3a,4,5,10b–hexahydropyrrolo 
[3,4-a] carbazole-10(1H)- carboxylate 209  (0.10 g, 
0.18 mmol) and platinum (IV) oxide (0.041 g, 0.18 
mmol) were dissolved in THF (5 mL). The reaction 
mixture was placed under hydrogen atmosphere for 6 h.  The resulting 
suspension was filtered through celite and the solvent was removed under 
reduced pressure. The crude brown solid was purified by column 
chromatography (petrol / ethyl acetate 1:1) to give (3aS,5S,10bS)-7-fluoro-5-
morpholino-2-phenyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione in (0.0661 g, 0.134 mmol, 75%) as a yellow solid. 
 
Mp. 192 – 193 oC. Rf : 0.2 (petrol / ethyl acetate 1:1). 1H NMR (300 MHz, 
CD2Cl2): δH 8.77 (s, 1H, NH), 7.45 – 7.32 (m, 4H, Ar), 7.25 (dd, J = 8.8, 4.4 
Hz, 1H, Ar), 7.20 – 7.09 (m, 2H, Ar), 6.89 – 6.82 (m, 1H, Ar), 4.27 (d, J = 8.7 
Hz, 1H, H6), 3.82 – 3.69 (m, 2H, H(10, 8)), 3.59 (dd, J = 5.2, 4.0 Hz, 4H, H(12,13)), 
2.63 (dt, J = 9.7, 4.6 Hz, 2H, H(11,14)), 2.53 – 2.35 (m, 3H, H(11,14, 9)), 2.00 (ddd, 
J = 13.3, 9.3, 3.6 Hz, 1H, H9).13C NMR (176 MHz, CD2Cl2): δC 178.0 (CO), 
174.7 (CO), 158.4 (d, JC-F = 247.5 Hz, C15), 132.9, 131.7, 129.9, 129.1, 128.7, 
127.4 (d, JC-F = 9.1 Hz), 126.5, 112.7 (d, JC-F = 4.2 Hz), 111.9 (d, JC-F = 9.1 Hz), 
110.1 (d, JC-F = 25.2 Hz), 104.4 (d, JC-F = 25.2 Hz), 67.1, 55.6, 50.7, 39.3, 38.0, 
25.4. IR (neat): νmax/cm-1: 3665 (NH), 2981 (CH), 1698 (CO). MS (pNSI): 
861.31 (30%, [2M+Na]+), 420.17 (20%, [M+H]+); HRMS (pNSI): calcd 
C24H23FN3O3 [M+H]+: 420.1718; observed: 420.1713. 
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(3aS,5S,10bS)-7-fluoro-5-(4-methylpiperazin-1-yl)-2-phenyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (220)  
 
Benzyl (3aS,5S,10bS)-7-fluoro-5-(4-
methylpiperazin-1-yl)- 1,3-dioxo-2-phenyl-
2,3,3a,4,5,10b-hexahydropyrrolo [3,4-a]carbazole-
10(1H)-carboxylate 210  (0.125 g, 0.22 mmol) and 
platinum (IV) oxide (0.05 g, 0.22 mmol) were 
dissolved in THF (5 mL). The reaction mixture was 
placed under hydrogen atmosphere for 5 h.  The resulting suspension was 
filtered through celite and the solvent was removed under reduced pressure. 
The crude brown solid was purified by column chromatography (petrol / ethyl 
acetate 1:1) to give (3aS,5S,10bS)-7-fluoro-5-(4-methylpiperazin-1-yl)-2-
phenyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione in 
(0.076 g, 0.175 mmol, 80%) as a yellow solid. 
 
Mp. 185 – 187 oC. Rf : 0.2 (petrol / methanol 1:1). 1H NMR (300 MHz, CD2Cl2): 
δH 8.82 (s, 1H, NH), 7.43 – 7.32 (m, 3H, Ar), 7.27 – 7.10 (m, 3H, Ar), 6.82 (td, 
J = 9.1, 2.6 Hz, 1H, Ar), 4.24 (d, J = 7.7 Hz, 1H, H6), 3.81 – 3.61 (m, 2H, H(8,10)), 
2.69 – 2.60 (m, 2H, H(11,14)), 2.39 (m, 6H, H(11,12,13,14)), 2.15 (s, 3H, H15), 2.12 
– 1,97 (m, 2H, H9). 13C NMR (176 MHz, CD2Cl2): δC 178.0 (CO), 175.0 (CO), 
159.1 (d, JC-F = 234.3 Hz, C16), 132.9, 131.7, 129.7, 129.0, 128.8, 128.7, 127.4 
(d, JC-F = 8.5 Hz), 126.5, 111.8 (d, JC-F = 8.5 Hz), 110.1(d, JC-F = 27.0 Hz), 104.8 
(d, JC-F = 24.3 Hz), 55.5, 55.4, 49.9, 45.7, 39.4, 38.2, 25.0 (C15). IR (neat): 
νmax/cm-1: 3714 (NH), 1694 (CO). MS (pNSI): 433.20 (54%, [M+H]+), 455.18 
(15%, [M+Na]+); HRMS (pNSI): calcd C25H26FN4O2 [M+H]+: 433.2034; 
observed: 433.2035. 
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Ethyl 3-((3aS,4S,10aS,10bS)-2-methyl-1,3-dioxo-10-tosyl-
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate 
(96)   
 
 
 
Table 1. Crystal data and structure refinement for MJH130012 
 
Identification code  MJH130012  
Empirical formula  C27H28N2O6S  
Formula weight  508.57  
Temperature/K  150.01(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  13.2104(2)  
b/Å  16.9699(2)  
c/Å  12.3460(2)  
α/°  90.00  
ȕ/°  112.420(2)  
Ȗ/°  90.00  
Volume/Å3  2558.51(7)  
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Z  4  
ρcalcmg/mm3  1.320  
m/mm-1  1.499  
F(000)  1072.0  
Crystal size/mm3  0.2466 × 0.2132 × 0.1543  
βΘ range for data collection  7.24 to 132.44°  
Index ranges  -14 ≤ h ≤ 15, -β0 ≤ k ≤ β0, -14 ≤ l ≤ 1γ  
Reflections collected  32427  
Independent reflections  4483[R(int) = 0.0372]  
Data/restraints/parameters  4483/0/426  
Goodness-of-fit on F2  1.053  
Final R indexes [I>=βσ (I)]  R1 = 0.0349, wR2 = 0.0937  
Final R indexes [all data]  R1 = 0.0396, wR2 = 0.0987  
Largest diff. peak/hole / e Å-3  0.36/-0.34  
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Ethyl 3-((3aS,4R,10aS,10bS)-2-methyl-1,3-dioxo-10-tosyl 
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate 
(98)     
 
 
 
Table 1. Crystal data and structure refinement for mjh130019 
 
Identification code  mjh130019  
Empirical formula  C27H28N2O6S  
Formula weight  508.57  
Temperature/K  150.01(10)  
Crystal system  monoclinic  
Space group  Ia  
a/Å  12.8199(2)  
b/Å  35.1366(6)  
c/Å  33.1373(7)  
α/°  90  
ȕ/°  99.333(2)  
Ȗ/°  90  
Volume/Å3  14729.0(5)  
Z  24  
ρcalcmg/mm3  1.376  
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m/mm-1  0.178  
F(000)  6432.0  
Crystal size/mm3  0.366 × 0.335 × 0.192  
Radiation  MoKα (Ȝ = 0.7107γ)  
βΘ range for data collection  5.496 to 52.892°  
Index ranges  -16 ≤ h ≤ 16, -4γ ≤ k ≤ 4γ, -41 ≤ l ≤ 41  
Reflections collected  26170  
Independent reflections  26170 [Rint = ?, Rsigma = 0.0719]  
Data/restraints/parameters  26170/2426/1964  
Goodness-of-fit on F2  0.870  
Final R indexes [I>=βσ (I)]  R1 = 0.0497, wR2 = 0.1082  
Final R indexes [all data]  R1 = 0.0939, wR2 = 0.1192  
Largest diff. peak/hole / e Å-3  0.57/-0.87  
Flack parameter 0.46(4) 
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Ethyl 3-((3aS,4R,10aS,10bS)-1,3-dioxo-2-phenyl-10-tosyl-
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate 
(103) 
 
 
 
Table 1. Crystal data and structure refinement for mjh150002_fa 
 
Identification code  mjh150002_fa  
Empirical formula  C32H31.4N2O6.7S  
Formula weight  583.25  
Temperature/K  150.0(2)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  10.76442(14)  
b/Å  16.9915(2)  
c/Å  15.4288(2)  
α/°  90  
ȕ/°  95.9049(13)  
Ȗ/°  90  
Volume/Å3  2807.02(6)  
Z  4  
ρcalcg/cm3  1.380  
ȝ/mm-1  0.168  
F(000)  1228.0  
Crystal size/mm3  0.23 × 0.12 × 0.09  
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Radiation  MoKα (Ȝ = 0.7107γ)  
βΘ range for data collection/°  6.516 to 56.196  
Index ranges  -1γ ≤ h ≤ 1γ, -ββ ≤ k ≤ ββ, -β0 ≤ l ≤ 1λ  
Reflections collected  43583  
Independent reflections  6313 [Rint = 0.0461, Rsigma = 0.0316]  
Data/restraints/parameters  6313/6/394  
Goodness-of-fit on F2  1.054  
Final R indexes [I>=βσ (I)]  R1 = 0.0408, wR2 = 0.0910  
Final R indexes [all data]  R1 = 0.0547, wR2 = 0.0969  
Largest diff. peak/hole / e Å-3  0.32/-0.43  
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Ethyl3-((3aS,4R,10aS,10bS)-1,3-dioxo-10-tosyl-1,2,3,3a,4,10,10a,10b-
octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate  (104) 
 
 
 
 
 
 
 
 
 
Table 1. Crystal data and structure refinement for mjh140029_fa 
  
Identification code  mjh140029_fa  
Empirical formula  C26H26N2O6S  
Formula weight  494.55  
Temperature/K  150.00(10)  
Crystal system  monoclinic  
Space group  P21/n  
a/Å  16.0840(2)  
b/Å  8.84160(10)  
c/Å  18.0999(2)  
α/°  90  
ȕ/°  106.2050(14)  
Ȗ/°  90  
Volume/Å3  2471.69(6)  
Z  4  
ρcalcg/cm3  1.329  
ȝ/mm-1  1.537  
F(000)  1040.0  
Crystal size/mm3  0.29 × 0.28 × 0.14  
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Radiation  CuKα (Ȝ = 1.54184)  
βΘ range for data collection/°  6.51 to 133.56  
Index ranges  -1λ ≤ h ≤ 1λ, -10 ≤ k ≤ 10, -β1 ≤ l ≤ β1  
Reflections collected  65129  
Independent reflections  4373 [Rint = 0.0518, Rsigma = 0.0153]  
Data/restraints/parameters  4373/345/344  
Goodness-of-fit on F2  1.033  
Final R indexes [I>=βσ (I)]  R1 = 0.0350, wR2 = 0.0889  
Final R indexes [all data]  R1 = 0.0391, wR2 = 0.0921  
Largest diff. peak/hole / e Å-3  0.33/-0.48  
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Ethyl 3-((3aS,4S,5S,10bS)-5-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-1-yl)-
1,3-dioxo-10-tosyl-1,2,3,3a,4,5,10,10b-octahydropyrrolo[3,4-a]carbazol-
4-yl)propanoate  (109) 
 
 
Table 1. Crystal data and structure refinement for mjh150028 
 
Identification code  mjh150028  
Empirical formula  C34H31N5O8S  
Formula weight  669.70  
Temperature/K  150.0(2)  
Crystal system  triclinic  
Space group  P-1  
a/Å  12.6562(3)  
b/Å  16.5471(3)  
c/Å  17.5025(4)  
α/°  80.1139(18)  
ȕ/°  72.2231(19)  
Ȗ/°  89.0852(17)  
Volume/Å3  3435.97(13)  
Z  4  
ρcalcg/cm3  1.295  
ȝ/mm-1  1.321  
F(000)  1400.0  
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Crystal size/mm3  0.19 × 0.14 × 0.05  
Radiation  CuKα (Ȝ = 1.54184)  
βΘ range for data collection/°  5.386 to 133.962  
Index ranges  -1γ ≤ h ≤ 15, -1λ ≤ k ≤ 1λ, -β0 ≤ l ≤ β0  
Reflections collected  49344  
Independent reflections  12132 [Rint = 0.0336, Rsigma = 0.0250]  
Data/restraints/parameters  12132/922/923  
Goodness-of-fit on F2  1.055  
Final R indexes [I>=βσ (I)]  R1 = 0.0414, wR2 = 0.1117  
Final R indexes [all data]  R1 = 0.0489, wR2 = 0.1166  
Largest diff. peak/hole / e Å-3  0.66/-0.52  
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(3aR,3bS,6R,6aS,11bR)-6-hydroxy-2-methyl-11-tosyl 
3a,3b,4,5,6,6a,11,11b-octahydro-1H-cyclopenta[c]pyrrolo[3,4 
a]carbazole-1,3(2H)-dione (113) 
 
 
 
 
 
 
Table 1. Crystal data and structure refinement for mjh140006 
  
Identification code  mjh140006  
Empirical formula  C26H26N2O5SCl2  
Formula weight  549.45  
Temperature/K  150.01(10)  
Crystal system  monoclinic  
Space group  P21/n  
a/Å  12.9390(2)  
b/Å  16.4953(3)  
c/Å  24.2101(5)  
α/°  90  
ȕ/°  96.0290(17)  
Ȗ/°  90  
Volume/Å3  5138.64(16)  
Z  8  
ρcalcmg/mm3  1.420  
m/mm-1  3.374  
F(000)  2288.0  
Crystal size/mm3  0.37 × 0.25 × 0.05  
Radiation  CuKα (Ȝ = 1.54184)  
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βΘ range for data collection  6.496 to 132.868°  
Index ranges  -1γ ≤ h ≤ 15, -18 ≤ k ≤ 1λ, -β7 ≤ l ≤ β8  
Reflections collected  42625  
Independent reflections  8988 [Rint = 0.0491, Rsigma = 0.0346]  
Data/restraints/parameters  8988/3/658  
Goodness-of-fit on F2  1.020  
Final R indexes [I>=βσ (I)]  R1 = 0.0443, wR2 = 0.1103  
Final R indexes [all data]  R1 = 0.0561, wR2 = 0.1198  
Largest diff. peak/hole / e Å-3  0.74/-0.74  
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(3aS,4R,10aS,10bS)-4-(3-hydroxypropyl)-2-methyl-10-tosyl-4,10,10a,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (117)  
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Crystal data and structure refinement for mjh140033_fa 
 
Identification code  mjh140033_fa  
Empirical formula  C25.95H26.95Cl2.85N2O5S  
Formula weight  579.94  
Temperature/K  150.01(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  10.33568(16)  
b/Å  31.6318(5)  
c/Å  8.57183(13)  
α/°  90  
ȕ/°  106.4841(16)  
Ȗ/°  90  
Volume/Å3  2687.25(7)  
Z  4  
ρcalcg/cm3  1.433  
ȝ/mm-1  4.015  
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F(000)  1204.0  
Crystal size/mm3  0.37 × 0.27 × 0.2  
Radiation  CuKα (Ȝ = 1.54184)  
βΘ range for data collection/°  5.588 to 133.572  
Index ranges  -1β ≤ h ≤ 1β, -γ5 ≤ k ≤ γ7, -λ ≤ l ≤ 10  
Reflections collected  37079  
Independent reflections  4756 [Rint = 0.0365, Rsigma = 0.0164]  
Data/restraints/parameters  4756/45/349  
Goodness-of-fit on F2  1.033  
Final R indexes [I>=βσ (I)]  R1 = 0.0412, wR2 = 0.1029  
Final R indexes [all data]  R1 = 0.0444, wR2 = 0.1054  
Largest diff. peak/hole / e Å-3  0.83/-0.43  
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(3aS,3bR,7S,7aS,12b)-7-hydroxy-2-methyl-12-tosyl-3b,4,5,6,7,7a,12,12b-
octahydrobenzo[c]pyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (122)        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.  Crystal data and structure refinement for mjh150010 
 
Identification code  mjh150010 
Chemical formula (moiety) C26H26N2O5S·0.5CH2Cl2 
Chemical formula (total) C26.5H27ClN2O5S 
Formula weight  521.01 
Temperature  100(2) K 
Radiation, wavelength  synchrotron, 0.6889 Å 
Crystal system, space group  monoclinic, P21/c 
Unit cell parameters a = 13.119(3) Å      = 90° 
 b = 16.319(3) Å      = 100.030(2)° 
 c = 22.882(5) Å       = 90° 
Cell volume 4823.9(18) Å3 
Z 8 
Calculated density  1.435 g/cm3 
Absorption coefficient m 0.231 mm1 
F(000) 2184 
Crystal colour and size colourless, 0.070 0.010  0.010 mm3 
Reflections for cell refinement 6929 (q range 2.2 to 25.5°) 
Data collection method Rigaku Saturn 724+on kappa 
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diffractometer 
 wide-frame w scans 
 range for data collection 1.5 to 25.8° 
Index ranges h 16 to 16, k 20 to 17, l 28 to 28 
Completeness to  = 24.4° 99.9 %  
Reflections collected 42956 
Independent reflections 10111 (Rint = 0.0955) 
Reflections with F2>2 6291 
Absorption correction none 
Structure solution direct methods 
Refinement method Full-matrix least-squares on F2 
Weighting parameters a, b 0.1315, 7.9105 
Data / restraints / parameters 10111 / 67 / 664 
Final R indices [F2>2] R1 = 0.0838, wR2 = 0.2270 
R indices (all data) R1 = 0.1379, wR2 = 0.2582 
Goodness-of-fit on F2 1.073 
Extinction coefficient 0.0093(11) 
Largest and mean shift/su 0.003 and 0.000 
Largest diff. peak and hole 0.81 and 1.12 e Å3 
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(3aS,4S,10aS,10bS)-4-(3-hydroxypropyl)-2-methyl-10-tosyl-4,10,10a,10b 
-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (135) 
 
 
Table 1. Crystal data and structure refinement for mjh140032_fa 
  
Identification code  mjh140032_fa  
Empirical formula  C25H26N2O5S  
Formula weight  466.54  
Temperature/K  150.01(10)  
Crystal system  monoclinic  
Space group  P21/n  
a/Å  11.80720(10)  
b/Å  11.35230(10)  
c/Å  16.4724(2)  
α/°  90  
ȕ/°  94.7820(10)  
Ȗ/°  90  
Volume/Å3  2200.26(4)  
Z  4  
ρcalcg/cm3  1.408  
ȝ/mm-1  1.654  
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F(000)  984.0  
Crystal size/mm3  0.38 × 0.11 × 0.06  
Radiation  CuKα (Ȝ = 1.54184)  
βΘ range for data collection/°  8.874 to 133.532  
Index ranges  -14 ≤ h ≤ 14, -1γ ≤ k ≤ 1γ, -1λ ≤ l ≤ 1λ  
Reflections collected  59078  
Independent reflections  3905 [Rint = 0.0517, Rsigma = 0.0161]  
Data/restraints/parameters  3905/0/304  
Goodness-of-fit on F2  1.038  
Final R indexes [I>=βσ (I)]  R1 = 0.0344, wR2 = 0.0884  
Final R indexes [all data]  R1 = 0.0403, wR2 = 0.0933  
Largest diff. peak/hole / e Å-3  0.26/-0.42  
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(3aS,5S,10bS)-5-ethoxy-2-methyl-10-tosyl-4,5,10,10b-tetrahydropyrrolo 
[ 3,4-a]carbazole-1,3(2H,3aH)-dione (158) 
 
 
 
 
 
 
 
 
 
 
Table 1. Crystal data and structure refinement for mjh150001_fa 
 
Identification code  mjh150001_fa  
Empirical formula  C24H24N2O5S  
Formula weight  452.51  
Temperature/K  150.00(10)  
Crystal system  monoclinic  
Space group  P21/n  
a/Å  12.8593(4)  
b/Å  12.5659(3)  
c/Å  14.2001(4)  
α/°  90  
ȕ/°  110.028(3)  
Ȗ/°  90  
Volume/Å3  2155.80(11)  
Z  4  
ρcalcg/cm3  1.394  
ȝ/mm-1  0.190  
F(000)  952.0  
Crystal size/mm3  0.3 × 0.11 × 0.06  
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Radiation  MoKα (Ȝ = 0.7107γ)  
βΘ range for data collection/°  6.484 to 56.366  
Index ranges  -17 ≤ h ≤ 15, -16 ≤ k ≤ 16, -18 ≤ l ≤ 18  
Reflections collected  17697  
Independent reflections  4675 [Rint = 0.0451, Rsigma = 0.0461]  
Data/restraints/parameters  4675/0/292  
Goodness-of-fit on F2  1.043  
Final R indexes [I>=βσ (I)]  R1 = 0.0466, wR2 = 0.1007  
Final R indexes [all data]  R1 = 0.0680, wR2 = 0.1106  
Largest diff. peak/hole / e Å-3  0.36/-0.39  
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(3aS,5S,10bS)-5-(diethylamino)-2-methyl-10-tosyl-4,5,10,10b 
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (166)   
 
 
 
 
Table 1. Crystal data and structure refinement for mjh140035_fa 
 
Identification code  mjh140035_fa  
Empirical formula  C26H29N3O4S  
Formula weight  479.58  
Temperature/K  150.00(10)  
Crystal system  triclinic  
Space group  P-1  
a/Å  9.9595(3)  
b/Å  10.9010(3)  
c/Å  12.2897(4)  
α/°  111.435(3)  
ȕ/°  108.410(3)  
Ȗ/°  91.082(2)  
Volume/Å3  1164.71(7)  
Z  2  
ρcalcg/cm3  1.367  
ȝ/mm-1  0.178  
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F(000)  508.0  
Crystal size/mm3  0.27 × 0.14 × 0.07  
Radiation  MoKα (Ȝ = 0.7107γ)  
βΘ range for data collection/°  6.558 to 56.33  
Index ranges  -1β ≤ h ≤ 1γ, -14 ≤ k ≤ 14, -15 ≤ l ≤ 16  
Reflections collected  36925  
Independent reflections  5252 [Rint = 0.0474, Rsigma = 0.0317]  
Data/restraints/parameters  5252/0/311  
Goodness-of-fit on F2  1.019  
Final R indexes [I>=βσ (I)]  R1 = 0.0423, wR2 = 0.0943  
Final R indexes [all data]  R1 = 0.0540, wR2 = 0.1002  
Largest diff. peak/hole / e Å-3  1.00/-0.41  
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(3aS,5S,10bS)-2-methyl-5-(pyrrolidin-1-yl)-10-tosyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione  (172) 
 
 
Table 1. Crystal data and structure refinement for mjh140036_fa 
 
Identification code  mjh140036_fa  
Empirical formula  C26H27N3O4S  
Formula weight  477.56  
Temperature/K  150.00(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  11.49030(17)  
b/Å  18.7328(2)  
c/Å  10.86055(13)  
α/°  90  
ȕ/°  98.5172(13)  
Ȗ/°  90  
Volume/Å3  2311.90(5)  
Z  4  
ρcalcg/cm3  1.372  
ȝ/mm-1  0.179  
F(000)  1008.0  
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Crystal size/mm3  0.28 × 0.15 × 0.12  
Radiation  MoKα (Ȝ = 0.7107γ)  
βΘ range for data collection/°  6.492 to 56.534  
Index ranges  -15 ≤ h ≤ 15, -β4 ≤ k ≤ β4, -14 ≤ l ≤ 14  
Reflections collected  72831  
Independent reflections  5399 [Rint = 0.0497, Rsigma = 0.0270]  
Data/restraints/parameters  5399/300/309  
Goodness-of-fit on F2  1.050  
Final R indexes [I>=βσ (I)]  R1 = 0.0415, wR2 = 0.0921  
Final R indexes [all data]  R1 = 0.0573, wR2 = 0.0985  
Largest diff. peak/hole / e Å-3  0.32/-0.37  
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Benzyl (3aS,5S,10bS)-2-methyl-5-morpholino-1,3-dioxo-2,3,3a,4,5,10b-
hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (183) 
 
Table 1.  Crystal data and structure refinement for mjh150003 
 
Identification code  mjh150003 
Chemical formula (moiety) C27H27N3O5 
Chemical formula (total) C27H27N3O5 
Formula weight  473.51 
Temperature  100(2) K 
Radiation, wavelength  synchrotron, 0.6889 Å 
Crystal system, space group  monoclinic, P21/n 
Unit cell parameters a = 5.8848(15) Å  = 90° 
 b = 18.422(5) Å =91.887(3)° 
 c = 20.968(5) Å = 90° 
Cell volume 2271.9(10) Å3 
Z 4 
Calculated density  1.384 g/cm3 
Absorption coefficient  0.091 mm1 
F(000) 1000 
Crystal colour and size colourless,0.200  0.200  0.030 mm3 
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Reflections for cell refinement 9121 (q range 2.2 to 27.4°) 
Data collection method Rigaku Saturn 724+on kappa 
diffractometer wide- frame w scans 
 range for data collection 1.4 to 27.4° 
Index ranges h 7 to 7, k 24 to 22, l27 to 27 
Completeness to  = 24.4° 98.6 %  
Reflections collected 20359 
Independent reflections 5531 (Rint = 0.0538) 
Reflections with F2>2 4375 
Absorption correction none 
Structure solution direct methods 
Refinement method Full-matrix least-squares on F2 
Weighting parameters a, b 0.0501, 2.0683 
Data / restraints / parameters 5531 / 0 / 317 
Final R indices [F2>2] R1 = 0.0579, wR2 = 0.1392 
R indices (all data) R1 = 0.0734, wR2 = 0.1464 
Goodness-of-fit on F2 1.060 
Largest and mean shift/su 0.000 and 0.000 
Largest diff. peak and hole 0.38 and 0.27 e Å3 
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Benzyl(3aS,10aS,10bS)-7-fluoro-2-methyl-1,3-dioxo-2,3,3a,4,10a,10b-
hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (201) 
 
 
 
 
 
 
Table 1. Crystal data and structure refinement for mjh140005 
 
Identification code  mjh140005  
Empirical formula  C23H19N2O4F  
Formula weight  406.40  
Temperature/K  150.00(10)  
Crystal system  triclinic  
Space group  P-1  
a/Å  7.4462(5)  
b/Å  9.1888(6)  
c/Å  14.7869(10)  
α/°  97.920(5)  
ȕ/°  102.985(6)  
Ȗ/°  104.265(6)  
Volume/Å3  935.28(11)  
Z  2  
ρcalcmg/mm3  1.443  
m/mm-1  0.885  
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F(000)  424.0  
Crystal size/mm3  0.42 × 0.18 × 0.11  
Radiation  CuKα (Ȝ = 1.54184)  
βΘ range for data collection  6.266 to 132.538°  
Index ranges  -8 ≤ h ≤ 8, -10 ≤ k ≤ 10, -17 ≤ l ≤ 17  
Reflections collected  11384  
Independent reflections  3245 [Rint = 0.0330, Rsigma = 0.0286]  
Data/restraints/parameters  3245/0/272  
Goodness-of-fit on F2  1.048  
Final R indexes [I>=βσ (I)]  R1 = 0.0374, wR2 = 0.0892  
Final R indexes [all data]  R1 = 0.0479, wR2 = 0.0959  
Largest diff. peak/hole / e Å-3  0.21/-0.20  
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1.0 Summary 
 
1.1 Study  
 
Primary antimicrobial screening study by whole cell growth inhibition assays, using the 
provided samples at a single concentration, in duplicate (n=2). The inhibition of growth is 
measured against 5 bacteria: Escherichia coli, Klebsiella pneumoniae, Acinetobacter 
baumannii, Pseudomonas aeruginosa and Staphylococcus aureus, and 2 fungi: Candida 
albicans and Cryptococcus neoformans. 
 
1.2 Collaborator 
 
Primary Investigator:  Dr Michael Hall (michael.hall@newcastle.ac.uk) 
Contact Person: Dr Michael Hall (michael.hall@newcastle.ac.uk) 
Organisation:   School of Chemistry 
  Newcastle University  
  United Kingdom 
 
1.3 Assay Parameters 
 
Test concentration 32 µg/mL 
QC Duplicate (n=2) 
Control MIC: Pass 
Plates Non-Binding Surface, 384 well plate 
Media Bacteria 
 Fungi 
Cation-adjusted Mueller Hinton broth 
Yeast Nitrogen Base 
Read Out  Bacteria 
 C. albicans 
 C. neoformans 
OD600 
OD530 
Resazurin OD600-570 
 
1.4 Outcomes   
 
Number of samples tested 8 
 Number of Actives 
selected for Hit Confirmation 
1 
E. coli 0 
K. pneumoniae - MDR 0 
A. baumannii 0 
P. aeruginosa 0 
S. aureus – MRSA 0 
C. albicans 1 
C. neoformans 0 
*Actives are defined as showing ≥80% inhibition of growth at the concentration tested 
 
      A full set of results can be found in Section 3.3. 
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1.5 Comments 
 
To confirm the inhibitory activity, the hit compounds will be re-tested against the strains in a 
dose response assay to determine the minimum inhibitory concentration (MIC) of the 
compounds. Furthermore, to further evaluate the antimicrobial potential of the compounds 
they will be assayed against a mammalian cell line to determine general cell toxicity. 
 
1.5.1 Summary antimicrobial active compounds 
 
Single Concentration – 32 µg/mL, n=2, where one or both replicates were deemed 
active the compound is deemed active. 
 
Inactive I Inhibition < 80% OR Z-Score < 2.5 
Active A Inhibition ≥ 80% AND Z-Score ≥ 2.5 
 
 
Sample Name 
CO-ADD 
Sample 
ID 
GP_020 GN_001 GN_003 GN_034 GN_042 FG_001 FG_002 
S. 
aureus 
E. coli 
K. 
pneumo
niae 
A. 
bauman
nii 
P. 
aerugin
osa 
C. 
albican
s 
C. 
neofor
mans 
ATCC 
43300 
ATCC 
25922 
ATCC 
700603 
ATCC 
19606 
ATCC 
27853 
ATCC 
90028 
ATCC 
208821 
MRSA 
FDA 
control 
strain 
MDR 
Type 
strain 
Type 
strain 
FDA 
control 
strain 
H99 
Type 
strain 
Antimicrobial activity at 32 µg/mL 
Mma-448-f2 C0142329 I I I I I A I 
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2.0 Methods 
 
2.1 Sample preparation 
 
Samples were provided by the collaborator as dry material, and were made to 10mg/mL in 
DMSO solution and stored frozen at -20 °C. 
 
An aliquot of each sample was diluted to 320 µg/mL in water, and plated in 384-well 
polypropylene plates (PP). 5 µL was plated in duplicate (n=2) into a 384-well non-binding 
surface plate (NBS) for each strain or cell type assayed against. Once cells were added 
this gave a final compound concentration range of 32  µg/mL. 
 
 
Final Sample Concentration: 32  µg/mL  
Final DMSO Concentration 1% 
Compound preparation in Water/DMSO 
 
2.2 Antimicrobial Assay 
 
2.2.1 Procedure 
 
All bacteria were cultured in Cation-adjusted Mueller Hinton broth (CAMHB) at 37 °C 
overnight. A sample of each culture was then diluted 40-fold in fresh broth and incubated 
at 37 °C for 1.5-3 h. The resultant mid-log phase cultures were diluted (CFU/mL measured 
by OD600), then 45 µL was added to each well of the compound containing plates, giving a 
cell density of 5×105 CFU/mL and the nominated final compound concentration. All the 
plates were covered and incubated at 37 °C for 18 h without shaking. 
 
2.2.2 Analysis 
 
Inhibition of bacterial growth was determined measuring absorbance at 600 nm (OD600), 
using a Tecan M1000 Pro monochromator plate reader. The percentage of growth 
inhibition was calculated for each well, using the negative control (media only) and positive 
control (bacteria without inhibitors) on the same plate as references. The significance of 
the inhibition values was determined by Z-scores, calculated using the average and 
standard deviation of the sample wells (no controls) on the same plate. Samples with 
inhibition value above 80% and Z-Score above 2.5 for either replicate (n=2 on different 
plates) were classed as actives. 
 
2.3 Antifungal Assay 
 
2.3.1 Procedure 
 
Fungi strains were cultured for 3 days on Yeast Extract-Peptone Dextrose (YPD) agar at 
30 °C. A yeast suspension of 1 x 106 to 5 x 106 cells/mL (as determined by OD530) was 
prepared from five colonies. These stock suspensions were diluted with Yeast Nitrogen 
Base (YNB) broth to a final concentration of 2.5 ×103 CFU/mL. Then, 45 µL of the fungi 
suspension was added to each well of the compound-containing plates. Plates were 
covered and incubated at 35 °C for 24 h without shaking. 
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2.3.2 Analysis 
 
Growth inhibition of C. albicans was determined measuring absorbance at 530 nm (OD530), 
while the growth inhibition of C. neoformans was determined measuring the difference in 
absorbance between 600 and 570 nm (OD600-570), after the addition of resazurin (0.001% 
final concentration) and incubation at 35 °C for additional 2 h. The absorbance was 
measured using a Biotek Synergy HTX plate reader. The percentage of growth inhibition 
was calculated for each well, using the negative control (media only) and positive control 
(bacteria without inhibitors) on the same plate. The significance of the inhibition values 
was determined by Z-scores, calculated using the average and standard deviation of the 
sample wells (no controls) on the same plate. Samples with inhibition value above 80% 
and Z-Score above 2.5 for either replicate (n=2 on different plates) were classed as 
actives. 
 
2.4 Antibiotic standards preparation and Quality control 
 
Colistin and Vancomycin were used as positive bacterial inhibitor standards for Gram-
negative and Gram-positive bacteria, respectively. Fluconazole was used as a positive 
fungal inhibitor standard for C. albicans and C. neoformans. 
 
The antibiotics were provided in 4 concentrations, with 2 above and 2 below its MIC value, 
and plated into the first 8 wells of column 23 of the 384-well NBS plates. 
 
The quality control (QC) of the assays was determined by the antimicrobial controls and 
the Z’-factor (using positive and negative controls). Each plate was deemed to fulfil the 
quality criteria (pass QC), if the Z’-factor was above 0.4, and the antimicrobial standards 
showed full range of activity, with full growth inhibition at their highest concentration, and 
no growth inhibition at their lowest concentration. 
 
2.5 Materials 
 
Material Code Brand Cat No. 
Compound preparation plate PP Corning 3364 
Assay Plates NBS 384w Corning 3640 
Growth media - bacteria CAMHB Bacto Laboratories 212322 
Culture agar - fungi YPD Becton Dickinson 242720 
Growth media - fungi YNB Becton Dickinson 233520 
Resazurin  Sigma-Aldrich R7017 
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2.6 Tested Samples 
 
Compound 
Barcode 
Sample 
Name 
CO-ADD 
Sample ID 
Full 
MW 
Amount Supplied 
Stock 
Conc. 
(mg/mL) 
Solvent Solid 
(mg) 
Solution 
Volume 
(µL) 
Conc. Unit 
FR09958692 Mma-431-f2 C0142324 323.4 1.0    10.0 DMSO 
FR09958693 Mma-456-f2 C0142325 339.4 1.0    10.0 DMSO 
FR09958694 Mma-428-f2 C0142326 341.39 1.0    10.0 DMSO 
FR09958695 Mma-452-f2 C0142327 355.41 1.0    10.0 DMSO 
FR09958784 Mma-454-f2 C0142328 357.39 1.1    10.0 DMSO 
FR09958785 Mma-448-f2 C0142329 419.46 1.1    10.0 DMSO 
FR09958786 Mma-449-f2 C0142330 432.5 0.7    10.0 DMSO 
FR09958787 Mma-453-f2 C0142331 403.46 1.0    10.0 DMSO 
 
2.7 Antibiotic Controls 
 
Sample Name Sample ID 
Full 
MW 
Stock 
Conc 
(mg/mL) 
Solvent Source 
Colistin - Sulfate MCC_000094:02 1400.63 10 DMSO Sigma; C4461 
Vancomycin - HCL MCC_000095:02 1485.71 10 DMSO Sigma; 861987 
Fluconazole MCC_008383:01 306.27 2.56 DMSO Sigma; F8929 
 
2.8 Microbial Strains 
 
ID Batch Organism Strain Description 
GN_001 02 Escherichia coli ATCC 25922 FDA control strain 
GN_003 02 Klebsiella pneumoniae ATCC 700603 MDR 
GN_034 02 Acinetobacter baumannii ATCC 19606 Type strain 
GN_042 02 Pseudomonas aeruginosa ATCC 27853 Quality control strain 
GP_020 02 Staphylococcus aureus ATCC 43300 MRSA 
FG_001 01 Candida albicans ATCC 90028 CLSI reference 
FG_002 01 Cryptococcus neoformans  ATCC 208821 H99 - Type strain 
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3.0 Results 
 
3.1 Test Information 
 
Raw data PSR0082 
Location IMB/UQ, SCMB/UQ 
 
3.2 Controls 
 
All antibiotic controls displayed inhibitory values within the expected range. 
 
Strain ID Species Antibiotic Pass/Fail 
GN_001:02 E. coli Colistin Pass 
GN_003:02 K. pneumoniae (MDR) Colistin Pass 
GN_034:02 A. baumannii Colistin Pass 
GN_042:02 P. aeruginosa Colistin Pass 
GP_020:02 S. aureus (MRSA) Vancomycin Pass 
FG_001:01 C. albicans Fluconazole Pass 
FG_002:01 C. neoformans (H99) Fluconazole Pass 
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3.3 Antimicrobial Activity 
 
3.3.1 Primary Screening 
Single Concentration – 32 µg/mL, n=2, where one or both replicates were deemed 
active the compound is deemed active. 
 
Inactive I Inhibition < 80% OR Z-Score < 2.5 
Active A Inhibition ≥ 80% AND Z-Score ≥ 2.5 
 
Sample 
Name 
CO-ADD 
Sample ID 
GP_020 GN_001 GN_003 GN_034 GN_042 FG_001 FG_002 
S. aureus E. coli 
K. 
pneumonia
e 
A. 
baumannii 
P. 
aeruginosa 
C. albicans 
C. 
neoforman
s 
ATCC 
43300 
ATCC 
25922 
ATCC 
700603 
ATCC 
19606 
ATCC 
27853 
ATCC 
90028 
ATCC 
208821 
MRSA 
FDA 
control 
strain 
MDR Type strain Type strain 
FDA 
control 
strain 
H99 
Type strain 
Antimicrobial activity at 32 µg/mL 
Mma-431-f2 C0142324 I	 I	 I	 I	 I	 I	 I	
Mma-456-f2 C0142325 I	 I	 I	 I	 I	 I	 I	
Mma-428-f2 C0142326 I	 I	 I	 I	 I	 I	 I	
Mma-452-f2 C0142327 I	 I	 I	 I	 I	 I	 I	
Mma-454-f2 C0142328 I	 I	 I	 I	 I	 I	 I	
Mma-448-f2 C0142329 I	 I	 I	 I	 I	 A	 I	
Mma-449-f2 C0142330 I	 I	 I	 I	 I	 I	 I	
Mma-453-f2 C0142331 I	 I	 I	 I	 I	 I	 I	
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Hall, M. J.;. RSC Advances 2015, 5(21), 16125-16152 
Diastereoselective synthesis of functionalised
carbazoles via a sequential Diels–Alder/ene
reaction strategy†
Joseph Cowell, Matokah Abualnaja, Stephanie Morton,‡ Ruth Linder,
Faye Buckingham, Paul G. Waddell, Michael R. Probert and Michael J. Hall*
An operationally simple one-pot, three-component, diastereoselective synthesis of saturated carbazoles
and related pyridazino[3,4-b]indoles, based on two sequential intermolecular pericyclic reactions, is
described. The reaction sequence involves an intermolecular Diels–Alder (D–A) reaction of a 3-vinyl-1H-
indole, containing an electron withdrawing N-protecting group, with a suitable dienophile. Due to the
electron withdrawing nature of the N-protecting group the resultant D–A cycloadducts are sufficiently
stabilised to allow for a subsequent in situ diastereospecific intermolecular ene reaction to take place
with an added enophile, generating functionalised carbazoles with relative stereocontrol of up to four
stereocentres.
Introduction
Carbazole scaffolds are common in many bioactive compounds
(e.g. staurosporine)1,2 with the indolocarbazole scaffold in
particular being found in a number of molecules with potential
therapeutic application, several of which have entered clinical
trials for the treatment of cancer (midostaurin (PKC412), les-
taurtinib (CEP-701), CEP-751, CEP-1347, edotecarin and beca-
tecarin).3,4 Therefore there is a growing interest in the
development of new synthetic routes to functionalised carbo-
zoles.5–9 Herein we describe our progress in the development of
a diastereoselective one-pot, three-component approach for the
synthesis of functionalised, partially saturated carbazoles and
pyridazino[3,4-b]indoles.
Results and discussion
The vinyl-indole synthesis of carbazoles, originally developed by
Nolan, Pindur, Porter and others, involves the D–A cycloaddi-
tion of a 2- or 3-vinyl-1H-indole (typically either unprotected or
containing an electron donating N-protecting group) with a
dienophile.10–22 The resulting D–A cycloadducts are oen
unstable and are therefore typically oxidised or undergo an
in situ 1,3-H shi to rearomatise the indole. We postulated that
if the intermediate D–A cycloadduct could instead be inter-
cepted via an alternative intermolecular reaction this would
provide a new multi-component route to functionalised carba-
zoles. Following on from our recent work on the D–A reactions
of vinyl-imidazoles,23,24 we decided to investigate if the D–A
cycloadducts of 3-vinyl-1H-indoles could be reacted in situ with
enophiles to give a new stereoselective three-component,
intermolecular D–A/intermolecular ene approach to the carba-
zole or pyridazino[3,4-b]indole scaffold (Fig. 1).25–29
We decided to focus our investigation on the D–A reactions
of 3-vinyl-1H-indoles containing an electron withdrawing
Fig. 1 Typical products of the D–A reaction between 3-vinyl-1H-
indoles and maleimides verses our proposed trapping of the D–A
cycloadduct via an intermolecular ene reaction.
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N-protecting group as we postulated that this would stabilise
the desired D–A cycloadducts sufficiently to allow either isola-
tion or further in situ chemistry.19,20 Despite the extensive body
of work that has been published on the vinyl-indole synthesis of
carbazoles,11–18 the incorporation of electron withdrawing N-
protecting groups has been less well studied with the
phenylsulfonyl group being the most common.25,30–33 We
therefore decide to focus our initial investigation on tosyl
protected systems and embarked on the synthesis of two N-
tosyl protected 3-alkenyl-indoles through reaction of 1H-
indole-3-carbaldehyde with tosyl chloride, followed by a Wittig
reaction with methylenetriphenyl-l5-phosphane or ethyl 4-(tri-
phenyl-l5-phosphanylidene)butanoate to give 1a and 1b
respectively (Scheme 1).
When we reacted 1-tosyl-3-vinyl-1H-indole 1a with 1-methyl-
1H-pyrrole-2,5-dione in DCM at reux for 48 hours, we were
pleased to isolate, in a 74% yield, the N-tosyl protected endo-
cycloadduct 2a, which showed little propensity towards spon-
taneous rearomatisation or oxidation. Whilst 4-phenyl-1,2,4-
triazole-3,5-dione (PTAD) reacted rapidly with 1a at 78 C in
DCM to give the stable D–A cycloadduct 2b in 88% yield
(Table 1).
Attempts to react the more sterically demanding ethyl (Z)-5-
(1-tosyl-1H-indol-3-yl)pent-4-enoate 1b with 1H-pyrrole-2,5-
diones under thermal conditions proved unsuccessful with no
D–A reaction being observed aer prolonged heating in toluene,
DCM or iso-propanol. The addition of 20 mol% of 1,3-bis(3,5-
bis(triuoromethyl)phenyl)thiourea34 also showed no improve-
ment in the D–A reaction, whilst the addition of one equivalent
of TiCl4 at 78
C for 10 minutes resulted in an efficient D–A
reaction but was accompanied by the unwanted rear-
omatisation of the indole. Addition of one equivalent of AlCl3 or
Me2AlCl in DCM at r.t., followed by heating to reux gave low
yields of the desired product 2c along with recovered starting
material. Further optimisation resulted in a nal protocol
whereby 2 equivalents of Me2AlCl were added to a DCM solution
of 1b and the requisite 1H-pyrrole-2,5-dione at 78 C, followed
by warming to reux in DCM for 48 hours to give N-tosyl pro-
tected D–A cycloadducts 2(c–e) in good yields (Table 2). The
structures of 2(a), 2(b) and 2(d) were conrmed by single crystal
X-ray analysis and are consistent with an endo-selective D–A
reaction (see ESI†).
Next we examined the reactivity of N-tosyl protected endo-
cycloadducts 2(a–e) towards enophiles. Reaction of 2a with
nitrosobenzene proceeded well at r.t. in 18 hours to give the ene
adduct 3a in 68% isolated yield. We therefore reacted D–A
adducts 2(a–e) with nitrosobenzene and 1-methyl-2-
nitrosobenzene at r.t. in DCM, giving high yields of the corre-
sponding ene adducts 3(a, b and e–h). The ene reactions of
2(a–c) also proceeded smoothly with PTAD at 0 C to give 3(c,
i and j). The reaction of 2a with 2,3,4,5,6-penta-
uorobenzaldehyde under thermal conditions was unsuccess-
ful. However addition of one equivalent of Me2AlCl at 78
C to
a mixture of 2a and 2,3,4,5,6-pentauorobenzaldehyde resulted
in formation of the ene cycloadduct 3d as a 6 : 1 mixture of
diastereomers, epimeric at the exo-cyclic hydroxyl position35
(Table 3).
Since both the D–A and ene reactions are performed in DCM
we then decided to examine the potential for reaction tele-
scoping by attempting a D–A/ene reaction sequence under
“domino” conditions.36 1-Tosyl-3-vinyl-1H-indole 1a, 1-methyl-
Scheme 1 Synthesis of N-tosyl-3-alkenyl-1H-indoles 1(a and b).
Table 1 D–A reactions of N-tosyl protected 1-tosyl-3-vinyl-1H-indole 1a
Starting material Dienophile Reaction Conditions R0 X Yielda Product
1 1a 40 C, 48 h Me CH 76% 2ab
2 1a 78 C, 3.5 h Ph N 88% 2bb
a Isolated yields. b Structure conrmed by single crystal X-ray analysis.
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1H-pyrrole-2,5-dione and nitrosobenzene were stirred together
for 5 days at r.t. in DCM, until 1a had been consumed by TLC.
Examination of the crude reaction mixture showed the forma-
tion of a number of by-products (including a rearomatised
isomer of D–A cycloadduct 2a) but the desired domino D–A/ene
product 3a could be isolated as a single diastereomer in a 40%
yield.
To improve both the yield and reaction exibility whilst
maintaining operational simplicity we next examined a one-pot,
sequential addition approach. 1-Tosyl-3-vinyl-1H-indole 1a and
5-methoxy-1-tosyl-3-vinyl-1H-indole 1c (synthesised as previ-
ously via tosyl protection of 5-methoxy-1H-indole-3-
carbaldehyde followed by a Wittig reaction with methylene-
triphenyl-l5-phosphane) were reacted with 1-methyl-1H-pyrrole-
2,5-dione or 1H-pyrrole-2,5-dione in reuxing DCM for 48 hours
to give the corresponding D–A cycloadducts. Nitrosobenzene,
1-methyl-2-nitrosobenzene, 2,3,4,5,6-pentauorobenzaldehyde
with one equivalent of Me2AlCl, or PTAD, were then added
directly to the reaction vessels containing the D–A cycloadducts
and the ene reactions conducted were under the previously
optimised conditions, depending on the enophile. This one-pot
three-component approach gave the corresponding D–A/ene
products 3(a–d and k–q) in excellent (70–89%) yields with no
purication or work-up of the intermediate D–A cycloadducts
required (Table 4).
We therefore continued with this approach, reacting 1a and
1c with PTAD as the dienophile followed by in situ addition of
enophiles (nitrosobenzene, 1-methyl-2-nitrosobenzene, or
PTAD) again giving the D–A/ene products 3(e, f, r and s) cleanly
and in good yields (Table 4).
We then decided to examine the range of electron with-
drawing N-protecting groups tolerated in our one-pot D–A/ene
reaction sequence with a view towards exibility in the
deprotection of the products. Boc protection of 1H-indole-3-
carbaldehyde proceeded in high yield (triethylamine, Boc
anhydride, DCM, 18 h, r.t.), however attempts to synthesise tert-
butyl 3-vinyl-1H-indole-1-carboxylate, by reaction of tert-butyl
3-formyl-1H-indole-1-carboxylate with methylenetriphenyl-l5-
phosphane, gave only a 13% yield of the desired product with
the major products arising from loss of the Boc group. We
therefore focused our efforts on use of the DMAS (dimethyla-
minosulfonyl) and Cbz protecting groups, and synthesised N,N-
dimethyl-3-vinyl-1H-indole-1-sulfonamide 1d (DMAS), benzyl-3-
vinyl-1H-indole-1-carboxylate 1e and benzyl-5-methoxy-3-vinyl-
1H-indole-1-carboxylate 1f (Cbz) via appropriate protection of
1H-indole-3-carbaldehyde followed by reaction with methyl-
enetriphenyl-l5-phosphane as previously.
N,N-Dimethyl-3-vinyl-1H-indole-1-sulfonamide 1d was reac-
ted in DCM with 1H-pyrrole-2,5-dione, 1-methyl-1H-pyrrole-2,5-
dione, 1-phenyl-1H-pyrrole-2,5-dione and PTAD. Aer 48 hours
at 40 C for the maleimides, or 1 hour at 78 C for PTAD, the
D–A reactions were complete and in situ ene reactions with
nitrosobenzene, 1-methyl-2-nitrosobenzene, 1,3-dibromo-2-
nitrosobenzene23 or 2,3,4,5,6-pentauorobenzaldehyde (cata-
lysed by one equivalent of Me2AlCl) were carried out to give
69–77% isolated yields of the desired three-component D–A/ene
products 3(t–x) (Table 4). Cbz protected 3-vinyl-1H-indoles
1(e and f) also underwent D–A reactions with 1H-pyrrole-2,5-
dione, 1-methyl-1H-pyrrole-2,5-dione or PTAD followed by in
situ ene reactions with nitrosobenzene, 1-methyl-2-
nitrosobenzene or PTAD to give 54–82% yields of 3(y–ll)
(Table 4). The Cbz protected products 3(y–ll) were isolable by
silica gel chromatography but proved less stable than their
DMAS or Tos protected counterparts. NMR investigations of
these compounds showed evidence of decomposition in solu-
tion at r.t., however they could be stored as solids under an
Table 2 D–A reactions of ethyl (Z)-5-(1-tosyl-1H-indol-3-yl)pent-4-enoate 1b
Starting material Dienophile Reaction conditions R0 X Yielda Product
1 1b 2 eq. Me2AlCl, 78
C 30 min, then 40 C 48 h Me CH 85% 2c
2 1b 2 eq. Me2AlCl, 78
C 30 min, then 40 C 48 h H CH 64% 2db
3 1b 2 eq. Me2AlCl, 78
C 30 min, then 40 C 48 h Ph CH 71% 2e
a Isolated yields. b Structure conrmed by single crystal X-ray analysis.
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atmosphere of nitrogen at 20 C for months at a time. Inter-
estingly the ene reactions of 2,3,4,5,6-pentauorobenzaldehyde
with D–A cycloadducts 3(d, m, p and v) gave a mixture of diaste-
reomers at the exo-cyclic hydroxyl group, with ratios from 5 : 1 to
>25 : 1. The relative stereochemistry of 3v was conrmed through
the solution of a single crystal X-ray structure (see ESI†) and is
consistent with an endo-selective ene reaction, providing some
support for an ene mechanism in this reaction rather than a
nucleophilic attack of the D–A cycloadducts to the carbonyl
carbon of the aldehyde in themanner of an vinylogous enamine.37
Finally we investigated the deprotection of our D–A/ene
reaction products. Tosyl and DMAS protected compounds
3(a–x) proved intransient to a range of basic (NaOH, KOH or
KOEt in EtOH, MeOH or H2O with Bu4NBr) and reducing (Mg,
Mg/Hg or Na/Hg) deprotection conditions. We therefore
focused on the deprotection of Cbz protected compounds
3(y–ll). Initial attempts at Cbz removal with H2 and Pd/C proved
unsuccessful. Atmospheric pressure hydrogenation with
Adam's catalyst in either MeOH and EtOH resulted in the
removal of the Cbz group from 3z, however unexpected
Table 3 Ene reactions of N-tosyl protected cycloadducts 2(a–e)
Starting material R R0 X Enophile Reaction conditions R00 Yielda Product
1 2a H Me CH r.t., 18 h N(Ph)OH 68% 3a
2 2a H Me CH r.t., 18 h N(o-Tol)OH 72% 3b
3 2a H Me CH 0 C, 2.5 h 73% 3c
4 2a H Me CH
1 eq. Me2AlCl, 78
C,
15 min r.t., 18 h
CH(C6F5)OH 82% 3d
b
5 2b H Ph N r.t., 18 h N(Ph)OH 74% 3e
6 2b H Ph N r.t., 18 h N(o-Tol)OH 72% 3f
7 2c (CH2)2CO2Et Me CH r.t., 24 h N(o-Tol)OH 59% 3g
8 2e (CH2)2CO2Et Ph CH r.t., 24 h N(o-Tol)OH 58% 3h
9 2c (CH2)2CO2Et Me CH 0
C, 6 h 56% 3i
10 2d (CH2)2CO2Et H CH 0
C, 6 h 56% 3j
a Isolated yields. b Isolated as a 6 : 1 mixture of diastereomers.
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Table 4 One-pot D–A/ene reactions of N-protected 3-vinyl-1H-indoles
Starting
Material P R% R0 X Enophile R00 Reaction conditions Product Yielda
1 1a Tos H Me CH –N(Ph)OH (i) 40 C, 48 h, (ii) r.t., 18 h 3a 71%
2 1a Tos H Me CH –N(o-Tol)OH (i) 40 C, 48 h, (ii) r.t., 18 h 3b 71%
3 1a Tos H Me CH (i) 40 C, 48 h, (ii) 0 C, 4 h 3c 76%
4 1a Tos H Me CH –CH(C6F5)OH
(i) 40 C, 48 h, (ii) Me2AlCl,
78 C to r.t., 18 h
3d 72%b
5 1a Tos H Ph N –N(Ph)OH (i) 78 C, 4 h, (ii) r.t., 24 h 3e 66%
6 1a Tos H Ph N –N(o-Tol)OH (i) 78 C, 4 h, (ii) r.t., 24 h 3f 66%
7 1a Tos H H CH –N(Ph)OH (i) 40 C, 48 h, (ii) r.t., 4 h 3k 89%
8 1a Tos H H CH –N(o-Tol)OH (i) 40 C, 48 h, (ii) r.t., 4 h 3l 82%c
9 1a Tos H H CH –CH(C6F5)OH
(i) 40 C, 48 h, (ii) Me2AlCl,
0 C to r.t., 18 h
3m 71%d
10 1a Tos H H CH (i) 40 C, 48 h, (ii) 0 C, 4 h 3n 75%
11 1c Tos OMe H CH –N(o-Tol)OH (i) 40 C, 48 h, (ii) r.t., 24 h 3o 76%
12 1c Tos OMe Me CH –CH(C6F5)OH
(i) 40 C, 48 h, (ii) Me2AlCl,
78 C, 15 min then r.t., 18 h
3p 70%e
13 1c Tos OMe H CH (i) 40 C, 48 h, (ii) 0 C, 4 h 3q 72%
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Paper RSC Advances
Pu
bl
ish
ed
 o
n 
20
 Ja
nu
ar
y 
20
15
. D
ow
nl
oa
de
d 
by
 N
ew
ca
stl
e U
ni
ve
rs
ity
 o
n 
14
/0
4/
20
16
 1
5:
37
:5
3.
 
View Article Online
Table 4 (Contd. )
Starting
Material P R% R0 X Enophile R00 Reaction conditions Product Yielda
14 1a Tos H Ph N (i) 78 C, 4 h, (ii) 0 C, 4 h 3r 65%c
15 1c Tos OMe Ph N –N(o-Tol)OH
(i) 78 C then r.t. 23 h,
(ii) r.t., 23 h
3s 72%
16 1d DMAS H Me CH –N(o-Tol)OH (i) 40 C, 48 h, (ii) r.t., 3 h 3t 74%
17 1d DMAS H Ph CH
–N(2,4-
(Br)2C6H4)-
OH
(i) 40 C, 48 h, (ii) r.t., 18 h 3u 69%c
18 1d DMAS H Me CH –CH(C6F5)OH
(i) 40 C, 48 h, (ii) Me2AlCl,
78 C, 1 h
3v 77%c,f
19 1d DMAS H Ph N –N(o-Tol)OH (i) 78 C, 1 h, (ii) r.t., 4 h 3w 76%
20 1d DMAS H H CH –N(o-Tol)OH (i) 40 C, 48 h, (ii) r.t., 3 h 3x 77%
21 1e Cbz H Me CH –N(Ph)OH (i) 40 C, 24 h, (ii) r.t., 18 h 3y 74%
22 1e Cbz H Me CH –N(o-Tol)OH (i) 40 C, 24 h, (ii) r.t., 18 h 3z 78%
23 1e Cbz H Me CH
(i) 40 C, 24 h, (ii) 0 C,
1 h then r.t., 18 h
3aa 54%
24 1e Cbz H H CH –N(Ph)OH (i) 40 C, 24 h, (ii) r.t., 18 h 3bb 70%
25 1e Cbz H H CH –N(o-Tol)OH (i) 40 C, 24 h, (ii) r.t., 4 h 3cc 83%
26 1e Cbz H H CH (i) 40 C, 24 h, (ii) 0 C, 1 h 3dd 58%
16130 | RSC Adv., 2015, 5, 16125–16152 This journal is © The Royal Society of Chemistry 2015
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nucleophilic substitutions of the hydroxy(aryl)amino group
by MeOH or EtOH also occurred to give 4a and 4b respectively.
This gave the rst indication that the removal of the elec-
tronically stabilising N-protecting group perhaps unsurpris-
ingly lowers the activation energy barrier towards substitution
chemistry at the indolylic position.38–40 Replacement of the
alcoholic solvent with THF resulted in a cleaner deprotection
of Cbz protected indoles 3(y–ll) to give 4(c–p) in 38–91% yields.
However the products 4(c–p) showed some evidence of
decomposition in CDCl3 aer a few hours at r.t., with the
appearance of new peaks in the 1H NMR spectra. Therefore
NMR analysis of 4(c–p) was carried out in either d2-DCM or d6-
DMSO (depending on solubility) in which decomposition was
slowed, although the appearance of minor peaks in the 1H
NMR could still be observed over time. The deprotection of
indoles 3(y–ll) with H2 and Adam's catalyst in THF has allowed
us to successfully demonstrate a one-pot, three-component
approach to our target library of deprotected partially satu-
rated carbazoles and pyridazino[3,4-b]indoles, which will be
the focus of future investigations (Table 5).
Conclusions
In conclusion, we have developed a practically simple
three-component approach to Tos, DMAS and Cbz
protected partially saturated carbazoles and pyridazino[3,4-b]-
indoles, based on a one-pot D–A/ene reaction, including the
examination of a deprotection strategy of the Cbz
Table 4 (Contd. )
Starting
Material P R% R0 X Enophile R00 Reaction conditions Product Yielda
27 1e Cbz H Ph N –N(Ph)OH (i) 78 C, 5 h, (ii) r.t., 3 h 3ee 72%
28 1e Cbz H Ph N –N(o-Tol)OH (i) 78 C, 5 h, (ii) r.t., 18 h 3ff 68%
29 1f Cbz OMe Me CH –N(Ph)OH (i) 40 C, 18 h, (ii) r.t., 1.5 h 3gg 73%
30 1f Cbz OMe Me CH –N(o-Tol)OH (i) 40 C, 18 h, (ii) r.t., 3 h 3hh 74%
31 1f Cbz OMe H CH –N(Ph)OH (i) 40 C, 18 h, (ii) r.t., 2.5 h 3ii 79%
32 1f Cbz OMe H CH –N(o-Tol)OH (i) 40 C, 18 h, (ii) r.t., 3.5 h 3jj 76%
33 1f Cbz OMe Ph N –N(Ph)OH (i) 78 C, 1.5 h, (ii) r.t., 20 h 3kk 78%
34 1f Cbz OMe Ph N –N(o-Tol)OH (i) 78 C, 1.5 h, (ii) r.t., 24 h 3ll 82%
a Isolated yields. b 5 : 1 endo : exo. c Structure conrmed by single crystal X-ray analysis. d 25 : 1 endo : exo. e 10 : 1 endo : exo. f Only one
diastereomer observed.
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group. Current work is looking into controlling the reactivity
and biological activity of the nal products as well as investi-
gating enantioselective D–A/ene approaches for molecules of
this type.
Experimental
3-Vinyl-1H-indole
In a Schlenk ask, methyltriphenylphosphonium iodide (2.14 g,
5.3 mmol) was dissolved in dry THF (13 mL). The solution was
cooled to 78 C and nbutyllithium (2.9 mL, 4.6 mmol) was
added over 10 minutes. The yellow solution was warmed to 0 C
and was le to stir for 1 hour before being cooled to 78 C. In a
separate Schlenk ask, 1H-indole-3-carboxylate (0.67 g,
4.6 mmol) was dissolved in THF (7 mL) and to the solution
sodium bis(trimethylsilyl)amide (2.3 mL, 4.6 mmol) was added.
This solution was transferred into the rst Schlenk ask and the
red solution was allowed to stir at room temperature for 1 hour.
The reaction was poured into water (30 mL) and extracted with
ethyl acetate (2  20 mL). The combined organic layers were
dried over MgSO4, ltered and the solvent removed under pres-
sure to leave the crude product as yellow oil. The product was
puried using column chromatography (petrol (40/60)–diethyl
ether 7 : 3, column diameter ¼ 4 cm, silica ¼ 20 cm) to give
3-vinyl-1H-indole (0.636 g, 4.4 mmol, 95%) as a yellow powder.
Mp: 78.4–80.7 C; Rf: 0.76 (Pet(40/60)–EA, 1 : 1);
1H NMR
(300 MHz, CDCl3): dH 8.02 (1H, br s), 7.85–7.80 (1H, m),
7.32–7.28 (1H, m), 7.18 (1H, s), 7.18–7.09 (2H, m), 6.83 (1H, ddd,
J ¼ 17.7, 11.2, 0.5 Hz), 5.65 (1H, dd, J ¼ 17.7, 1.5 Hz), 5.11 (1H,
dd, J ¼ 11.2, 1.5 Hz); 13C NMR (101 MHz, CDCl3): d 136.8, 129.5,
125.7, 123.6, 122.6, 120.4, 120.2, 115.9, 111.4, 110.9; IR (neat):
nmax/cm
1 3660, 2981.
1a – 1-tosyl-3-vinyl-1H-indole
Into a Schlenk ask, was placed 1H-indole-3-carbaldehyde
(5.0 g, 34.5 mmol) and DCM (100 mL). The resulting stirred
solution was cooled to 0 C before triethylamine (12 mL,
86.2 mmol) was added dropwise via syringe. To the stirred
solution, p-toluenesulfonyl chloride (7.23 g, 37.9 mmol) in DCM
was added dropwise over a period of 20 minutes. The solution
was stirred at 0 C for a further one hour before warming to
room temperature over 18 hours. The solution was washed into
a separating funnel with DCM (20 mL) and washed with water
(2  100 mL) and brine (100 mL). The organic extracts were
dried over MgSO4, ltered and the solvent removed under
reduced pressure to give the crude product as a pale orange oil.
Table 5 Deprotection of 3(y, z, bb and cc)
Starting material R0 X R00 R00 Solvent Product Yielda
1 3z Me CH –N(o-Tol)OH H MeOH 4a 60%
2 3z Me CH –N(o-Tol)OH H EtOH 4b 24%
3 3y Me CH –N(Ph)OH H THF 4c 75%
4 3z Me CH –N(o-Tol)OH H THF 4d 87%
5 3aa Me CH H THF 4e 91%
6 3bb H CH –N(Ph)OH H THF 4f 41%
7 3cc H CH –N(o-Tol)OH H THF 4g 70%
8 3dd H CH H THF 4h 64%
9 3ee Ph N –N(Ph)OH H THF 4i 65%
10 3ff Ph N –N(o-Tol)OH H THF 4j 44%
11 3gg Me CH –N(Ph)OH OMe THF 4k 70%
12 3hh Me CH –N(o-Tol)OH OMe THF 4l 70%
13 3ii H CH –N(Ph)OH OMe THF 4m 60%
14 3jj H CH –N(o-Tol)OH OMe THF 4n 85%
15 3kk Ph N –N(Ph)OH OMe THF 4o 38%
16 3ll Ph N –N(o-Tol)OH OMe THF 4p 61%
a Isolated yields.
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The product was puried by recrystallisation from hot ethyl
acetate (150 mL) to give 1-tosyl-1H-indole-3-carbaldehyde
(8.38 g, 28 mmol, 82%) as orange crystals.
Mp: 145.3–148.8 C; Rf: 0.83 (Pet(40/60)–EA 1 : 4);
1H NMR
(300 MHz, CDCl3): dH 10.11 (1H, s), 8.29–8.26 (1H, m), 8.19–8.16
(1H, m), 8.16 (1H, s), 7.89–7.85 (1H, m), 7.78 (2H, d, J ¼ 8.4 Hz),
7.36–7.25 (2H, m), 7.22 (2H, d, J¼ 8.4 Hz), 2.29 (3H, s); 13C NMR
(101 MHz, CDCl3): d 185.3, 146.1, 136.2, 135.4, 134.1, 130.3,
130.2, 127.2, 127.1, 126.2, 124.9, 122.5, 122.2, 113.1, 21.5;
IR (neat): nmax/cm
1 3140, 1663; anal. calcd for C16H13NO3S: C,
64.20; H, 4.38; N, 4.68. Found: C, 63.97; H, 4.52; N, 4.72.
A Schlenk ask was charged with methyl-
triphenylphosphonium iodide (1.29 g, 3.2 mmol) dissolved in
dry THF (25mL) under a nitrogen atmosphere. The solution was
cooled to 78 C and nbutyllithium (1.81 mL, 2.97 mmol) was
added dropwise via syringe over 10 minutes. The solution was
warmed to 0 C and le to stir for 2 hours. In a separate Schlenk
ask, 1-tosylindoline-3-carbaldehyde (0.8 g, 2.7 mmol) was
dissolved in THF (5 mL). The indole solution was transferred via
cannula to the Schlenk ask containing the solution of meth-
yltriphenylphosphonium iodide and the solution was stirred for
18 hours. The reaction poured into water (50 mL) and extracted
with ether (3  40 mL). The organic layers were washed with
brine (20 mL), dried over MgSO4, ltered and the solvent was
removed under reduced pressure to leave the crude product as
an orange oil. The crude product was puried by column
chromatography (petrol (40/60)–ethyl acetate; 10 : 1, 2 cm
diameter column) to give 1-tosyl-3-vinyl-1H-indole (0.56 g,
3.9 mmol, 70%) as a pale yellow powder.
Mp: 90.3–94.6 C; Rf: 0.86 (Pet(40/60)–EA, 1 : 1);
1H NMR
(300 MHz, CDCl3): dH 7.93–7.90 (1H, m), 7.69 (2H, d, J¼ 8.4 Hz),
7.70–7.65 (1H, m), 7.53 (1H, s), 7.29–7.19 (2H, m), 7.29–7.17 (2H,
m), 7.15 (2H, d, J ¼ 8.4 Hz), 6.70 (1H, app ddd, J ¼ 17.9, 11.3,
0.7 Hz), 5.72 (dd, 1H, J¼ 17.9, 1.2 Hz), 5.28 (1H, dd, J¼ 11.3, 1.2
Hz), 2.26 (3H, s); 13C NMR (101 MHz, CDCl3): dC 145.1, 135.6,
135.2, 130.0, 129.1, 127.6, 126.9, 125.0, 124.2, 123.6, 121.0,
120.5, 115.4, 113.8, 21.7; IR (neat): nmax/cm
1 3119, 3072; anal.
calcd for C17H15NO2S: C, 68.66; H, 5.08; N, 4.71. Found: C,
68.70; H, 5.21; N, 4.61.
1b – ethyl (Z)-5-(1-tosyl-1H-indol-3-yl)pent-4-enoate
In a Schlenk ask, (4-ethoxy-4-oxobutyl) triphenylphosphonium
bromide (3.32 g, 7.26 mmol) was dissolved in dry THF (20 mL).
The solution was cooled to 78 C and sodium bis (trime-
thylsilyl) amide (1.00 M in THF, 8.58 mL, 8.58 mmol) was added
dropwise over 10 min. The mixture was warmed to 0 C and le
to stir. Aer 2 hours, 1-(toluene-4-sulfonyl)-1H-indol-3-
carboxaldehyde (2.00 g, 6.60 mmol) was dissolved in dry THF
(10 mL) in a separate round bottomed ask, and transferred via
cannula into the reaction solution. The reaction mixture was
stirred at room temperature and for 48 hours, quenched with
saturated NH4Cl(aq.) (30 mL), extracted with EtOAc (2 200 mL),
and the combined organic layers washed with brine, dried over
MgSO4 and ltered. The solvent was removed under reduced
pressure to give a crude product as orange oil. The product was
puried by column chromatography (petrol (40/60)–ethyl
acetate 10 : 1) to give two fractions the rst containing ethyl (Z)-
5-(1-tosyl-1H-indol-3-yl)pent-4-enoate (1.568 g, 3.94 mmol, 60%)
as a colourless oil, and a second fraction containing a 20 : 1
mixture of (Z) and (E) ethyl-5-(1-tosyl-1H-indol-3-yl)pent-4-
enoate (0.294 g, 0.739 mmol, 11%) also as a colourless oil.
Rf: 0.70 (Pet(40/60)–EA 7 : 3);
1H NMR (400 MHz, CDCl3): dH
7.97 (1H, d, J¼ 7.9 Hz, 1H), 7.77 (2H, d, J ¼ 7.8 Hz), 7.57 (1H, s),
7.49 (1H, d, J ¼ 7.9 Hz), 7.32 (1H, t, J ¼ 7.9 Hz), 7.25 (1H, t,
J ¼ 7.9 Hz), 7.20 (2H, d, J ¼ 7.8 Hz), 6.44 (1H, d, J ¼ 11.2 Hz),
5.78 (1H, dt, J ¼ 11.2, 7.5 Hz), 4.14 (2H, q, J ¼ 6.5 Hz), 2.67–2.62
(2H, m), 2.48 (2H, t, J ¼ 6.9 Hz), 2.30 (3H, s), 1.24 (3H, t, J ¼ 6.5
Hz); 13C NMR (100 MHz, CDCl3): dC 172.8, 145.1, 135.1, 134.6,
132.1, 130.8, 129.9, 126.8, 124.9, 123.6, 123.4, 119.5, 118.96,
113.6, 60.5, 34.1, 25.2, 21.6, 14.3; IR (neat): nmax/cm
1: 1727,
1597. MS (pNSI): 415.2 (100%, [M + NH4]
+), 398.1 (20%, [M +
H]+), 420.1 (10%, [M + Na]+); HRMS (pNSI): calcd C22H24NO4S [M
+ H]+: 398.14120; observed: 398.14120.
1c – 5-methoxy-1-tosyl-3-vinyl-1H-indole
To a stirred round bottomed ask was added 5-methoxy-1H-
indole-3-carbaldehyde (0.70 g, 4.00 mmol) and DCM (20 mL)
and the solution was cooled to 0 C. To the stirred solution was
added triethylamine (1.40 mL, 10.0 mmol) and the resulting
solution was stirred at 0 C for 1 hour. To the stirred solution
was added p-toluenesulfonyl chloride (0.84 g, 4.40 mmol) in
DCM (10 mL) and the solution was stirred at room temperature
for 18 hours. The reaction was poured into water (50 mL) and
extracted with DCM (3 20mL). The combined organic extracts
were dried over MgSO4, ltered and the solvent was removed
under reduced pressure to leave the crude product as a pale
orange solid. The product was puried using column chroma-
tography (petrol (40/60)–ether–DCM 2 : 1 : 1, column diameter
¼ 2 cm, silica ¼ 15 cm) to give 5-methoxy-1-tosyl-1H-indole-3-
carbaldehyde (1.14 g, 3.48 mmol, 87%) as a pale brown powder.
Mp: 126.1–128.4 C; Rf: 0.71 (Pet(40/60)–Et2O–DCM 2 : 1 : 1);
1H NMR (300 MHz, CDCl3): dH 10.07 (1H, s), 8.19 (1H, s),
7.86–7.83 (1H, m), 7.84 (2H, d, J ¼ 8.5 Hz), 7.72 (1H, d, J ¼ 2.6
Hz), 7.29 (2H, d, J ¼ 8.5 Hz), 7.02 (1H, dd, J ¼ 9.1, 2.6 Hz),
3.86 (3H, s), 2.38 (3H, s); 13C NMR (101 MHz, CDCl3): dC 185.6,
157.8, 146.2, 136.8, 134.4, 130.4, 129.8, 127.4, 127.2, 122.3,
116.2, 114.2, 104.1, 55.8, 21.8; IR (neat): nmax/cm
1 3128, 2832,
1671; anal. calcd for C17H15NO4S: C, 61.99; H, 4.59; N, 4.25.
Found: C, 61.77; H, 4.70; N, 4.29.
In a Schlenk ask, methyltriphenylphosphonium iodide
(1.35 g, 3.34 mmol) was dissolved in dry THF (30 mL). The
solution was cooled to 78 C and nBuLi (1.2 mL, 3.03 mmol)
was added over 5 minutes. The yellow solution was warmed to
0 C and was allowed to stir for 1 hour before being cooled to
78 C. To the stirred solution, 5-methoxy-1-tosyl-1H-indole-3-
carbaldehyde (1.00 g, 3.03 mmol) in DCM (10 mL) was added
and the solution was stirred at room temperature for 3 hours.
The reaction was poured into water (40 mL) and extracted with
ethyl acetate (3  20 mL). The combined organic layers were
dried over MgSO4, ltered and the solvent removed under
pressure to leave the crude product an orange oil. The product
was puried using column chromatography (petrol (40/60)–
This journal is © The Royal Society of Chemistry 2015 RSC Adv., 2015, 5, 16125–16152 | 16133
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ethyl acetate 2 : 1, column diameter ¼ 2 cm, silica ¼ 16 cm) to
give 5-methoxy-1-tosyl-3-vinyl-1H-indole (0.79 g, 2.42 mmol,
80%) as a brown powder.
Mp: 101.4–103.9 C; Rf: 0.66 (Pet(40/60)–EA 2 : 1);
1H NMR
(300 MHz, CDCl3): dH 7.87 (1H, d, J¼ 9.0 Hz), 7.73 (2H, d, J¼ 8.4
Hz), 7.55 (1H, s), 7.19 (2H, d, J¼ 8.3 Hz), 7.14 (1H, d, J¼ 2.5 Hz),
6.93 (1H, dd, J ¼ 9.0, 2.5 Hz), 6.72 (1H, dd, J ¼ 17.9, 11.3 Hz),
5.73 (1H, dd, J ¼ 17.9, 1.1 Hz), 5.32 (1H, dd, J ¼ 11.3, 1.1 Hz),
3.82 (3H, s), 2.31 (3H, s); 13C NMR (101 MHz, CDCl3): dC 156.7,
145.0, 135.1, 130.3, 130.1, 130.0, 127.6, 126.9, 124.9, 121.1,
115.2, 114.7, 113.7, 103.2, 55.8, 21.7; IR (neat): nmax/cm
1 3128,
2832, 1671; MS (pNSI): 328.1 (100%, (M + H)+), 350.1 (15%, (M +
Na)+), 672.2 (2M + NH4)
+; HRMS (pNSI): calcd for C18H18NO3S
[M + H]+: 328.1002; observed: 328.1007.
1d – N,N-dimethyl-3-vinyl-1H-indole-1-sulfonamide
To a stirred round bottomed ask was added 1H-indole-3-
carbaldehyde (3.0 g, 20.7 mmol) and THF (70 mL) and the
solution was cooled to 0 C. To the stirred solution was added
sodium hydride (1.7 g, 41.4 mmol) in THF (30 mL) and the
resulting solution was stirred at 0 C for 1 hour. To the stirred
solution was added dimethylsulfamoyl chloride (2.4 mL,
20.7 mmol) and the solution was stirred at room temperature
for 18 hours. The reaction was poured into water (100 mL) and
extracted with DCM (3 60mL). The combined organic extracts
were dried over MgSO4, ltered and the solvent was removed
under reduced pressure to leave the crude product as a pale red
pink solid. The product was puried by recrystallization from
ethyl acetate to give 3-formyl-N,N-dimethyl-1H-indole-1-
sulfonamide (97%, 5.07 g, 20.1 mmol) as a pink powder.
Mp: 149.0–150.9 C; Rf: 0.63 (Pet(40/60)–EA, 1 : 1);
1H NMR
(300 MHz, CDCl3): dH 10.08 (1H, s), 8.31 (1H, app dd, J¼ 7.2, 1.4
Hz), 8.09 (1H, s), 7.94–7.88 (1H, m), 7.40 (2H, app ddd, J ¼ 5.9,
3.3, 1.6 Hz), 2.91 (6H, s); 13C NMR (101 MHz, CDCl3): dC 185.5,
137.3, 136.0, 126.1, 125.9, 124.9, 122.6, 120.8, 113.6, 38.6; IR
(neat): nmax/cm
1 3124, 2945, 1662; anal. calcd for C11H12N2O3S:
C, 52.37; H, 4.79; N, 11.10. Found: C, 52.23; H, 4.91; N, 10.92.
In a Schlenk ask, methyltriphenylphosphonium iodide
(7.00 g, 17.4 mmol) was dissolved in dry THF (75 mL). The
solution was cooled to 78 C and nBuLi (6.4 mL, 15.9 mmol)
was added over 10 minutes. The yellow solution was warmed to
0 C and was le to stir for 1 hour before being cooled to78 C.
To the stirred solution, 3-formyl-N,N-dimethyl-1H-indole-1-
sulfonamide (4.00 g, 15.9 mmol) was added and the solution
was stirred at room temperature for 3 hours. The reaction was
poured into water (70 mL) and extracted with ethyl acetate
(3  50 mL). The combined organic layers were dried over
MgSO4, ltered and the solvent removed under pressure to leave
the crude product as yellow oil. The product was puried using
column chromatography (petrol (40/60)–diethyl ether 4 : 1,
column diameter¼ 3 cm, silica¼ 14 cm) to giveN,N-dimethyl-3-
vinyl-1H-indole-1-sulfonamide (3.11 g, 12.4 mmol, 78%) as a
pale orange powder.
Mp: 68.7–67.8 C; Rf: 0.63 (Pet(40/60)–EA 2 : 1);
1H NMR
(300 MHz, CDCl3): dH 7.98 (1H, dd, J¼ 8.0, 1.4 Hz), 7.85 (1H, dd,
J¼ 7.7, 1.5 Hz), 7.35 (2H, app ddd, J¼ 7.0, 5.3, 1.6 Hz), 6.83 (1H,
dd, J ¼ 17.8, 11.2 Hz), 5.84 (1H, dd, J ¼ 17.8, 1.2 Hz), 5.38 (1H,
dd, J¼ 11.3, 1.2 Hz), 2.86 (6H, s); 13C NMR (101 MHz, CDCl3): dC
136.1, 128.2, 127.8, 125.2, 124.7, 123.1, 120.4, 118.8, 114.9,
114.0, 38.6; IR (neat): nmax/cm
1 3123, 2945; anal. calcd for
C12H14N2O2S: C, 57.58; H, 5.64; N, 11.19. Found: C, 57.68; H,
5.75; N, 11.05.
1e – benzyl-3-vinyl-1H-indole-1-carboxylate
To a solution of 1H-indole-3-carbaldehyde (1.0 g, 6.9 mmol) in
DCM (20 mL) at 0 C was added triethylamine (1.8 mL,
17.3 mmol) dropwise. The solution was stirred at room
temperature for 1 hour before benzyl chloroformate (1.4 mL,
8.3mmol) was added. The solution was stirred for 18 hours aer
which it was poured into water and extracted with DCM (3  20
mL). The organic fractions were combined, dried with MgSO4,
ltered and the solvent was removed under reduced pressure to
give the crude product as an orange powder. The crude product
was puried by column chromatography (column diameter ¼
2.5 cm, eluent¼ petrol (40/60)–ethyl acetate 2 : 1) to give benzyl-
3-formyl-1H-indole-1-carboxylate (1.74 g, 6.35 mmol, 92%) as a
pale orange powder.
Mp: 91–92 C; Rf: 0.68 (Pet–EA, 2 : 1);
1H NMR (300 MHz,
CDCl3): dH 10.06 (1H, s), 8.30–8.25 (1H, m), 8.23 (1H, s),
8.17 (1H, d, J ¼ 8.0 Hz), 7.50 (2H, app dd, J ¼ 7.7, 1.8 Hz),
7.42 (3H, app ddd, J ¼ 6.6, 5.1, 1.5 Hz), 7.38 (1H, app t, J ¼ 1.6
Hz), 7.37–7.34 (1H, m), 5.49 (2H, s); 13C NMR (101 MHz, CDCl3):
dC 185.8, 150.2, 136.1, 136.1, 134.3, 129.3, 129.0, 128.9, 126.5,
126.1, 125.0, 122.3, 122.3, 115.2, 69.9; IR (neat): nmax/cm
1 3127,
3008, 1733; MS (pNSI): 280.1 (100%, (M + H)+), 302.1 (96%, (M +
Na)+), 581.2 (25%, (2M + Na)+); HRMS (pNSI): calcd for
C17H14NO3 [M + H]
+: 280.0968; observed: 280.0970.
To a stirred Schlenk ask, methylenetriphenylphosphorane
(2.38 g, 5.90 mmol) was dissolved in dry THF (30 mL). The
solution was cooled to 78 C and nBuLi (2.15 mL, 5.35 mmol)
was added over 10 minutes. The yellow solution was warmed to
0 C and was le to stir for 1 hour before being cooled to 78
C. To the stirred solution, benzyl 3-formyl-1H-indole-1-
carboxylate (1.50 g, 5.35 mmol) was added and the solution
was stirred at room temperature for 3 hours. The reaction was
poured into water (50 mL) and extracted with ethyl acetate
(3  40 mL). The combined organic layers were dried with
MgSO4, ltered and the solvent removed under pressure to
leave the crude product as yellow oil. The product was puried
using column chromatography (petrol (40/60)–ethyl acetate
2 : 1, column diameter¼ 2 cm, silica ¼ 15 cm) to give benzyl-3-
vinyl-1H-indole-1-carboxylate (1.14 g, 4.07 mmol, 76%) as a
yellow powder.
Mp: 43–45 C; Rf: 0.73 (Pet(40/60)–EA, 2 : 1);
1H NMR
(300 MHz, CDCl3): dH 8.33 (1H, d, J ¼ 7.1 Hz), 7.91–7.86 (1H,
m), 7.74 (1H, s), 7.58–7.55 (2H, m), 7.52–7.44 (4H, m),
7.43–7.36 (1H, m), 6.87 (1H, dd, J ¼ 17.8, 11.3 Hz), 5.96–5.87
(1H, d, J ¼ 17.8 Hz), 5.51 (2H, s), 5.44 (1H, d, J ¼ 11.3 Hz); 13C
NMR (101 MHz, CDCl3): dC 150.8, 135.1, 128.9, 128.9, 128.8,
128.6, 128.4, 128.0, 125.1, 123.6, 123.4, 120.2, 120.2, 115.5,
115.0, 68.9; IR (neat): nmax/cm
1 3153, 2962, 1729; MS
(pAPCI): 181.1 (50%), 260.1 (100%), 278.1 (25%, (M + H)+);
16134 | RSC Adv., 2015, 5, 16125–16152 This journal is © The Royal Society of Chemistry 2015
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HRMS (pAPCI): calcd for C18H16NO2 [M + H]
+: 278.1176;
observed: 278.1173.
1f – benzyl-5-methoxy-3-vinyl-1H-indole-1-carboxylate
To a stirred Schlenk ask, methylenetriphenylphosphorane
(3.54 g, 8.70 mmol) was dissolved in dry THF (34 mL). The
solution was cooled to 78 C and nBuLi (3.1 mL, 7.87 mmol)
was added over 10 minutes. The yellow solution was warmed
to 0 C and was le to stir for 1 hour before being cooled to
78 C. In a separate Schlenk ask, 5-methoxy-1H-indole-3-
carbaldehyde (1.38 g, 7.87 mmol) was dissolved in THF
(10 mL) and to the solution sodium bis(trimethylsilyl)amide
(7.87 mL, 7.87 mmol) was added. This solution was trans-
ferred into the rst Schlenk ask and the red solution was
allowed to stir at room temperature for 1 hour. The reaction
was poured into water (50 mL) and extracted with ethyl
acetate (2  30 mL). The combined organic layers were dried
with MgSO4, ltered and the solvent removed under pressure
to leave the crude product as yellow oil. The product was
puried using column chromatography (petrol (40/60)–
diethyl ether 2 : 1, column diameter ¼ 2.5 cm, silica ¼ 16 cm)
to give 5-methoxy-3-vinyl-1H-indole (1.38 g, 7.6 mmol, 97%)
as a yellow powder.
Mp: 190–193 C; Rf: 0.49 (Pet–Et2O, 2 : 1);
1H NMR
(300 MHz, CDCl3): dH 8.28 (1H, s), 7.66 (1H, d, J ¼ 2.4 Hz),
7.29 (1H, d, J ¼ 8.8 Hz), 7.24 (1H, d, J ¼ 2.7 Hz), 7.20–7.10 (2H,
m), 7.18 (1H, d, J ¼ 2.5 Hz), 7.15 (2H, dd, J ¼ 4.5, 2.1 Hz),
7.10 (1H, s), 5.95 (1H, dd, J ¼ 17.8, 1.5 Hz), 5.46 (1H, dd,
J ¼ 11.2, 1.5 Hz), 4.07 (3H, s); 13C NMR (101 MHz, CDCl3): dC
154.4, 132.5, 130.8, 126.4, 126.1, 114.2, 113.0, 112.0, 109.1,
102.0, 55.9; IR (neat): nmax/cm
1 3410, 2925, 2836; MS (pNSI):
174.1 (100%, (M + H)+), 520.3 (100%, (3M + H)+); HRMS (pNSI):
calcd for C11H12NO [M + H]
+: 174.0913; observed: 174.0912.
To a stirred Schlenk ask, 5-methoxy-3-vinyl-1H-indole
(1.15 g, 6.61 mmol) was dissolved in THF (30 mL) and the
solution was cooled to 0 C. To the stirred solution, sodium
bis(trimethylsilyl)amide (7.27 mL, 7.27 mmol) was added and
the solution was stirred for 30 minutes before benzyl chlor-
oformate (0.90 mL, 6.61 mmol) was added. The solution was
stirred for 30 minutes at room temperature before being added
to water (50 mL) and extracted with ethyl acetate (3  30 mL).
The combined organic washings were dried with MgSO4,
ltered and the solvent was removed under reduced pressure to
give the crude product as an orange oil. The product was puri-
ed using column chromatography (petrol (40/60)–ethyl acetate
5 : 1, column diameter ¼ 2.0 cm, silica ¼ 15 cm) to give benzyl-
5-methoxy-3-vinyl-1H-indole-1-carboxylate (1.78 g, 4.7 mmol,
71%) as a pale yellow oil.
Rf: 0.82 (Pet(40/60)–EA, 5 : 1);
1H NMR (400 MHz), dH 8.09
(1H, s), 7.66 (1H, s), 7.50 (2H, d, J ¼ 7.2 Hz), 7.45–4.37 (1H,
m), 7.25 (1H, d, J ¼ 2.5 Hz), 6.96 (1H, dd, J ¼ 9.0, 2.2 Hz),
6.79 (1H, dd, J ¼ 17.8, 11.4 Hz), 5.80 (1H, d, J ¼ 17.8 Hz), 5.42
(2H, s), 5.34 (1H, d, J ¼ 11.4 Hz), 3.85 (3H, s); 13C NMR (101
MHz, CDCl3): dC 156.4, 135.2, 129.7, 128.9, 128.9, 128.7,
128.6, 128.0, 124.1, 124.1, 120.0, 116.1, 114.8, 113.3, 103.3,
68.8, 55.8; IR (neat): nmax/cm
1 2955, 2834, 1726; MS (pAPCI):
181.1 (32%), 260.1 (100%), 308.1 (28%, (M + H)+); HRMS
(pAPCI): calcd for C19H18NO3 [M + H]
+: 308.1281; observed:
308.1277.
2a – (3aS*,10bS*)-2-methyl-10-tosyl-4,10,10a,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione
Into a round bottomed ask, 1-tosyl-3-vinyl-1H-indole (2.0 g,
6.7 mmol) and DCM (10 mL) was added. To the stirred
solution, N-methylmalemide (0.75 g, 6.7 mmol) was added
and the solution was stirred at 40 C for 48 hours. The solvent
was removed under reduced pressure to leave the crude
product as orange oil. The product was puried by column
chromatography (petrol (40/60)–ethyl acetate, 4 : 1, column
diameter ¼ 4 cm, silica ¼ 15 cm) to give (3aS*,10bS*)-2-
methyl-10-tosyl-4,10,10a,10b-tetrahydropyrrolo[3,4-a]carba-
zole-1,3(2H,3aH)-dione (2.01 g, 5.0 mmol, 76%) as a white
powder.
Mp: 204.2–208.0 C; Rf: 0.09 (Pet(40/60)–EA, 1 : 1);
1H NMR
(300 MHz, CDCl3): dH 7.72 (2H, d, J ¼ 8.0 Hz), 7.61 (1H, d,
J ¼ 8.5 Hz), 7.21–7.19 (2H, d, J ¼ 8.0), 7.21–7.16 (1H, m),
6.92 (1H, app t, J ¼ 7.5 Hz), 6.01–5.96 (1H, m), 4.47 (1H, dd,
J ¼ 7.0, 3.3 Hz), 3.99 (1H, app t, J ¼ 8.1 Hz), 3.12 (1H, app t,
J ¼ 8.1 Hz), 2.99–2.92 (1H, m), 2.76 (3H, s), 2.30 (3H, s), 2.11
(1H, ddd, J ¼ 18.0, 6.4, 2.4 Hz); 13C NMR (101 MHz, CDCl3): dC
178.9, 174.2, 144.7, 144.6, 137.4, 134.3, 130.4, 129.9, 127.5,
126.4, 123.9, 121.0, 115.4, 112.9, 61.6, 43.3, 37.2, 25.3, 25.1,
21.7; IR (neat): nmax/cm
1 2981, 2889, 1694; MS (pNSI):
409.2 (61%, (M + H)+), 426.1 (100%, (M + (NH4))
+), 834.3 (52%,
(2M + (NH4))
+); HRMS (pNSI): calcd C22H21N2O4S [M + H]
+:
409.1217; observed: 409.1218.
2b – 2-phenyl-11-tosyl-11,11a-dihydro-1H,5H-[1,2,4]triazolo
[10,20:1,2]pyridazino[3,4-b]indole-1,3(2H)-dione
To a stirred round bottomed ask was added 1-tosyl-3-vinyl-1H-
indole (100 mg, 0.34 mmol) and DCM (7 mL) and the solution
was cooled to 78 C. To the stirred solution was added
4-phenyl-3H-1,2,4-triazole-3,5(4H)-dione (60 mg, 0.34 mmol)
and the resulting solution was stirred at 78 C for 3.5 hours
before the solvent was removed under reduced pressure to leave
the crude product as a pale red solid. The product was puried
by column chromatography (petrol (40/60)–ether–DCM 2 : 1 : 1,
column diameter ¼ 1 cm, silica ¼ 20 cm) to give 2-phenyl-11-
tosyl-11,11a-dihydro-1H,5H-[1,2,4]triazolo[10,20:1,2]pyridazino-
[3,4-b]indole-1,3(2H)-dione (88%, 140 mg, 0.30 mmol) as a pale
red powder.
Mp: 160.1–162.8 C; Rf: 0.14 (Pet(40/60)–Et2O–DCM
2 : 1 : 1); 1HNMR (300 MHz, CDCl3): dH 7.86 (2H, d, J¼ 8.4 Hz),
7.63–7.55 (2H, m), 7.51–7.46 (2H, m), 7.46–7.42 (1H, m),
7.42–7.39 (1H, m), 7.38–7.34 (2H, m), 7.26–7.22 (2H, m),
7.09 (1H, app td, J ¼ 7.5, 1.0 Hz), 6.26 (1H, td, J ¼ 2.6, 1.8 Hz),
6.18 (1H, app dt, J ¼ 5.3, 2.7 Hz), 4.56–4.46 (1H, app td,
J ¼ 17.6, 2.8 Hz), 4.39 (1H, ddd, J ¼ 17.6, 5.2, 1.9 Hz), 2.37 (3H,
s); 13C NMR (75 MHz, CDCl3): dC 152.7, 150.8, 144.7, 143.7,
135.6, 134.8, 131.5, 130.4, 129.6, 128.9, 128.5, 128.1, 126.8,
125.7, 125.2, 120.9, 117.4, 113.8, 74.8, 44.6, 21.4; IR (neat):
nmax/cm
1 3070, 2926, 1719; MS (pNSI): 473.1 (100%, (M + H)+),
This journal is © The Royal Society of Chemistry 2015 RSC Adv., 2015, 5, 16125–16152 | 16135
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522.2 (30%); HRMS (pNSI): calcd for C25H21N4O4S [M + H]
+:
473.1278; observed: 473.1277.
2c – ethyl-3-((3aS*,4R*,10bS*)-2-methyl-1,3-dioxo-10-tosyl-
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)
propanoate
Dimethylaluminum chloride (1.0 M in hexane, 9.38 ml,
9.38 mmol) was added dropwise to a solution of N-methyl-
maleimide (0.521 g, 4.69 mmol) in dry DCM (15 mL) at 78 C.
The mixture le to stir for 30 min. A solution of ethyl-(Z)-5-(1-
tosyl-1H-indol-3-yl) pent-4-enoate (4.69 mmol, 1.863 g) in dry
DCM (15 mL) was added dropwise at 78 C. The reaction
mixture was then warmed to reux for 48 hours and quenched
with saturated NaHCO3(aq.) (20 mL) and extracted with DCM
(2  100 mL). The combined organic layers were washed with
brine, dried over MgSO4 and ltered. The solvent was removed
under reduced pressure to give the crude yellow solid. The
product was puried by column chromatography (petrol (40/60)–
ethyl acetate 2 : 1) to yield ethyl 3-((3aS*,4R*,10bS*)-2-methyl-
1,3-dioxo-10-tosyl-1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]-
carbazol-4-yl)propanoate in (2.038 g, 4.01 mmol, 85%) a bright
yellow solid.
Mp: 187–188 C; Rf: 0.3 (Pet(40/60)–EA 2 : 1);
1H NMR
(400 MHz, CDCl3): dH 7.79 (2H, d, J ¼ 7.3 Hz), 7.62 (1H, d,
J ¼ 7.0 Hz), 7.25–7.21 (4H, m), 6.95 (1H, t, J ¼ 7.0 Hz), 6.09 (1H,
dd, J ¼ 3.7, 6.7 Hz), 4.85 (1H, dd, J ¼ 3.7, 6.9 Hz), 4.15 (1H, t,
J ¼ 6.9 Hz), 4.07 (2H, m), 3.15–3.12 (1H, m), 3.05–3.02 (1H, m),
2.83 (3H, s), 2.43–2.36 (2H, m), 2.35 (3H, s), 1.91–1.75 (2H, m),
1.19 (3H, t, J ¼ 7.3 Hz); 13C NMR (101 MHz, CDCl3): dC 178.6,
174.0, 172.79, 144.6, 144.0, 136.6, 134.0, 130.5, 130.0, 127.5,
126.6, 123.9, 121.0, 116.3, 115.4, 60.6, 59.9, 44.22, 42.98, 37.2,
33.1, 28.3, 25.3, 21.70, 14.3; IR (neat): nmax/cm
1: 1776, 1698;
HRMS (pNSI): calcd C27H29N2O6S [M + H]
+: 509.1741;
observed: 509.1731.
2d – ethyl-3-((3aS*,4R*,10bS*)-1,3-dioxo-10-tosyl-
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)
propanoate
Dimethyl aluminum chloride (1.0 M in hexane, 2.86 mL,
2.86 mmol) was added dropwise to a solution of N-maleimide
(0.14 g, 1.43 mmol) in dry DCM (5 mL) at 78 C. The mixture
le to stir for 30 min. A solution of ethyl-(Z)-5-(1-tosyl-1H-indol-
3-yl)-pent-4-enoate (0.57 g, 1.43 mmol) in dry DCM (10 mL) was
added. The reactionmixture was slowly heated to reux for 48 h,
quenched with saturated NaHCO3(aq.) (5 mL). The organic layer
was extracted with DCM (1  100 mL), washed with brine, dried
over MgSO4 and ltered. The solvent was removed under
reduced pressure to give the crude yellow solid product which
was puried by column chromatography (petrol (40/60)–ethyl
acetate 2 : 1 gradient to 1 : 1 petrol–ethyl acetate) to yield ethyl 3-
((3aS*,4R*,10bS*)-1,3-dioxo-10-tosyl-1,2,3,3a,4,10,10a,10b-octa-
hydropyrrolo[3,4-a]carbazol-4-yl)propanoate in (0.452 g, 0.91
mmol, 64%) as a white solid.
Mp: 218–220 C; Rf: 0.14 (Pet(40/60)–EA 1 : 1);
1H NMR
(400 MHz, CDCl3): dH 7.78 (2H, d, J¼ 6.9 Hz), 7.64 (1H, d, J¼ 6.8
Hz), 7.27–7.22 (4H, m), 6.98 (1H, t, J ¼ 7.8 Hz), 6.16 (1H, dd,
J ¼ 3.6, 7.1 Hz), 4.84 (1H, dd, J ¼ 3.6, 7.3 Hz), 4.18 (1H, t, J ¼ 7.3
Hz), 4.12–4.05 (2H, m), 3.16–1.12 (1H, m), 3.10 (1H, t, J ¼ 7.3
Hz), 2.40 (2H, t, J ¼ 7.3 Hz), 2.35 (3H, s), 1.89–1.76 (2H, m),
1.20 (3H, t, J ¼ 7.5 Hz). 13C NMR (101 MHz, CDCl3): dC 178.3,
173.6, 172.7, 144.5, 144.1, 136.6, 133.8, 130.5, 129.8, 127.5,
126.6, 123.8, 120.0, 116.4, 115.5, 60.8, 59.6, 45.2, 44.0, 36.9, 33.0,
27.8, 21.5, 14.1; IR (neat): nmax/cm
1: 3657, 2981, 1776, 1703; MS
(pNSI): 512.18 (100%, [M + NH4]
+), 495.15 (55%, [M + H]+),
340.14 (31%, [M  Ts]); HRMS (pNSI): calcd C26H27N2O6S [M +
H]+: 495.1584; observed: 495.1585.
2e – ethyl 3-((3aS*,4R*,10bS*)-1,3-dioxo-2-phenyl-10-tosyl-
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)
propanoate
Dimethyl aluminum chloride (1.0M in THF, 2.39mL, 2.39mmol)
was added dropwise to a solution of N-phenylmaleimide (0.207 g,
1.19 mmol) in dry DCM (5 mL) at 78 C. The mixture le to stir
for 30 min. A solution of ethyl (Z)-5-(1-tosyl-1H-indol-3-yl) pent-4-
enoate (0.475 g, 1.19 mmol) in dry DCM (10 mL) was added. The
reaction mixture was heated to reux for 48 h, quenched with
saturated NaHCO3(aq.) (10 mL) and extracted with DCM (100 mL).
The organic layer was washed with brine, dried over MgSO4 and
ltered. The solvent was removed under reduced pressure to give
the crude yellow solid product which was puried by column
chromatography (petrol (40/60)–ethyl acetate 2 : 1) to yield ethyl
3-((3aS*,4R*,10bS*)-1,3-dioxo-2-phenyl-10-tosyl-1,2,3,3a,4,10,10a,
10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate in (0.5095 g,
0.84 mmol, 71%) as a white solid.
Mp: 201–203 C; Rf: 0.2 (Pet(40/60)–EA 2 : 1);
1H NMR
(400 MHz, CDCl3): dH 7.81 (2H, d, J¼ 7.3 Hz), 7.60 (1H, d, J¼ 7.3
Hz), 7.34–7.21 (7H, m), 7.06 (2H, d, J ¼ 7.3 Hz), 6.97 (1H, t,
J ¼ 7.3 Hz), 6.20 (1H, dd, J ¼ 3.4, 7.1 Hz), 4.59 (1H, dd, J ¼ 3.4,
7.1 Hz), 4.18 (1H, t, J¼ 7.3 Hz), 4.13–4.05 (2H, m), 3.26–3.20 (2H,
m), 2.45–2.40 (2H, m), 2.35 (3H, s), 1.89–1.85 (2H, m), 1.20 (3H,
t, J¼ 6.9 Hz); 13C NMR (101 MHz, CDCl3): dC 177.5, 172.9, 172.7,
144.6, 144.3, 137.0, 134.1, 131.7, 130.7, 130.0, 129.0, 128.5,
127.6, 126.7, 126.3, 124.0, 120.9, 116.2, 115.5, 60.8, 60.0, 44.3,
43.1, 37.7, 33.2, 28.3, 21.6, 14.2; IR (neat): nmax/cm
1: 1776,
1703; MS (pNSI): 588.21 (100%, [M + NH4]
+), 1158.39 (33%, [2M
+ NH4]
+); HRMS (pNSI): calcd C32H31N2O6S [M + H]
+: 571.18;
observed: 571.1891.
3a – (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-2-methyl-10-
tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione
To a stirred round bottomed ask was added 1-tosyl-3-vinyl-1H-
indole (100 mg, 0.34 mmol), DCM (5 mL) and 1-methyl-1H-
pyrrole-2,5-dione (38 mg, 0.34 mmol). The resulting solution
was heated at reux for 48 hours. The reaction was allowed to
cool to room temperature, nitrosobenzene (40 mg, 0.34 mmol)
was added, and the solution was stirred at room temperature for
18 hours. The solvent was removed under reduced pressure to
leave the crude product as a pale yellow solid which was puried
by column chromatography (petrol (40/60)–ethyl acetate 4 : 1,
column diameter ¼ 1 cm, silica ¼ 16 cm) to give
(3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-2-methyl-10-tosyl-
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4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione
as a yellow powder (71%, 128 mg, 0.24 mmol).
Mp: 196.8–199.5 C; Rf: 0.64 (Pet(40/60)–EA, 1 : 1);
1H NMR
(500MHz, CD2Cl2): dH 7.94 (1H, d, J¼ 8.4 Hz), 7.69 (2H, d, J¼ 8.2
Hz), 7.60 (1H, d, J¼ 7.9 Hz), 7.32–7.25 (3H,m), 7.23 (2H, d, J¼ 8.2
Hz), 7.18–7.13 (3H,m), 7.02 (1H, t, J¼ 7.3 Hz), 5.06 (1H, d, J¼ 8.0
Hz), 4.75 (1H, app. t, J ¼ 5.9 Hz), 4.72 (1H, s), 3.64 (1H, app q, J¼
7.2 Hz), 2.95 (3H, s), 2.43 (1H, app dt, J ¼ 13.6, 6.4 Hz), 2.35 (3H,
s), 2.06 (1H, ddd, J ¼ 13.6, 7.2, 4.9); 13C NMR (101 MHz, CD2Cl2):
dC 178.1, 173.6, 150.7, 145.3, 137.5, 134.9, 131.4, 129.7, 128.9,
128.9, 126.8, 125.2, 124.2, 122.6, 121.7, 120.2, 117.2, 115.4, 58.0,
40.5, 39.5, 25.0, 23.3, 21.4; IR (neat): nmax/cm
1 3661, 2990, 2886,
1690; MS (pNSI): 407.1 (66%, (M (C6H5NOH))
+), 516.2 (49%, (M
+ H)+), 533.2 (100%, (M + NH4)
+), 1031.3 (57%, (2M + H)+), 1053.3
(13%, (2M + Na)+); HRMS (pNSI): calcd for C28H26N3O5S [M + H]
+:
516.1588; observed: 516.1584.
Note: 1H NMR run at 35 C, broad signals observed at room
temperature.
3b – (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-2-methyl-10-
tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione
To a stirred round bottomed ask was added 1-tosyl-3-vinyl-1H-
indole (100 mg, 0.34 mmol), DCM (5 mL) and 1-methyl-1H-
pyrrole-2,5-dione (38 mg, 0.34 mmol). The resulting solution
was heated at reux for 48 hours. The reaction was allowed to
cool to room temperature, 1-methyl-2-nitrosobenzene (42 mg,
0.17 mmol) was added and the solution was stirred at room
temperature for 18 hours. The solvent was removed under
reduced pressure to leave the crude product as a pale yellow
solid. The product was puried by column chromatography
(petrol (40/60)–ethyl acetate 4 : 1, column diameter ¼ 1 cm,
silica ¼ 14 cm) to give (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)
amino)-2-methyl-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]-
carbazole-1,3(2H,3aH)-dione (71%, 128 mg, 0.24 mmol) as a
yellow powder.
Mp: 193.0–196.7 C; Rf: 0.59 (Pet(40/60)–EA 1 : 1);
1H NMR
(400MHz, CD2Cl2): dH 7.89 (1H, d, J¼ 8.3 Hz), 7.65 (2H, d, J¼ 8.4
Hz), 7.40 (1H, d, J ¼ 7.9 Hz), 7.28 (1H, d, J ¼ 7.7 Hz), 7.21–7.18
(3H, m), 7.13–6.99 (4H, m), 5.04 (1H, d, J ¼ 8.1 Hz), 4.87 (1H, s),
4.27 (1H, app t, J¼ 5.4 Hz), 3.73 (1H, app td, J¼ 8.0, 6.1 Hz), 2.91
(3H, s), 2.58 (1H, app dt, J ¼ 12.9, 6.2 Hz), 2.32 (3H, s), 2.25 (3H,
s), 1.95 (1H, ddd, J ¼ 12.9, 7.8, 4.5 Hz); 13C NMR (101 MHz,
CD2Cl2): dC 178.2, 173.6, 149.3, 145.3, 137.3, 134.9, 131.6, 130.9,
129.7, 129.7, 129.2, 126.8, 126.2, 125.0, 124.9, 124.1, 121.4, 120.5,
115.3, 57.3, 40.6, 39.4, 25.0, 24.6, 21.4, 18.3; IR (neat): nmax/cm
1
3662, 2990, 2886, 1701; MS (pNSI): 407.1 (98%, (M  ((o-CH3) 
C6H4NOH))
+), 530.2 (52%, (M + H)+), 547.2 (65%, (M + NH4)
+),
1059.3 (100%, (2M + H)+); HRMS (pNSI): calcd for C29H28N3O5S
[M + H]+: 530.1744; observed: 530.1743.
3c – (3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-
1-yl)-2-methyl-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]
carbazole-1,3(2H,3aH)-dione
To a stirred round bottomed ask was added 1-tosyl-3-vinyl-1H-
indole (100 mg, 0.34 mmol), DCM (5 mL) and 1-methyl-1H-
pyrrole-2,5-dione (38 mg, 0.34 mmol) and the resulting solution
was heated at reux for 48 hours. The reaction was cooled to
0 C before PTAD (60 mg, 0.34 mmol) was added. The reaction
was stirred at 0 C for 4 hours. The solvent was removed under
reduced pressure to leave the crude product as a pale red
powder. The product was puried by column chromatography
(petrol (40/60)–ethyl acetate 4 : 1, column diameter ¼ 1 cm,
silica ¼ 14 cm) to give (3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-
1,2,4-triazolidin-1-yl)-2-methyl-10-tosyl-4,5,10,10b-tetrahydro-
pyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (76%, 150 mg, 0.26
mmol) as a white powder.
Mp: 183.4–187.7 C; Rf: 0.05 (Pet(40/60)–EA 1 : 1);
1H NMR
(400 MHz, CDCl3): dH 7.84 (2H, d, J¼ 8.4 Hz), 7.67 (1H, d, J¼ 8.2
Hz), 7.52 (1H, d, J ¼ 7.6 Hz), 7.46–7.31 (5H, m), 7.29–7.19 (2H,
m), 7.17 (2H, d, J¼ 8.3 Hz), 5.55 (1H, app t, J¼ 4.7 Hz), 5.08 (1H,
d, J ¼ 7.7 Hz), 3.66 (1H, ddd, J ¼ 10.5, 7.7, 5.8 Hz), 2.96 (3H, s),
2.49 (1H, app dt, J ¼ 14.8, 5.3 Hz), 2.28 (3H, s), 2.14 (1H, ddd,
J ¼ 14.8, 10.5, 5.5 Hz); 13C NMR (101 MHz, CDCl3): dC 177.4,
173.4, 153.6, 152.8, 145.5, 137.0, 135.3, 132.3, 130.8, 130.0,
129.3, 128.5, 127.5, 126.9, 125.7, 125.6, 124.3, 119.4, 115.4,
114.9, 47.8, 40.3, 39.0, 28.4, 25.4, 21.7; IR (neat): nmax/cm
1
3665, 2984, 2884, 1699; MS (pNSI): 601.2 (100%, (M + NH4)
+),
1184.3 (13%, (2M + NH4)
+); HRMS (pNSI): calcd for C30H29N6O6S
[M + NH4]
+: 601.1864; observed: 601.1861.
3d – (3aS*,5S*,10bS*)-5-((S*)-hydroxy(peruorophenyl)
methyl)-2-methyl-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]
carbazole-1,3(2H,3aH)-dione
To a stirred round bottomed ask was added 1-tosyl-3-vinyl-1H-
indole (100 mg, 0.34 mmol) DCM (5 mL) and 1-methyl-1H-
pyrrole-2,5-dione (38 mg, 0.34 mmol) and the resulting solution
was heated at reux for 48 hours. The reaction was cooled to
78 C and 2,3,4,5,6-pentauorobenzaldehyde (0.04 mL,
0.34 mmol) was added followed by DMAC (1 M in hexane, 0.34
mL, 0.34 mmol). The reaction was stirred at 78 C for
15 minutes before being allowed to warm to room temperature.
The reaction was stirred at room temperature for 18 hours. The
reaction was poured into saturated sodium bicarbonate solu-
tion (10 mL) and extracted with DCM (2  10 mL). The
combined organic layers were dried with MgSO4, ltered and
the solvent was removed under reduced pressure to give the
crude product as a pale brown solid. The product was puried
by column chromatography (petrol (40/60)–ethyl acetate 3 : 1,
column diameter¼ 2 cm, silica¼ 15 cm) to give a separable 5 : 1
mixture of (3aS*,5S*,10bS*)-5-((S*)-hydroxy(peruorophenyl)
methyl)-2-methyl-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]-
carbazole-1,3(2H,3aH)-dione and (3aS*,5S*,10bS*)-5-((R*)-
hydroxy(peruorophenyl)methyl)-2-methyl-10-tosyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (72%, 149
mg, 0.25 mmol).
Major diastereomer: Mp: 120.4–121.7 C; Rf: 0.24 (Pet(40/60)–
EA 3 : 1); 1HNMR (300 MHz, CDCl3): dH d 7.85 (3H, app d, J¼ 8.4
Hz), 7.31–7.22 (4H,m), 7.22–7.14 (1H, m), 5.13 (1H, d, J¼ 8.1 Hz),
4.99 (1H, d, J ¼ 7.5 Hz), 3.71–3.52 (2H, m), 3.01 (3H, s), 2.38 (3H,
s), 2.20–2.10 (1H, m), 1.67 (1H, app td, J¼ 13.8, 5.3 Hz); 13C NMR
(101 MHz, CDCl3): dC 177.7, 173.3, 145.3, 137.4, 135.4, 129.8,
This journal is © The Royal Society of Chemistry 2015 RSC Adv., 2015, 5, 16125–16152 | 16137
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129.7, 129.6, 127.2, 125.3, 123.9, 120.1, 119.9, 115.2, 70.2, 41.5,
39.1, 36.9, 28.7, 25.2, 21.7; IR (neat): nmax/cm
1 3371, 2981, 2889,
1690; MS (pNSI): 605.1 (40%, (M + H)+), 622.1 (88%, (M + NH4)
+),
627.1 (100%, (M + Na)+), 643.1 (17%), 709.1 (15%); HRMS (pNSI):
calcd for C29H21F5N2NaO5S [M + Na]
+: 627.0984; observed:
627.0968. Note: 13C NMR missing peaks due to C–F coupling.
3e – 6-(hydroxy(phenyl)amino)-2-phenyl-11-tosyl-5,6-dihydro-
[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]indole-1,3(2H,11H)-
dione
To a stirred round bottomed ask was added 1-tosyl-3-vinyl-1H-
indole (100 mg, 0.34 mmol) and DCM (5 mL) and the solution
was cooled to78 C. To this solution PTAD (70mg, 0.34 mmol)
was added and the reaction was stirred at 78 C for 3.5 hours.
The reaction was warmed to room temperature, nitrosobenzene
(44 mg, 0.34 mmol) was added and the reaction was stirred for
18 hours. The solvent was removed under reduced pressure to
leave the crude product as a pale yellow oil. The product was
puried by column chromatography (column diameter ¼ 1 cm,
silica ¼ 16 cm, eluent ¼ petrol (40/60)–ether–DCM 2 : 1 : 1) to
give 6-(hydroxy(phenyl)amino)-2-phenyl-11-tosyl-5,6-dihydro-
[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]indole-1,3(2H,11H)-
dione (72%, 54 mg, 0.09 mmol) as a white powder.
Mp: 176.1–180.0 C; Rf: 0.48 (Pet(40/60)–Et2O 2 : 1);
1H NMR
(400 MHz, CDCl3): dH 8.03 (1H, d, J¼ 8.3 Hz), 7.62 (2H, d, J¼ 8.1
Hz), 7.56 (2H, d, J ¼ 7.6 Hz), 7.46 (2H, app t, J ¼ 7.7 Hz),
7.42–7.36 (1H, m), 7.23–7.07 (7H, m), 7.05–6.99 (2H, m),
6.59 (1H, d, J ¼ 7.4 Hz), 5.81 (1H, br s), 5.18 (1H, d, J ¼ 13.5 Hz),
4.59 (1H, s), 3.23 (1H, d, J ¼ 13.5 Hz), 2.30 (3H, s); 13C NMR
(101 MHz, DMSO-d6): dC 152.7, 152.2, 150.5, 146.0, 134.9, 132.9,
132.5, 131.8, 130.4, 129.8, 129.3, 129.2, 128.5, 127.3, 127.3,
125.5, 125.4, 122.5, 119.8, 117.6, 116.6, 108.6, 55.9, 44.6, 21.6; IR
(neat): nmax/cm
1 2981, 2884, 1714; MS (pAPCI): 138.1 (100%),
157.0 (95%), 213.1 (50%), 248.1 (86%), 279.1 (62%), 317.1 (33%),
333.1 (29%), 471.1 (31%), 564.2 (11%), 580.2 (10%, (M + H)+);
HRMS (pAPCI): calcd for C31H26N5O5S [M + H]
+: 580.1649;
observed: 580.1640.
3f – 6-(hydroxy(o-tolyl)amino)-2-phenyl-11-tosyl-5,6-dihydro-
[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]indole-1,3(2H,11H)-
dione
To a stirred round bottomed ask was added 1-tosyl-3-vinyl-1H-
indole (100 mg, 0.34 mmol) and DCM (5 mL) and the solution
cooled to78 C. To this solution PTAD (70 mg, 0.34 mmol) was
added and the reaction was stirred at 78 C for 3.5 hours. The
reaction was warmed to room temperature and 1-methyl-2-
nitrosobenzene (42 mg, 0.34 mmol) was added and the reac-
tion was stirred for 18 hours. The solvent was removed under
reduced pressure to leave the crude product as a pale yellow oil.
The product was puried by column chromatography (column
diameter ¼ 1 cm, silica ¼ 14 cm, eluent ¼ petrol (40/60)–ether–
DCM 2 : 1 : 1) to give 6-(hydroxy(o-tolyl)amino)-2-phenyl-11-
tosyl-5,6-dihydro-[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]indole-
1,3(2H,11H)-dione as a white powder (78%, 60 mg, 0.10 mmol).
Mp: 149.7–153.1 C; Rf: 0.32 (Pet(40/60)–Et2O–DCM 2 : 1 : 1);
1HNMR (300 MHz, CDCl3): dH 7.99 (1H, d, J¼ 8.3 Hz), 7.61–7.58
(5H, m), 7.43–7.40 (1H, m), 7.47 (2H, app t, J¼ 7.7 Hz), 7.40–7.37
(1H, m), 7.18 (2H, app t, J¼ 7.8 Hz), 7.11 (2H, d, J¼ 8.2 Hz), 6.97
(2H, app q, J ¼ 7.2 Hz), 6.85 (1H, d, J ¼ 7.5 Hz), 6.50 (1H, d, J ¼
7.8 Hz), 5.93 (1H, s), 5.24 (1H, d, J ¼ 13.5 Hz), 4.44 (1H, s), 3.11
(1H, d, J ¼ 13.5 Hz), 2.29 (3H, s), 1.91 (3H, s); 13C NMR (101
MHz, CDCl3): dC 153.3, 150.3, 148.7, 145.4, 135.1, 133.7, 132.0,
131.7, 131.3, 130.6, 129.6, 129.3, 128.7, 127.9, 127.2, 127.0,
126.8, 125.9, 124.9, 124.8, 122.6, 118.0, 116.8, 107.0, 59.1, 44.5,
21.7, 17.8; IR (neat): nmax/cm
1 3068, 2981, 1713; MS (pAPCI):
138.1 (100%), 157.0 (82%), 262.1 (55%), 279.1 (76%),
317.1 (50%), 391.3 (37%), 471.1 (21%), 594.2 (10%, (M + H)+);
HRMS (pAPCI): calcd for C32H28N5O5S [M + H]
+: 594.1806;
observed: 594.1801.
3g – ethyl 3-((3aS*,4S*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-2-
methyl-1,3-dioxo-10-tosyl-1,2,3,3a,4,5,10,10b-
octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate
A solution of 2-nitrosotoluene (0.035 g, 0.29 mmol) and ethyl
3-((3aS*,4R*,10bS*)-2-methyl-1,3-dioxo-10-tosyl-1,2,3,3a,4,10,10a,
10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate (0.150 g,
0.29 mmol) in dry DCM (10 mL) was stirred at room tempera-
ture for 24 hours. The solvent was removed under reduced
pressure to give the crude green solid product which was puri-
ed by column chromatography (petrol (40/60)–ethyl acetate
2 : 1) to give ethyl 3-((3aS*,4S*,5S*,10bS*)-5-(hydroxy(o-tolyl)
amino)-2-methyl-1,3-dioxo-10-tosyl-1,2,3,3a,4,5,10,10b-octahy-
dropyrrolo[3,4-a]carbazol-4-yl)propanoate (0.109 g, 0.17 mmol,
59%) as a bright yellow solid.
Mp: 190–192 C; Rf: 0.26 (Pet(40/60)–EA 2 : 1);
1H NMR
(400 MHz, CDCl3): dH 7.95 (1H, d, J¼ 7.2 Hz), 7.61 (2H, d, J¼ 7.2
Hz), 7.18 (2H, d, J¼ 7.2 Hz), 7.10 (1H, d, J¼ 7.2 Hz), 7.05 (1H, t, J
¼ 7.2 Hz), 6.81 (1H, t, J ¼ 7.2 Hz), 6.65 (1H, t, J ¼ 7.5 Hz), 6.19
(1H, t, J ¼ 7.5 Hz), 5.88 (1H, d, J ¼ 7.2 Hz), 5.46 (1H, d, J ¼ 7.2
Hz), 4.99 (1H, br s), 4.95 (1H, d, J ¼ 7.2 Hz), 4.30 (1H, d, J ¼ 4.6
Hz), 4.11 (2H, q, J ¼ 7.0 Hz), 3.80–3.75 (1H, m), 3.01 (3H, s),
2.70–2.54 (4H, m), 2.41 (3H, s), 2.33 (3H, s), 1.92–1.85 (1H, m),
1.24 (3H, t, J ¼ 7.0 Hz). 13C NMR (101 MHz, CDCl3): dC 178.2,
173.3, 149.9, 144.6, 139.9, 137.1, 134.1, 131.9, 130.6, 130.3,
129.4, 128.7, 127.0, 125.7, 124.8, 124.4, 123.6, 122.1, 118.9,
118.0, 115.7, 60.6, 57.8, 45.1, 42.4, 40.0, 32.5, 25.2, 23.3, 21.6,
18.5, 14.3; IR (neat): nmax/cm
1: 3655, 2980, 1702; MS (pNSI):
507.15 (100%, [M  (Tol-N-OH)]), 652.20 (55%, [M + Na]+);
HRMS (pNSI): calcd C34H35N3O7S [M + Na]
+: 652.2088; observed:
652.2082.
3h – ethyl 3-((3aS*,4S*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-
1,3-dioxo-2-phenyl-10-tosyl-1,2,3,3a,4,5,10,10b-
octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate
A solution of 2-nitrosotoluene (0.016 g, 0.13 mmol) and ethyl
3-((3aS*,4R*,10bS*)-1,3-dioxo-2-phenyl-10-tosyl-1,2,3,3a,4,10,
10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate (0.08 g,
0.13 mmol) in dry DCM (10 mL) was stirred at room temperature
for 24 hours. The solvent was removed under reduced pressure
to give the crude yellow product which was puried by column
chromatography (petrol (40/60)–ethyl acetate 2 : 1) to give ethyl
3-((3aS*,4S*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-1,3-dioxo-2-
16138 | RSC Adv., 2015, 5, 16125–16152 This journal is © The Royal Society of Chemistry 2015
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phenyl-10-tosyl-1,2,3,3a,4,5,10,10b-octahydropyrrolo[3,4-a]-
carbazol-4-yl)propanoate in (0.415 g, 0.059 mmol, 58%) as a
bright yellow solid.
Mp: 182–184 C; Rf: 0.34 (Pet(40/60)–EA 2 : 1);
1H NMR (400
MHz, CDCl3): dH 7.94 (1H, d, J¼ 6.7 Hz), 7.64 (2H, d, J¼ 6.7 Hz),
7.45–7.37 (5H, m), 7.20–7.00 (4H, m), 6.84 (1H, t, J ¼ 6.9 Hz),
6.66 (1H, t, J ¼ 6.9 Hz), 6.24 (1H, t, J ¼ 6.2 Hz), 5.95 (1H, d, J ¼
6.9 Hz), 5.66 (1H, d, J ¼ 6.4 Hz), 5.20 (1H, d, J ¼ 7.4 Hz), 4.99
(1H, br s), 4.39 (1H, d, J ¼ 4.0 Hz), 4.08 (2H, q, J ¼ 7.2 Hz), 4.03–
3.98 (1H, m), 2.72–2.61 (4H, m), 2.42 (3H, s), 2.33 (3H, s), 2.14–
2.08 (1H, m). 1.20 (3H, t, J¼ 7.2 Hz); 13CNMR (101MHz, CDCl3):
dC 177.0, 173.3, 172.2, 150.1, 144.6, 137.1, 134.2, 131.0, 131.8,
130.5, 130.3, 129.4, 129.0, 128.6, 128.5, 127.0, 126.5, 125.8,
124.8, 124.5123.5, 122.2, 119.1, 118.1, 115.6, 60.0, 57.7, 45.3,
42.6, 40.0, 32.4, 23.1, 21.6, 18.5, 14.5; IR (neat): nmax/cm
1: 3858,
3826, 1709, 1595; MS (pNSI): 569.17 (100%, [MN(OH)(o-Tol)]),
692.24 (30%, [M + H]+); HRMS (pNSI): calcd C39H36N3O7S [M 
H]+: 690.2268; observed: 690.2266.
3i – ethyl 3-((3aS*,4S*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-
triazolidin-1-yl)-2-methyl-1,3-dioxo-10-tosyl-
1,2,3,3a,4,5,10,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)
propanoate
A solution of 4-phenyl-3H-1,2,4-triazole-3,5(4H)-dione (0.052 g,
0.29 mmol) and ethyl 3-((3aS*,4R*,10bS*)-2-methyl-1,3-dioxo-
10-tosyl-1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-
4-yl)propanoate (0.150 g, 0.29 mmol) in dry DCM (10 mL) was
stirred at 0 C for 6 hours. The solvent was removed under
reduced pressure to give the crude product which was puried
by column chromatography (petrol (40/60)–ethyl acetate 1 : 1) to
give ethyl 3-((3aS*,4S*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-
triazolidin-1-yl)-2-methyl-1,3-dioxo-10-tosyl-1,2,3,3a,4,5,10,10b-
octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate in (56%,
0.110 g, 0.161 mmol) as a white solid.
Mp: 264–265 C; Rf: 0.30 (Pet(40/60)–EA 1 : 1);
1H NMR
(400 MHz, CDCl3): dH 8.86 (1H, br s), 7.78 (2H, d, J ¼ 7.0 Hz),
7.71 (1H, d, J¼ 7.9 Hz), 7.47 (1H, d, J ¼ 7.9 Hz), 7.44–7.40 (1H,
m), 7.36–7.30 (3H, m), 7.23–7.17 (2H, m), 7.02 (2H, d, J ¼ 7.0
Hz), 5.66 (1H, d, J ¼ 6.2 Hz), 5.04 (1H, d, J ¼ 6.5 Hz), 4.08 (2H,
q, J ¼ 6.2 Hz), 3.44 (1H, dd, J ¼ 6.5, 11.9 Hz), 3.02 (3H, s),
2.68–2.51 (3H, m), 2.15 (3H, s), 2.14–2.09 (1H, m), 1.90–1.82
(1H, m), 1.20 (3H, t, J ¼ 6.2 Hz); 13C NMR (101 MHz, CDCl3):
dC 176.6, 173.4, 173.2, 153.6, 152.6, 145.2, 136.8, 135.5, 132.1,
130.7, 129.7, 129.3, 128.6, 127.2, 126.8, 125.6, 124.2, 119.0,
114.8, 114.4, 60.8, 44.3, 42.0, 39.3, 30.9, 25.4, 23.0, 21.5, 14.2;
IR (neat): nmax/cm
1: 3659, 1775, 1691; MS (pNSI): 701.23
(100%, [M + NH4]
+), 1384.44 (17%, [2M + NH4]
+); HRMS
(pNSI): calcd C35H34N5O8S [M + H]
+: 684.2123; observed:
684.2115.
3j – ethyl 3-((3aS*,4S*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-
triazolidin-1-yl)-1,3-dioxo-10-tosyl-1,2,3,3a,4,5,10,10b-
octahydropyrrolo[3,4-a]carbazol-4-yl)propanoate
A solution of 4-phenyl-3H-1,2,4-triazole-3,5(4H)-dione (0.037 g,
0.21 mmol) and ethyl 3-((3aS*,4R*,10bS*)-1,3-dioxo-10-tosyl-
1,2,3,3a,4,10,10a,10b-octahydropyrrolo[3,4-a]carbazol-4-yl)-
propanoate (0.105 g, 0.21 mmol) in dry DCM (10 mL) was stirred
at 0 C for 6 h. The solvent was removed to give the crude white
solid product which was puried by trituration from DCM to
yield ethyl 3-((3aS*,4S*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-
triazolidin-1-yl)-1,3-dioxo-10-tosyl-1,2,3,3a,4,5,10,10b-octahy-
dropyrrolo[3,4-a]carbazol-4-yl)propanoate in (57%, 0.08 g, 0.119
mmol) as a white solid.
Mp: 269–271 C; 1H NMR (300 MHz, d6-DMSO): dH 11.44 (1H,
br s), 10.68 (1H, br s), 7.87–7.76 (3H, m), 7.51–7.39 (4H, m), 7.29–
7.25 (6H, m), 5.69 (1H, d, J¼ 6.1 Hz), 5.28 (1H, d, J¼ 6.8 Hz), 4.05
(2H, q, J ¼ 6.8 Hz), 3.45 (1H, dd, J ¼ 6.8, 11.3 Hz), 3.58–3.52 (1H,
m), 2.67–2.65 (1H, m), 2.25 (3H, s), 2.49–2.44 (2H, m), 1.80–1.70
(1H, m), 1.18 (3H, t, J ¼ 6.8 Hz); 13C NMR (101 MHz, d6-DMSO):
178.6, 175.0, 172.99, 154.4, 153.1, 145.5, 136.6, 134.9, 133.1, 131.7,
130.4, 129.4, 128.6, 127.6, 127.1, 126.3, 125.6, 124.5, 119.3, 115.9,
114.9, 60.3, 45.2, 43.0, 38.0, 30.7, 23.6, 21.4, 14.5; IR (neat): nmax/
cm1: 3659, 1775, 1692; MS (pNSI): 687.22 (100%, [M + NH4]
+),
1356.41 (27%, [2M + NH4]
+), 692.17 (12%, [M + Na]+); HRMS
(pNSI): calcd C34H35N6O8S [M +H]
+: 687.2232; observed: 687.2229.
3k – (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-10-tosyl-
4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-
dione
To a stirred round bottomed ask was added 1-tosyl-3-vinyl-1H-
indole (100 mg, 0.34 mmol), DCM (5 mL) and 1H-pyrrole-2,5-
dione (33 mg, 0.34 mmol) and the resulting solution was
heated at reux for 48 hours. The reaction was cooled to room
temperature and nitrosobenzene (36 mg, 0.34 mmol) was
added. The reaction was stirred at room temperature for 4 hours
before the solvent was removed under reduced pressure to leave
the crude product as a white solid. The product was puried by
trituration from DCM to give (3aS*,5S*,10bS*)-5-(hydroxy-
(phenyl)amino)-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]-
carbazole-1,3(2H,3aH)-dione (89%, 151 mg, 0.30 mmol) as a
white powder.
Mp: 203.7–206.9 C; Rf: 0.15 (Pet(40/60)–EA 2 : 1);
1H NMR
(300 MHz, DMSO-d6): dH 11.26 (1H, s), 8.45 (1H, s), 7.88 (1H, d,
J ¼ 8.3 Hz). 7.76 (2H, d, J ¼ 8.2 Hz), 7.42 (1H, d, J ¼ 7.8 Hz), 7.33
(2H, d, J ¼ 8.2 Hz), 7.29–7.04 (5H, m), 6.89 (1H, t, J ¼ 7.2 Hz),
5.17 (1H, d, J¼ 7.8 Hz), 4.88 (1H, app t, J¼ 4.4 Hz), 3.65 (1H, app
td, J¼ 8.8, 5.9 Hz), 2.32 (3H, s), 2.36–2.27 (1H, m), 1.81 (1H, ddd,
J ¼ 14.0, 9.4, 5.0 Hz); 13C NMR (101 MHz, DMSO-d6): dC 179.4,
174.7, 152.0, 144.7, 136.4, 135.0, 131.5, 129.8, 128.9, 128.4,
126.6, 124.4, 123.4, 121.2, 120.7, 120.6, 117.0, 114.4, 56.8, 41.5,
40.6, 25.2, 20.9; IR (neat): nmax/cm
1 3452, 2981, 1715; MS
(pNSI): 393.1, (100%, (M (C6H5NOH)
+)), 502.1 (14%, (M + H)+),
519.2 (96%, (M + NH4)
+), 524.1 (17%, (M + Na)+), 1003.3 (40%,
(2M + H)+), 1025.3 (15%, (2M + Na)+); HRMS (pNSI): calcd for
C27H24N3O5S [M + H]
+: 502.1431; observed: 502.1428.
3l – (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-10-tosyl-
4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-
dione
To a stirred round bottomed ask was added 1-tosyl-3-vinyl-1H-
indole (100 mg, 0.34 mmol), DCM (5 mL) and 1H-pyrrole-2,5-
dione (33 mg, 0.34 mmol) was added and the resulting
This journal is © The Royal Society of Chemistry 2015 RSC Adv., 2015, 5, 16125–16152 | 16139
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solution was heated at reux for 48 hours. The reaction was
cooled to room temperature and 1-methyl-2-nitrosobenzene (41
mg, 0.34 mmol) was added. The reaction was stirred at room
temperature for 4 hours before the solvent was removed under
reduced pressure to leave the crude product as a pale yellow
solid. The product was puried by column chromatography
(petrol (40/60)–ether–DCM 2 : 1 : 1, column diameter ¼ 2 cm,
silica ¼ 14 cm) to give (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)
amino)-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione (82%, 143 mg, 0.28 mmol) as a yellow
powder.
Mp: 171.1–174.0 C; Rf: 0.13 (Pet(40/60)–EA 2 : 1);
1H NMR
(400 MHz, CDCl3): d 7.90 (1H, d, J ¼ 8.4 Hz), 7.73 (2H, d, J ¼ 8.2
Hz), 7.77 (1H, s), 7.35 (2H, dd, J¼ 15.7, 7.9 Hz), 7.20 (3H, app d, J
¼ 8.2 Hz), 7.09 (2H, d, J¼ 7.5 Hz), 7.07–7.00 (2H, m), 5.17 (1H, d,
J ¼ 8.1 Hz), 4.75 (1H, s), 4.39 (1H, app t, J ¼ 5.1 Hz), 3.80 (1H,
app q, J ¼ 8.3, 5.7 Hz), 2.64 (1H, app dt, J ¼ 13.1, 5.5 Hz), 2.34
(3H, s), 2.26 (3H, s), 1.96 (1H, ddd, J ¼ 15.9, 7.9, 3.7 Hz); 13C
NMR (75 MHz, CDCl3): dC 178.3, 173.4, 149.3, 144.7, 137.4,
135.8, 131.3, 130.9, 129.8, 129.6, 129.5, 129.0, 127.0, 126.3,
125.1, 124.7, 123.7, 121.5, 120.1, 115.3, 57.3, 42.0, 40.8, 26.0,
21.4, 18.3; IR (neat): nmax/cm
1 3294, 2981, 1713; MS (pAPCI):
293.1 (16%), 332.1 (13%), 342.1 (16%), 393.1 (100%, (M (o-Tol)
N(OH))+), 489.1 (54%, (M  H2O)
+), 516.2 (26%, (M + H)+);
HRMS (pAPCI): calcd for C28H26N3O5S [M + H]
+: 516.1588;
observed: 516.1576.
3m – (3aS*,5S*,10bS*)-5-((S*)-hydroxy(peruorophenyl)
methyl)-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione
To a stirred round bottomed ask was added 1-tosyl-3-vinyl-1H-
indole (100 mg, 0.34 mmol), DCM (5 mL) and 1H-pyrrole-2,5-
dione (33 mg, 0.34 mmol). The resulting solution was heated
at reux for 48 hours. The reaction was cooled to 0 C and
pentauorobenzaldehyde (67 mg, 0.34 mmol) and DMAC (1 M
in hexane, 0.34 mL, 0.34 mmol) were added. The solution was
stirred at 0 C for 1 hour and then warmed to room temperature
for 18 hours. The reaction was poured into sodium bicarbonate
(15 mL) and extracted with DCM. The combined organic layers
were dried with MgSO4, ltered and the solvent was removed
under reduced pressure to give the crude product as an offwhite
solid. The product was puried by column chromatography
(diameter ¼ 1.5 cm, silica ¼ 15 cm, eluent ¼ petrol (40/60)–EA
2 : 1) to give (3aS*,5S*,10bS*)-5-((S*)-hydroxy(peruorophenyl)
methyl)-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione (71%, 0.1427 g, 0.24 mmol) as an off white
solid.
Mp: 181.3–185.1 C; Rf: 0.22 (Pet(40/60)–EA 2 : 1);
1H NMR
(400MHz, CDCl3): dH 8.03 (1H, br s), 7.81 (3H, app d, J¼ 7.9 Hz),
7.28 (1H, d, J ¼ 8.0 Hz), 7.25–7.22 (3H, m), 7.16 (1H, app t, J ¼
7.6 Hz), 5.08 (1H, d, J ¼ 8.3 Hz), 5.05 (1H, d, J ¼ 7.4 Hz), 3.61–
3.66 (1H, m), 3.49–3.57 (1H, m), 2.34 (3H, s), 2.09 (1H, dd, J ¼
14.0, 4.5 Hz), 1.74 (1H, app td, J ¼ 13.9, 5.3 Hz); 13C NMR (101
MHz, CDCl3): dC 177.4, 173.0, 145.3, 137.4, 135.5, 129.8, 129.7,
129.1, 127.1, 125.5, 123.9, 120.2, 120.0, 115.3, 70.2, 42.5, 40.3,
36.8, 28.5, 21.7; IR (neat): nmax/cm
1 3240, 2981, 1717; MS
(pAPCI): 157.0 (79%), 221.1 (61%), 393.1 (15%, (M 
(C6F5COH)
+)), 443.1 (51%), 573.1 (8%, (M  H2O)
+), 591.1
(100%, (M + H)+); HRMS (pAPCI): calcd for C28H20F5N2O5S [M +
H]+: 591.1008; observed: 591.1001. Note: 13C NMR missing peaks
due to C–F coupling.
3n – (3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-
1-yl)-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione
To a stirred round bottomed ask was added 1-tosyl-3-vinyl-1H-
indole (100 mg, 0.34 mmol), DCM (5 mL) and 1H-pyrrole-2,5-
dione (33 mg, 0.34 mmol). The resulting solution was heated
at reux for 48 hours. The reaction was cooled to 0 C and PTAD
was added. The solution was stirred at 0 C for 4 hours and the
solvent was removed under reduced pressure to give the crude
product as pale red. The product was puried by column chro-
matography (diameter ¼ 1.5 cm, silica ¼ 17 cm, eluent ¼ petrol
(40/60)–EA 1 : 1) to give (3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-
1,2,4-triazolidin-1-yl)-10-tosyl-4,5,10,10b-tetrahydropyrrolo-
[3,4-a]carbazole-1,3(2H,3aH)-dione (23%, 0.044 g, 0.08 mmol) as
an off white solid.
Mp: 206.4–209.7 C; Rf: 0.10 (Pet(40/60)–EA 2 : 1);
1H NMR
(400 MHz, DMSO-d6): dC 11.37 (1H, s), 10.77 (1H, s), 7.82 (2H, d, J
¼ 8.3 Hz), 7.72 (1H, d, J ¼ 7.9 Hz), 7.48–7.43 (2H, m), 7.42–7.35
(4H, m), 7.28 (2H, d, J¼ 8.5 Hz), 7.25–7.18 (2H, m), 5.46 (1H, app
t, J¼ 4.9 Hz), 5.19 (1H, d, J¼ 7.7 Hz), 3.77–3.65 (1H, m), 2.41 (1H,
app dt, J ¼ 9.8, 5.1 Hz), 2.26 (3H, s), 2.24–2.16 (1H, m); 13C NMR
(101 MHz, CDCl3): dH 178.8, 173.6, 153.6, 152.4, 145.4, 136.9,
135.3, 132.2, 130.9, 129.9, 129.2, 128.4, 127.5, 126.9, 125.7, 125.6,
124.2, 119.3, 115.1, 114.8, 47.3, 41.5, 40.2, 28.8, 21.7; IR (neat):
nmax/cm
1 3194, 2981, 2980, 1699; MS (pNSI): 587.2 (100% (M +
NH4)
+), 592.1 (30% (M + Na)+); HRMS (pNSI): calcd for
C29H27N6O6S [M + NH4]
+: 587.1707; observed: 587.1706.
3o – (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-7-methoxy-
10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione
To a stirred round bottomed ask was added 6-methoxy-1-tosyl-
3-vinyl-1H-indole (111 mg, 0.34 mmol), DCM (5 mL) and 1H-
pyrrole-2,5-dione (33 mg, 0.34 mmol). The resulting solution
was heated at reux for 48 hours. The reaction was cooled to
room temperature and 1-methyl-2-nitrosobenzene (41 mg,
0.34 mmol) was added. The reaction was stirred at room
temperature for 24 hours before the solvent was removed under
reduced pressure to leave the crude product as a pale yellow
solid. The product was puried by column chromatography
(petrol (40/60)–ethyl acetate 2 : 1) to give (3aS*,5S*,10bS*)-5-
(hydroxy(o-tolyl)amino)-7-methoxy-10-tosyl-4,5,10,10b-tetrahydro
pyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (76%, 141 mg, 0.26
mmol) as a light brown solid.
Mp: 185 C decomposed; Rf: 0.26 (Pet(40/60)–EA 4 : 3);
1H
NMR (400 MHz, DMSO-d6): dH 11.19 (1H, s), 8.34 (1H, s), 7.69
(1H, d, J ¼ 9.1 Hz), 7.61 (2H, d, J ¼ 8.2 Hz), 7.27 (2H, d, J ¼ 8.2
Hz), 7.08–6.97 (2H, m), 6.95–6.85 (2H, m), 6.72 (1H, dd, J ¼ 9.1,
2.4 Hz), 6.40 (1H, s), 5.07 (1H, d, J ¼ 7.9 Hz), 4.20 (1H, app t, J ¼
4.4 Hz), 3.76 (1H, app q, J ¼ 8.4 Hz), 3.47 (3H, s), 2.53–2.47 (1H,
16140 | RSC Adv., 2015, 5, 16125–16152 This journal is © The Royal Society of Chemistry 2015
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m), 2.28 (s, 3H), 2.08 (s, 3H), 1.75 (1H, ddd, J¼ 13.6, 9.8, 4.4 Hz);
13C NMR (101 MHz, DMSO-d6): dC 180.5, 175.4, 156.3, 151.7,
145.3, 134.7, 133.1, 131.1, 131.0, 130.8, 130.3, 129.7, 127.1,
126.4, 124.6, 122.1, 121.2, 115.9, 113.8, 103.3, 57.1, 55.3, 42.2,
26.9, 21.5, 21.3, 18.5; IR (neat): n(max)/cm
1 3388, 3071, 2552,
1727; MS (pNSI): 355.1 (50%), 371.1 (100%), 423.1 (57%), 445.1
(30%), 546.2 (5%, (M + H)+), 568.2 (16%, (M + Na)+), 584.1 (21%);
HRMS (pNSI): calcd for C29H28N3O6S1 [M + H]
+: 546.1693;
observed: 546.1690.
3p – (3aS*,5S*,10bS*)-5-((S*)-hydroxy(peruorophenyl)
methyl)-7-methoxy-2-methyl-10-tosyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione
To a stirred round bottomed ask was added 5-methoxy-1-tosyl-
3-vinyl-1H-indole (112 mg, 0.34 mmol), DCM (5 mL) and 1-
methyl-1H-pyrrole-2,5-dione (38 mg, 0.34 mmol). The reaction
was heated at reux for 48 hours. The reaction was cooled to
78 C and pentauorobenzaldehyde (0.04 mL, 0.34 mmol) and
DMAC (1 M in hexane, 0.34 mL, 0.34 mmol) were added. The
solution was stirred at 78 C for 15 minutes and then at room
temperature for 18 hours. The solvent was removed under
reduced pressure to give the crude product as an off white solid.
The product was puried by column chromatography (column
diameter ¼ 2 cm, silica ¼ 15 cm, eluent ¼ petrol (40/60)–EA
3 : 1) to give a 8 : 1 mixture of (3aS*,5S*,10bS*)-5-((S*)-hydroxy-
(peruorophenyl)methyl)-7-methoxy-2-methyl-10-tosyl-4,5,10,
10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione and
(3aS*,5S*,10bS*)-5-((R*)-hydroxy(peruorophenyl)methyl)-7-
methoxy-2-methyl-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]-
carbazole-1,3(2H,3aH)-dione (70%, 0.151 mg, 0.24 mmol) as a
white powder.
Major diastereomer: Mp: 136.7–139.0 C; Rf: 0.40 (Pet(40/60)–
EA 2 : 1); 1H NMR (400 MHz, CDCl3): dH 7.76 (2H, d, J ¼ 8.3 Hz),
7.69 (1H, d, J¼ 9.1 Hz), 7.22 (2H, d, J¼ 8.3 Hz), 6.83 (1H, dd, J¼
9.1, 2.5 Hz), 6.72 (1H, d, J¼ 2.5 Hz), 5.08 (1H, d, J¼ 8.3 Hz), 4.87
(1H, d, J ¼ 7.4 Hz), 3.71 (3H, s), 3.58–3.47 (2H, m), 2.94 (3H, s),
2.34 (3H, s), 2.11–2.04 (1H, m), 1.60 (1H, td, J¼ 13.9, 5.3 Hz); 13C
NMR (101 MHz, CDCl3): dC 177.7, 173.2, 156.8, 145.2, 135.2,
132.0, 130.9, 130.3, 129.8, 127.0, 120.6, 116.2, 114.0, 102.6, 70.2,
55.6, 41.5, 39.0, 36.9, 28.6, 25.3, 21.7; IR (neat): nmax/cm
1 2981,
2884, 1709; MS (pAPCI): 157.0 (80%), 221.1 (92%), 281.1 (49%)
475.1 (94%), 635.1 (100%, (M + H)+); HRMS (pAPCI): calcd for
C30H24F5N2O6S [M + H]
+: 635.1270; observed: 635.1266. Note:
13C NMR missing peaks due to C–F coupling.
3q – (3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-
1-yl)-7-methoxy-10-tosyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]
carbazole-1,3(2H,3aH)-dione
To a stirred round bottomed ask was added 5-methoxy-1-tosyl-
3-vinyl-1H-indole (112 mg, 0.34 mmol), DCM (5 mL) and 1H-
pyrrole-2,5-dione (33 mg, 0.34 mmol). The reaction was heated
at reux for 48 hours. The reaction was cooled to 0 C and PTAD
(60 mg, 0.34 mmol) was added. The reaction was stirred at 0 C
for 4 hours before the solvent was removed under reduced
pressure to give the crude product as a pale red solid. The
product was puried by column chromatography (column
diameter ¼ 2 cm, silica ¼ 16 cm, eluent ¼ petrol (40/60)–EA
1 : 1) to give (3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-tri-
azolidin-1-yl)-7-methoxy-10-tosyl-4,5,10,10b-tetrahydropyrrolo-
[3,4-a]carbazole-1,3(2H,3aH)-dione (75%, 0.152 mg, 0.25 mmol)
as a pale yellow powder.
Mp: 189.9–193.3 C; Rf: 0.07 (Pet(40/60)–EA 1 : 1);
1H NMR
(400 MHz, CDCl3): dH 9.31 (1H, br), 7.67 (2H, d, J ¼ 7.5 Hz), 7.55
(1H, d, J ¼ 8.8 Hz), 7.38–7.23 (5H, m), 7.00 (2H, d, J ¼ 7.8 Hz),
6.90 (1H, s), 6.80 (1H, d, J¼ 8.9 Hz), 5.53 (1H, br s), 5.18 (1H, d, J
¼ 6.7 Hz), 3.74–3.69 (1H, m), 3.64 (3H, s), 2.48–2.55 (1H, m),
2.17 (3H, s), 2.12–2.02 (2H, m); 13C NMR (101 MHz, CDCl3): dC
179.0, 173.9, 156.9, 153.7, 152.7, 145.2, 135.1, 132.7, 131.5,
131.0, 129.8, 129.2, 128.4, 128.0, 127.2, 125.6, 115.9, 115.5,
114.3, 101.9, 55.7, 47.6, 41.6, 40.1, 28.8, 21.6; IR (neat): nmax/
cm1 2972, 2885, 1781, 1709; MS (pNSI): 617.2 (69%, (M +
NH4)
+), 622.1 (100%, (M + Na)+), 644.1 (48%); HRMS (pNSI):
calcd for C30H29N6O7S [M + NH4]
+: 617.1813; observed:
617.1817.
3r – 6-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-1-yl)-2-phenyl-11-
tosyl-5,6-dihydro-[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]
indole-1,3(2H,11H)-dione
To a stirred round bottomed ask was added 1-tosyl-3-vinyl-1H-
indole (100 mg, 0.34 mmol) and DCM (5 mL). The resulting
solution was cooled to78 C and then PTAD (70 mg, 0.34 mmol)
was added. The reaction was stirred at 78 C for 3.5 hours. The
reaction was warmed to 0 C and a further equivalent of PTAD (60
mg, 0.34 mmol) was added. The reaction was stirred 0 C for 4
hours, resulting in the formation of a white precipitate. The
reaction mixture was ltered and 6-(3,5-dioxo-4-phenyl-1,2,4-tri-
azolidin-1-yl)-2-phenyl-11-tosyl-5,6-dihydro-[1,2,4]triazolo[10,20:1,2]
pyridazino[3,4-b]indole-1,3(2H,11H)-dione (65%, 134 mg, 0.207
mmol) was recovered as a white powder.
Mp: 227.8–230.6 C; 1H NMR (400 MHz, DMSO-d6): dH 10.76
(1H, s, NH), 7.91 (1H, d, J ¼ 7.8 Hz), 7.61 (2H, d, J ¼ 8.3 Hz),
7.48–7.24 (15H, m), 5.52 (1H, s), 4.76 (1H, d, J ¼ 13.8 Hz), 3.86
(1H, d, J¼ 13.8 Hz), 2.24 (3H, s); 13C NMR (101 MHz, DMSO-d6):
dC 154.3, 153.5, 150.6, 149.5, 146.0, 135.1, 133.3, 133.0, 131.7,
131.5, 130.4, 129.6, 129.5, 129.4, 128.8, 128.1, 127.6, 127.5,
126.9, 125.9, 125.4, 119.3, 116.8, 104.1, 48.8, 43.3, 21.6; IR
(neat): nmax/cm
1 2971, 2883, 1714; MS (pNSI): 263.0 (36%),
345.0 (51%), 371.1 (42%), 665.2 (89%, (M + NH4)
+), 670.1 (100%,
(M + Na)+); HRMS (pNSI): calcd for C33H25N7NaO6S [M + Na]
+:
670.1479; observed: 670.1475.
3s – 6-(hydroxy(phenyl)amino)-2-phenyl-11-tosyl-5,6-dihydro-
[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]indole-1,3(2H,11H)-
dione
To a stirred round bottomed ask was added 1-tosyl-3-vinyl-
1H-indole (100 mg, 0.34 mmol) and DCM (5 mL) and the
solution was cooled to 78 C. To this solution PTAD (70 mg,
0.34 mmol) was added and the reaction was stirred at 78 C
for 3.5 hours. The reaction was warmed to room temperature
nitrosobenzene (44 mg, 0.34 mmol) was added and the
reaction was stirred for 18 hours. The solvent was removed
under reduced pressure to leave the crude product as a pale
This journal is © The Royal Society of Chemistry 2015 RSC Adv., 2015, 5, 16125–16152 | 16141
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yellow oil. The product was puried by column chromatog-
raphy (column diameter ¼ 1 cm, silica ¼ 16 cm, eluent ¼
petrol (40/60)–ether–DCM 2 : 1 : 1) to give 6-(hydroxy(phenyl)
amino)-2-phenyl-11-tosyl-5,6-dihydro-[1,2,4]triazolo[10,20:1,2]
pyridazino[3,4-b]indole-1,3(2H,11H)-dione (72%, 141 mg,
0.24 mmol) as a white powder.
Mp: 176.1–180.0 C; Rf: 0.48 (Pet(40/60)–Et2O 2 : 1);
1H NMR
(400 MHz, CDCl3): dH 8.03 (1H, d, J¼ 8.3 Hz), 7.62 (2H, d, J¼ 8.1
Hz), 7.56 (2H, d, J¼ 7.6 Hz), 7.46 (2H, app t, J¼ 7.7 Hz), 7.42–7.36
(1H, m), 7.23–7.07 (7H, m), 7.05–6.99 (2H, m), 6.59 (1H, d, J¼ 7.4
Hz), 5.81 (1H, br s), 5.18 (1H, d, J ¼ 13.5 Hz), 4.59 (1H, s), 3.23
(1H, d, J ¼ 13.5 Hz), 2.30 (3H, s); 13C NMR (101 MHz, DMSO-d6):
dC 152.7, 152.2, 150.5, 146.0, 134.9, 132.9, 132.5, 131.8, 130.4,
129.8, 129.3, 129.2, 128.5, 127.3, 127.3, 125.5, 125.4, 122.5, 119.8,
117.6, 116.6, 108.6, 55.9, 44.6, 21.6; IR (neat): nmax/cm
1 2981,
2884, 1714; MS (pAPCI): 138.1 (100%), 157.0 (95%), 213.1 (50%),
248.1 (86%), 279.1 (62%), 317.1 (33%), 333.1 (29%), 471.1 (31%),
564.2 (11%), 580.2 (10%, (M + H)+); HRMS (pAPCI): calcd for
C31H26N5O5S [M + H]
+: 580.1649; observed: 580.1640.
3t – (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-N,N,2-
trimethyl-1,3-dioxo-1,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]
carbazole-10(2H)-sulfonamide
To a stirred bottomed ask was added N,N-dimethyl-3-vinyl-1H-
indole-1-sulfonamide (85 mg, 0.34 mmol), DCM (5 mL) and 1-
methyl-1H-pyrrole-2,5-dione (38 mg, 0.34 mmol). The solution
was heated at reux for 48 hours. The reaction was cooled to
room temperature and 1-methyl-2-nitrosobenzene (41 mg, 0.34
mmol) was added. The reaction was stirred for 3 hours at room
temperature before the solvent was removed under reduced
pressure to give the crude product. The crude product was puri-
ed by column chromatography (column diameter ¼ 2 cm,
silica ¼ 16 cm, eluent ¼ petrol (40/60)–ethyl acetate 2 : 1) to give
(3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-N,N,2-trimethyl-1,3-
dioxo-1,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(2H)-
sulfonamide (74%, 0.122 g, 0.25 mmol) as an off white solid.
Mp: 169.3–171.9 C; Rf: 0.32 (Pet(40/60)–EA 2 : 1);
1H NMR
(400 MHz, CDCl3): dH 7.84 (1H, d, J¼ 8.4 Hz), 7.60 (1H, d, J¼ 7.9
Hz), 7.50 (1H, d, J¼ 8.0 Hz), 7.28 (1H, app t, J¼ 7.8 Hz), 7.21–7.16
(2H, m), 7.13 (1H, d, J ¼ 8.1 Hz), 7.07–7.03 (1H, m), 4.98–4.96
(2H, m), 4.35–4.31 (1H, m), 3.69 (1H, app t, J ¼ 7.7 Hz), 2.93 (9H,
s), 2.60 (1H, app dt, J¼ 13.1, 6.2 Hz), 2.33 (3H, s), 1.97 (1H, ddd, J
¼ 13.1, 7.7, 4.6 Hz); 13C NMR (101 MHz, CDCl3): dC 178.4, 173.8,
149.2, 137.4, 131.9, 131.1, 129.6, 128.4, 126.6, 125.3, 124.7, 123.7,
121.5, 120.4, 118.8, 115.0, 57.5, 40.5, 39.4, 38.4, 25.2, 24.7, 18.7;
IR (neat): nmax/cm
1 3426, 2981, 1712; MS (pAPCI): 221.1 (9%),
251.1 (13%), 360.1 (100%, (M  (o-Tol)N(OH))+), 465.2 (15%, (M
 H2O)
+), 483.2 (15%, (M + H)+); HRMS (pAPCI): calcd for
C24H27N4O5S1 [M + H]
+: 483.1697; observed: 483.1685.
3u – (3aS*,5S*,10bS*)-5-((2,6-dibromophenyl) (hydroxy)
amino)-N,N-dimethyl-1,3-dioxo-2-phenyl-1,3,3a,4,5,10b-
hexahydropyrrolo[3,4-a]carbazole-10(2H)-sulfonamide
To a stirred round bottomed ask was added N,N-dimethyl-3-
vinyl-1H-indole-1-sulfonamide (85 mg, 0.34 mmol), DCM (5 mL)
and 1-phenyl-1H-pyrrole-2,5-dione (59 mg, 0.34 mmol) and the
resulting solution was heated at reux for 48 hours. The reac-
tion was cooled to room temperature and 2,6-dibromoni-
trosobenzene (90 mg, 0.34 mmol) was added. The reaction was
stirred at room temperature for 18 hours and the solvent was
removed under reduced pressure to give the crude product as a
pale yellow solid. The product was puried by column chro-
matography (petrol (40/60)–ethyl acetate 3 : 1, column diameter
¼ 2 cm, silica ¼ 17 cm) to give (3aS*,5S*,10bS*)-5-((2,6-dibro-
mophenyl) (hydroxy)amino)-N,N-dimethyl-1,3-dioxo-2-phenyl-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-sulfon-
amide (69%, 162 mg, 0.23 mmol) as a pale orange powder.
Mp: 241–242 C; Rf: 0.43 (Pet(40/60)–Et2O 4 : 1);
1HNMR (400
MHz, CDCl3): d 7.53 (2H, d, J ¼ 7.8 Hz), 7.46–7.30 (7H, m), 7.15
(1H, app t, J ¼ 7.4 Hz), 7.02 (1H, app t, J¼ 7.5 Hz), 6.71 (1H, app
td, J ¼ 8.0, 2.1 Hz), 6.05 (1H, s), 5.49–5.47 (1H, m), 5.17–5.12
(1H, m), 4.35–4.27 (1H, m), 3.18–3.11 (1H, m), 2.92 (6H, s), 1.80
(1H, app t, J ¼ 13.1 Hz); 13C NMR (101 MHz, CD2Cl2): dC 177.9,
172.5, 144.6, 136.1, 134.3, 132.7, 132.1, 132.0, 129.5, 129.1,
128.6, 128.2, 126.6, 124.0, 122.8, 119.2, 115.1, 113.6, 77.6, 54.7,
42.7, 39.0, 38.0, 30.0; IR (neat): nmax/cm
1 3431, 2927, 1780,
1715; MS (pNSI): 422.1 (25%, (MN(OH)C6H3Br2)
+), 689.0 (76%
(M + H)+), 711.0 (54%, (M + Na)+), HRMS (pNSI): calcd C28H25-
Br2N4O5S [M + H]
+: 688.9888; observed: 688.9886.
3v – (3aS*,5S*,10bS*)-5-((S*)-hydroxy(peruorophenyl)
methyl)-N,N-dimethyl-1,3-dioxo-1,3,3a,4,5,10b-
hexahydropyrrolo[3,4-a]carbazole-10(2H)-sulfonamide
To a stirred round bottomed ask was added N,N-dimethyl-3-
vinyl-1H-indole-1-sulfonamide (85 mg, 0.34 mmol), DCM (5 mL)
and 1-methyl-1H-pyrrole-2,5-dione (38 mg, 0.34 mmol). The
reaction was heated at reux for 48 hours. The reaction was
cooled to 78 C and pentauorobenzaldehyde (66 mg, 0.34
mmol) and DMAC (1 M in hexane, 0.34 mL, 0.34 mmol) were
added and the reaction was stirred for 1 hour. The reaction was
poured into a solution of sodium bicarbonate (10 mL) and
extracted with DCM (3 10mL). The combined organic extracts
were dried with MgSO4, ltered and the solvent was removed
under reduced pressure to leave the crude product as a pale
pink solid. The product was puried by column chromatog-
raphy (diameter ¼ 2 cm, silica ¼ 17 cm, eluent¼ petrol (40/60)–
EA 2 : 1) to give (3aS*,5S*,10bS*)-5-((S*)-hydroxy(per-
uorophenyl)methyl)-N,N-dimethyl-1,3-dioxo-1,3,3a,4,5,10b-
hexahydropyrrolo[3,4-a]carbazole-10(2H)-sulfonamide (77%,
0.145 g, 0.26 mmol) as a pale pink solid.
Mp: 255.8–257.2 C; Rf: 0.30 (Pet(40/60)–EA 2 : 1);
1H NMR
(400 MHz, CDCl3): dH 7.77 (1H, d, J¼ 8.3 Hz), 7.39 (1H, d, J¼ 7.8
Hz), 7.33–7.28 (1H, m), 7.21 (1H, app t, J ¼ 7.8 Hz), 5.14 (1H, d, J
¼ 8.0 Hz), 4.80 (1H, d, J ¼ 7.3 Hz), 3.67–3.62 (1H, m), 3.48 (1H,
ddd, J ¼ 12.8, 7.2, 5.0 Hz), 2.98 (6H, s), 2.93 (3H, s), 2.49 (1H, br
s), 2.06 (1H, app dd, J ¼ 14.9, 4.1 Hz), 1.59 (1H, app dt, J ¼ 13.8,
6.9 Hz); 13C NMR (101 MHz, CDCl3): dC 177.8, 173.4, 137.2,
130.0, 129.3, 125.0, 123.5, 120.0, 118.2, 114.6, 70.3, 41.5, 39.2,
38.2, 36.7, 28.6, 25.2; IR (neat): nmax/cm
1 3415, 2972, 2884,
1713; MS (pNSI): 371.1 (22%), 558.1 (81% (M + H)+), 580.1
(100%, (M + Na)+), HRMS (pNSI): calcd C24H20F5N3O5S [M + H]
+:
558.1117; observed: 558.1118.
16142 | RSC Adv., 2015, 5, 16125–16152 This journal is © The Royal Society of Chemistry 2015
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Note: 13C NMR missing peaks due to C–F coupling.
3w – 6-(hydroxy(o-tolyl)amino)-N,N-dimethyl-1,3-dioxo-2-
phenyl-2,3,5,6-tetrahydro-[1,2,4]triazolo[10,20:1,2]pyridazino
[3,4-b]indole-11(1H)-sulfonamide
To a stirred round bottomed ask was added N,N-dimethyl-3-vinyl-
1H-indole-1-sulfonamide (85 mg, 0.34 mmol), DCM (5 mL) and
cooled to 78 C. To this solution PTAD (60 mg, 0.34 mmol) was
added and the reaction stirred at 78 C for 1 hour. 1-Methyl-2-
nitrosobenzene (41 mg, 0.34 mmol) was added and the reaction
was stirred 4 hours before the solvent was removed under reduced
pressure to give the crude product. The crude product was puried
by column chromatography (column diameter ¼ 2 cm, silica ¼ 16
cm, eluent¼ petrol (40/60)–ethyl acetate 2 : 1) to give 6-(hydroxy(o-
tolyl)amino)-N,N-dimethyl-1,3-dioxo-2-phenyl-2,3,5,6-tetrahy-
dro-[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]indole-11(1H)-
sulfonamide (76%, 0.141 g) as an off white solid.
Mp: 168.5–172.8 C; Rf: 0.25 (Pet(40/60)–EA 2 : 1);
1H NMR
(300 MHz, CDCl3): dH 7.87 (1H, d, J¼ 8.3 Hz), 7.73 (1H, d, J¼ 8.1
Hz), 7.60 (2H, d, J ¼ 7.4 Hz), 7.51 (2H, t, J ¼ 7.6 Hz), 7.46–7.38
(1H, m), 7.30–7.18 (2H, m), 7.04 (2H, t, J ¼ 7.5 Hz), 6.90 (1H, d, J
¼ 7.6 Hz), 6.71 (1H, d, J ¼ 7.8 Hz), 5.76 (1H, s), 5.37 (1H, d, J ¼
14.1 Hz), 4.66 (1H, s), 3.46 (1H, d, J ¼ 14.1 Hz), 2.90 (6H, s), 1.94
(3H, s); 13C NMR (101 MHz, CDCl3): dC 153.5, 150.5, 148.7,
135.1, 132.1, 131.9, 131.2, 130.6, 129.4, 128.7, 127.1, 126.9,
126.8, 125.9, 124.4, 124.2, 122.7, 118.1, 115.9, 104.7, 59.4, 44.7,
38.7, 17.9; IR (neat): nmax/cm
1 3322, 2971, 1707; MS (pNSI):
339.1 (33%), 424.1 (94%, (MMeC6H4NOH)
+), 547.2 (72%, (M +
H)+), 569.2 (100%, (M + Na)+); HRMS (pNSI): calcd C27H27N6O5S
[M + H]+: 547.1758; observed: 547.1761.
3x – (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-N,N-dimethyl-
1,3-dioxo-1,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-
10(2H)-sulfonamide
To a round bottomed ask was added N,N-dimethyl-3-vinyl-1H-
indole-1-sulfonamide (85 mg, 0.34 mmol), DCM (5 mL) and 1H-
pyrrole-2,5-dione (33 mg, 0.34 mmol). The reaction was heated
at reux for 48 hours and then cooled to room temperature. 1-
Methyl-2-nitrosobenzene (41 mg, 0.34mmol) was added and the
reaction is stirred for 4.5 hours. The solvent was removed to give
the crude product as pale yellow solid. The crude product was
puried by trituration from DCM to give (3aS*,5S*,10bS*)-5-
(hydroxy(o-tolyl)amino)-N,N-dimethyl-1,3-dioxo-1,3,3a,4,5,10b-
hexahydropyrrolo[3,4-a]carbazole-10(2H)-sulfonamide (77%,
123 mg, 0.26 mmol) as a white solid.
Mp: 199.9–201.0 C; Rf: 0.64 (Pet(40/60)–EA 3 : 1);
1H NMR
(300 MHz, DMSO-d6): dH 11.15 (1H, s), 8.38 (1H, s), 7.88 (1H, d, J
¼ 8.4 Hz), 7.36 (1H, d, J ¼ 7.9 Hz), 7.31–7.20 (2H, m), 7.13 (3H,
app dt, J ¼ 14.3, 7.3 Hz), 7.01 (1H, d, J ¼ 7.3 Hz), 4.98 (1H, d, J ¼
7.8 Hz), 4.38 (1H, app t, J ¼ 4.8 Hz), 3.73 (1H, app q, J ¼ 7.8 Hz),
2.70 (6H, s), 2.45–2.37 (1H, m), 2.36 (3H, s), 1.77–1.65, 1.77 (1H,
m); 13C NMR (101 MHz, DMSO-d6): dC 180.4, 175.5, 151.6, 137.2,
133.2, 131.1, 129.3, 129.1, 126.6, 124.4, 124.3, 123.4, 121.8,
121.1, 118.6, 115.3, 56.5, 42.2, 41.1, 38.7, 26.6, 18.9; IR (neat):
nmax/cm
1 3426, 2981, 1712; MS (pAPCI): 237.1 (60%), 346.1
(100%, (M  MeC6H4NOH)
+), 451.1 (25%, (M  H2O)
+), 469.2
(22%, (M + H)+); HRMS (pAPCI): calcd C23H25N4O5S [M + H]
+:
469.1540; observed: 469.1537.
3y – benzyl (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-2-
methyl-1,3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]
carbazole-10(1H)-carboxylate
To a stirred Schlenk ask was added benzyl 3-vinyl-1H-indole-1-
carboxylate (94 mg, 0.34 mmol), DCM (5 mL) and 1-methyl-1H-
pyrrole-2,5-dione (33 mg, 0.34 mmol). The resulting solution
was heated at reux for 24 hours. The reaction was allowed to
cool to room temperature and to the stirred solution nitro-
sobenzene (36 mg, 0.34 mmol) was added and the solution was
stirred for 18 hours. The solvent was removed under reduced
pressure to leave the crude product as a pale yellow solid. The
product was puried by column chromatography (petrol (40/
60)–ethyl acetate 3 : 1, column diameter ¼ 2 cm, silica ¼ 14 cm)
to give benzyl (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-2-
methyl-1,3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carba-
zole-10(1H)-carboxylate (74%, 124 mg, 0.25 mmol) as a yellow
powder.
Mp: 105.7–109.2 C; Rf: 0.34 (Pet(40/60)–EA 2 : 1);
1H NMR
(400MHz, CD2Cl2): dH 8.10 (1H, br d, J¼ 8.1 Hz), 7.70 (1H, br d, J
¼ 7.3 Hz), 7.49 (2H, br d, J ¼ 6.6 Hz), 7.39 (3H, br app q, J ¼ 6.9,
6.4 Hz), 7.35–7.25 (3H, br m), 7.22–7.13 (3H, br m), 7.01 (1H, br
app t, J ¼ 6.7 Hz), 5.55 (1H, d, J ¼ 11.8 Hz), 5.41 (1H, d, J ¼ 11.8
Hz), 4.88 (1H, br d, J ¼ 6.8 Hz), 4.87 (1H, br s), 4.80–4.77 (1H, br
m), 3.54–3.41 (1H, br m), 2.85 (3H, s), 2.40–2.25 (1H, br m),
2.08–1.93 (1H, br m); 13C NMR (101 MHz, CD2Cl2): dC 178.4,
174.6, 151.6, 151.0, 137.0, 135.0, 130.0, 129.0, 128.9, 128.8,
128.8, 127.6, 125.0, 123.3, 122.3, 120.0, 118.3, 117.1, 115.1, 69.5,
57.7, 40.2, 39.2, 24.9, 22.6; IR (neat): nmax/cm
1 3433, 2953,
1699; MS (pNSI): 387.1 (97%, (M N(OH)Ph)+), 494.2 (100%, (M
 H)+), 518.2 (30%, (M + Na)+), 991.4 (15%, (2M + H)+), 1013.3
(10%, (2M + Na)+); HRMS (pNSI): calcd C29H25N3O5Na [M + Na]
+:
518.1686; observed: 518.1676.
3z – benzyl (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-2-
methyl-1,3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]
carbazole-10(1H)-carboxylate
To a stirred Schlenk ask was added benzyl 3-vinyl-1H-
indole-1-carboxylate (94 mg, 0.34 mmol), DCM (5 mL) and 1-
methyl-1H-pyrrole-2,5-dione (33 mg, 0.34 mmol). The
resulting solution was heated at reux for 24 hours. The
reaction was allowed to cool to room temperature and to the
stirred solution 1-methyl-2-nitrosobenzene (41 mg, 0.34
mmol) was added and the solution was stirred for 18 hours.
The solvent was removed under reduced pressure to leave the
crude product as a pale yellow solid. The product was puried
by column chromatography (petrol (40/60)–ethyl acetate 3 : 1,
column diameter ¼ 2 cm, silica ¼ 16 cm) to give benzyl
(3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-2-methyl-1,3-dioxo-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carbox-
ylateas (78%, 135 mg, 0.26 mmol) as a yellow powder.
Mp: 128.4–131.5 C; Rf: 0.45 (Pet(40/60)–EA 3 : 1);
1H NMR
(400 MHz, CDCl3): dH 8.11 (1H, d, J ¼ 8.3 Hz), 7.59 (1H, d, J ¼
7.8 Hz), 7.55 (1H, d, J ¼ 8.1 Hz), 7.50–7.48 (2H, m), 7.45–7.38
This journal is © The Royal Society of Chemistry 2015 RSC Adv., 2015, 5, 16125–16152 | 16143
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(3H, m), 7.29–7.23 (1H, m), 7.20 (1H, app t, J ¼ 7.6 Hz), 7.14 (1H,
d, J¼ 7.6Hz), 7.10 (1H, d, J¼ 7.8 Hz), 7.05 (1H, d, J¼ 7.3 Hz), 5.56
(1H, d, J ¼ 11.8 Hz), 5.46 (1H, d, J ¼ 11.8 Hz), 5.02 (1H, s), 4.93
(1H, d, J¼ 7.6 Hz), 4.38 (1H, t, J¼ 5.2 Hz), 3.63 (1H, app q, J¼ 6.9
Hz), 2.91 (3H, s), 2.59 (1H, app dt, J ¼ 12.3, 6.0 Hz), 2.29 (3H, s),
1.92 (1H, ddd, J ¼ 12.5, 7.5, 4.6 Hz); 13C NMR (101 MHz, CDCl3):
dC 178.5, 174.6, 151.7, 149.2, 136.8, 134.8, 131.1, 129.9, 129.0,
129.0, 128.9, 128.9, 127.7, 126.6, 125.3, 125.0, 123.3, 121.5, 120.1,
118.1, 115.3, 69.6, 57.4, 40.4, 39.1, 25.2, 24.1, 18.6; IR (neat): nmax/
cm1 3450, 2954, 1699; MS (pNSI): 343.1 (40%), 387.1 (82%, (M
(N(OH)(o-Tol)))+), 508.2 (100%, (M (H2) + H)
+), 532.2 (59%, (M +
Na)+); HRMS (pNSI): calcd C30H27N3O5Na [M + Na]
+: 532.1843;
observed: 532.1834.
3aa – (3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-
1-yl)-2-methyl-1,3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-
a]carbazole-10(1H)-carboxylate
To a stirred Schlenk ask was added benzyl 3-vinyl-1H-indole-
1-carboxylate (189 mg, 0.68 mmol), 1-methyl-1H-pyrrole-2,5-
dione (76 mg, 0.68 mmol) and DCM (10 mL). The reaction
mixture was heated at reux for 24 hours. The reaction was
cooled to 0 C and then 4-phenyl-1,2,4-triazolidine-3,5-dione
(120 mg, 0.68 mmol) was added. The reaction was stirred at
0 C for 1 hour then at room temperature for 18 hours. The
solvent was removed under reduced pressure to leave the
crude product as an orange powder. The product was puried
by column chromatography (petrol (40/60)–ethyl acetate 1 : 1,
column diameter ¼ 2 cm, silica ¼ 20 cm) to give
(3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-1-yl)-
2-methyl-1,3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]-
carbazole-10(1H)-carboxylate (54%, 207 mg, 0.37 mmol) as an
off-white powder and (3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-
1,2,4-triazolidin-1-yl)-2-methyl-1,3-dioxo-2,3,3a,4,5,10b-hexahy-
dropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (27%, 76 mg,
0.19 mmol) as a white powder.
Mp: 202.3–203.9 C; Rf: 0.15 (Pet(40/60)–EA 1 : 1);
1H NMR
(400 MHz, CDCl3): dH 8.38 (1H, s), 8.07 (1H, d, J ¼ 8.4 Hz), 7.51
(1H, app dt, J¼ 7.6, 0.9 Hz), 7.49–7.37 (4H, m), 7.39–7.33 (6H, m),
7.30 (1H, ddd, J ¼ 8.6, 7.3, 1.3 Hz), 7.21 (1H, app td, J ¼ 7.5, 1.0
Hz), 5.53 (1H, app t, J ¼ 5.2 Hz), 5.44 (1H, d, J ¼ 11.8 Hz), 5.38
(1H, d, J¼ 11.8 Hz), 4.89 (1H, d, J¼ 8.0 Hz), 3.50 (1H, ddd, J¼ 9.6,
8.0, 5.5 Hz), 2.87 (3H, s), 2.41 (1H, app dt, J ¼ 14.2, 5.5 Hz), 2.14
(1H, ddd, J ¼ 14.2, 9.5, 5.5 Hz); 13C NMR (101 MHz, CDCl3): dC
177.4, 173.6, 153.6, 152.2, 151.3, 136.9, 134.5, 130.9, 130.8, 129.3,
129.1, 128.9, 128.9, 128.4, 126.1, 125.8, 125.3, 123.8, 118.8, 115.7,
113.8, 69.8, 47.5, 40.0, 38.4, 27.5, 25.2; IR (neat): nmax cm
1 3462,
2969, 1699; MS (pNSI): 199.2 (16%), 387.1 (19%, (M  PTAD)+),
564.2 (59%, (M + H)+), 581.2 (100%, (M + NH4)
+), 643.2 (15%),
1144.4 (39%, (2M + NH4)
+); HRMS (pNSI): calcd C31H26N5O6 [M +
H]+: 564.1878; observed: 564.1873.
3bb – benzyl (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-1,3-
dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-
10(1H)-carboxylate
To a stirred Schlenk ask was added benzyl 3-vinyl-1H-indole-1-
carboxylate (189 mg, 0.68 mmol), 1H-pyrrole-2,5-dione (66 mg,
0.68 mmol) and DCM (10 mL). The resulting solution was
heated at reux for 24 hours. The reaction was allowed to cool to
room temperature and to the stirred solution nitrosobenzene
(73 mg, 0.68 mmol) was added and the solution was stirred for
18 hours. The solvent was removed under reduced pressure to
leave the crude product as a yellow powder. The product was
puried by column chromatography (petrol (40/60)–ethyl
acetate 2 : 1, column diameter ¼ 2 cm, silica ¼ 20 cm) to give
benzyl(3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-1,3-dioxo-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carbox-
ylate (70%, 230 mg, 0.48 mmol) as a yellow powder.
Mp: 177.1–177.8 C; Rf: 0.38 (Pet(40/60)–EA 2 : 1);
1H NMR
(500 MHz, CD2Cl2): dH 8.20 (1H, s), 8.11 (1H, d, J ¼ 8.3 Hz), 7.66
(1H, d, J ¼ 7.8 Hz), 7.50 (2H, dd, J ¼ 7.9, 1.6 Hz), 7.43–7.36 (3H,
m), 7.33 (2H, app t, J ¼ 7.8 Hz), 7.28 (1H, app t, J ¼ 7.8 Hz), 7.22
(2H, d, J ¼ 8.0 Hz), 7.16 (1H, app t, J ¼ 7.5 Hz), 7.02 (1H, app t, J
¼ 7.3 Hz), 5.55 (1H, d, J¼ 11.9 Hz), 5.40 (1H, d, J¼ 11.9 Hz), 5.19
(1H, s), 4.96 (1H, br d, J ¼ 8.1 Hz), 4.82 (1H, app t, J ¼ 5.7 Hz),
3.56 (1H, br app q, J ¼ 7.4 Hz), 2.35 (1H, br app dd, J ¼ 13.4, 6.7
Hz), 2.00–1.92 (1H, br m); 13C NMR (101 MHz, CD2Cl2): dC 178.5,
174.5, 151.6, 150.7, 136.9, 134.9, 129.7, 129.0, 128.9, 128.9,
128.8, 127.6, 125.1, 123.3, 122.6, 119.8, 118.0, 117.3, 115.2, 69.5,
57.7, 41.4, 40.6, 23.0; IR (neat): nmax/cm
1
¼ 3418, 3329, 2970,
1705; MS (pNSI): 199.2 (87%), 373.1 (68%, (M  (N(OH)Ph))+),
480.2 (100%, (M  (H2) + H)
+); HRMS (pNSI): calcd
C28H23N3O5Na [M + Na]
+: 504.1530; observed: 504.1522.
3cc – benzyl (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-1,3-
dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-
10(1H)-carboxylate
To a stirred Schlenk ask was added benzyl 3-vinyl-1H-indole-1-
carboxylate (94 mg, 0.34 mmol), DCM (5 mL) and 1H-pyrrole-
2,5-dione (33 mg, 0.34 mmol). The resulting solution was
heated at reux for 24 hours. The reaction was allowed to cool to
room temperature and to the stirred solution 1-methyl-2-
nitrosobenzene (41 mg, 0.34 mmol) was added and the solu-
tion was stirred for 4 hours. The solvent was removed under
reduced pressure to leave the crude product as a pale yellow
solid. The product was puried by column chromatography
(petrol (40/60)–ethyl acetate 3 : 2, column diameter ¼ 2 cm,
silica ¼ 16 cm) to give benzyl-(3aS*,5S*,10bS*)-5-(hydroxy(o-
tolyl)amino)-1,3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]-
carbazole-10(1H)-carboxylate (83%, 140 mg, 0.28 mmol) as a
yellow powder.
Mp: 181.4–183.9 C; Rf: 0.48 (Pet(40/60)–EA 3 : 2);
1H NMR
(400 MHz, DMSO-d6): dH 11.26 (1H, s), 8.41 (1H, s), 7.93 (1H, d, J
¼ 8.3 Hz), 7.51 (2H, d, J ¼ 7.0 Hz), 7.45–7.33 (4H, m), 7.18–7.08
(3H, m), 7.03–6.91 (3H, m), 5.56 (1H, d, J¼ 12.1 Hz), 5.32 (1H, d,
J¼ 12.1 Hz), 4.96 (1H, d, J¼ 8.0 Hz), 4.34 (1H, app t, J¼ 3.7 Hz),
3.73 (1H, app q, J¼ 8.7 Hz), 2.50–2.44 (1H, m), 2.17 (3H, s), 1.74–
1.64 (1H, m); 13C NMR (101 MHz, DMSO-d6): dC 180.6, 176.5,
151.6, 136.2, 135.7, 131.1, 130.8, 130.0, 129.2, 129.1, 129.1,
128.2, 126.6, 124.7, 124.5, 122.9, 122.2, 120.6, 117.5, 114.4, 69.2,
57.1, 41.8, 40.2, 26.7, 18.6; IR (neat): nmax/cm
1 3495, 3325,
2953, 1711; MS (pNSI): 373.1 (51%, (M (N(OH)(o-Tol)))+), 494.2
16144 | RSC Adv., 2015, 5, 16125–16152 This journal is © The Royal Society of Chemistry 2015
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(16%, (M  (H2) + H)
+), 518.2 (21%, (M + Na)+); HRMS (pNSI):
calcd C29H25N3O5Na [M + Na]
+: 518.1686; observed: 518.1681.
3dd – benzyl (3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-
triazolidin-1-yl)-1,3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo
[3,4-a]carbazole-10(1H)-carboxylate
To a stirred Schlenk ask was added benzyl 3-vinyl-1H-indole-1-
carboxylate (189 mg, 0.68 mmol), DCM (10 mL) and 1H-pyrrole-
2,5-dione (66 mg, 0.68 mmol). The resulting solution was
heated at reux for 24 hours. The reaction was cooled to 0 C
and 4-phenyl-1,2,4-triazolidine-3,5-dione (120 mg, 0.68 mmol)
was added. The solution was stirred at 0 C for 1 hour. The
solvent was removed under reduced pressure to leave the crude
product as an off white solid. The product was puried by
column chromatography (petrol (40/60)–ethyl acetate 1 : 1,
column diameter ¼ 2 cm, silica ¼ 13 cm) to give benzyl
(3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-1-yl)-
1,3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-
10(1H)-carboxylate (58%, 216 mg, 0.39 mmol) as a pale pink
powder.
Mp: 174.6–177.1 C; Rf: 0.06 (Pet(40/60)–EA 1 : 1);
1H NMR
(400 MHz, CD2Cl2): dH 8.78 (1H, s), 8.05 (1H, d, J ¼ 8.3 Hz), 7.54
(1H, d, J ¼ 7.7 Hz), 7.44–7.38 (6H, m), 7.38–7.30 (4H, m), 7.30–
7.24 (1H, m), 7.20 (1H, app t, J ¼ 7.5 Hz), 5.51 (1H, app t, J ¼ 5.3
Hz), 5.45 (1H, d, J ¼ 11.9 Hz), 5.31 (1H, d, J ¼ 11.9 Hz), 4.98 (1H,
d, J¼ 7.9 Hz), 3.46 (1H, app q, J¼ 8.1 Hz), 2.36–2.30 (1H, m), 2.18
(1H, ddd, J ¼ 13.9, 8.6, 5.3 Hz); 13C NMR (101 MHz, CD2Cl2): dC
178.1, 173.8, 153.7, 152.4, 151.4, 136.8, 134.7, 131.1, 130.6, 129.1,
128.9, 128.8, 128.8, 128.4, 126.2, 125.7, 125.6, 123.7, 119.0, 115.5,
114.2, 69.7, 47.7, 41.0, 39.5, 26.8; IR (neat): nmax/cm
1
¼ 3169,
2975, 1699; MS (pNSI): 279.1 (38%), 373.1 (13%, (M  PTAD)+),
550.2 (21%, (M + H)+), 567.2 (100% (M + NH4)
+), 1116.4 (39%,
(2M + NH4)
+), 1666.5 (6%, (3M + NH4)
+); HRMS (pNSI): calcd
C30H24N5O6 [M + H]
+: 550.1721; observed: 550.1719.
3ee – benzyl (R*)-6-(hydroxy(phenyl)amino)-1,3-dioxo-2-
phenyl-2,3,5,6-tetrahydro-1H,11H-[1,2,4]triazolo[10,20:1,2]
pyridazino[3,4-b]indole-11-carboxylate
To a stirred Schlenk ask was added benzyl 3-vinyl-1H-indole-1-
carboxylate (189 mg, 0.68 mmol) and DCM (10 mL). The solu-
tion was cooled to 78 C and 4-phenyl-1,2,4-triazolidine-3,5-
dione (120 mg, 0.68 mmol) was added. The reaction was stirred
at 78 C for 5 hours. The reaction was warmed to room
temperature, nitrosobenzene (73 mg, 0.68 mmol) was added and
the reaction was stirred for 3 hours. The solvent was removed
under reduced pressure to leave the crude product as a pale
yellow oil. The product was puried by column chromatography
(petrol (40/60)–ethyl acetate 2 : 1, column diameter ¼ 1 cm,
silica ¼ 16 cm) to give benzyl (R*)-6-(hydroxy(phenyl)amino)-1,3-
dioxo-2-phenyl-2,3,5,6-tetrahydro-1H,11H-[1,2,4]triazolo[10,20:1,2]
pyridazino[3,4-b]indole-11-carboxylate (72%, 274 mg, 0.49
mmol) as a white powder.
Mp: 101.2–103.1 C; Rf: 0.53 (Pet(40/60)–EA 2 : 1);
1H NMR
(400 MHz, CD2Cl2): dH 8.09 (1H, d, J ¼ 8.2 Hz), 7.51–7.38 (8H,
m), 7.38–7.24 (5H, m), 7.23–7.07 (4H, m), 6.87 (1H, d, J ¼ 7.9
Hz), 6.36 (1H, s), 5.52 (1H, d, J ¼ 12.1 Hz), 5.39 (1H, d, J ¼ 12.1
Hz), 5.22 (1H, dd, J ¼ 14.0, 1.7 Hz), 4.97–4.89 (1H, m), 3.66
(1H, dd, J ¼ 14.0, 3.4 Hz); 13C NMR (101 MHz, CD2Cl2): dC
147.2, 147.0, 146.6, 145.6, 131.0, 130.1, 127.3, 126.2, 125.4,
125.2, 124.9, 124.9, 124.9, 124.8, 124.8, 122.4, 122.3, 120.7,
120.5119.7, 115.8, 114.5, 110.5, 97.2, 66.2, 55.1, 39.6; IR
(neat): nmax/cm
1
¼ 3337, 3063, 1716; MS (pAPCI): 395.1
(100%), 451.1 (59%, (M  (N(OH)Ph))+), 542.2 (5%, (M 
(H2O) + H)
+), 558.2 (1%, (M  H)+), 560.2 (1%, (M + H)+);
HRMS (pAPCI): calcd C32H26N5O5 [M + H]
+: 560.1928;
observed: 560.1913.
3ff – benzyl (R*)-6-(hydroxy(o-tolyl)amino)-1,3-dioxo-2-phenyl-
2,3,5,6-tetrahydro-1H,11H-[1,2,4]triazolo[10,20:1,2]pyridazino
[3,4-b]indole-11-carboxylate
To a stirred Schlenk ask was added benzyl 3-vinyl-1H-
indole-1-carboxylate (94 mg, 0.34 mmol) and DCM (10 ml).
The reaction mixture was cooled to 78 C and 4-phenyl-
1,2,4-triazolidine-3,5-dione (60 mg, 0.34 mmol) was added.
The reaction mixture was stirred at 78 C for 5 hours, 1-
methyl-2-nitrosobenzene was added (41 mg, 0.34 mmol) and
the reaction stirred at room temperature for 18 hours. The
solvent was removed under reduced pressure to leave the
crude product as a yellow powder. The product was puried
by column chromatography (petrol (40/60)–ethyl acetate 3 : 1,
column diameter ¼ 2 cm, silica ¼ 20 cm) to give benzyl (R*)-6-
(hydroxy(o-tolyl)amino)-1,3-dioxo-2-phenyl-2,3,5,6-tetrahydro-
1H,11H-[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]indole-11-car
boxylate (68%, 132 mg, 0.23 mmol) as an off white powder.
Mp: 163.8–165.1 C; Rf: 0.49 (Pet(40/60)–EA 3 : 1);
1HNMR (400
MHz, CD2Cl2): dH 8.01 (1H, d, J¼ 8.3 Hz), 7.65 (1H, dd, J¼ 8.1, 1.3
Hz), 7.54–7.38 (7H,m), 7.35 (3H, dd, J¼ 5.0, 2.1 Hz), 7.19 (2H, app
dtd, J ¼ 8.5, 7.2, 6.7, 1.4 Hz), 6.99 (2H, app tdd, J ¼ 7.5, 3.4, 1.2
Hz), 6.90 (1H, dd, J ¼ 7.7, 1.4 Hz), 6.75 (1H, d, J ¼ 7.8 Hz), 5.87
(1H, s, OH), 5.48 (1H, d, J ¼ 11.9 Hz), 5.34 (1H, d, J ¼ 11.9 Hz),
5.19 (1H, dd, J ¼ 14.1, 2.3 Hz), 4.63 (1H, app t, J ¼ 2.3 Hz), 3.52
(1H, dd, J¼ 14.1, 2.3Hz), 1.94 (3H, s); 13CNMR (101MHz, CDCl3):
dC 151.9, 150.3, 150.0, 148.8, 134.6, 133.6, 131.6, 131.1, 130.6,
130.0, 129.4, 128.9, 128.9, 128.8, 128.8, 127.0, 126.6, 126.0, 125.7,
124.4, 123.6, 122.7, 117.9, 114.6, 101.7, 70.1, 58.6, 43.5, 17.7; IR
(neat): nmax/cm
1
¼ 3291, 2981, 1782, 1737, 1699; MS (pNSI):
199.2 (100%), 407.2 (79%), 451.1 (81%, (M  (N(OH)(o-Tol)))+),
572.2 (25%, (M  H)+), 596.2 (65%, (M + Na)+); HRMS (pNSI):
calcd C33H27N5O5Na [M + Na]
+: 596.1904; observed: 596.1898.
3gg – benzyl (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-7-
methoxy-2-methyl-1,3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo
[3,4-a]carbazole-10(1H)-carboxylate
To a stirred Schlenk ask was added benzyl 5-methoxy-3-vinyl-
1H-indole-1-carboxylate (209 mg, 0.68 mmol), DCM (10 mL) and
1-methyl-1H-pyrrole-2,5-dione (76 mg, 0.68 mmol). The result-
ing solution was heated at reux for 18 hours. The reaction was
cooled to room temperature and nitrosobenzene (72 mg, 0.68
mmol) was added and the reaction was stirred for 1.5 hours. The
solvent was removed under reduced pressure to leave the crude
product as a pale orange oil. The product was puried by
column chromatography (petrol (40/60)–ethyl acetate 2 : 1,
This journal is © The Royal Society of Chemistry 2015 RSC Adv., 2015, 5, 16125–16152 | 16145
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column diameter ¼ 1 cm, silica ¼ 16 cm) to give benzyl
(3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-7-methoxy-2-methyl-1,
3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-
carboxylate (73%, 218 mg, 0.44 mmol) as an orange powder.
Mp: 106.8–110.2 C; Rf: 0.65 (Pet(40/60)–EA 2 : 1);
1HNMR (400
MHz, CD2Cl2): dH 7.97 (1H, br d, J ¼ 8.3 Hz), 7.49–7.47 (2H, m),
7.41–7.37 (3H, m), 7.33–7.30 (2H, m), 7.21–7.19 (2H, m), 7.05–7.00
(2H, m), 6.85 (1H, br d, J ¼ 8.4 Hz), 5.53 (1H, d, J ¼ 11.9 Hz), 5.39
(1H, d, J¼ 11.9 Hz), 5.02 (1H, br s), 4.91–4.87 (1H, m), 4.75 (1H, br
s), 3.68 (3H, s), 3.50 (1H, br s), 2.86 (3H, s), 2.36 (1H, br s), 2.01 (1H,
br s); 13C NMR (101 MHz, CD2Cl2): dC 178.3, 174.5, 156.3, 151.5,
151.1, 135.0, 131.5, 130.7, 129.0, 128.9, 128.8, 128.8, 128.4, 122.4,
117.7, 117.2, 115.9, 113.4, 102.4, 69.4, 57.9, 55.6, 40.3, 39.2, 24.9,
23.4; IR (neat): nmax/cm
1
¼ 3408, 2969, 2890, 1699; MS (pNSI):
417.1 (100%, (M  (N(OH)Ph))+), 524.2 (68%, (M  (H2) + H)
+),
548.2 (16%, (M + Na)+), 1073.4 (4%, (2M + Na)+); HRMS (pNSI):
calcd C30H27N3O6Na [M + Na]
+: 548.1792; observed: 548.1785.
3hh – benzyl (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-7-
methoxy-2-methyl-1,3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo
[3,4-a]carbazole-10(1H)-carboxylate
To a stirred Schlenk ask was added benzyl 5-methoxy-3-vinyl-
1H-indole-1-carboxylate (209 mg, 0.68 mmol), DCM (10 mL) and
1-methyl-1H-pyrrole-2,5-dione (76 mg, 0.68 mmol). The result-
ing solution was heated at reux for 18 hours. The reaction was
cooled to room temperature and 1-methyl-2-nitrosobenzene (82
mg, 0.68 mmol) was added. The solution was stirred at room
temperature for 3 hours. The solvent was removed under
reduced pressure to leave the crude product as a pale yellow
solid. The product was puried by column chromatography
(petrol (40/60)–ethyl acetate 2 : 1, column diameter ¼ 2 cm,
silica ¼ 15 cm) to give benzyl (3aS*,5S*,10bS*)-5-(hydroxy(o-
tolyl)amino)-7-methoxy-2-methyl-1,3-dioxo-2,3,3a,4,5,10b-hexa-
hydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (74%, 279 mg,
0.50 mmol) as a pale yellow powder.
Mp: 107.6–110.1 C; Rf: 0.29 (Pet(40/60)–EA 2 : 1);
1H NMR (400
MHz, CD2Cl2): dH 7.93 (1H, d, J¼ 9.1 Hz), 7.54 (1H, dd, J¼ 8.1, 1.3
Hz), 7.49–7.45 (2H, m), 7.43–7.35 (3H, m), 7.19 (1H, ddd, J ¼ 7.6,
6.9, 1.9Hz), 7.10–7.01 (2H,m), 6.88 (1H, d, J¼ 2.6Hz), 6.80 (1H, dd,
J ¼ 9.1, 2.6 Hz), 5.52 (1H, d, J¼ 11.9 Hz), 5.37 (1H, d, J ¼ 11.9 Hz),
5.18 (1H, s), 4.87 (1H, d, J¼ 8.1 Hz), 4.33–4.29 (1H, m), 3.65 (3H, s),
3.67–3.61 (1H, m), 2.86 (3H, s), 2.61 (1H, app dt, J ¼ 13.4, 5.9 Hz),
2.22 (3H, s), 1.86 (1H, ddd, J ¼ 13.4, 8.5, 4.3 Hz); 13C NMR (101
MHz, CD2Cl2): dC 178.4, 174.4, 156.1, 151.6, 149.8, 135.0, 134.9,
131.2, 130.8, 130.6, 130.4, 128.8, 128.8, 128.5, 126.4, 125.3, 121.7,
117.5, 115.7, 113.6, 102.0, 69.3, 57.8, 55.4, 40.5, 38.9, 25.0, 24.9,
18.2; IR (neat): nmax/cm
1
¼ 3370, 2965, 2887, 1699; MS (pNSI):
207.1 (39%), 417.1 (34%, (M (N(OH)(o-Tol)))+), 438.2 (100%, (M
(H2) + H)
+), 1075.4 (15%, (2(M  (H2) + H)
+)); HRMS (pNSI): calcd
C31H28N3O6 [M  (H2) + H]
+: 538.1976; observed: 538.1973.
3ii – benzyl (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-7-
methoxy-1,3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]
carbazole-10(1H)-carboxylate
To a stirred Schlenk ask was added benzyl 5-methoxy-3-vinyl-
1H-indole-1-carboxylate (209 mg, 0.68 mmol), DCM (10 mL) and
1H-pyrrole-2,5-dione (66 mg, 0.68 mmol). The resulting solution
was heated at reux for 18 hours. The reaction was cooled to
room temperature and nitrosobenzene (72 mg, 0.68 mmol) was
added and the reaction was stirred for 2.5 hours. The solvent
was removed under reduced pressure to leave the crude product
as a pale orange oil. The product was puried by column
chromatography (petrol (40/60)–ethyl acetate 2 : 1, column
diameter ¼ 1 cm, silica ¼ 16 cm) to give benzyl
(3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-7-methoxy-1,3-
dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-
carboxylate (79%, 317 mg, 0.54 mmol) as a pale orange powder.
Mp: 134.2–136.9 C; Rf: 0.34 (Pet(40/60)–EA 3 : 2);
1H NMR
(400 MHz, CD2Cl2): dH 8.42 (1H, br s), 7.94 (1H, d, J ¼ 9.0 Hz),
7.47–7.44 (2H, m), 7.40–7.34 (3H, m), 7.30–7.27 (2H, m), 7.19–
7.17 (2H, m), 7.01–6.98 (1H, m), 6.93 (1H, br s), 6.81 (1H, d, J ¼
9.0 Hz), 5.49 (1H, d, J ¼ 11.9 Hz), 5.39 (1H, br s), 5.34 (1H, d, J ¼
11.9 Hz), 4.92 (1H, br d, J ¼ 6.2 Hz), 4.74 (1H, br s), 3.64 (3H, s),
3.57–3.51 (1H, br m), 2.39–2.35 (1H, br m), 1.91–1.89 (1H, br m);
13CNMR (101MHz, CD2Cl2): dC 178.6, 174.4, 156.2, 151.5, 151.0,
135.0, 131.4, 130.3, 129.0, 128.9, 128.8, 128.8, 128.4, 122.6,
117.5, 117.4, 116.0, 113.5, 102.3, 69.4, 57.9, 55.6, 41.5, 40.5, 24.0;
IR (neat): nmax/cm
1
¼ 3233, 2952, 1708; MS (pNSI): 403.1 (37%,
(M  (N(OH)Ph))+), 510.2 (100%, (M  (H2) + H)
+), 532.1 (26%,
(M  (H2) + Na)
+); HRMS (pNSI): calcd C29H24N3O6 [M  (H2) +
H]+: 510.1654; observed: 510.1660.
3jj – benzyl (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-7-
methoxy-1,3-dioxo-2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]
carbazole-10(1H)-carboxylate
To a stirred Schlenk ask was added benzyl 5-methoxy-3-vinyl-
1H-indole-1-carboxylate (209 mg, 0.68 mmol), DCM (10 mL) and
1H-pyrrole-2,5-dione (66 mg, 0.68 mmol). The resulting solution
was heated at reux for 18 hours. The reaction was cooled to
room temperature and 1-methyl-2-nitrosobenzene (82 mg, 0.68
mmol) was added. The solution was stirred at room temperature
for 3.5 hours. The solvent was removed under reduced pressure
to leave the crude product as a pale yellow solid. The product was
puried by column chromatography (petrol (40/60)–ethyl acetate
2 : 1, column diameter ¼ 2 cm, silica ¼ 14 cm) to give benzyl
(3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-7-methoxy-1,3-dioxo-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxy-
late (76%, 255 mg, 0.52 mmol) as a pale yellow powder.
Mp: 193.0–195.6 C; Rf: 0.20 (Pet(40/60)–EA 2 : 1);
1HNMR (400
MHz, CD2Cl2): dH 7.92 (1H, d, J¼ 9.7 Hz), 7.81 (1H, s), 7.53 (1H, d,
J ¼ 7.8 Hz), 7.46 (2H, dd, J ¼ 7.8, 1.6 Hz), 7.42–7.33 (3H, m), 7.21–
7.15 (1H, m), 7.09–7.00 (2H, m), 6.84–6.75 (2H, m), 5.50 (1H, d, J¼
11.9 Hz), 5.35 (1H, d, J¼ 11.9 Hz), 5.16 (1H, s), 4.96 (1H, d, J¼ 7.6
Hz), 4.37 (1H, app t, J ¼ 4.9 Hz), 3.71 (1H, app td, J ¼ 8.7, 5.6 Hz),
3.64 (3H, s), 2.64 (1H, app dt, J ¼ 13.6, 5.6 Hz), 2.21 (3H, s), 1.88
(1H, ddd, J ¼ 13.6, 9.3, 4.3 Hz); 13C NMR (101 MHz, DMSO-d6): dC
180.6, 176.4, 155.6, 151.8, 151.7, 135.8, 131.6, 130.8, 130.7, 130.2,
129.1, 129.1, 129.0, 126.7, 124.8, 122.3, 117.2, 115.2, 113.5, 102.7,
69.1, 57.3, 55.5, 41.9, 40.3, 27.2, 18.5; IR (neat): nmax/cm
1
¼ 3457,
3367, 2981, 2886, 1712; MS (pNSI): 403.1 (100%, (M  (N(OH)(o-
Tol)))+), 524.1 (75%, (M  (H2) + H)
+), 548.2 (16%, (M + Na)+),
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1073.4 (5%, (2M + Na)+); HRMS (pNSI): calcd C30H27N3O6Na [M +
Na]+: 548.1792; observed: 548.1785.
3kk – benzyl (R*)-6-(hydroxy(phenyl)amino)-8-methoxy-1,3-
dioxo-2-phenyl-2,3,5,6-tetrahydro-1H,11H-[1,2,4]triazolo
[10,20:1,2]pyridazino[3,4-b]indole-11-carboxylate
To a stirred Schlenk ask was added benzyl 5-methoxy-3-vinyl-
1H-indole-1-carboxylate (209 mg, 0.68 mmol) and DCM (10
mL). The solution was cooled to 78 C and 4-phenyl-1,2,4-
triazolidine-3,5-dione (120 mg, 0.68 mmol) was added. The
reaction was stirred at 78 C for 1.5 hours. The reaction was
warmed to room temperature, nitrosobenzene (73 mg, 0.68
mmol) was added and the reaction was stirred for 20 hours.
The solvent was removed under reduced pressure to leave the
crude product as a pale yellow oil. The product was puried by
column chromatography (petrol (40/60)–ethyl acetate 2 : 1,
column diameter ¼ 1 cm, silica ¼ 16 cm) to give benzyl (R*)-6-
(hydroxy(phenyl)amino)-8-methoxy-1,3-dioxo-2-phenyl-2,3,5,6-
tetrahydro-1H,11H-[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]-
indole-11-carboxylate (78%, 312 mg, 0.53 mmol) as a white
powder.
Mp: 110.4–113.2 C; Rf: 0.20 (Pet(40/60)–EA 2 : 1);
1H NMR
(400 MHz, CD2Cl2): dH 7.88 (1H, d, J ¼ 9.1 Hz), 7.42–7.38 (5H,
m), 7.36–7.32 (3H, m), 7.29–7.26 (2H, m), 7.24–7.20 (2H, m),
7.13 (2H, d, J¼ 8.1 Hz), 7.05 (1H, app t, J¼ 7.3 Hz). 6.76 (1H, dd,
J ¼ 9.1, 2.6 Hz), 6.24 (1H, s), 6.10 (1H, d, J ¼ 2.5 Hz), 5.43 (1H, d,
J ¼ 12.0 Hz), 5.32–5.29 (1H, m), 5.25–5.18 (1H, m), 4.84–4.80
(1H, m), 3.64 (1H, dd, J ¼ 14.0, 3.3 Hz), 3.55 (3H, s); 13C NMR
(101 MHz, CD2Cl2): dC 156.5, 151.1, 150.3, 149.4, 134.8, 131.2,
130.3, 129.2, 129.0, 129.0, 128.70, 128.7, 128.7, 128.6, 128.2,
126.9, 126.2, 124.6, 119.7, 115.3, 113.2, 101.0, 100.5, 69.9, 59.1,
55.5, 44.0; IR (neat): nmax/cm
1
¼ 3336, 2935, 1716; MS (pNSI):
481.1 (17%, (M  (N(OH)Ph))+), 588.2 (100%, (M  (H2) + H)
+),
612.2 (15%, (M + Na)+); HRMS (pNSI): calcd C33H27N5O6Na [M +
Na]+: 612.1854; observed: 612.1838.
3ll – benzyl (R*)-6-(hydroxy(o-tolyl)amino)-8-methoxy-1,3-
dioxo-2-phenyl-2,3,5,6-tetrahydro-1H,11H-[1,2,4]triazolo
[10,20:1,2]pyridazino[3,4-b]indole-11-carboxylate
To a stirred Schlenk ask was added benzyl 5-methoxy-3-vinyl-
1H-indole-1-carboxylate (209 mg, 0.68 mmol) and DCM (10 mL).
The solution was cooled to 78 C and 4-phenyl-1,2,4-
triazolidine-3,5-dione (120 mg, 0.68 mmol) was added. The
reaction was stirred at 78 C for 1.5 hours. The reaction was
warmed to room temperature, 1-methyl-2-nitrosobenzene (73
mg, 0.68 mmol) was added and the reaction was stirred for 24
hours. The solvent was removed under reduced pressure to
leave the crude product as a pale orange oil. The product was
puried by column chromatography (petrol (40/60)–ethyl
acetate 2 : 1, column diameter ¼ 2 cm, silica ¼ 17 cm) to give
benzyl (R*)-6-(hydroxy(o-tolyl)amino)-8-methoxy-1,3-dioxo-2-
phenyl-2,3,5,6-tetrahydro-1H,11H-[1,2,4]triazolo[10,20:1,2]pyr-
idazino[3,4-b]indole-11-carboxylate (82%, 338 mg, 0.56 mmol)
as an off white powder.
Mp: 181.1–183.0 C; Rf: 0.55 (Pet(40/60)–EA 2 : 1);
1H NMR
(400 MHz, DMSO-d6): dH 8.70 (1H, s), 7.84 (1H, d, J ¼ 9.0 Hz),
7.55–7.48 (2H, m), 7.46–7.41 (3H, m), 7.41–7.33 (4H, m), 7.33–
7.29 (2H, m), 7.13–7.03 (2H, m), 6.97 (1H, app td, J ¼ 7.4, 1.3
Hz), 6.83 (1H, dd, J ¼ 9.1, 2.6 Hz). 6.38 (1H, s), 5.43 (1H, d, J ¼
12.1 Hz), 5.33 (1H, d, J¼ 12.1 Hz), 4.80 (1H, dd, J¼ 13.7, 1.8 Hz),
4.71 (1H, dd, J¼ 3.3, 1.8 Hz), 3.68–3.61 (1H, dd, J¼ 13.7, 3.3 Hz),
3.58 (s, 3H), 2.30 (s, 3H); 13C NMR (101 MHz, CD2Cl2): dC 156.3,
151.6, 150.8, 150.3, 149.8, 135.3, 131.6, 130.9, 130.3, 130.0,
129.7, 129.2, 129.1, 129.1, 128.9, 128.0, 127.4, 127.1, 126.8,
125.2, 121.8, 115.3, 113.2, 103.1, 101.9, 69.9, 55.9, 55.6, 43.9,
18.2; IR (neat): nmax/cm
1
¼ 3212, 2939, 1720; MS (pNSI): 481.2
(100%, (MN(OH)(o-Tol))+), 602.2 (34%, (M (H2) + H)
+), 626.2
(100%, (M + Na)+); HRMS (pNSI): calcd C34H29N5O6Na [M + Na]
+:
626.2010; observed: 626.2006.
4a – (3aS*,5S*,10bS*)-5-methoxy-2-methyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione
To a stirred Schlenk ask was added benzyl (3aS*,5S*,10bS*)-5-
(hydroxy(o-tolyl)amino)-2-methyl-1,3-dioxo-2,3,3a,4,5,10b-hexa-
hydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (120 mg, 0.24
mmol), platinum(IV) oxide (53 mg, 0.24 mmol) and methanol (5
mL). The resulting suspension was placed under an atmosphere
of H2 and stirred at room temperature for 18 hours. The
suspension was ltered through celite and the solvent was
removed under reduced pressure to leave the crude product as
an orange solid, The crude product was puried by column
chromatography (petrol (40/60)–ethyl acetate 1 : 1, column
diameter ¼ 2 cm, silica ¼ 13 cm) to give (3aS*,5S*,10bS*)-5-
methoxy-2-methyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carba-
zole-1,3(2H,3aH)-dione (60%, 41 mg, 0.14 mmol) as a pale
yellow powder.
Mp: 139.4–142.7 C; Rf: 0.25 (Pet(40/60)–EA 1 : 1);
1H NMR
(400 MHz, CD2Cl2): dH 8.91 (1H, s), 7.56 (1H, d, J ¼ 7.8 Hz),
7.34 (1H, d, J ¼ 7.7 Hz), 7.14 (1H, app t, J ¼ 7.5 Hz), 7.09 (1H,
app t, J ¼ 7.4 Hz), 4.73 (1H, app t, J ¼ 2.7 Hz), 4.14 (1H, d, J ¼
8.8 Hz), 3.31–3.25 (1H, m), 3.22 (3H, s), 2.94 (1H, app t, J ¼ 2.4
Hz), 2.90 (3H, s), 1.88 (1H, ddd, J ¼ 14.2, 6.9, 2.2 Hz); 13C
NMR (101 MHz, CD2Cl2): dC 178.9, 176.1, 136.4, 128.8, 126.6,
122.3, 120.1, 118.2, 111.9, 111.3, 69.4, 56.1, 39.5, 37.3, 27.4,
25.1; IR (neat): nmax/cm
1 3398, 2931, 2870, 1689; MS (pNSI):
285.0 (29%), 355.1 (100%), 371.1 (57%), 560.0 (21%); HRMS
(pNSI): calcd C15H13N2O2 [M  OMe]
+: 253.0972; observed:
253.0974.
4b – (3aS*,5S*,10bS*)-5-ethoxy-2-methyl-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione
To a stirred Schlenk ask was added benzyl (3aS*,5S*,10bS*)-5-
(hydroxy(o-tolyl)amino)-2-methyl-1,3-dioxo-2,3,3a,4,5,10b-hexa-
hydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (100 mg, 0.20
mmol), platinum(IV) oxide (45 mg, 0.20 mmol) and ethanol (5
mL). The resulting suspension was placed under an atmosphere
of H2 and stirred at room temperature for 18 hours. The
suspension was ltered through celite and the solvent was
removed under reduced pressure to leave the crude product as
an yellow solid, The crude product was puried by column
chromatography (petrol (40/60)–ethyl acetate 2 : 1, column
diameter ¼ 2 cm, silica ¼ 15 cm) to give (3aS*,5S*,10bS*)-5-
This journal is © The Royal Society of Chemistry 2015 RSC Adv., 2015, 5, 16125–16152 | 16147
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ethoxy-2-methyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione (24%, 20 mg, 0.04 mmol) as a brown
powder.
Mp: 100.6–102.8 C; Rf: 0.16 (Pet(40/60)–EA 2 : 1);
1H NMR
(400 MHz, CD2Cl2): dH 8.78 (1H, s), 7.54 (1H, d, J¼ 7.7 Hz), 7.35
(1H, d, J ¼ 7.7 Hz), 7.17–7.12 (1H, m), 7.09 (1H, app t, J ¼ 7.0
Hz), 4.83 (1H, app t, J ¼ 2.8 Hz), 4.16 (1H, d, J ¼ 8.8 Hz), 3.55
(1H, app td, J ¼ 6.9, 1.8 Hz), 3.32–3.26 (2H, m), 2.93–2.91 (1H,
m), 2.90 (3H, s), 1.88 (1H, ddd, J¼ 14.3, 7.1, 2.7 Hz), 0.97 (1H, t,
J¼ 7.0 Hz); 13C NMR (101 MHz, CD2Cl2): dC 178.9, 176.0, 136.3,
128.8, 126.5, 122.3, 120.1, 118.1, 112.5, 111.3, 67.4, 63.5, 39.5,
37.3, 27.9, 25.0, 15.2; IR (neat): nmax/cm
1 3300, 2969, 1690; MS
(pAPCI): 108.1 (24%), 298.1 (6%, (M)+), 299.1 (5%, (M + H)+);
HRMS (pAPCI): calcd C17H19N2O3 [M + H]
+: 299.1390;
observed: 299.1387.
4c – (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-2-methyl-
4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-
dione
To a stirred Schlenk ask was added benzyl (3aS*,5S*,10bS*)-
5-(hydroxy(phenyl)amino)-2-methyl-1,3-dioxo-2,3,3a,4,5,10b-
hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (120 mg,
0.25 mmol), platinum(IV) oxide (57 mg, 0.25 mmol) and THF (5
mL). The resulting suspension was placed under an atmosphere
of H2 and stirred at room temperature for 5 hours. The
suspension was ltered through celite and the solvent was
removed under reduced pressure to leave the crude product as a
yellow solid, The crude product was puried by trituration from
DCM to give (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-2-
methyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-
dione (75%, 68 mg, 0.19 mmol) as a pale yellow powder.
Mp: 157.2–161.9 C; Rf: 0.17 (Pet(40/60)–EA 1 : 1);
1H NMR
(400 MHz, DMSO-d6): dH 11.06 (1H, s), 8.20 (1H, s), 7.35 (1H, d, J
¼ 8.0 Hz), 7.26 (1H, d, J ¼ 8.0 Hz), 7.24–7.19 (2H, m), 7.17–7.08
(2H, m), 6.98 (1H, app ddd, J ¼ 8.2, 7.0, 1.2 Hz), 6.91–6.81 (1H,
m), 6.81 (1H, app ddd, J¼ 8.0, 6.9, 1.0 Hz), 4.88 (1H app t, J¼ 4.9
Hz), 4.27 (1H, d, J ¼ 8.8 Hz), 3.64 (1H, app td, J ¼ 8.8, 6.1 Hz),
2.81 (3H, s), 2.33 (1H, app dt, J¼ 13.7, 6.1 Hz), 1.84 (1H, ddd, J¼
13.7, 8.8, 4.9 Hz); 13C NMR (101 MHz, DMSO-d6): dC 179.8,
176.3, 153.3, 137.0, 130.0, 129.0, 126.3, 121.5, 121.2, 119.9,
119.0, 117.2, 111.7, 110.0, 57.4, 39.6, 39.3, 25.8, 25.1; IR (neat):
nmax/cm
1 3374, 3306, 2919, 1683; MS (pAPCI): 108.0 (28%),
251.1 (100%), 253.1 (68%, (M  (N(OH)Ph) + H)+), 344.1 (13%,
(M  (OH) + H)+), 361.1 (3%, (M + H)+); HRMS (pAPCI): calcd
C21H20N3O3 [M + H]
+: 362.1499; observed: 362.1501.
Note: H1 NMR ran at 40 C.
4d – (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-2-methyl-
4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-
dione
To a stirred Schlenk ask was added benzyl (3aS*,5S*,10bS*)-5-
(hydroxy(o-tolyl)amino)-2-methyl-1,3-dioxo-2,3,3a,4,5,10b-hexa-
hydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (100 mg, 0.20
mmol), platinum(IV) oxide (45 mg, 0.20 mmol) and THF (5 mL).
The resulting suspension was placed under an atmosphere of
H2 and stirred at room temperature for 7 hours. The suspension
was ltered through celite and the solvent was removed under
reduced pressure to leave the crude product as a yellow solid.
The crude product was puried by column chromatography
(petrol (40/60)–ethyl acetate 1 : 1, column diameter ¼ 2 cm,
silica ¼ 16 cm) to give (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)
amino)-2-methyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione (87%, 65 mg, 0.17 mmol) as a pale orange
powder.
Mp: 179.3–181.0 C; Rf: 0.60 (Pet(40/60)–EA 1 : 1);
1H NMR
(400 MHz, DMSO-d6): dH 11.08 (1H, s), 8.28 (1H, s), 7.50 (1H, d, J
¼ 8.0 Hz), 7.29 (1H, d, J ¼ 8.1 Hz), 7.14–7.10 (1H, m), 6.91–6.87
(4H, m), 6.67 (1H, app t, J ¼ 7.4 Hz), 4.29 (1H, d, J ¼ 8.2 Hz), 4.27
(1H, app t, J ¼ 3.9 Hz), 3.83–3.74 (1H, m), 2.81 (3H, s), 2.65–2.56
(1H, m), 1.98 (3H, s), 1.67 (1H, ddd, J ¼ 13.6, 10.5, 3.9 Hz); 13C
NMR (101 MHz, DMSO-d6): dC 180.0, 176.3, 152.2, 136.7, 130.7,
130.5, 130.3, 126.5, 126.5, 124.5, 122.4, 121.2, 119.3, 118.9, 111.7,
109.7, 58.3, 40.0, 38.6, 27.3, 25.1, 18.3; IR (neat): nmax/cm
1 3379,
2955, 2873, 1691; MS (pAPCI): 108.1 (98%), 251.1 (100%), 253.1
(61%, (M (N(OH)(o-Tol)) + H)+), 271.1 (6%, (M (N(OH)(o-Tol))
+ OH2)
+), 358.2 (13%, (M  OH)+); HRMS (pAPCI): calcd
C22H22N3O3 [M + H]
+: 376.1656; observed: 376.1658.
4e – (3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-
1-yl)-2-methyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione
To a stirred Schlenk ask was added benzyl (3aS*,5S*,10bS*)-5-
(3,5-dioxo-4-phenyl-1,2,4-triazolidin-1-yl)-2-methyl-1,3-dioxo-
2,3,3a,4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carbox-
ylate (110 mg, 0.20 mmol), platinum(IV) oxide (46 mg, 0.20
mmol) and THF (5 mL). The resulting suspension was placed
under an atmosphere of H2 and stirred at room temperature for
5 hours. The suspension was ltered through celite and the
solvent was removed under reduced pressure to leave the crude
product as a yellow solid. The product was puried by tritura-
tion from DCM to give (3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-
1,2,4-triazolidin-1-yl)-2-methyl-4,5,10,10b-tetrahydropyrrolo-
[3,4-a]carbazole-1,3(2H,3aH)-dione (91%, 79 mg, 0.18 mmol) as
an off-white solid.
Mp: 262.4–264.0 C; 1H NMR (400 MHz, DMSO-d6): dH 11.43
(1H, s), 10.67 (1H, br s), 7.52–7.42 (4H, m), 7.39–7.37 (2H, m),
7.21 (1H, d, J¼ 7.9 Hz), 7.06 (1H, app t, J¼ 7.6 Hz), 6.94 (1H, app
t, J¼ 7.5 Hz), 5.39 (1H, app t, J¼ 6.1 Hz), 4.33 (1H, d, J¼ 8.0 Hz),
3.72 (1H, app q, J ¼ 6.8 Hz), 2.81 (3H, s), 2.35–2.31 (2H, m); 13C
NMR (101 MHz, DMSO-d6): dC 178.9, 175.8, 152.7, 152.7, 137.2,
132.3, 130.7, 129.5, 128.5, 126.7, 125.3, 122.2, 119.9, 118.4,
112.3, 107.3, 48.1, 39.5, 38.3, 27.7, 25.3; IR (neat): nmax/cm
1
3229, 1693; MS (pAPCI): 178.1 (35%), 253.1 (100%, (M  (PTAD)
+ H)+); HRMS (ASAP) calcd C15H13N2O2 [M  PTAD + H]
+:
253.0972; observed: 253.0969.
4f – (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione
To a stirred Schlenk ask was added benzyl (3aS*,5S*,10bS*)-5-
(hydroxy(phenyl)amino)-1,3-dioxo-2,3,3a,4,5,10b-hexahydro-
pyrrolo[3,4-a]carbazole-10(1H)-carboxylate (90 mg, 0.18 mmol),
platinum(IV) oxide (41 mg, 0.18 mmol) and THF (5 mL). The
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resulting suspension was placed under an atmosphere of H2
and stirred at room temperature for 10 hours. The suspension
was ltered through celite and the solvent was removed under
reduced pressure to leave the crude product as an yellow solid,
The crude product was puried by column chromatography
(petrol (40/60)–ethyl acetate 1 : 1, column diameter ¼ 2 cm,
silica ¼ 14 cm) to give (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)
amino)-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione (41%, 26 mg, 0.07 mmol) as a yellow powder.
Mp: 150.0–153.1 C; Rf: 0.33 (Pet(40/60)–EA 1 : 1);
1HNMR (400
MHz, DMSO-d6): dH 11.22 (1H, s), 11.09 (1H, s), 8.24 (1H, s), 7.33
(1H, d, J¼ 8.1 Hz), 7.27–7.23 (1H, m), 7.20 (2H, app d, J¼ 7.3 Hz),
7.12 (2H, d, J ¼ 7.7 Hz), 7.00–6.95 (1H, m), 6.85 (1H, app t, J ¼ 7.2
Hz), 6.80 (1H app t, J ¼ 7.3 Hz), 4.89 (1H, app t, J ¼ 4.9 Hz), 4.25
(1H, d, J ¼ 8.1 Hz), 3.63–3.52 (1H, m), 2.27 (1H, app dt, J ¼ 13.6,
5.6 Hz), 1.80 (1H, ddd, J ¼ 13.6, 9.2, 4.8 Hz); 13C NMR (101 MHz,
DMSO-d6): dC 181.2, 177.6, 153.3, 137.0, 130.3, 129.0, 126.3, 121.4,
121.1, 119.9, 118.9, 117.2, 111.7, 109.9, 57.4, 40.9, 40.6, 25.7; IR
(neat): nmax/cm
1 3302, 2924, 1706;MS (pAPCI): 108.1 (18%), 237.1
(100), 239.1 (46%, (M  (N(OH)Ph) + H)+); HRMS (pAPCI): calcd
C14H11N2O2 [M  (N(OH)Ph) + H]
+: 239.0815; observed: 239.0810.
4g – (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione
To a stirred Schlenk ask was added benzyl (3aS*,5S*,10bS*)-5-
(hydroxy(o-tolyl)amino)-1,3-dioxo-2,3,3a,4,5,10b-hexahydro-
pyrrolo[3,4-a]carbazole-10(1H)-carboxylate (120 mg, 0.24
mmol), platinum(IV) oxide (54 mg, 0.24 mmol) and THF (5 mL).
The resulting suspension was placed under an atmosphere of
H2 and stirred at room temperature for 6 hours. The suspension
was ltered through celite and the solvent was removed under
reduced pressure to leave the crude product as a yellow solid,
The crude product was puried by column chromatography
(petrol (40/60)–ethyl acetate 2 : 3, column diameter ¼ 2 cm,
silica ¼ 17 cm) to give (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)
amino)-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-
dione- (70%, 61 mg, 0.17 mmol) as an off white solid.
Mp: 149.9–153.2 C; Rf: 0.52 (Pet(40/60)–EA 2 : 3);
1H NMR
(400 MHz, CD2Cl2): dH 8.81 (1H, s), 8.21 (1H, s), 7.56 (1H, d, J ¼
8.0 Hz), 7.30 (1H, d, J¼ 7.9 Hz), 7.18 (2H, d, J¼ 6.9 Hz), 7.06 (1H,
app t, J ¼ 7.6 Hz), 7.03–6.99 (2H, m), 6.91–6.85 (1H, m), 5.36 (1H,
s), 4.51 (1H, app t, J ¼ 4.5 Hz), 4.19 (1H, d, J ¼ 8.6 Hz), 3.80 (1H,
app td, J ¼ 9.3, 6.4 Hz), 2.74 (1H, app dt, J ¼ 13.6, 5.5 Hz), 2.15
(3H, s), 1.83 (1H, ddd, J¼ 13.6, 10.1, 4.1 Hz); 13C NMR (101 MHz,
DMSO-d6): dC 181.5, 177.6, 152.2, 136.7, 130.6, 130.5, 130.5, 126.5,
126.5, 124.5, 122.4, 121.1, 119.3, 118.9, 111.6, 109.5, 58.3, 55.5,
40.9, 27.3, 18.3; IR (neat): nmax/cm
1 3372, 3298, 1683; MS (nNSI)
¼ 186.0 (100%), 237.1 (97%, (M  (N(OH)(o-Tol))  H)), 358.1
(35%, (M  H2)
), 394.1 (23%); HRMS (nNSI): calcd C21H18N3O3
[M  H]: 360.1354; observed: 360.1348.
4h – (3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-triazolidin-
1-yl)-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione
To a stirred Schlenk ask was added benzyl (3aS*,5S*,10bS*)-5-
(3,5-dioxo-4-phenyl-1,2,4-triazolidin-1-yl)-1,3-dioxo-2,3,3a,4,5,
10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate (110
mg, 0.20 mmol), platinum(IV) oxide (46 mg, 0.20 mmol) and
THF (5 mL). The resulting suspension was placed under an
atmosphere of H2 and stirred at room temperature for 5 hours.
The suspension was ltered through celite and the solvent was
removed under reduced pressure to leave the crude product as a
white solid. The crude product was puried by trituration from
DCM to give (3aS*,5S*,10bS*)-5-(3,5-dioxo-4-phenyl-1,2,4-tri-
azolidin-1-yl)-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione (64%, 53 mg, 0.13 mmol) as a white powder.
Mp: 212.6–213.9 C; 1H NMR (400 MHz, DMSO-d6): dH 11.39
(1H, s), 11.36 (1H, s), 10.66 (1H, s), 7.51–7.44 (4H, m), 7.41–7.37
(2H, m), 7.23 (1H, d, J¼ 7.8 Hz), 7.07 (1H, app t, J¼ 7.5 Hz), 6.96
(1H, app t, J ¼ 7.5 Hz), 5.42 (1H, app t, J ¼ 6.0 Hz), 4.29 (1H, d, J
¼ 8.0 Hz), 3.69 (1H, app q, J ¼ 6.8 Hz), 2.37–2.21 (2H, m); 13C
NMR (101 MHz, DMSO-d6): dC 180.3, 177.1, 152.7, 152.6, 137.2,
132.3, 131.0, 129.5, 128.5, 126.7, 125.3, 122.2, 119.9, 118.4,
112.3, 107.1, 55.5, 48.1, 40.9, 27.5; IR (neat): nmax/cm
1
¼ 3310,
3155, 3077, 1719, 1674; MS (pAPCI): 239.1 (100%, (M (PTAD) +
H)+), 414.1 (2%, (MH)+); HRMS (pAPCI): calcd C22H16N5O4 [M
 H]+: 414.1197; observed: 414.1185.
4i – (R*)-6-(hydroxy(phenyl)amino)-2-phenyl-6,11-dihydro-
1H,5H-[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]indole-
1,3(2H)-dione
To a stirred Schlenk ask was added benzyl (R*)-6-(hydroxy-
(phenyl)amino)-1,3-dioxo-2-phenyl-2,3,5,6-tetrahydro-1H,11H-
[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]indole-11-carboxylate
(110mg, 0.20mmol), platinum(IV) oxide (46mg, 0.20mmol) and
THF (5 mL). The resulting suspension was placed under an
atmosphere of H2 and stirred at room temperature for 5 hours.
The suspension was ltered through celite and the solvent was
removed under reduced pressure to leave the crude product as a
yellow solid. The product was puried by trituration from DCM
to give (R*)-6-(hydroxy(phenyl)amino)-2-phenyl-6,11-dihydro-
1H,5H-[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]indole-1,3(2H)-
dione (65%, 55 mg, 0.13 mmol) as an off-white solid.
Mp: 174.3–175.2 C; 1H NMR (400 MHz, DMSO-d6): dH 11.63
(1H, s), 8.61 (1H, s), 7.54–7.38 (6H,m), 7.18 (2H, app t, J¼ 7.8 Hz),
7.10 (2H, app d, J¼ 7.8 Hz), 7.00–6.96 (2H, m), 6.91–6.83 (2H, m),
5.18–5.15 (1H,m), 4.48 (1H, dd, J¼ 13.0, 2.0 Hz), 3.77 (1H, dd, J¼
13.0, 4.2 Hz); 13C NMR (101 MHz, DMSO-d6): dC 152.6, 149.6,
146.6, 134.2, 131.7, 129.8, 129.6, 128.9, 128.9, 127.0, 125.8, 122.3,
121.1, 120.2, 118.5, 118.3, 112.3, 92.4, 57.4, 43.4; IR (neat): nmax/
cm1 3431, 3054, 1698; MS (pAPCI): 317.1 (100%, (M  (N(OH)
Ph) + H)+), 407.1 (5%, (M  H2O)
+); HRMS (pAPCI) calcd
C24H19N5O3 [M  H]
+: 424.1404; observed: 424.1398.
4j – (R*)-6-(hydroxy(o-tolyl)amino)-2-phenyl-6,11-dihydro-
1H,5H-[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]indole-
1,3(2H)-dione
To a stirred Schlenk ask was added benzyl (R*)-6-(hydroxy(o-
tolyl)amino)-1,3-dioxo-2-phenyl-2,3,5,6-tetrahydro-1H,11H-[1,2,4]-
triazolo[10,20:1,2]pyridazino[3,4-b]indole-11-carboxylate (140
mg, 0.24 mmol), platinum(IV) oxide (55 mg, 0.24 mmol) and
THF (5 mL). The resulting suspension was placed under an
This journal is © The Royal Society of Chemistry 2015 RSC Adv., 2015, 5, 16125–16152 | 16149
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atmosphere of H2 and stirred at room temperature for 5 hours.
The suspension was ltered through celite and the solvent was
removed under reduced pressure to leave the crude product as a
white solid. The crude product was puried by trituration from
DCM to give (R*)-6-(hydroxy(o-tolyl)amino)-2-phenyl-6,11-
dihydro-1H,5H-[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]indole-
1,3(2H)-dione (44%, 46 mg, 0.11 mmol) as a white powder.
Mp: 188.1–189.6 C; 1H NMR (400 MHz, DMSO-d6): dH 11.65
(1H, s), 8.58 (1H, s), 7.59–7.51 (5H, m), 7.47–7.42 (1H, m), 7.36
(1H, d, J ¼ 8.0 Hz), 7.17–7.13 (1H, m), 6.96–6.91 (3H, m), 6.79–
6.69 (2H, m), 4.69 (1H, d, J ¼ 12.8 Hz), 4.58 (1H, br s), 3.62 (1H,
dd, J¼ 12.8, 3.3 Hz), 2.06 (3H, s); 13CNMR (101MHz, DMSO-d6):
dC 151.4, 150.4, 146.8, 134.0, 131.8, 131.2, 130.6, 129.8, 129.7,
128.9, 127.0, 126.7, 126.0, 125.1, 122.6, 121.0, 120.1, 118.1,
112.2, 92.3, 57.8, 43.5, 18.2; IR (neat): nmax/cm
1
¼ 3426, 3380,
2950, 1712; MS (pAPCI): 108.1 (100%), 317.1 (37%, (M 
(N(OH)(o-Tol)) + H)+), 422.2 (4%, (M  (H2O) + H)
+), 438.2 (6%,
(M  H)+); HRMS (pAPCI): calcd C25H20N5O3 [M  H]
+:
438.1561; observed: 438.1553.
4k – (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-7-methoxy-2-
methyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione
To a stirred Schlenk ask was added benzyl (3aS*,5S*,10bS*)-5-
(hydroxy(phenyl)amino)-7-methoxy-2-methyl-1,3-dioxo-2,3,3a,
4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate
(130mg, 0.25mmol), platinum(IV) oxide (57mg, 0.25mmol) and
THF (5 mL). The resulting suspension was placed under an
atmosphere of H2 and stirred at room temperature for 5 hours.
The suspension was ltered through celite and the solvent was
removed under reduced pressure to leave the crude product as
an orange solid. The crude product was puried by column
chromatography (petrol (40/60)–ethyl acetate 3 : 2, column
diameter ¼ 2 cm, silica ¼ 14 cm) to give (3aS*,5S*,10bS*)-5-
(hydroxy(phenyl)amino)-7-methoxy-2-methyl-4,5,10,10b-tetra-
hydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione (70%, 69 mg,
0.18 mmol) as a pale yellow powder.
Mp: 149.1–151.2 C; Rf: 0.19 (Pet(40/60)–EA 3 : 2);
1HNMR (400
MHz, DMSO-d6): dH 10.95 (1H, s), 8.29 (1H, s), 7.23–7.19 (2H, m),
7.18 (1H, d, J¼ 2.8 Hz), 7.14–7.10 (2H, m), 6.87–6.83 (1H, m), 6.57
(1H, dd, J ¼ 8.7, 2.5 Hz), 6.51 (1H, d, J¼ 2.5 Hz), 4.83 (1H, app t, J
¼ 4.8Hz), 4.24 (1H, d, J¼ 8.2Hz), 3.64 (1H, app td, J¼ 9.1, 6.1Hz),
3.48 (3H, s), 2.80 (3H, s), 2.35 (1H, ddd, J ¼ 13.7, 6.1, 4.8 Hz), 1.83
(1H, ddd, J ¼ 13.7, 9.1, 4.8 Hz); 13C NMR (101 MHz, DMSO-d6): dC
179.9, 176.3, 153.6C1, 153.4, 132.0, 130.6, 129.0, 126.6, 121.2,
117.4, 112.3, 111.5, 109.5, 101.7, 57.7, 55.5, 39.5, 39.1, 27.1, 25.1;
IR (neat): nmax/cm
1
¼ 3394, 2937, 2833, 1690; MS (pAPCI): 283.1
(100%, (M  (N(OH)Ph) + H)+), 374.1 (18%, (M  (H2O) + H)
+),
390.1 (2%, (M  H)+), 392.2 (1%, (M + H)+); HRMS (pAPCI): calcd
C22H22N3O4 [M + H]
+: 392.1605; observed: 392.1597.
4l – (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-7-methoxy-2-
methyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-
1,3(2H,3aH)-dione
To a stirred Schlenk ask was added benzyl (3aS*,5S*,10bS*)-5-
(hydroxy(o-tolyl)amino)-7-methoxy-2-methyl-1,3-dioxo-2,3,3a,
4,5,10b-hexahydropyrrolo[3,4-a]carbazole-10(1H)-carboxylate
(108mg, 0.20mmol), platinum(IV) oxide (46mg, 0.20mmol) and
THF (5 mL). The resulting suspension was placed under
an atmosphere of H2 and stirred at room temperature for
5 hours. The suspension was ltered through celite and
the solvent was removed under reduced pressure to leave the
crude product as a white solid. The crude product was
puried by column chromatography (petrol (40/60)–ethyl
acetate 1 : 1, column diameter ¼ 2 cm, silica ¼ 15 cm) to
give (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-7-methoxy-2-
methyl-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,
3aH)-dione (70%, 57 mg, 0.14 mmol) as an off white powder.
Mp: 139.7–142.5 C; Rf: 0.36 (Pet(40/60)–EA 1 : 1);
1H NMR
(400 MHz, DMSO-d6): dH 10.89 (1H, s), 8.36 (1H, s), 7.52 (1H, d, J
¼ 8.0 Hz), 7.15–7.11 (2H, d, J ¼ 8.7 Hz), 6.93–6.85 (2H, m), 6.49
(1H, dd, J ¼ 8.7, 2.4 Hz), 6.23–6.17 (1H, m), 4.28 (1H, d, J ¼ 8.2
Hz), 4.22 (1H, app t, J ¼ 3.8 Hz), 3.78 (1H, ddd, J ¼ 10.8, 8.2, 6.1
Hz), 3.45 (3H, s), 2.81 (3H, s), 2.70–2.63 (1H, m), 1.89 (3H, s),
1.66 (1H, ddd, J ¼ 14.1, 10.8, 3.8 Hz); 13C NMR (101 MHz,
DMSO-d6): dC 180.1, 176.3, 153.2, 152.5, 131.6, 131.1, 130.7,
130.4, 126.8, 126.5, 124.7, 122.7, 112.2, 111.4, 109.2, 100.6, 58.8,
55.3, 39.6, 38.4, 28.3, 25.1, 18.1; IR (neat): nmax/cm
1
¼ 3384,
2954, 2866, 1693; MS (pAPCI): 283.1 (100%, (M (N(OH)(o-Tol))
+ H)+), 388.2 (34%, (M  (H2O) + H)
+), 404.2 (13%, (M  H)+),
406.2 (11%, (M + H)+); HRMS (pAPCI): calcd C23H24N3O4 [M +
H]+: 406.1761; observed: 406.1750.
4m – (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)amino)-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione
To a stirred Schlenk ask was added benzyl (3aS*,5S*,10bS*)-5-
(hydroxy(phenyl)amino)-1,3-dioxo-2,3,3a,4,5,10b-hexahydro-
pyrrolo[3,4-a]carbazole-10(1H)-carboxylate (90 mg, 0.18 mmol),
platinum(IV) oxide (41 mg, 0.18 mmol) and THF (5 mL). The
resulting suspension was placed under an atmosphere of H2
and stirred at room temperature for 10 hours. The suspension
was ltered through celite and the solvent was removed under
reduced pressure to leave the crude product as an yellow solid,
The crude product was puried by column chromatography
(petrol (40/60)–ethyl acetate 1 : 1, column diameter ¼ 2 cm,
silica ¼ 14 cm) to give (3aS*,5S*,10bS*)-5-(hydroxy(phenyl)
amino)-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,
3aH)-dione (41%, 26 mg, 0.07 mmol) as a yellow powder.
Mp: 150.0–153.1 C; Rf: 0.33 (Pet(40/60)–EA 1 : 1);
1H NMR
(400 MHz, DMSO-d6): dH 11.22 (1H, s), 11.09 (1H, s), 8.24 (1H, s),
7.33 (1H, d, J¼ 8.1 Hz), 7.27–7.23 (1H, m), 7.20 (2H, app d, J¼ 7.3
Hz), 7.12 (2H, d, J¼ 7.7Hz), 7.00–6.95 (1H,m), 6.85 (1H, app t, J¼
7.2 Hz), 6.80 (1H app t, J ¼ 7.3 Hz), 4.89 (1H, app t, J ¼ 4.9 Hz),
4.25 (1H, d, J ¼ 8.1 Hz), 3.63–3.52 (1H, m), 2.27 (1H, app dt, J ¼
13.6, 5.6 Hz), 1.80 (1H, ddd, J ¼ 13.6, 9.2, 4.8 Hz); 13C NMR (101
MHz, DMSO-d6): dC 181.2, 177.6, 153.3, 137.0, 130.3, 129.0, 126.3,
121.4, 121.1, 119.9, 118.9, 117.2, 111.7, 109.9, 57.4, 40.9, 40.6,
25.7; IR (neat): nmax/cm
1 3302, 2924, 1706; MS (pAPCI): 108.1
(18%), 237.1 (100), 239.1 (46%, (M  (N(OH)Ph) + H)+); HRMS
(pAPCI): calcd C14H11N2O2 [M  (N(OH)Ph) + H]
+: 239.0815;
observed: 239.0810.
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4n – (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)amino)-4,5,10,10b-
tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione
To a stirred Schlenk ask was added benzyl (3aS*,5S*,10bS*)-5-
(hydroxy(o-tolyl)amino)-1,3-dioxo-2,3,3a,4,5,10b-hexahydro-
pyrrolo[3,4-a]carbazole-10(1H)-carboxylate (120 mg, 0.24
mmol), platinum(IV) oxide (54 mg, 0.24 mmol) and THF (5 mL).
The resulting suspension was placed under an atmosphere of
H2 and stirred at room temperature for 6 hours. The suspension
was ltered through celite and the solvent was removed under
reduced pressure to leave the crude product as a yellow solid,
The crude product was puried by column chromatography
(petrol (40/60)–ethyl acetate 2 : 3, column diameter ¼ 2 cm,
silica ¼ 17 cm) to give (3aS*,5S*,10bS*)-5-(hydroxy(o-tolyl)
amino)-4,5,10,10b-tetrahydropyrrolo[3,4-a]carbazole-1,3(2H,
3aH)-dione (70%, 61 mg, 0.17 mmol) as an off white solid.
Mp: 149.9–153.2 C; Rf: 0.52 (Pet(40/60)–EA 2 : 3);
1H NMR
(400 MHz, CD2Cl2): dH 8.81 (1H, s), 8.21 (1H, s), 7.56 (1H, d, J ¼
8.0 Hz), 7.30 (1H, d, J ¼ 7.9 Hz), 7.18 (2H, d, J ¼ 6.9 Hz), 7.06
(1H, app t, J¼ 7.6 Hz), 7.03–6.99 (2H, m), 6.91–6.85 (1H, m), 5.36
(1H, s), 4.51 (1H, app t, J ¼ 4.5 Hz), 4.19 (1H, d, J ¼ 8.6 Hz), 3.80
(1H, app td, J ¼ 9.3, 6.4 Hz), 2.74 (1H, app dt, J ¼ 13.6, 5.5 Hz),
2.15 (3H, s), 1.83 (1H, ddd, J ¼ 13.6, 10.1, 4.1 Hz); 13C NMR (101
MHz, DMSO-d6): dC 181.5, 177.6, 152.2, 136.7, 130.6, 130.5,
130.5, 126.5, 126.5, 124.5, 122.4, 121.1, 119.3, 118.9, 111.6,
109.5, 58.3, 55.5, 40.9, 27.3, 18.3; IR (neat): nmax/cm
1 3372,
3298, 1683; MS (nNSI) ¼ 186.0 (100%), 237.1 (97%, (M 
(N(OH)(o-Tol))  H)), 358.1 (35%, (M  H2)
), 394.1 (23%);
HRMS (nNSI): calcd C21H18N3O3 [M  H]
: 360.1354; observed:
360.1348.
4o – (R*)-6-(hydroxy(phenyl)amino)-8-methoxy-2-phenyl-6,11-
dihydro-1H,5H-[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]
indole-1,3(2H)-dione
To a stirred Schlenk ask was added benzyl (R*)-6-(hydroxy
(phenyl)amino)-8-methoxy-1,3-dioxo-2-phenyl-2,3,5,6-tetra-
hydro-1H,11H-[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]indole-
11-carboxylate (118 mg, 0.20 mmol), platinum(IV) oxide (46 mg,
0.20 mmol) and THF (5 mL). The resulting suspension was
placed under an atmosphere of H2 and stirred at room
temperature for 5 hours. The suspension was ltered through
celite and the solvent was removed under reduced pressure to
leave the crude product as a yellow solid. The product was
puried by trituration from DCM to give (R*)-6-(hydroxy(phenyl)
amino)-8-methoxy-2-phenyl-6,11-dihydro-1H,5H-[1,2,4]triazolo
[10,20:1,2]pyridazino[3,4-b]indole-1,3(2H)-dione (38%, 35 mg,
0.08 mmol) as an off-white solid.
Mp: 173.7–176.4 C; Rf: 0.18 (Pet–EA 3 : 1);
1HNMR (400MHz,
DMSO-d6): dH 11.44 (1H, s) 8.62 (1H, s), 7.54–7.47 (4H, m), 7.44–
7.41 (1H, m) 7.25–7.18 (3H, m), 7.12 (2H, d, J ¼ 7.7 Hz), 6.90 (1H,
app t, J¼ 6.8 Hz), 6.56 (1H, d, J¼ 8.7 Hz), 6.26 (1H, s), 5.12 (1H, br
s), 4.51 (1H, d, J ¼ 13.0 Hz), 3.81 (1H, dd, J ¼ 13.0, 3.3 Hz), 3.49
(3H, s); 13C NMR (101 MHz, DMSO-d6): dC 154.3, 152.9, 149.7,
146.4, 131.8, 130.1, 129.6, 129.6, 128.9, 128.9, 127.0, 126.3, 122.3,
118.4, 112.9, 110.7, 100.8, 92.3, 57.7, 55.5, 44.3; IR (neat): nmax/
cm1 3362, 3000, 1758, 1700; MS (pAPCI): 213.1 (70%), 347.1
(100%, (M (N(OH)Ph) + H)+); HRMS (pAPCI): calcd C25H20N5O4
[M  H]+: 454.1510; observed: 454.1502.
4p – (R*)-6-(hydroxy(o-tolyl)amino)-8-methoxy-2-phenyl-6,11-
dihydro-1H,5H-[1,2,4]triazolo[10,20:1,2]pyridazino[3,4-b]
indole-1,3(2H)-dione
To a stirred Schlenk ask was added benzyl (R*)-6-(hydroxy(o-
tolyl)amino)-8-methoxy-1,3-dioxo-2-phenyl-2,3,5,6-tetrahydro-
1H,11H-[1,2,4]triazolo[10,20:1,2]pyridazino[3,4 b]indole-11-carbo-
xylate (120 mg, 0.20 mmol), platinum(IV) oxide (46 mg, 0.20
mmol) and THF (5 mL). The resulting suspension was placed
under an atmosphere of H2 and stirred at room temperature for
5 hours. The suspension was ltered through celite and the
solvent was removed under reduced pressure to leave the crude
product as a white solid. The crude product was puried by
trituration from DCM to (R*)-6-(hydroxy(o-tolyl)amino)-8-
methoxy-2-phenyl-6,11-dihydro-1H,5H-[1,2,4]triazolo[10,20:1,2]-
pyridazino[3,4 b]indole-1,3(2H)-dione (64%, 53 mg, 0.13 mmol)
as a white powder.
Mp: 171.9–173.8 C; 1H NMR (400 MHz, DMSO-d6): dH 11.44
(1H, s), 8.64 (1H, s), 7.59 (1H, d, J ¼ 8.1 Hz), 7.54–7.50 (4H, m),
7.46–7.43 (1H,m), 7.19 (1H, d, J¼ 8.5 Hz), 7.15 (1H, d, J¼ 7.5 Hz),
6.97–6.91 (2H, m), 6.50 (1H, dd, J ¼ 8.7, 2.2 Hz), 6.01 (1H, s), 4.73
(1H, d, J ¼ 12.8 Hz), 4.52 (1H, s), 3.67–3.61 (1H, m), 3.47 (3H, s),
1.96 (3H, s); 13CNMR (101MHz, DMSO-d6): dC 154.1, 151.8, 150.5,
146.4, 131.8, 131.6, 130.6, 130.0, 129.7, 128.9, 128.7, 127.0, 126.7,
126.5, 125.3, 122.8, 112.7, 110.7, 100.0, 91.8, 58.3, 55.4, 44.3, 18.0;
IR (neat): nmax/cm
1
¼ 3442, 3394, 2939, 1699; MS (pAPCI): 347.1
(68%, (M  (N(OH)(o-Tol) + H)+)), 391.1 (100%), 452.2 (4%, (M 
(H2O) + H)
+), 468.2 (2%, (M  H)+); HRMS (pAPCI): calcd
C26H22N5O4 [M  H]
+: 468.1666; observed: 468.1658.
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